US Patent Applications in Skin Care Formulation Published in 2010

Thank you for visiting FormulaScan . Please click on the Patent No to study the full patent document

US PATENT APLICATIONS IN SKIN CARE FORMULATION PUBLISHED IN 2010



Application No.: US20100000896A1  Published: 07/Jan/2010

Title: STACKABLE PLANT POT

Applicant/Assignee:

Application No.: 12/307288   Filing Date: 31/Aug/2007

Abstract:A stackable plant pot including a cavity provided with water flow directing gutters, a recesses centrally located water catchment region with drainage slits and suited to receive a moisture retaining device, and a soil holding region located above the water catchment region.

Priority: AU20060903563 Applic. Date: 2006-07-03; WO2007AU01422 Applic. Date: 2007-08-31

Inventor: KEATS JOHN RODNEY [AU]


Application No.: US20100001091A1  Published: 07/Jan/2010

Title: Piezoelectric atomizer comprising a fragrancing liquid composition

Applicant/Assignee: L'OREAL

Application No.: 12/496184   Filing Date: 01/Jul/2009

Abstract:The invention relates to a cosmetic assembly comprising: (A) a cosmetic or dermatological composition contained inside a reservoir, said composition being liquid and comprising, in a physiologically acceptable medium: (i) from 1 to 90% by weight of a fragrance concentrate

(ii) from 1 to 98.5% by weight of at least one non-volatile solvent for said concentrate having a density of less than 1

(iii) at least from 0.5% to 50% by weight of at least one volatile alcohol for said concentrate

said composition having a viscosity less than or equal to 8 mPa.s

the amounts being defined relative to the total weight of the composition

(B) a spraying device comprising a container containing said liquid cosmetic composition, equipped with a piezoelectric spraying mechanism that makes it possible to spray the cosmetic composition in the form of droplets. The invention also relates to a method of fragrancing human keratin materials and especially skin, lips, hair, scalp, nails, comprising at least one step of spraying a fragrancing composition by means of a device as defined previously. The invention also relates to a method of fragrancing the surrounding air comprising at least one step of spraying a fragrancing composition by means of a spraying device as defined previously.

Priority: FR20080054482 Applic. Date: 2008-07-02; US20080080518P Applic. Date: 2008-07-14

Inventor: BARA ISABELLE [FR]; ALBELDA VIRGINIE [FR]; CHARBONNIER-CIVIER CAROLE [FR]


Application No.: US20100003198A1  Published: 07/Jan/2010

Title: Antimicrobial Topical and Other Preparations Containing Fluorescent or Illumination Dye and Tracer Agents or Compounds

Applicant/Assignee:

Application No.: 12/498217   Filing Date: 06/Jul/2009

Abstract:A formulation for topical application to human skin and other surface preparation compositions containing antimicrobial, antifungal and antiviral compounds which remain on human skin and other surface compositions to reduce or dominate bacteria, virus and fungi present, prevent future contamination by their presence and substantive character, contain agents or compounds that contain antibacterial, antiviral and antifungal properties and flourescent dyes and tracers that contain illumination properties exhibiting various colons including clear and no color pigment, that when exposed to certain light such as ultraviolet, will produce an illumination effect in various colors including dear and no color for a period of time within a preferred range of thirty minutes to six hours or longer from the time of initial application, and prior to for instance application of ultraviolet light, such flourescent dyes and tracers appear to be clear in color, invisible or have no color pigment showing on the skin or other surfaces, but when exposed to for instance ultraviolet fight, the surface illuminates allowing a person to determine if human skin or other surface has been adequately covered with the antibacterial, antifungal or antiviral composition agent or compound, and to significantly increase the activity to reduce and eliminate bacteria, virus and fungi on the surface, and support programs for antibacterial, antifungal and antiviral quality control, compliance, verification and education for industry and human handwash technique.

Priority: US20080133936P Applic. Date: 2008-07-07

Inventor: STOLMEIER PATRICK JOHN [US]; STOLMEIER JONATHAN P [US]


Application No.: US20100003201A1  Published: 07/Jan/2010

Title: Silicone composition

Applicant/Assignee: MOMENTIVE PERFORMANCE MATERIALS, INC

Application No.: 12/217548   Filing Date: 07/Jul/2008

Abstract:This invention relates to silicone-containing compositions, method of making said silicone-containing compositions, and to personal care and other products based on such compositions.

Priority:

Inventor: WAHL ROY UWE [US]


Application No.: US20100003204A1  Published: 07/Jan/2010

Title: Nanoparticle hybrid sunscreens

Applicant/Assignee: ENERGY MATERIALS CORPORATION

Application No.: 12/459541   Filing Date: 02/Jul/2009

Abstract:The invention discloses and claims a new class of chemical compositions with ideal sunscreen properties. The chemical composition comprises spherical particles between 200 nm and 10 microns in diameter prepared by an emulsion polymerization of tetraalkoxysilanes or organotrialkoxysilanes or organobridged trialkoxysilanes with a dye monomer bearing two or more alkoxysilyl groups attached to the bridging chromophore. The resulting spheres absorb ultraviolet light. The dye can be any organic chromophore capable of receiving multiple trialkoxysilyl groups resulting in multipoint covalent attachment that precludes leaching of the dye from the spheres. The formic acid-toluene-monomer emulsion polymerization allows for large-scale (>100 gram) synthesis of monodisperse particles under acidic, non-aqueous conditions without surfactants. The particles less than 1 micron in diameter are smooth as talc to the touch and will provide a smooth formulation for sunscreen creams or lotions.

Priority: US20080133875P Applic. Date: 2008-07-02

Inventor: LOY DOUGLAS ANSON [US]; SHEA KENNETH J [US]; BODAY DYLAN J [US]; WERTZ JASON T [US]


Application No.: US20100003206A1  Published: 07/Jan/2010

Title: Cosmetic Composition Containing A Protein And An Enzyme Inhibitor

Applicant/Assignee:

Application No.: 12/541439   Filing Date: 14/Aug/2009

Abstract:The present invention is a cosmetic composition comprising a water-soluble protein-based film-forming agent, the film-forming agent having a tertiary structure capable of undergoing a helix-coil transformation, a protease inhibitor in an amount sufficient to protect the protein on the stratum corneum and a cosmetically acceptable vehicle so that the protease inhibitor prolongs the pulling effect of the film-forming agent.

Priority: US2005-030664 Applic. Date: 2005-01-06; US20040535198P Applic. Date: 2004-01-07

Inventor: GIACOMONI PAOLO ULDERICO [US]; MANIRAZMAN ABUL M [US]; LENTINI PETER J [US]; HARVEY GEDEON [US]


Application No.: US20100003207A1  Published: 07/Jan/2010

Title: Photoprotective compositions comprising photosensitive 1,3,5-triazine compounds, dibenzoylmethane compounds and siliceous s-triazines substituted with two aminobenzoate or aminobenzamide groups

Applicant/Assignee: L'OREAL

Application No.: 11/987212   Filing Date: 28/Nov/2007

Abstract:UV-photoprotective, topically applicable cosmetic/dermatological compositions contain: (a) at least one dibenzoylmethane compound, (b) at least one 1,3,5-triazine compound that is photosensitive in the presence of a dibenzoylmethane compound, and (c) at least one siliceous s-triazine compound substituted with two aminobenzoate or aminobenzamide groups, or a tautomeric form thereof, the 1,3,5-triazine compounds being improvedly photostable in such compositions.

Priority: FR20060055164 Applic. Date: 2006-11-28; US20060873000P Applic. Date: 2006-12-06

Inventor: CANDAU DIDIER [FR]; RICHARD HERVE [FR]


Application No.: US20100003208A1  Published: 07/Jan/2010

Title: Skin Care Products, As Well As Foods and Beverages Containing 6-O-PUFA Ascorbic Esters

Applicant/Assignee: SUNTORY HOLDINGS LIMITED

Application No.: 12/558986   Filing Date: 14/Sep/2009

Abstract:Skin care products which contain as a vitamin C component 6-O-PUFA ascorbates represented by general formula (I): RCO-A (I) where RCO- is an acyl group derived from a polyunsaturated fatty acid, and A is a residue of ascorbic acid that binds by -O- derived from the hydroxyl group in ascorbic acid. The products show improved transfer of ascorbic acid to tissues or cells, allow the functions of ascorbic acid to be exhibited efficiently, and also have the potential to show the functions of PUFAs. Also provided are foods and beverages that contain 6-O-PUFA ascorbates represented by general formula (I).

Priority: JP20040237942 Applic. Date: 2004-08-18; US2007-660211 Applic. Date: 2007-02-15; WO2005JP15383 Applic. Date: 2005-08-18

Inventor: FUKAMI HARUKAZU [JP]; KAWASHIMA HIROSHI [JP]; ONO YOSHIKO [JP]


Application No.: US20100003249A1  Published: 07/Jan/2010

Title: POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION

Applicant/Assignee: ABLYNX N.V

Application No.: 12/487895   Filing Date: 19/Jun/2009

Abstract:The invention relates to a method suitable for administering protein therapeutic molecules orally, sublingually, topically, intravenously, subcutaneously, nasally, vaginally, rectally or by inhalation so as to avoid inactivation, by using VHH polypeptides derived from Camelidae antibodies. The invention further relates to the said therapeutic molecules. The invention further a method for delivering therapeutic molecules to the interior of cells. The invention further relates to anti-IgE therapeutic molecules.

Priority: EP20030447005 Applic. Date: 2003-01-10; WO2003EP06581 Applic. Date: 2003-06-23; WO2003EP07313 Applic. Date: 2003-07-08; US2005-534292 Applic. Date: 2005-05-09; WO2003BE00190 Applic. Date: 2003-11-07; US20020425073P Applic. Date: 2002-11-08; US20020425063P Applic. Date: 2002-11-08

Inventor: SILENCE KAREN [BE]; VAECK MARK [BE]; VAN BERGEN EN HENEGOUWEN PAUL M P [NL]


Application No.: US20100003292A1  Published: 07/Jan/2010

Title: FINE-GRANULOMETRY FUNGAL EXTRACT CHITINE-GLUCANE

Applicant/Assignee:

Application No.: 12/312656   Filing Date: 20/Nov/2007

Abstract:The present invention relates to a chitin-glucan copolymer in the form of micrometric particles. The present invention in particular provides a composition containing a chitin-glucan copolymer in the form of micrometric particles for the preparation of cosmetic compositions, and in particular dermatological or dermocosmetic compositions. In particular, the present invention relates to a cosmetic composition for face or body care, such as hydrating, firming or smoothing the skin, and exercising an anti-aging effect, including an anti-wrinkle effect. The purpose of the invention is also to provide a porous material that can for example be used in tissue engineering or cell culture, or that can be used as a material in the cosmetics or pharmaceutical industry.

Priority: FR20060054998 Applic. Date: 2006-11-20; WO2007EP62601 Applic. Date: 2007-11-20

Inventor: GAUTIER SANDRINE [BE]; BRUYERE JEAN-MICHEL [BE]; MAQUET VERONIQUE [BE]


Application No.: US20100003311A1  Published: 07/Jan/2010

Title: Antimicrobial Composition

Applicant/Assignee:

Application No.: 12/304204   Filing Date: 13/Jun/2007

Abstract:Use of a composition comprising hyaluronic acid or a pharmaceutically acceptable salt thereof, in the manufacture of a topical medicament for antimicrobial treatment of the skin or mucosa.

Priority: IT2006MI01132 Applic. Date: 2006-06-13; WO2007GB02197 Applic. Date: 2007-06-13

Inventor: MASTRODONATO MARCO [IT]


Application No.: US20100003315A1  Published: 07/Jan/2010

Title: Method and Composition for the Treatment of Skin Conditions

Applicant/Assignee:

Application No.: 12/330281   Filing Date: 08/Dec/2008

Abstract:The present invention relates to artificial seawater and its use to treat a variety of skin conditions, when that sea water has more magnesium in it than in naturally occurring seawater. The treatment of acne would healing and the like can be improved with the product of the present invention and with treatments thereof.

Priority: US2008-166605 Applic. Date: 2008-07-02

Inventor: WILLEFORD KENNETH L [US]


Application No.: US20100003344A1  Published: 07/Jan/2010

Title: Cosmetic Skincare Method Employing Mechanical Stresses

Applicant/Assignee: L'OREAL

Application No.: 12/085225   Filing Date: 17/Nov/2006

Abstract:The present invention concerns in particular a cosmetic skincare method comprising the simultaneous or sequential application: (i) of a composition comprising at least one agent increasing the expression of mechano-receptors in the cells of the skin

(ii) of a device intended to apply and/or maintain, controlledly, mechanical stresses to/on the skin. It also relates to a cosmetic kit comprising at least a composition comprising at least one agent increasing the expression of mechanoreceptors in the cells of the skin

and a device intended to apply and/or maintain, controlledly, mechanical stresses to/on the skin. The joint use of said composition and said device makes it possible to potentiate and/or prolong the effect of mechanical stresses induced by the application of said device on the improvement in the thickness of the skin, the improvement in the radiance of the complexion, the improvement in the density of the skin and/or the improvement in the mechanical properties of the skin (firmness, elasticity, tonicity) and/or to promote regeneration of the skin and/or its cicatrization.

Priority: FR20050053527 Applic. Date: 2005-11-21; US20050741912P Applic. Date: 2005-12-05; WO2006EP68630 Applic. Date: 2006-11-17

Inventor: CASSIN GUILLAUME [FR]


Application No.: US20100004311A1  Published: 07/Jan/2010

Title: EXCITATORY AMINO ACID INHIBITORS FOR TREATING SENSITIVE SKINS

Applicant/Assignee: L'OREAL

Application No.: 12/556901   Filing Date: 10/Sep/2009

Abstract:Sensitive human skin/scalp/mucous membrane conditions, for example skin irritation and/or dry patches and/or erythemas and/or dysaesthesic sensations and/or sensations of heating and/or pruritus, are therapeutically treated by topically applying thereto an effective condition-alleviating amount of at least one inhibitor of at least one excitatory amino acid.

Priority: FR19970011959 Applic. Date: 1997-09-25; US2003-401685 Applic. Date: 2003-03-31; US1998-160151 Applic. Date: 1998-09-25

Inventor: BRETON LIONEL [FR]; NONOTTE ISABELLE [FR]


Application No.: US20100004321A1  Published: 07/Jan/2010

Title: Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent

Applicant/Assignee:

Application No.: 12/308796   Filing Date: 29/Jun/2007

Abstract:The present invention provides a plasmid pSOFLysK contained in the bacterial strain Lactococcus lactis NZ9800 referred herein as Lactococcus lactis NZ9800-pSOFLysK (subsequently designated Lactococcus lactis DPC6132) encoding anti-staphylococcal activity as deposited with DSMZ under accession No. ncimb 41409 and plasmids substantially similar thereto also providing anti-staphylococcal activity. In another aspect, the present invention provides a gene encoding an anti-staphylococcal protein, Lysin (LysK) as encoded by the plasmid pSOFLysK in Lactococcus lactis/VZ9800-pSOFLysK (subsequently designated Lactococcus lactis DPC6132). The recombinant lysine also has applications in diagnostics given its lytic mechanism.

Priority: IE20060000488 Applic. Date: 2006-06-29; WO2007IE00064 Applic. Date: 2007-06-29

Inventor: ROSS PAUL [IE]; COFFEY AIDAN [IE]


Application No.: US20100004337A1  Published: 07/Jan/2010

Title: ELECTROSTATICALLY CHARGED MULTI-ACTING NASAL APPLICATION, PRODUCT, AND METHOD

Applicant/Assignee: TRUTEK CORP

Application No.: 12/467271   Filing Date: 16/May/2009

Abstract:A product to reduce and method of reducing the risk of inhalation of harmful substances by applying a formulation composition to a substrate or the skin in close proximity of one or more nostrils. This formulation, when applied creates an electrostatic field having a charge. The electrostatic field attracts airborne particulates of opposite charge to the substrate that are in close proximity to the substrate close to the skin and a biocidic agent renders microorganisms coming in contact the substrate or skin less harmful.

Priority: US20080085555D Applic. Date: 2008-08-01; US20080078478P Applic. Date: 2008-07-07; US20080078472P Applic. Date: 2008-07-07

Inventor: WAHI ASHOK [US]


Application No.: US20100004472A1  Published: 07/Jan/2010

Title: BIOSURFACTANT-CONTAINING SKIN CARE COSMETIC AND SKIN ROUGHNESS-IMPROVING AGENT

Applicant/Assignee: TOYO BOSEKI KABUSHIKI KAISHA NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCEAND TECHNOLOGY

Application No.: 12/094727   Filing Date: 21/Nov/2006

Abstract:The present invention relates to a cosmetic for skin roughness improvement/skin care containing a biosurfactant, particularly MEL-A, MEL-B or MEL-C.

Priority: JP20050340902 Applic. Date: 2005-11-25; JP20060172238 Applic. Date: 2006-06-22; WO2006JP323239 Applic. Date: 2006-11-21

Inventor: KITAGAWA MASARU [JP]; SUZUKI MICHIKO [JP]; YAMAMOTO SHUHEI [JP]; SOGABE ATSUSHI [JP]; KITAMOTO DAI [JP]; IMURA TOMOHIRO [JP]; FUKUOKA TOKUMA [JP]; MORITA TOMOTAKE [JP]


Application No.: US20100004524A1  Published: 07/Jan/2010

Title: SENSOR

Applicant/Assignee: DAYTON TECHNOLOGIES LIMITED

Application No.: 12/195281   Filing Date: 20/Aug/2008

Abstract:A sensor for sensing physiological signal from outside the human body, said sensor comprising an electrode for abutment against the skin

and a transmission conductor electrically connected to said electrode, said transmission conductor formed from a flexible material, wherein in use a substrate is disposed between the skin and said transmission conductor, and said substrate is permeable to moisture and air thereby exposing said transmission conductor to said moisture.

Priority: HK20080107402 Applic. Date: 2008-07-04

Inventor: YUEN PAUL ANTHONY [CN]


Application No.: US20100007193A1  Published: 14/Jan/2010

Title: Applicator, a packaging and applicator device including such an applicator, a method of manufacturing such an applicator, and a machine for manufacturing such an applicator

Applicant/Assignee: L'OREAL

Application No.: 12/585333   Filing Date: 11/Sep/2009

Abstract:An applicator for applying a cosmetic or a skin care product may include a stem including at least one stamped portion forming a joint, and an applicator member disposed at a first end of the stem.

Priority: FR20050051825 Applic. Date: 2005-06-29; US2006-474313 Applic. Date: 2006-06-26; US20050701063P Applic. Date: 2005-07-21

Inventor: GUERET JEAN-LOUIS [FR]


Application No.: US20100008879A1  Published: 14/Jan/2010

Title: Whitening agent

Applicant/Assignee: SHISEIDO COMPANY, LTD

Application No.: 12/585271   Filing Date: 10/Sep/2009

Abstract:A whitening agent containing a solvent extract of a plant Elephantopus mollis H. B. & K. belonging to Compositae having a superior whitening action and having a superior effect in lightening and whitening pigmentation after suntans, senile lentigo, freckles, melasma, is provided.

Priority: JP20040277298 Applic. Date: 2004-09-24; US2007-662284 Applic. Date: 2007-03-09; WO2005JP17434 Applic. Date: 2005-09-15

Inventor: UMISHIO KENICHI [JP]; MAEDA KAZUHISA [JP]; KOBAYASHI KOJI [JP]


Application No.: US20100008885A1  Published: 14/Jan/2010

Title: METHODS AND KITS IMPARTING BENEFITS TO KERATIN-CONTAINING SUBSTRATES

Applicant/Assignee:

Application No.: 12/169984   Filing Date: 09/Jul/2008

Abstract:This invention relates to methods for providing cosmetic or other benefits to keratin-containing substrates by sequential treatment with cationically and anionically charged compounds, and compositions and kits containing them.

Priority:

Inventor: DALY SUSAN [US]; JACHOWICZ JANUSZ [US]; BIANCHINI ROBERT [US]


Application No.: US20100008897A1  Published: 14/Jan/2010

Title: COMPOSITION FOR PROVIDING A BENEFIT TO A KERATIN-CONTAINING SUBSTRATE

Applicant/Assignee:

Application No.: 12/170007   Filing Date: 09/Jul/2008

Abstract:This invention relates to compositions and methods for providing cosmetic and other potential benefits to keratin-containing substrates. The compositions contain at least one naturally-occurring cationic protein with a biological function in a cosmetically acceptable carrier, such that the naturally-occurring cationic protein retains its essential configuration, preserving its biological function, when it is in proximity to a keratin-containing substrate.

Priority:

Inventor: DALY SUSAN [US]; JACHOWICZ JANUSZ [US]; BIANCHINI ROBERT [US]


Application No.: US20100008960A1  Published: 14/Jan/2010

Title: Beauty/medication patch

Applicant/Assignee:

Application No.: 12/585466   Filing Date: 16/Sep/2009

Abstract:A beauty/medication patch including a substrate, an outer layer, and a medication lotion

the outer layer being made of a degradable material being disposed on the substrate

one or a plurality of micro-probe array being disposed on a surface of the outer layer

the medication lotion being coated between the substrate and the outer layer, and/or admixed in the substrate

the patch being attached to a human skin, the micro-probe array piercing through a stratum corneum layer of the human skin and naturally being degraded by human skin or absorbed and metabolized by a human body

and the medication lotion penetrating into the skin and being absorbed by the human skin.

Priority: TW20070114662 Applic. Date: 2007-04-25; US2007-979388 Applic. Date: 2007-11-02

Inventor: MENG HSIEN KAI [TW]; HSIEH SHU PIN [TW]; YEH YUAN YI [TW]; LIN CHANG WEI [TW]


Application No.: US20100008973A1  Published: 14/Jan/2010

Title: Compositions And Methods For Wound Healing

Applicant/Assignee: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

Application No.: 12/542377   Filing Date: 17/Aug/2009

Abstract:The present invention is related to the field of wound healing or tissue regeneration due to disease (i.e., for example, cardiovascular diseases, osteoarthritic diseases, or diabetes). In particular, the present invention provides compositions and methods comprising molecules with linked alpha-gal epitopes for induction of recruitment of macrophages localized within or surrounding damaged tissue. The recruited macrophages and stem cells promote the repair and regeneration of the treated injured tissue. In some embodiments, the present invention provides treatments for tissue repair in normal subjects and in subjects having impaired healing capabilities, such as diabetic and aged subjects. In some embodiments, the present invention provides treatments for injured tissues such as brain, peripheral nerve, muscle, cartilage, bone, gastrointestinal tract and dysfunctional endocrine tissues.

Priority: WO2008US08731 Applic. Date: 2008-07-17; US20070961047P Applic. Date: 2007-07-17

Inventor: GALILI URI [US]


Application No.: US20100009016A1  Published: 14/Jan/2010

Title: DEHYDROEPIANDROSTERONE PRODUCTION PROMOTER AND USE THEREOF

Applicant/Assignee: ARKRAY, INC

Application No.: 12/307667   Filing Date: 30/Jan/2008

Abstract:A new orally administerable DHEA production promoter is provided. A composition containing an extract of at least one selected from the group consisting of plants of Rosaceae Crataegus, Saururaceae Houttuynia, Vitaceae Vitis, and Compositae Anthemis is provided as a DHEA production promoter. The extract may be of one of the plants or extracts of two or more of them may be used in combination. A specific example is preferably a mixture of extracts of all four of the aforementioned plants. This DHEA production promoter also can be used as, for example, an anti-aging agent such as a skin improver as well as a pharmaceutical agent such as an immunostimulator, an antidiabetic agent, an anti-osteoporosis agent, an antiarteriosclerotic agent, an anti-obesity agent, a sleep-promoting agent, and a central nervous system depressant.

Priority: JP20070073415 Applic. Date: 2007-03-20; WO2008JP51421 Applic. Date: 2008-01-30

Inventor: YAGI MASAYUKI [JP]; KAWAL HIROSHIGE [JP]; KUBO MOTOKI [JP]; YONEI YOSHIKAZU [DE]; MATSUURA NOBUYASU [JP]


Application No.: US20100009931A1  Published: 14/Jan/2010

Title: ASSOCIATION OF A TENSOR AGENT OR DEVICE AND A SACCHARIDE COMPOUND

Applicant/Assignee: L'OREAL

Application No.: 12/299563   Filing Date: 04/May/2007

Abstract:The invention concerns a composition for topical application on the skin comprising, in a physiological acceptable medium, at least one saccharide compound which augments the expression of mechanoreceptors in skin cells and at least one tensor agent. The invention also concerns a skin care health kit comprising (a) a composition comprising at least one tensor agent and (b) a composition comprising at least one saccharide compound which increases the expression of mechanoreceptors in skin cells. The invention also concerns a kit comprising (a) a composition comprising at least one saccharide compound which augments the expression of mechanoreceptors in skin cells and (b) a tensor device designed to apply and/or maintain in a controlled manner mechanical constraints on the skin. The invention also concerns a process for cosmetic treatment of the skin comprising the simultaneous or sequential application of said compositions and/or tensor devices.

Priority: FR20060051644 Applic. Date: 2006-05-05; FR20060051645 Applic. Date: 2006-05-05; US20060800409P Applic. Date: 2006-05-16; US20060800410P Applic. Date: 2006-05-16; WO2007FR51222 Applic. Date: 2007-05-04

Inventor: LABOUREAU JULIEN [FR]; CASSIN GUILLAUME [FR]


Application No.: US20100009933A1  Published: 14/Jan/2010

Title: HYDROXYLATED AMIDE SKIN MOISTURIZER

Applicant/Assignee: L'OREAL

Application No.: 12/302398   Filing Date: 03/May/2007

Abstract:The invention relates to the cosmetic use, as a skin moisturizer, of a compound of formula (I): with (i) R1 and R2 represent a hydrogen atom or a C1-C6-alkyl group, or (ii) R1 and R2 can form, together with the nitrogen atom which bears them, a saturated heterocycle with 5 to 7 ring members

R5 representing a hydrogen atom or a (C1-C3) alkyl group

R6 representing a hydrogen atom or a (C1-C4) alkyl group

R3 represents a hydrogen atom or a (C1-C6) alkyl-group, or -OR3 represents a phosphate group

it being possible for the two groups R3 to form, together, an isopropylidene group

R4 represents a hydrogen atom or -OR4 represents a-phosphate group

and the salts, solvates and isomers thereof. The invention also relates to a cosmetic composition comprising a compound (I) and the corresponding new compounds.

Priority: FR20060051987 Applic. Date: 2006-05-31; US20060811094P Applic. Date: 2006-06-06; WO2007EP54278 Applic. Date: 2007-05-03

Inventor: MARAT XAVIER [FR]


Application No.: US20100009940A1  Published: 14/Jan/2010

Title: 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs

Applicant/Assignee:

Application No.: 12/171045   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs, and specifically 2-methylene-(20E)-20(22)-dehydro-19-nor-1alpha,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits relatively high transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also shows lower activity in vivo on bone calcium mobilization and similar in vivo intestinal calcium transport activity compared to the native hormone 1alpha,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; TADI BULLI PADMAJA [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009941A1  Published: 14/Jan/2010

Title: 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs

Applicant/Assignee:

Application No.: 12/171056   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs, and specifically 2-methylene-20(21)-dehydro-19-nor-1alpha,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits relatively high transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also shows lower activity in vivo on bone calcium mobilization and similar in vivo intestinal calcium transport activity compared to the native hormone 1alphaa,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; TADI BULLI PADMAJA [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009942A1  Published: 14/Jan/2010

Title: 2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs

Applicant/Assignee:

Application No.: 12/171071   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs, and specifically 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-1alpha, 25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits relatively high transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has significant calcemic activity in vivo having about the same bone calcium mobilization activity and intestinal calcium transport activity as the native hormone 1alpha,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; TADI BULLI PADMAJA [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009943A1  Published: 14/Jan/2010

Title: 2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs

Applicant/Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION

Application No.: 12/171094   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs, and specifically 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-1alpha,24(R)-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits relatively high transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion.

This compound also shows lower activity in vivo on bone calcium mobilization and intestinal calcium transport activity compared to the native hormone 1alpha,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; BARYCKI RAFAL [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009944A1  Published: 14/Jan/2010

Title: 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring

Applicant/Assignee:

Application No.: 12/171103   Filing Date: 10/Jul/2008

Abstract:19-nor-vitamin D analogs having an additional dihydrofuran ring connecting the 1alpha-oxygen and carbon-2 of the A-ring of the analog, and pharmaceutical uses therefore, are described. These compounds exhibit selective in vitro and in vivo activities, making them therapeutic agents for the treatment or prophylaxis of autoimmune diseases, some types of cancers, secondary hyperparathyroidism, psoriasis, or other skin diseases.

Priority:

Inventor: DELUCA HECTOR F [US]; GLEBOCKA AGNIESZKA [US]; SOKOLOWSKA KATARZYNA [PL]; SICINSKI RAFAL R [PL]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009945A1  Published: 14/Jan/2010

Title: 19-NOR-VITAMIN D ANALOGS WITH 3,2-DIHYDROFURAN RING

Applicant/Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION

Application No.: 12/171108   Filing Date: 10/Jul/2008

Abstract:19-nor-vitamin D analogs having an additional dihydrofuran ring connecting the 3beta-oxygen and carbon-2 of the A-ring of the analog, and pharmaceutical uses therefore, are described. These compounds exhibit selective in vitro and in vivo activities, making them therapeutic agents for the treatment or prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases.

Priority:

Inventor: DELUCA HECTOR F [US]; GLEBOCKA AGNIESZKA [US]; SOKOLOWSKA KATARZYNA [PL]; SICINSKI RAFAL R [PL]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009946A1  Published: 14/Jan/2010

Title: 2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs

Applicant/Assignee:

Application No.: 12/171113   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs, and specifically 2-methylene-19,26-dinor-(20R,22E,25R)-1alpha,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also shows very low activity in vivo on bone calcium mobilization and relatively high intestinal calcium transport activity compared to the native hormone 1alpha,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; CHIELLINI GRAZIA [US]; GRZYWACZ PAWEL [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100009947A1  Published: 14/Jan/2010

Title: 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs

Applicant/Assignee:

Application No.: 12/171120   Filing Date: 10/Jul/2008

Abstract:This invention discloses 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs, and specifically 2-methylene-19,26-dinor-(20S,22E,25R)-1alpha,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity as well as pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also shows no activity in vivo on bone calcium mobilization and relatively low intestinal calcium transport activity compared to the native hormone 1alpha,25-dihydroxyvitamin D3, and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.

Priority:

Inventor: DELUCA HECTOR F [US]; CHIELLINI GRAZIA [US]; GRZYWACZ PAWEL [US]; PLUM LORI A [US]; CLAGETT-DAME MARGARET [US]


Application No.: US20100010049A1  Published: 14/Jan/2010

Title: Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/318902   Filing Date: 12/Jan/2009

Abstract:Compounds corresponding to the following general formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine or else into cosmetic compositions

novel compounds of formula (II) are also thus useful:

Priority: FR20060052908 Applic. Date: 2006-07-11; WO2007EP57019 Applic. Date: 2007-07-10; US20060831210P Applic. Date: 2006-07-17

Inventor: SUZUKI ITARU [FR]; ERDELMEIER IRENE [FR]; YADAN JEAN-CLAUDE [FR]; PELISSON ISABELLE [FR]


Application No.: US20100010084A1  Published: 14/Jan/2010

Title: HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS

Applicant/Assignee:

Application No.: 12/503739   Filing Date: 15/Jul/2009

Abstract:The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of retinoids and retinoid-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.

Priority: WO2007IB50122 Applic. Date: 2007-01-15

Inventor: YU CHONGXI [US]


Application No.: US20100010100A1  Published: 14/Jan/2010

Title: DERMATOLOGICAL COMPOSITIONS WITH ANTI-AGING AND SKIN EVEN-TONING PROPERTIES

Applicant/Assignee:

Application No.: 12/499042   Filing Date: 07/Jul/2009

Abstract:The present invention relates to methods and compositions comprising benzoquinones such as Duroquinone, for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible and/or tactile discontinuities of the skin resulting from skin pigmentation or skin aging are also disclosed.

Priority: US20080134516P Applic. Date: 2008-07-09

Inventor: HINMAN ANDREW W [US]; MILLER GUY M [US]


Application No.: US20100010325A1  Published: 14/Jan/2010

Title: System for Noninvasive Determination of Analytes in Tissue

Applicant/Assignee:

Application No.: 12/562050   Filing Date: 17/Sep/2009

Abstract:An apparatus and method for noninvasive determination of analyte properties of human tissue by quantitative infrared spectroscopy to clinically relevant levels of precision and accuracy. The system includes subsystems optimized to contend with the complexities of the tissue spectrum, high signal-to-noise ratio and photometric accuracy requirements, tissue sampling errors, calibration maintenance problems, and calibration transfer problems. The subsystems can include an illumination/modulation subsystem, a tissue sampling subsystem, a data acquisition subsystem, a computing subsystem, and a calibration subsystem. The invention can provide analyte property determination and identity determination or verification from the same spectroscopic information, making unauthorized use or misleading results less likely than in systems that use separate analyte and identity determinations. The invention can be used to control and monitor individuals accessing controlled environments.

Priority: US2006-515565 Applic. Date: 2006-09-05; US2005-305964 Applic. Date: 2005-12-19; US2004-852415 Applic. Date: 2004-05-24; US2001-832585 Applic. Date: 2001-04-11; US2002-281576 Applic. Date: 2002-10-28; US2003-378237 Applic. Date: 2003-03-03; US2004-753506 Applic. Date: 2004-01-08; US20090147107P Applic. Date: 2009-01-25

Inventor: RIDDER TRENT [US]; VER STEEG BEN [US]; MCNALLY JAMES [US]; MAYNARD JOHN [US]; ABBINK RUSSELL [US]; MILLS MIKE [US]; LAAKSONEN BENTLEY [US]


Application No.: US20100010459A1  Published: 14/Jan/2010

Title: UNDERGARMENT FOR INCONTINENT PERSON AND TREATMENT DEVICE CONNECTED TO AN UNDERGARMENT

Applicant/Assignee:

Application No.: 12/441026   Filing Date: 12/Sep/2007

Abstract:The present invention relates to an undergarment (1) comprising: a supporting part (2) which surrounds at least the hips and the top of each thigh

and a flexible collecting bag (10) positioned in the crotch.

Priority: FR20060053719 Applic. Date: 2006-09-13; WO2007FR51926 Applic. Date: 2007-09-12

Inventor: PIETTE FRANCOIS [FR]; TAMBRUN ROGER [FR]


Application No.: US20100010591A1  Published: 14/Jan/2010

Title: NON-INVASIC THERAPEUTIC TREATMENT DEVICE

Applicant/Assignee: SYBARITIC, INC

Application No.: 12/437142   Filing Date: 07/May/2009

Abstract:A non-invasive therapeutic device includes a housing comprising a cavity and a bottom surface. A plurality of light emitting arrays are positioned within the bottom surface. At least one fan positioned within the cavity to provide at least cooling to the patient. The device includes a controller positioned on the housing for controlling the plurality of light emitting arrays and the at least one fan such that a phototherapy treatment can be applied to a selected region of a patient.

Priority: US20080051209P Applic. Date: 2008-05-07

Inventor: DAFFER STEVEN J [US]


Application No.: US20100011477A1  Published: 21/Jan/2010

Title: Clothing Protector

Applicant/Assignee:

Application No.: 12/354687   Filing Date: 15/Jan/2009

Abstract:Systems and methods for providing clothing protection are discussed herein. A clothing protector comprises a pad and an adhesive surface. The pad is configured to provide a layer between an outer clothing and skin. The pad extends below an upper edge of a diaper. The adhesive surface is coupled to the pad, wherein the adhesive surface is configured to attach to an inside of the outer clothing.

Priority: US20080011330P Applic. Date: 2008-01-15

Inventor: LEE PEARL POON [US]


Application No.: US20100015071A1  Published: 21/Jan/2010

Title: Compositions for Improving Skin Conditions Comprising Alpha-Bisabolol as an Active Ingredient

Applicant/Assignee: BIOSPECTRUM INC

Application No.: 12/527756   Filing Date: 27/Feb/2008

Abstract:The present invention relates to a composition for improving skin condition comprising alpha-bisabolol as an active ingredient. alpha-Bisabolol used as an active ingredient has greater skin whitening effect inhibiting melanin synthesis by inhibiting intracellular tyrosinase activities compared to arbutin used as an existing skin whitening agent. In addition, alpha-bisabolol exhibits the inhibition effect on collagenase activity and promotion effect on collagen biosynthesis at a molecular level, contributing to excellent efficacy in improvement of skin wrinkles. Meanwhile, alpha-bisabolol indicates the improvement effects on UV-induced skin damage and the skin growth promotion or hair loss prevention. Therefore, alpha-bisabolol has the excellent improvement effects on skin condition. Furthermore, alpha-bisabolol has the excellent anti-obesity and anti-oxidation effects. The composition of this invention can be applied to cosmetic, pharmaceutical and food composition having no cytotoxicities and side effects with safety.

Priority: KR20070019899 Applic. Date: 2007-02-27; WO2008KR01141 Applic. Date: 2008-02-27

Inventor: PARK DEOK HOON [KR]; KIM SAE BOM [KR]; LEE JONG SUNG [KR]


Application No.: US20100015074A1  Published: 21/Jan/2010

Title: Cosmetic Makeup and/or Care Process

Applicant/Assignee: L'OREAL

Application No.: 11/988158   Filing Date: 13/Jul/2006

Abstract:The present invention relates to a cosmetic process for making up and/or caring for keratin material(s), comprising the application, on contact with a keratin material, of a cosmetic composition comprising at least 75% by weight of compound(s) approved for food use relative to its total weight and having a covering power of greater than or equal to 30.

Priority: FR20050052205 Applic. Date: 2005-07-13; US20050712105P Applic. Date: 2005-08-30; WO2006IB52391 Applic. Date: 2006-07-13

Inventor: BLIN XAVIER [FR]


Application No.: US20100015119A1  Published: 21/Jan/2010

Title: EPITHELIUM-IMPROVING AGENT

Applicant/Assignee:

Application No.: 12/519671   Filing Date: 19/Feb/2008

Abstract:It is intended to provide an epithelium improving agent which improves the epithelial functions of various organs and, therefore, is usable in growing melanin-pigmented hair, relieving inflammatory symptoms in gingivitis and paradentitis, treating and relieving cold syndrome and bronchial asthma and, moreover, restoring sexual sensibility. An epithelium improving agent which comprises coenzyme Q10, cysteine, vitamins A, C and E and a skin extract of a rabbit inoculated with a vaccinia virus as the main components. In the case of treating gingivitis, paradentitis, cold syndrome and bronchial asthma, loratadine is further added. To an epithelium improving agent which is to be used in stimulating hair growth or restoring sexual sensibility, liquid paraffin and a hydrophilic ointment is further added to give a cream. Thus, the above problem can be solved.

Priority: JP20070104316 Applic. Date: 2007-03-13; JP20070279618 Applic. Date: 2007-09-27; WO2008JP53137 Applic. Date: 2008-02-19

Inventor: KOBAYASHI HARUZO [JP]


Application No.: US20100015134A1  Published: 21/Jan/2010

Title: Therapy With CD4 Binding Peptides and Radiation

Applicant/Assignee: GENMAB A/S

Application No.: 11/990581   Filing Date: 18/Aug/2006

Abstract:The present invention relates to a peptide, such as an antibody, capable of binding to CD4 and use thereof for the mediation of radiation treatment of a clinical condition. The radiation treatment may for instance by treatment with PUVA.

Priority: US20050709943P Applic. Date: 2005-08-18; WO2006DK00454 Applic. Date: 2006-08-18

Inventor: PARREN PAUL [NL]; BAADSGAARD OLE [DK]; ALEXANDER DENIS [GB]


Application No.: US20100015187A1  Published: 21/Jan/2010

Title: MACRO-SIZED LIPID CAPSULE EMULSION COMPOSITION AND COSMETIC COMPOSITION CONTAINING THE SAME

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 12/300251   Filing Date: 30/Nov/2006

Abstract:An emulsion composition of the invention has macro-sized (0.01 to 5 mm) lipid capsule particles and it is for a skin cosmetic composition. An emulsion composition of the invention exhibits improved stability for its particle size by adjusting a size of the particle through a combination of liquid phase oil and integument lipid or lipoid material and encapsulating the liquid phase oil with the integument lipid. The emulsion composition of the invention has unique outward appearance and use feeling due to the macro-sized particles in it, also exhibits excellent skin safety and moisture persistence by containing no surfactant and maintains an activity of an oleophilic effective ingredient which is apt to be oxidized for a long time.

Priority: KR20060042420 Applic. Date: 2006-05-11; WO2006KR05111 Applic. Date: 2006-11-30

Inventor: KANG CHAN KOO [KR]; KANG HAK HEE [KR]; PARK CHANG HOON [KR]; HAN SANG HOON [KR]


Application No.: US20100015190A1  Published: 21/Jan/2010

Title: Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material

Applicant/Assignee:

Application No.: 12/439220   Filing Date: 28/Aug/2007

Abstract:The present invention relates to human metabolism, in particular fat reduction and a cosmetic and pharmaceutical formulation, as well as respective uses in particular together with a dressing material according to the invention.

Priority: DE200610042113 Applic. Date: 2006-09-07; US20060840779P Applic. Date: 2006-08-28; WO2007EP07508 Applic. Date: 2007-08-28

Inventor: HASSLER GERARD [CH]


Application No.: US20100015447A1  Published: 21/Jan/2010

Title: MICROPHASIC MICRO-COMPONENTS AND METHODS FOR CONTROLLING MORPHOLOGY VIA ELECTRIFIED JETTING

Applicant/Assignee:

Application No.: 12/506712   Filing Date: 21/Jul/2009

Abstract:The disclosure provides methods for preparation of multiphasic micro-components, such as core-shell or anisotropic (e.g., Janus) multiphasic particles with well-defined structures using electrohydrodynamic co-jetting of two polymer solutions containing polyelectrolytes. Suitable polyelectrolytes include polyacrylic acid (PAA), poly(acrylamide acrylic acid (PAAm), and/or poly(acryl amide-co-acrylic acid) (PAAm-AA), sodium polystyrene sulfonate (PSS), polyethylene imine (PEI), polypeptides, copolymers, and combinations of these. Control of certain variables, such as relative conductivities of the two jetting solutions, controls the particle morphologies formed, leading to a predetermined phase orientation for the same polymer system. In certain aspects, after cross-linking, core-shell particles are stable in aqueous solutions and exhibit reproducible swelling behavior, while maintaining the original core-shell geometry. In addition, micro-components formed in accordance with the present teachings are pH-responsive based on external environmental pH. Thus, such micro-components are useful for a variety of different applications, including micro- and nano-active ingredient delivery systems.

Priority: US2007-763842 Applic. Date: 2007-06-15; US2005-272194 Applic. Date: 2005-11-10; US20080082396P Applic. Date: 2008-07-21; US20040626792P Applic. Date: 2004-11-10; US20050651288P Applic. Date: 2005-02-09; US20060814706P Applic. Date: 2006-06-16

Inventor: LAHANN JOERG [US]; KAZEMI ABBASS [US]


Application No.: US20100016198A1  Published: 21/Jan/2010

Title: Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them

Applicant/Assignee:

Application No.: 12/507011   Filing Date: 21/Jul/2009

Abstract:Compositions comprising sulfo-estolides and alkyl ester sulfonates are described. Detergent formulations, such as laundry detergents, softeners, and other materials, containing any of these materials are disclosed, as well as personal care formulations, hard surface cleaner formulations, and automatic dishwasher detergent formulations. Laundry methods employing these formulations are also disclosed. These formulations are useful as laundry detergents and can be biodegradable, heavy duty liquids, 2x or 3x and up to 6x concentrates, low foaming, and/or effective in a high efficiency washing machine. Methods for laundering fabrics with the compositions are also disclosed.

Priority: WO2009US31455 Applic. Date: 2009-01-20; US20080022662P Applic. Date: 2008-01-22

Inventor: BERNHARDT RANDAL J [US]; ALONSO LOURDES R [US]; DADO GREGORY P [US]; FILIPOVIC EDDIE I [US]; GARIEPY CHRISTOPHER A [US]; MASTERS RONALD A [US]; MURPHY DENNIS S [US]; PYTEL JACQUELINE MAAS [US]; SAJIC BRANKO [US]; SHAPIRO IRENE [US]; WEITGENANT JEREMY AARON [US]


Application No.: US20100016346A1  Published: 21/Jan/2010

Title: ELASMOBRANCH-REPELLING DOMPOUNDS AND METHODS OF USE

Applicant/Assignee: SHARK DEFENSE L.L.C

Application No.: 11/922065   Filing Date: 12/Jun/2006

Abstract:Compounds for repelling elasmobranch having an aldehyde or derivative, a carboxylic acid a derivative, a ketone or a derivative thereof, a di-ketone or a derivative thereof, a pyridine or derivative thereof, or an antipyrine or a derivative thereof and methods of use thereof.

Priority: US20050689652P Applic. Date: 2005-06-11; US20050750451P Applic. Date: 2005-12-14; WO2006US22912 Applic. Date: 2006-06-12

Inventor: STROUD ERIC MATTHEW [US]


Application No.: US20100016347A1  Published: 21/Jan/2010

Title: SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS

Applicant/Assignee: UNIGEN PHARMACEUTICALS, INC

Application No.: 12/506497   Filing Date: 21/Jul/2009

Abstract:The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.

Priority: US20080082422P Applic. Date: 2008-07-21

Inventor: NANDY SANDIP K [US]; LIU JIYUN [US]; NESTEROV ALEXANDRE MIKHAILOVITCH [US]; HERTEL CARMEN [US]; PADMAPRIYA ABEYSINGHE A [US]


Application No.: US20100016413A1  Published: 21/Jan/2010

Title: PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS

Applicant/Assignee:

Application No.: 12/446976   Filing Date: 05/Nov/2007

Abstract:Systems for pathotropic (disease-seeking) targeted gene delivery are provided, including viral particles with extremely high titers. In particular, the viral particles are engineered to specifically deliver therapeutic or diagnostic agents to a disease site, such as cancer metastic sites. Personalized dosing regimens are also provided to treat diseases such as cancer efficaciously with reduced adverse side effects.

Priority: US2006-055666 Applic. Date: 2006-11-03; WO2007US23305 Applic. Date: 2007-11-05

Inventor: HALL FREDERICK L [US]; LEVY JOHN P [US]; REED REBECCA A [US]; GORDON ERLINDA M [US]


Application No.: US20100016436A1  Published: 21/Jan/2010

Title: Transdermal Administration of Active Agents, in Particular Diclofenac

Applicant/Assignee: PHARMACODEX LTD

Application No.: 12/086045   Filing Date: 07/Dec/2006

Abstract:The present invention relates to compositions for transdermal administration of therapeutic agents for providing a local and sustained therapeutic effect, wherein the extent of systemic administration can be controlled. In particular, the invention relates to spreadable compositions, or compositions which may be solid at a temperature of about 25 DEG C. or less and have a softening point of not higher than 35 DEG C., for use in the treatment of pain and/or inflammation or administration of a local anaesthetic, wherein transdermal administration of the therapeutic agent may be either rapid or sustained.

Priority: GB20050024958 Applic. Date: 2005-12-07; WO2006GB50434 Applic. Date: 2006-12-07

Inventor: STANIFORTH JOHN [GB]; GOGGOM PAUL [GB]


Application No.: US20100016443A1  Published: 21/Jan/2010

Title: METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING

Applicant/Assignee: SOL-GEL TECHNOLOGIES LTD

Application No.: 12/525331   Filing Date: 03/Feb/2008

Abstract:The invention relates to a process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid, water-insoluble particulate matter with an ionic additive and an aqueous medium to obtain a dispersion of said particulate matter having positive charges on its surface

(b) subjecting the particulate matter to a coating procedure comprising precipitating a metal oxide salt onto the surface of the particulate matter to form a metal oxide layer thereon to thereby obtain particulate matter coated by a metal oxide coating layer

(c) repeating step (b) at least 4 more times

and (d) aging said coating layer. The invention further relates to particles comprising a particulate matter coated by a metal oxide layer, to a use of the particles for topical administration, and to a method for preventing, reducing, or eliminating pests at a locus, using the particles.

Priority: US20070898700P Applic. Date: 2007-02-01; WO2008IL00141 Applic. Date: 2008-02-03

Inventor: TOLEDANO OFER [IL]; BAR-SIMANTOV HAIM [IL]; BILMAN NISSIM [IL]; SHAPIRO LEORA [IL]; ABU-REZIQ RAED [IL]; SRIADIBHATLA SRIKANTH [US]; SOMMER WILLIAM T [US]


Application No.: US20100021398A1  Published: 28/Jan/2010

Title: COMPOSITIONS AND METHODS FOR LIGHTENING SKIN AND PROTECTING SKIN FROM ULTRAVIOLET RADIATION WITH GLUTATHIONE

Applicant/Assignee:

Application No.: 12/355666   Filing Date: 16/Jan/2009

Abstract:A glutathione composition for lightening or protecting skin is disclosed together with a method for lightening skin or protecting the skin from the effects of ultraviolet radiation is accomplished by administering glutathione to the skin. The glutathione may be glutathione modified with at least one fatty acid or the glutathione molecule is acetylated/esterified. In instances where it is acetylated/esterified, it may optionally be associated with cyclodextrin.

Priority: US20080022165P Applic. Date: 2008-01-18

Inventor: SKINNER KEITH K [US]


Application No.: US20100021399A1  Published: 28/Jan/2010

Title: COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING N-ACETYLCYSTEINE

Applicant/Assignee: ZAMBON S.P.A

Application No.: 12/374828   Filing Date: 13/Jul/2007

Abstract:The present invention relates to odour improved dermatological or cosmetic preparations comprising N-acetylcysteine and a polyol system containing one or more polyols as masking odour agents. The emulsions of the present invention are useful in the treatment of dermatological disorders or cosmetic skin conditions.

Priority: EP20060015440 Applic. Date: 2006-07-25; WO2007EP57271 Applic. Date: 2007-07-13

Inventor: RAMPOLDI LUCA [IT]; MORETTO ALBERTO [IT]; GRASSANO ALESSANDRO [IT]


Application No.: US20100021400A1  Published: 28/Jan/2010

Title: Active Sunscreen Composition

Applicant/Assignee: RHODE ISLAND HOSPITAL

Application No.: 12/430739   Filing Date: 27/Apr/2009

Abstract:The invention relates to topical compositions comprising a fluorescent dye that absorbs UVA and UVB radiation and converts it into a healing light, in combination with a dermatologically acceptable excipient. The compositions of the invention are useful for repairing photo-damaged skin cells and reducing or preventing future skin damage as a result of exposure to UV light.

Priority: US20080125526P Applic. Date: 2008-04-25

Inventor: JAY GREGORY D [US]; CRAWFORD GREGORY [US]


Application No.: US20100021402A1  Published: 28/Jan/2010

Title: Compounds, Formulations, and Methods for Ameliorating Telangiectasis

Applicant/Assignee: GALDERMA LABORATORIES INC

Application No.: 12/544663   Filing Date: 20/Aug/2009

Abstract:Methods, compounds, and topical formulations for treatment of telangiectasias are disclosed. The methods comprise topically applying a composition comprising an alpha-adrenergic receptor agonist to telangiectatic skin. Amelioration of telangiectasia symptoms begins within minutes after topical application of a disclosed composition. A single application can significantly lessen telangiectasia discoloration for at least about 2 hours.

Priority: US2006-449079 Applic. Date: 2006-06-08; US2004-853585 Applic. Date: 2004-05-25; US20030473611P Applic. Date: 2003-05-27

Inventor: DEJOVIN JACK A [US]; DEJOVIN ISABELLE JEAN [US]; POWALA CHRISTOPHER [US]


Application No.: US20100021404A1  Published: 28/Jan/2010

Title: Cosmetic composition with skin tightening effect

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/585755   Filing Date: 24/Sep/2009

Abstract:The present invention relates to a mixture, having a skin-tightening effect, which is made up of: 10 to 80% by Weight of a polysaccharide, preferably of an alginate, having a molecular weight of less than 600,000 Daltons, preferably less than 400,000 Daltons and more preferably less than 200,000 Daltons, 15 to 75% by weight of a polyhydroxylated agent selected from sugars and their derivatives, particularly sugar esters and sugar, ethers, preferably sorbitol, 3 to 15% by Weight of polyvinyl alcohol) or polyvinylpyrrolidone, and 0 to 25% by weight of cellulose or of a derivative of cellulose, such as carboxymethylcellulose or hydroxymethylcellulose. The present invention also relates to cosmetic compositions which contain this mixture. These cosmetic compositions enable a mechanical smoothing of the surface of the skin to be obtained progressively with great comfort of use and enables a good fixing of make-up products.

Priority: FR20010011123 Applic. Date: 2001-08-27; US2004-487693 Applic. Date: 2004-02-26; WO2002FR02941 Applic. Date: 2002-08-27

Inventor: DELAGE-GROUILLER HERVE [FR]; NOE BRIGITTE [FR]; MAHE CHRISTIAN [FR]


Application No.: US20100021405A1  Published: 28/Jan/2010

Title: EXTERNAL PREPARATION FOR SKIN

Applicant/Assignee:

Application No.: 12/445177   Filing Date: 11/Oct/2007

Abstract:The present invention provides an external preparation for skin comprising a phospholipid having an iodine value of 80 to 110, ethanol in an amount of 55 to 83 wt % and water in an amount of 15 to 43 wt %, which is improved in it's preparation stability by suppressing an increase in an acid value of phospholipid. The present invention also provides an external preparation for skin which is improved in percutaneous absorption of medically effective ingredient(s). The present invention provides further a method for suppressing an increase in an acid value of phospholipid by comprising phospholipid having high iodine value and high concentration of ethanol and water, as well as a method for improving percutaneous absorption of medically effective ingredient(s) in external preparation for skin.

Priority: JP20060279252 Applic. Date: 2006-10-12; WO2007JP69860 Applic. Date: 2007-10-11

Inventor: ABE MASAMICHI [JP]; HARADA AYAKO [JP]; HONMA YOICHI [JP]


Application No.: US20100021408A1  Published: 28/Jan/2010

Title: BLOCK POLYMER, COSMETIC COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS

Applicant/Assignee: L'OREAL

Application No.: 12/506328   Filing Date: 21/Jul/2009

Abstract:A block polymer containing, in a block with a Tg greater than 20 DEG C., at least one monomer of formula (I): The invention also relates to a cosmetic composition comprising the block polymer in a cosmetically acceptable medium, and also to a cosmetic process for treating keratin materials using the composition, and most particularly to a process for making up the lips.

Priority: FR20080055070 Applic. Date: 2008-07-24; US20080095034P Applic. Date: 2008-09-08

Inventor: FARCET CELINE [FR]


Application No.: US20100021415A1  Published: 28/Jan/2010

Title: COSMETIC USE OF ORGANIC RESINATES

Applicant/Assignee: CHANEL PARFUMS BEAUTE

Application No.: 12/531162   Filing Date: 14/Mar/2008

Abstract:A cosmetic method for releasing an active principle in a controlled fashion to uninjured skin, as a function of the ion content in or on skin, by exchange with the ions, in order to provide at least one cosmetic benefit to the skin, the method includes applying onto skin a composition containing, in a cosmetically acceptable medium, at least one resinate including one organic ion-exchange resin and at least one ionizable cosmetic active principle bonded in noncovalent fashion to the resin.

Priority: FR20070001840 Applic. Date: 2007-03-14; US20070941741P Applic. Date: 2007-06-04; WO2008EP53109 Applic. Date: 2008-03-14

Inventor: CASADO-CHAUDANSON AUDREY MARJORIE [FR]; PASTOR AUDREY CELINE MARCELLE [FR]


Application No.: US20100021510A1  Published: 28/Jan/2010

Title: NEURONAL EXOCYTOSIS INHIBITING PEPTIDES

Applicant/Assignee: LIPOTEC, S.A

Application No.: 12/447136   Filing Date: 24/Oct/2007

Abstract:The invention relates to peptides of general formula (I): R1-AA-R2 (I) which can regulate neuronal exocytosis, their stereoisomers and racemic or non-racemic mixtures thereof, and the cosmetically or pharmaceutically acceptable salts thereof, wherein AA is a sequence of 3 to 40 adjacent amino acids contained in the amino acid sequence of the SNAP-25 protein, R1 is selected from the group consisting of H or alkyl, aryl, aralkyl or acyl group

and R2 is selected from the group consisting of amino, hydroxyl or thiol, substituted or non-substituted with aliphatic or cyclic groups, with the condition that when R1 is H or acetyl, R2 is not non-substituted amino, hydroxyl or thiol. The invention also relates to a method of obtaining such peptides, cosmetic or pharmaceutical compositions containing them and their use to treat those conditions requiring neuronal exocytosis regulation, preferably for treating the skin.

Priority: ES20060002720 Applic. Date: 2006-10-25; WO2007ES00603 Applic. Date: 2007-10-24

Inventor: CARRENO SERRAIMA CRISTINA [ES]; PONSATI OBIOLS BERTA [ES]; VAN DEN NEST WIM [ES]; FERNANDEZ CARNEADO JIMENA [ES]; FERRER MONTIEL ANTONIO [ES]; CEBRIAN PUCHE JUAN [ES]; ALMINANA DOMENECH NURIA [ES]


Application No.: US20100021511A1  Published: 28/Jan/2010

Title: DISPERSION COMPOSITION, COSMETIC PREPARATION FOR SKIN CARE, AND METHOD FOR PRODUCING DISPERSION COMPOSITION

Applicant/Assignee: FUJIFILM CORPORATION

Application No.: 12/522152   Filing Date: 27/Dec/2007

Abstract:The present invention provides: a dispersion composition including a carotenoid-containing oily component, the dispersion composition being obtained by mixing an aqueous dispersion containing emulsion particles containing the carotenoid-containing oily component and a phospholipid or a derivative thereof with an aqueous composition containing ascorbic acid or a derivative thereof and an oily component that is 20% by mass or less relative to the mass of the whole dispersion composition, and the dispersion composition having emulsion particles having an average particle diameter of 200 nm or less

a dispersion composition including a carotenoid-containing oily component, the dispersion composition being obtained by mixing an aqueous dispersion containing emulsion particles containing a carotenoid-containing oily component and a phospholipid or a derivative thereof with an aqueous composition containing ascorbic acid or a derivative thereof and a pH adjusting agent, and the dispersion composition having a pH value in the range of 5 to 7.5

and a cosmetic preparation for skin care including one or other of the dispersion compositions.

Priority: JP20070000679 Applic. Date: 2007-01-05; JP20070169635 Applic. Date: 2007-06-27; WO2007JP75210 Applic. Date: 2007-12-27

Inventor: KAWABUCHI TATSUO [JP]; KUBO TOSHIAKI [JP]; OGAWA MANABU [JP]; SUZUKI KEIICHI [JP]; TASHIRO TOMOKO [JP]; SUDO YUKIO [JP]


Application No.: US20100021571A1  Published: 28/Jan/2010

Title: Compositions and Methods for Treating Acne

Applicant/Assignee: REVANCE THERAPEUTICS, INC

Application No.: 11/816670   Filing Date: 30/Mar/2006

Abstract:This invention provides anti-acne kits that are useful for treating acne, especially severe cases of acne. The anti-acne kits include a vasoconstrictor and an anti-acne agent, and optionally one or more of a a skin lightening therapeutic, a sealing layer, a skin cleanser, an astringent, a skin penetration enhancer, a sunscreen, and nutritional supplements that promote healing of acne lesions. This invention also provides methods for treating acne using a vasoconstrictor in conjunction with an anti-acne agent.

Priority: US20050666531P Applic. Date: 2005-03-30; WO2006US12095 Applic. Date: 2006-03-30

Inventor: WAUGH JACOB M [US]; LEE JAE HOON [US]


Application No.: US20100022461A1  Published: 28/Jan/2010

Title: Novel Derivatives of Cyclic Compound And The Use Thereof

Applicant/Assignee: WONKISOPHARM CO., LTD

Application No.: 12/307153   Filing Date: 02/Jul/2007

Abstract:Disclosed is tonovel cyclic derivatives having potent inhibiting effect on melanin formation and skin hyper-pigmentation activity with no adverse response to skin. They can be used as the therapeutics for treating and preventing the skin disease caused by over-reproduced melanin.

Priority: KR20060062703 Applic. Date: 2006-07-04; WO2007KR03199 Applic. Date: 2007-07-02

Inventor: CHO HYUN CHUL [KR]; CHOI YONGHYUN [KR]; YHEI JONGHAN [KR]


Application No.: US20100022546A1  Published: 28/Jan/2010

Title: ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME

Applicant/Assignee: H. LUNDBECK A/S

Application No.: 12/504711   Filing Date: 17/Jul/2009

Abstract:The present invention provides adamantyl-diamide derivatives of formula (1): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof

and pharmaceutical compositions and methods using the same.

Priority: US20090160804P Applic. Date: 2009-03-17; US20080083563P Applic. Date: 2008-07-25

Inventor: JIMENENZ HERMOGENES N [US]; LI GUIYING [US]; DOLLER DARIO [US]; GRENON MICHEL [US]; WHITE ANDREW D [US]; MA GIL [US]; GUO MAOJUN [CN]


Application No.: US20100022642A1  Published: 28/Jan/2010

Title: Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/318938   Filing Date: 13/Jan/2009

Abstract:Dermatological/cosmetic compositions contain, in a physiologically acceptable medium, at least one retinoid, dispersed benzoyl peroxide and a gelling system comprising at least two categories of compounds.

Priority: FR20060052967 Applic. Date: 2006-07-13; WO2007EP57091 Applic. Date: 2007-07-11

Inventor: LOUIS FABIENNE [FR]; WILLCOX NATHALIE [FR]; SEGURA-ORSONI SANDRINE [FR]


Application No.: US20100022654A1  Published: 28/Jan/2010

Title: ANTIMICROBIAL COMPOSITIONS

Applicant/Assignee:

Application No.: 12/445376   Filing Date: 25/Oct/2007

Abstract:Antimicrobial compositions are provided that include a hydroalcoholic solvent system comprising a lower C2-C5 alcohol and water

a cationic antimicrobial agent such as chlorhexidine gluconate

a fatty component containing at least one free hydroxyl group, such as a C12-C21 fatty alcohol, a C12-C21 fatty ester, a C12-C21 fatty ether, a C12-C21 fatty amide, and combinations thereof

and optionally an emollient ester such as diesters of bibasic acids and triesters of citric acid. The compositions described herein display improved antimicrobial efficacy and improved cosmetic elegance.

Priority: US20060863335P Applic. Date: 2006-10-27; WO2007US82465 Applic. Date: 2007-10-25

Inventor: ASMUS ROBERT A [US]; HOBBS TERRY R [US]


Application No.: US20100022657A1  Published: 28/Jan/2010

Title: Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine

Applicant/Assignee: NORGINE EUROPE BV

Application No.: 12/586973   Filing Date: 30/Sep/2009

Abstract:1R,2S-Methoxamine may be used topically for effective treatment of faecal incontinence at low doses without local or systemic side effects, for example, without affecting blood pressure. 1R,2S-Methoxamine may be used to treat other disturbances and disorders of the gastrointestinal, as a pressor agent, as a nasal decongestant and in ophthalmology, at low does and without significant side effects.

Priority: GB20010030763 Applic. Date: 2001-12-21; WO2002GB05864 Applic. Date: 2002-12-20; US2004-499873 Applic. Date: 2004-12-27

Inventor: BARRAS NORMAN [GB]; THOMPSON JEFFREY MARTIN [GB]


Application No.: US20100022961A1  Published: 28/Jan/2010

Title: SUPERTHIN WOUND DRESSING HAVING FOLDED RELEASE SHEET

Applicant/Assignee: JENTEC , INC

Application No.: 12/302695   Filing Date: 21/Jun/2007

Abstract:A wound dressing, which is easy to apply in very few steps, the dressing having a thin film section surrounded by a thicker outside border section. The border section provides rigidity to the dressing by virtue of being thicker than the inner thin film portion of the dressing. The wound dressing has a film on one side of the dressing layer and a release sheet on a skin-contacting side of the dressing layer.

Priority: US20060816295P Applic. Date: 2006-06-23; WO2007US71736 Applic. Date: 2007-06-21

Inventor: DEWEY JAMES C [US]


Application No.: US20100022997A1  Published: 28/Jan/2010

Title: Method and process for producing youthful-appearing, small-pored, and smooth skin

Applicant/Assignee:

Application No.: 10/735362   Filing Date: 12/Dec/2003

Abstract:The method and process for producing youthful appearing, small-pored, and smooth skin comprises pre-treating the skin topically with retinoic acid, applying a contaminant in oil to the skin, and removing the contaminate by exploding or rupturing it with laser light. When treating the face, removing the contaminant requires only about 4 minutes. The laser light itself does not injure the skin but the rupture of the contaminant produces thermal injury in the high dermis leaving the epidermis intact. Repeated intermittent laser treatments and applications of topical retinoic acid produces the desired results in the skin indefinitely as long as the treatment and applications are continued.

Priority: US2002-047335 Applic. Date: 2002-01-14

Inventor: PARSONS DIANA J [US]


Application No.: US20100023003A1  Published: 28/Jan/2010

Title: SKIN REJUVINATION RESURFACING DEVICE AND METHOD OF USE

Applicant/Assignee: SPAMEDICA INTERNATIONAL SRL

Application No.: 12/573923   Filing Date: 06/Oct/2009

Abstract:A skin rejuvenation resurfacing apparatus comprising an oscillating, reciprocating high speed, needle-based device and its related procedure for inducing mechanical trauma to an area of the skin to be treated.

Priority: US2005-315841 Applic. Date: 2005-12-22; US2009-555914 Applic. Date: 2009-09-09

Inventor: MULHOLLAND R STEPHEN [CA]


Application No.: US20100028270A1  Published: 04/Feb/2010

Title: URETHANE COMPOUND COMPRISING AN INCORPORATED POLYETHER GROUP-CONTAINING SILICONE DERIVATIVE AND A NITROGEN HETEROCYCLE

Applicant/Assignee: BASF AKTIENGESELLSCHAFT

Application No.: 11/722189   Filing Date: 22/Dec/2005

Abstract:The present invention relates to a urethane compound which comprises, in incorporated form, at least one polyether group-containing silicone derivative, at least one nitrogen heterocycle and at least one polyisocyanate, to cosmetic and pharmaceutical compositions which comprise such a urethane compound, and to the use of such a urethane compound.

Priority: DE200410062201 Applic. Date: 2004-12-23; WO2005EP13927 Applic. Date: 2005-12-22

Inventor: NGUYEN-KIM SON [DE]


Application No.: US20100028276A1  Published: 04/Feb/2010

Title: SUNSCREEN COMPOSITIONS

Applicant/Assignee:

Application No.: 12/449932   Filing Date: 05/May/2007

Abstract:Sunscreen and sunblock formulations that provide cytoprotective and immuno-enhancing additives avoiding endocrine disrupting agents, (a) at least one inorganic sun-blocking or sunscreen agent that is a proven non-endocrine disrupter, (b) at least one emollient proven to be a non-endocrine disrupter

and (c) an oil component capable of protecting skin from harmful effects of radiation including sunlight and ultraviolet light wherein the oil is a carrier oil, an essential oil, or both are described. The formulations preferably include an essential oil of a naturally-occurring substance as well as suitable inorganic components including titanium dioxide, zinc oxide, silica or silicon dioxide, fluoropolymers, and mixtures thereof. Suitable organic components include butylmethoxy dibenzoylmethane. Cold-processed Aloe barbadensis Miller-Stockton, a single species of Aloe barbadensis containing glucose-rich mannose-containing oligosaccharide or oligosaccharides, can also be used. Test methodologies and results indicate specific differences from conventional formulations.

Priority: WO2007US05672 Applic. Date: 2007-03-05

Inventor: GRUNE GUERRY L [US]


Application No.: US20100028277A1  Published: 04/Feb/2010

Title: COMPOSITION CONTAINING A COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, AND COSMETIC TREATMENT PROCESS

Applicant/Assignee: L'OREAL

Application No.: 12/495875   Filing Date: 01/Jul/2009

Abstract:Composition containing, in a cosmetically or dermatologically acceptable medium, a compound that may be obtained by reaction between: an oil bearing at least one nucleophilic and/or electrophilic reactive function, and a junction group capable of establishing hydrogen bonds with one or more partner junction groups, the junction group bearing at least one reactive function capable of reacting with the reactive function borne by the oil, and also comprising at least one unit of formula (I) or (II):

Priority: FR20080054556 Applic. Date: 2008-07-04; US20080080283P Applic. Date: 2008-07-14

Inventor: CHODOROWSKI-KIMMES SANDRINE [FR]; RODRIGUEZ IVAN [FR]


Application No.: US20100028278A1  Published: 04/Feb/2010

Title: USE OF CHROMAN-4-ONE DERIVATIVES

Applicant/Assignee: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG

Application No.: 12/531369   Filing Date: 21/Feb/2008

Abstract:The invention relates to the use of compounds of the formula (I) or of a composition comprising at least one compound of the formula (I), containing radicals as described in the claims, for the care, preservation or improvement of the general state of the skin or hair.

Priority: DE200710013366 Applic. Date: 2007-03-16; WO2008EP01352 Applic. Date: 2008-02-21

Inventor: CAROLA CHRISTOPHE [DE]; ROSSKOPF RALF [DE]


Application No.: US20100028288A1  Published: 04/Feb/2010

Title: MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE

Applicant/Assignee: FIRMENICH SA

Application No.: 12/438713   Filing Date: 24/Aug/2007

Abstract:The invention relates to a malodor counteractancy or counteracting (MOC) method that resorts to the use of specific malodor counteracting (MOC) mixtures of fragrance ingredients. More particularly, the invention relates to new MOC compositions capable of neutralizing or masking in an efficient manner malodors of a large variety of such as body or animal malodors, kitchen malodors, toilet and bathroom malodors, and tobacco malodor. The novel MOC compositions of the invention contain at least one nitrile material in combination with another fragrance material and can be used in any finished consumer products such as air fresheners, kitchen or toilet/bathroom cleaning or freshening products, textile treatment products and products for application on the human skin or hair, or on animal fur, litter containers or cages.

Priority: EP20060119640 Applic. Date: 2006-08-28; WO2007IB53399 Applic. Date: 2007-08-24

Inventor: TRANZEAT LYSE [GB]; O'LEARY NICHOLAS [US]; KOS WESSEL-JAN [GB]


Application No.: US20100028317A1  Published: 04/Feb/2010

Title: Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators

Applicant/Assignee:

Application No.: 12/489619   Filing Date: 23/Jun/2009

Abstract:Compositions and methods for enhancing repair of damaged DNA in skin cells. Topical compositions comprising at least one agent that upregulates circadian gene expression in skin cells and at least one non-circadian agent that delays mitosis in skin cells. Preferably, such compositions comprise one or more keratinocyte clock and per1 gene activators, along with SIRT1 or one or more sirt1 activators. More preferably, the sirt1 activator is a synergistic combination of specific peptidic sirt1 activators and resveratrol. Preferably, such compositions are easy to use, efficacious, cosmetically acceptable, chemically, thermodynamically and light stable, safe for topical use, have little or no side effects, and commercially feasible in a personal care marketplace.

Priority: US2007-837658 Applic. Date: 2007-08-13; US2009-367705 Applic. Date: 2009-02-09

Inventor: MAES DANIEL H [US]; PERNODET NADINE A [US]; MAMMONE THOMAS [US]; PELLE EDWARD [US]; COLLINS DONALD F [US]; SLUTSKY LENNY [US]; GOLDGRABEN KERRI [US]; MCCARTHY JAMES TIMOTHY [US]


Application No.: US20100028391A1  Published: 04/Feb/2010

Title: Cosmetics Comprising A Modified Organopolysiloxane

Applicant/Assignee:

Application No.: 11/993436   Filing Date: 21/Jun/2006

Abstract:This invention relates to a cosmetics characterized in that it contains a gelling agent comprising an organopolysiloxane having a silicon-bonded organic group represented by general formula:R1-X-CO-NH-[X-N(-CO-X-R1)]p-X- (1) (wherein R1 designates a group containing metal salt of a carboxylic acid represented by formula -COO- (Mn+)1/n, (where M is a metal that has a valence of 1 or higher)

X's designate the same or different C2 to C14 bivalent hydrocarbon groups

and p designates an integer from 0 to 10.). Preferably, the organosiloxane has an optionally substituted C9 or more univalent hydrocarbon group. Adding the gelling agent makes it possible to provide a cosmetic possessing superior temporal stability, water retention properties, sensory feel, gloss, curl retention, and cleansing power.

Priority: JP20050180066 Applic. Date: 2005-06-21; JP20050180072 Applic. Date: 2005-06-21; JP20060166880 Applic. Date: 2006-06-16; WO2006JP312848 Applic. Date: 2006-06-21

Inventor: OKAWA TADASHI [JP]; IIMURA TOMOHIRO [JP]


Application No.: US20100028392A1  Published: 04/Feb/2010

Title: Personal Care Article

Applicant/Assignee:

Application No.: 12/226118   Filing Date: 05/Apr/2007

Abstract:A personal care article including a substrate having impregnated therein, applied thereon or arranged to substantially encase, a cosmetic composition which includes a hair modification active, wherein the pH of the composition is substantially less than 9.0, and at least a portion of the article has exfoliating properties.

Priority: GB20060006992 Applic. Date: 2006-04-07; GB20060012486 Applic. Date: 2006-06-23; WO2007GB01305 Applic. Date: 2007-04-05

Inventor: CAWTHORNE LEE [GB]; DODD KAREN [GB]; TINDAL ANNE [GB]


Application No.: US20100028399A1  Published: 04/Feb/2010

Title: Use of Polymers

Applicant/Assignee: CROMA-PHARMA GESELLSCHAFT M.B.H

Application No.: 12/520820   Filing Date: 21/Dec/2007

Abstract:The present invention relates to the use of a thiol-group-containing polymer for preparing an implant for tissue augmentation, wherein the basis polymer is a polysaccharide.

Priority: AT20060002136 Applic. Date: 2006-12-22; US20060871534P Applic. Date: 2006-12-22; WO2007AT00585 Applic. Date: 2007-12-21

Inventor: HORNOF MARGIT [AT]


Application No.: US20100028458A1  Published: 04/Feb/2010

Title: MILD COMPOSITION FOR SKIN DISINFECTION

Applicant/Assignee: ASEPTIX RESEARCH B.V

Application No.: 12/312874   Filing Date: 12/Dec/2007

Abstract:The present invention discloses compositions for aqueous skin disinfection comprising hydrogen peroxide in a concentration of at least 0.1% to 10% (w/w), preferably 0.2-6%, and an N-acylated amino acid and/or peptide in the range of 0.1-20% (w/w), preferably 0.1-10%, more preferably 0.2-8%, and most preferably 0.2-5% (w/w). The N-acylated amino acid composition may be N-acylated glutamic acid and/or an N-acylated wheat protein hydro-lysate, or a salt thereof.

Priority: EP20060126044 Applic. Date: 2006-12-13; WO2007EP63831 Applic. Date: 2007-12-12

Inventor: BOBBERT ILJA [NL]


Application No.: US20100028463A1  Published: 04/Feb/2010

Title: EXTRACT OF STEWARTIA KOREANA AND USE THEREOF

Applicant/Assignee: RNA, INC

Application No.: 12/279194   Filing Date: 13/Feb/2007

Abstract:The present invention relates to an extract of Stewartia koreana and use thereof. More particularly, it relates to an extract of Stewartia koreana which is extracted with any one selected from the group consisting of water, a C1-4 low alcohol, a polar solvent, a non-polar solvent and a mixture thereof, and a pharmaceutical composition for promoting angiogenesis or tissue regeneration and a cosmetic for improving wrinkles comprising the same as an effective ingredient. The extract of Stewartia koreana according to the present invention promotes migration and multiplication of endothelial cell and shows excellent effect in angiogenesis and wound healing and thus, is useful in treatment or prevention of diseases which requires angiogenesis for healing of wounded and frostbitten region, wound healing after surgical operation, and treatment and prevention of gastric ulcer, ischaemic heart diseases and hair loss. Also, the extract shows the dermal tissue regenerating effect and thus, is useful as a cosmetic for improving wrinkles.

Priority: KR20060013888 Applic. Date: 2006-02-13; WO2007KR00763 Applic. Date: 2007-02-13

Inventor: KIM JI YOUNG [KR]; CHUNG DAE KYUN [KR]; LEE TAE HOON [KR]; LEE GUY WILHEM [KR]; LEE JUNG MIN [KR]


Application No.: US20100028638A1  Published: 04/Feb/2010

Title: Absorbent Article With Barrier Component

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 12/535271   Filing Date: 04/Aug/2009

Abstract:An absorbent article may comprise a barrier component, the barrier component may comprise a nonwoven barrier sheet, the nonwoven barrier sheet may comprise a spunbond nonwoven web comprising spunbond fibers, and the nonwoven barrier sheet may further comprise a meltblown nonwoven web comprising meltblown fibers. The spunbond fibers may have a number average fiber diameter of from about 6 to about 18 microns. The meltblown fibers may have a number average fiber diameter from about 1 to about 5 microns. And, the total weight percentage (by basis weight of the nonwoven barrier sheet) of the meltblown web may be from about 5% to about 30%.

Priority: US20080085903P Applic. Date: 2008-08-04

Inventor: REICHARDT NICOLE ANJA [DE]; SPRINGOB CHRISTIAN [DE]; WISE BRANDON ELLIS [US]; HUMMELGAARD LONE KONDRUP [DK]; UDENGAARD BRIAN [DK]


Application No.: US20100029537A1  Published: 04/Feb/2010

Title: DELIVERY PARTICLE

Applicant/Assignee: APPLETON PAPERS INC. (A DELAWARE CORPORATION)

Application No.: 12/508214   Filing Date: 23/Jul/2009

Abstract:The present application relates to encapsulated benefit agents, compositions comprising such encapsulated benefit agents and processes for making and using compositions comprising such encapsulated benefit agents that do not require or require a reduced amount of scavenger materials. Such encapsulated benefit agents, compositions comprising such encapsulated benefit agents are processed such that no or lower levels of scavenger materials are required.

Priority: US20080084786P Applic. Date: 2008-07-30

Inventor: DIHORA JITEN ODHAVJI [US]; VANDERVEKEN WALTER FRANCISCUS JOANNA [BE]; KIRKSEY JR SANFORD THEODORE [US]; DEBRAAL JOHN CHARLES [US]; BOBNOCK ROBERT STANLEY [US]; DRUCKREY ADAM KEITH [US]; HART GARY THOMAS [US]


Application No.: US20100029539A1  Published: 04/Feb/2010

Title: DELIVERY PARTICLE

Applicant/Assignee:

Application No.: 12/507814   Filing Date: 23/Jul/2009

Abstract:The present application relates to encapsulated benefit agents, compositions comprising such encapsulated benefit agents and processes for making and using compositions comprising such encapsulated benefit agents that do not require or require a reduced amount of scavenger materials. Such encapsulated benefit agents, compositions comprising such encapsulated benefit agents are processed such that no or lower levels of scavenger materials are required.

Priority: US20080084786P Applic. Date: 2008-07-30

Inventor: DIHORA JITEN ODHAVJI [US]; VANDERVEKEN WALTER FRANCISCUS [BE]; KIRKSEY JR SANFORD THEODORE [US]; DEBRAAL JOHN CHARLES [US]; BOBNOCK ROBERT STANLEY [US]; HART GARY THOMAS [US]; DRUCKREY ADAM KEITH [US]


Application No.: US20100029553A1  Published: 04/Feb/2010

Title: Microfluidic Device for Controlled Aggregation of Spider Silk

Applicant/Assignee: TECHNISCHE UNIVERSITAET MUENCHEN

Application No.: 12/227498   Filing Date: 21/May/2007

Abstract:The present invention is directed to a device and method of controlling the phase separation of one or a mixture of two or more spider silk proteins, leading to the defined and controllable assembly of the said silk protein(s) to defined morphologies, such as spheres, nano fibrils, threads, etc.

Priority: EP20060011841 Applic. Date: 2006-06-08; WO2007EP54878 Applic. Date: 2007-05-21

Inventor: SCHEIBEL THOMAS [DE]


Application No.: US20100029564A1  Published: 04/Feb/2010

Title: NOVEL PROCESS OF SOLUBILIZING PROTEIN FROM A PROTEINACEOUS MATERIAL AND COMPOSITIONS THEREOF

Applicant/Assignee: BIOVA, L.L.C

Application No.: 12/508750   Filing Date: 24/Jul/2009

Abstract:The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.

Priority: US2008-253719 Applic. Date: 2008-10-17; US20070980607P Applic. Date: 2007-10-17

Inventor: STROHBEHN RONALD E [US]; ETZEL LISA R [US]; FIGGINS JESSE [US]


Application No.: US20100029583A1  Published: 04/Feb/2010

Title: PROCESS FOR OBTAINING AN ACTIVE INGREDIENT WITH AN IMMEDIATE TENSOR EFFECT ON THE SKIN, ACTIVE INGREDIENT AND COMPOSITIONS

Applicant/Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE, DITE SILAB

Application No.: 12/442441   Filing Date: 21/Sep/2007

Abstract:The invention relates to a method for obtaining an active ingredient having an immediate anti-wrinkle and skin-tensioning effect, characterised in that it comprises extracting and purifying high molecular weight polysaccharides from oat bran and/or fibres and/or grains, and solutioning and stabilising the polysaccharides in water. The invention also relates to the product thus obtained, to uses thereof, and to cosmetic compositions containing this active ingredient.

Priority: FR20060053903 Applic. Date: 2006-09-22; FR20070053714 Applic. Date: 2007-03-08; WO2007FR51992 Applic. Date: 2007-09-21

Inventor: PAUFIQUE JEAN [FR]


Application No.: US20100029601A1  Published: 04/Feb/2010

Title: Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy

Applicant/Assignee: GALDERMA S.A

Application No.: 12/457732   Filing Date: 19/Jun/2009

Abstract:Topical application of a triple combination immixture of fluocinolone acetonide, tretinoin and hydroquinone is useful for the maintenance therapy of melasma to prevent hyperpigmentation recurrence or reduce the severity of the hyperpigmentation recurrence.

Priority: WO2007EP64269 Applic. Date: 2007-12-19; US20060875529P Applic. Date: 2006-12-19

Inventor: ARELLANO MENDOZA IVONNE [MX]


Application No.: US20100029602A1  Published: 04/Feb/2010

Title: LOW-DOSE MOMETASONE FORMULATIONS

Applicant/Assignee: PERRIGO ISRAEL PHARMACEUTICALS LTD

Application No.: 12/535406   Filing Date: 04/Aug/2009

Abstract:Provided is a topical cream composition for the delivery of mometasone furoate comprising low dose mometasone furoate for the treatment of corticosteroid responsive dermatoses. The composition of the present invention can be safely applied over large surface areas of the skin (including areas with wrinkles and/or hair), and can be used therapeutically for extended periods of time (e.g., greater than 3 weeks). Treatment with the composition of the present invention carries reduced and/or fewer side effects compared with commercially available mometasone furoate cream products. The cream composition of the present invention is safe for the use of babies and infants under 2 years old. Additionally provided are methods of preparing and using the composition of the invention.

Priority: WO2008IL00485 Applic. Date: 2008-04-09; US20070911185P Applic. Date: 2007-04-11

Inventor: ARKIN MOSHE [IL]; ZEEVI AMIRA [IL]; CHERKEZ STEPHEN [IL]; ASCULAI EILON [IL]; UZAN RINA [IL]; BRAGHINSKI BELLA [IL]


Application No.: US20100029764A1  Published: 04/Feb/2010

Title: COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION

Applicant/Assignee: REVALESIO CORPORATION

Application No.: 12/435262   Filing Date: 04/May/2009

Abstract:Provided are electrokinetically-altered fluids (e.g., gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. Particular aspects of the present invention provide compositions and methods suitable for modulation of at least one of cellular membrane potential and cellular membrane conductivity. Additional aspects provide compositions and methods suitable for modulating intracellular signal transduction, including modulation of at least one of membrane structure, membrane potential or membrane conductivity, membrane proteins or receptors, ion channels, and calcium dependant cellular messaging systems, comprising use of the inventive electrokinetically altered solutions to impart electrochemical and/or conformational changes in membranous structures (e.g., membrane proteins, receptors and/or other components) including G-protein coupled receptors (GPCRs), G-proteins, and/or intracellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes).

Priority: US2008-256774 Applic. Date: 2008-10-23; US20070982719P Applic. Date: 2007-10-25; US20070982720P Applic. Date: 2007-10-25; US20080048332P Applic. Date: 2008-04-28; US20080048340P Applic. Date: 2008-04-28; US20080048347P Applic. Date: 2008-04-28; US20080048404P Applic. Date: 2008-04-28

Inventor: WATSON RICHARD L [US]; WOOD ANTHONY B [US]; ARCHAMBEAU GREGORY J [US]


Application No.: US20100029766A1  Published: 04/Feb/2010

Title: Blends Comprising a Substituted Fatty Acid or a Derivative Thereof

Applicant/Assignee:

Application No.: 12/508635   Filing Date: 24/Jul/2009

Abstract:The invention concerns blends of a hydroquinone substituted poly unsaturated fatty acid (as present in Kombo nut oil) or a derivative thereof, which blends comprised: (i) 0.1-99.9 wt % of the substituted acid (ii) 0-99.8 wt % of Kombo butter glycerides (iii) 0.1-99.9 wt % of other triglycerides Food products and food supplements comprising such hydroquinone substituted acids are also part of the invention. The substituted acids display many useful health benefits.

Priority: EP20010307523 Applic. Date: 2001-09-04; EP20020251500 Applic. Date: 2002-03-04; US2002-230352 Applic. Date: 2002-08-29

Inventor: BARCLAY SCOTT SINCLAIR [GB]; BOSLEY JOHN ANTHONY [GB]; CAIN FREDERICK WILLIAM [NL]; KOENEN CLAUDIA [NL]; ROGERS JULIA SARAH [GB]; SCHMID ULRIKE [NL]


Application No.: US20100029784A1  Published: 04/Feb/2010

Title: NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES

Applicant/Assignee:

Application No.: 12/499051   Filing Date: 07/Jul/2009

Abstract:The present invention relates to methods and compositions comprising naphthoquinones such as 2,3-dimethylnaphthalene-1,4-dione, for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible and/or tactile discontinuities of the skin resulting from skin pigmentation or skin aging are also disclosed.

Priority: US20080137415P Applic. Date: 2008-07-30

Inventor: HINMAN ANDREW W [US]; MILLER GUY M [US]


Application No.: US20100030058A1  Published: 04/Feb/2010

Title: Methods of Treating Wrinkles, Developing Wrinkle Treatments And Evaluating Treatment Efficacy, Based On Newly Discovered Similarities Between Wrinkles And Skin Wounds

Applicant/Assignee:

Application No.: 12/500374   Filing Date: 09/Jul/2009

Abstract:Disclosed are methods of measuring an endogenous wrinkle electric field and methods of characterizing topical applications, or other treatments, in terms of their effect on the endogenous electric field of wrinkles. Also included, are methods of developing topical applications, or other treatments that have a desired effect on the endogenous electric field of a wrinkle. The methods disclosed herein, are based on a new model of wrinkle physiology that exploits previously unknown similarities between skin wounds and wrinkles.

Priority: US20080085213P Applic. Date: 2008-07-31

Inventor: MAMMONE THOMAS [US]; IONITA-MANZATU VASILE [US]; HAWKINS GEOFFREY [US]; REIN GLEN [US]


Application No.: US20100030129A1  Published: 04/Feb/2010

Title: DERMAL PATCH

Applicant/Assignee: POWER PAPER LTD

Application No.: 12/575630   Filing Date: 08/Oct/2009

Abstract:The invention is generally directed to a kit and patch for transdermal or intradermal delivery of at least one substance into the skin. The kit includes a dermal patch having an electrochemical cell with two electrodes and a retainer for retaining a conductive fluid which further includes an active substance. The conductive fluid can be deposited on at least one of the two electrodes. Alternatively, the conductive fluid can be applied topically to the skin.

Priority: US2004-757414 Applic. Date: 2004-01-15; WO2002IL00848 Applic. Date: 2002-10-23; US20010330526P Applic. Date: 2001-10-24

Inventor: NITZAN ZVI [IL]; GROSS YOSSI [IL]; MAVOR DANIELA [IL]; TAMARKIN DOV [IL]


Application No.: US20100030571A1  Published: 04/Feb/2010

Title: Physician's practice aesthetic care program

Applicant/Assignee:

Application No.: 12/221562   Filing Date: 04/Aug/2008

Abstract:Disclosed is a method of generating a revenue stream by providing cosmetic medical aesthetic treatments to patients within their personal medical doctor's or other physician's (PMD's) office such that a second party business entity can provide sourcing of resources required, equipment, software, personnel hiring, operational and clinical training and consulting, development, placement and management of advertising and marketing, and a lead management system for the PMD or group of PMDs. The combining of similarly contracted physicians into an advertising and marketing group is also part of the present disclosure. Another important aspect of the disclosure is that the methods include providing a revenue sharing program between PMDs.

Priority:

Inventor: JONES DENNIS R [US]; NOON THOMAS R [US]


Application No.: US20100032500A1  Published: 11/Feb/2010

Title: MULTIPLE CONFIGURATION SHOWER DEVICE

Applicant/Assignee:

Application No.: 12/293641   Filing Date: 27/Mar/2007

Abstract:A multiple configuration shower device includes at least one handle (2) connected to a flexible duct for supplying water and at least one water dispensing element (5). The dispensing element (5) is provided with a plurality of water ejection faces (5a, 5b, 5c, 5d), each provided with respective nozzles (U), and comprising at least one connector (6), provided between the handle (2) and the dispensing element (5), which is adapted to allow the manual rotation of the dispensing element (5) about at least one axis which is substantially perpendicular to the handle (2), so as to arrange selectively at least one of the ejection faces (5a, 5b, 5c, 5d) substantially in the direction of the user.

Priority: IT2006BO00219 Applic. Date: 2006-03-30; IT2006BO00220 Applic. Date: 2006-03-30; WO2007IB00818 Applic. Date: 2007-03-27

Inventor: RIGHINI GIUSEPPE [IT]


Application No.: US20100034758A1  Published: 11/Feb/2010

Title: Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals

Applicant/Assignee:

Application No.: 11/835165   Filing Date: 07/Aug/2007

Abstract:The present invention relates to the Synthesis of Triterpenoid peptides and mechanism of action for Anti ageing and skin care. The present invention is directed towards anti-aging skin care compositions comprising peptides which are made by linking herbal actives to a pentapeptide for enhanced anti ageing activity by regenerating the dermal matrix. In detail, the present invention relates to the synthesis of Triterpenoid peptides, providing an enhanced and synergistic activity for reducing the consequences of ageing such as appearance of fine expression lines and wrinkles on the skin by cosmetic modes of application. The Triterpenoid peptides of the present invention with its novel dual action mode can be used for skin ageing & collagen insufficiency. Its Triterpenoid group acts by preventing oxidation and excess activity of serine proteases like elastase and collagenase that result in wrinkling of skin. With added peptides which boost the collagen and other matrix protein, Triterpenoid peptides provide a complete protection against pre mature ageing and functions as a best anti ageing ingredient.

Priority:

Inventor: MAJEED MUHAMMED [US]; CHANDRAMOULI RENUKESHWAR H [IN]; NAGABHUSHANAM KALYANAM [US]; SOOD RATTAN [IN]; PRAKASH SUBBALAKSHMI [US]; ANAND SUSMITHA [IN]


Application No.: US20100034761A1  Published: 11/Feb/2010

Title: PERSONAL CARE AND COSMETICS COMPOSITIONS COMPRISING BIOLOGICALLY-BASED MONO AND DI ESTERS

Applicant/Assignee:

Application No.: 12/579538   Filing Date: 15/Oct/2009

Abstract:Personal care compositions comprising esters of 1,3-propanediol and acceptable carriers are provided. The esters can have at least 3% biobased carbon, and the compositions can further comprise 1,3-propanediol that is biologically-derived. Also provided are processes for producing personal care compositions comprising esters of 1,3-propanediol and acceptable carriers. The processes comprise providing biologically produced 1,3-propanediol, contacting the 1,3-propanediol with organic acids, which produces the esters, recovering the esters, and incorporating the esters into personal care formulations. Also provided are processes of making a personal care composition comprising providing an ester of 1,3 propanediol and mixing the ester with an acceptable carrier to form a personal care composition.

Priority: US2007-705227 Applic. Date: 2007-02-12; US20060772471P Applic. Date: 2006-02-10; US20060772194P Applic. Date: 2006-02-10; US20060772193P Applic. Date: 2006-02-10; US20060772111P Applic. Date: 2006-02-10; US20060772120P Applic. Date: 2006-02-10; US20060772110P Applic. Date: 2006-02-10; US20060772112P Applic. Date: 2006-02-10; US20060846948P Applic. Date: 2006-09-25; US20060853920P Applic. Date: 2006-10-24; US20060859264P Applic. Date: 2006-11-15; US20060872705P Applic. Date: 2006-12-04; US20070880824P Applic. Date: 2007-01-17

Inventor: FENYVESI GYORGYI [US]; WEHNER ANN [US]; JOERGER MELISSA [US]; POLADI RAJA HARI PRASAD R [US]


Application No.: US20100034763A1  Published: 11/Feb/2010

Title: Skin Lightening Composition Comprising CO2 Extracts

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/185885   Filing Date: 05/Aug/2008

Abstract:Skin lightening additives and skin lightening compositions with carbon dioxide obtained plant extracts are described. The compositions are suitable for topical application and may comprise CO2 obtained Chamomile extract.

Priority:

Inventor: MADISON STEPHEN ALAN [US]


Application No.: US20100034764A1  Published: 11/Feb/2010

Title: Method for Preparing a Lipophilic Vine Extract

Applicant/Assignee:

Application No.: 12/460742   Filing Date: 23/Jul/2009

Abstract:The present invention relates to a method for preparing a lipophilic extract from lignified portions of vine, such as shoots, stock and roots, characterized in that said method comprises a step for extraction from said lignified portions with an apolar solvent

to an extract obtained by such a method

to the use of such an extract as an excipient in a cosmetic composition

and to a cosmetic composition comprising such an extract.

Priority: FR20080055117 Applic. Date: 2008-07-25

Inventor: PECHER VIRGINIE [FR]; ANDRE PATRICE [FR]


Application No.: US20100034810A1  Published: 11/Feb/2010

Title: PYRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION

Applicant/Assignee:

Application No.: 12/567051   Filing Date: 25/Sep/2009

Abstract:This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl

n is 0 to 5

m is 1 to 4

R1 is hydrogen

aryl

formyl

C1-6alkylcarbonyl

C1-6alkyl

C1-6alkyloxycarbonyl

substituted C1-6alkyl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyloxy

substituted C1-6alkyloxyC1-6alkylcarbonyl

R2 is hydroxy, halo, optionally substituted C1-6alkyl, C3-7cycloalkyl, optionally substituted C2-6alkenyl, optionally substituted C2-6alkynyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S(-O)pR6, -NH-S(-O)pR6, -C(-O)R6, -NHC(-O)H, -C(-O)NHNH2, -NHC(-O)R6, -C(-NH)R6 or a 5-membered heterocycle

X1 is -NR5-, -NH-NH-, -N-N-, -O-, -C(-O)-, C1-4alkanediyl, -CHOH-, -S-, -S(-O)p-, -X2-C1-4alkanediyl- or -C1-4alkanediyl-X2-

R3 is NHR13

NR13R14

-C(-O)-NHR13

-C(-O)-NR13R14

-C(-O)-R15

-CH-N-NH-C(-O)-R16

substituted C1-6alkyl

optionally substituted C1-6alkyloxyC1-6alkyl

substituted C2-6alkenyl

substituted C2-6alkynyl

C1-6alkyl substituted with hydroxy and a second substituent

-C(-N-O-R8)-C1-4alkyl

R7

or -X3-R7

R4 is halo, hydroxy, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxy, cyano, nitro, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl, formyl, amino, mono- or di(C1-4alkyl)amino

and pharmaceutical compositions comprising them.

Priority: WO2003EP01291 Applic. Date: 2003-02-07; US2004-544735 Applic. Date: 2004-02-04; WO2004EP01011 Applic. Date: 2004-02-04

Inventor: HEERES JAN [BE]; LEWI PAULUS JOANNES [BE]; JANSSEN PAUL ADRIAAN JAN [BE]; ARTS FRANK XAVIER JOZEF HERWIG [BE]; DE JONGE MARC RENE [NL]; KOYMANS LUCIEN MARIA HENRICUS [BE]; DAEYAERT FREDERIK FRANS DESIRE [BE]; VINKERS HENDRIK MAARTEN [BE]; GULLEMONT JEROME EMILE GEORGES [FR]; PASQUIER ELISABETH THERESA JEANNE [FR]


Application No.: US20100034838A1  Published: 11/Feb/2010

Title: Transdermal Administration of Active Agents for Systemic Effect

Applicant/Assignee:

Application No.: 12/086047   Filing Date: 07/Dec/2006

Abstract:The present invention relates to compositions for transdermal administration of a therapeutic agent for providing a systemic therapeutic effect. In particular, the invention relates to spreadable compositions, or compositions which may be solid at a temperature of about 25 DEG C. or less and have a softening point of not higher than 35 DEG C., wherein transdermal administration of the therapeutic agent may be either rapid or sustained.

Priority: GB20050024961 Applic. Date: 2005-12-07; WO2006GB50437 Applic. Date: 2006-12-07

Inventor: STANIFORTH JOHN [GB]; GOGGIN PAUL [GB]


Application No.: US20100034866A1  Published: 11/Feb/2010

Title: Fused stem cells useful for the treatment of diabetes and methods thereof

Applicant/Assignee:

Application No.: 12/311090   Filing Date: 19/Sep/2007

Abstract:Methods disclosed include methods of treating T1DM, said method comprising delivering a therapeutic amount of beta-MSC to a subject in need thereof. Further disclosed are fusion cells comprising and MSC and a second cell wherein the nuclei of the MSC and the second cell are not fused in the fusion cell.

Priority: US20060845712P Applic. Date: 2006-09-19; WO2007US20359 Applic. Date: 2007-09-19

Inventor: WESTENFELDER CHRISTOF [US]


Application No.: US20100034873A1  Published: 11/Feb/2010

Title: TRANSDERMAL RICINOLEIC ACID COMPOSITIONS

Applicant/Assignee:

Application No.: 12/186825   Filing Date: 06/Aug/2008

Abstract:Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.

Priority:

Inventor: DELPRETE KEITH [US]


Application No.: US20100034889A1  Published: 11/Feb/2010

Title: EFFERVESCENT TABLETS/GRANULES

Applicant/Assignee: PHYZZ, INC

Application No.: 12/536769   Filing Date: 06/Aug/2009

Abstract:This invention provides an effervescent solid form that dissolves in cold water quickly enough to not disappoint consumers yet not so quickly that the visual interest generated during the effervescent reaction is lost. This performance is achieved by forming effervescent particles that are dense enough to retard dissolution and small enough to not take too long to dissolve. The aim of this invention is to provide a beverage in solid effervescent form that takes between about 30 and about 120 seconds to dissolve in warm water. The granules may carry functional additives such as flavors, vitamins, minerals, sweeteners, colors and drugs. The granules may also be compounded of materials intended to provide relief from skin or topical discomfort, as in the form of a wash or bath additive. The granules may also be formulated to provide cleaning agents, such as ceramic cleaners and denture cleaners.

Priority: US20080086830P Applic. Date: 2008-08-07

Inventor: RAU ALLEN [US]; QUINN NICOLE [US]; STADOLNIK DONALD [US]; STERNER ERIC [US]


Application No.: US20100035258A1  Published: 11/Feb/2010

Title: ASSAY AND METHOD

Applicant/Assignee:

Application No.: 12/446885   Filing Date: 26/Oct/2007

Abstract:The present invention relates to a method and assay useful for determining the sensitivity of the cells of a subject to genetic damage from electromagnetic radiation. The assay may comprise a substrate suitable for mounting a sample of lymphocytes from a subject and an electromagnetic radiation source.

Priority: GB20060021272 Applic. Date: 2006-10-26; WO2007GB04082 Applic. Date: 2007-10-26

Inventor: SHARPE DAVID THOMAS [GB]; THOMAS DENYER MORGAN CLIVE [GB]; ANDERSON DIANA [GB]; BRITLAND STEPHEN THOMAS [GB]; GOPALAN RAJENDRAN [GB]


Application No.: US20100035327A1  Published: 11/Feb/2010

Title: Use of rice-derived products in a universal cell culture medium

Applicant/Assignee:

Application No.: 12/228172   Filing Date: 11/Aug/2008

Abstract:The invention is used as an additive to a culture medium to maintain and grow various cells including stem cells and support their manufactured and secreted products including cytokines, chemokines and growth factors in an environment which provides: a) metabolic enabling or enhancement of measurable parameters within the cellular population b) availability and usage of nutrients to cells c) distinct and positive effect on cellular dynamics (i.e. cellular proliferation and secretion of manufactured products by the cells) d) stabilized environment for maintaining conditions for growth and other cellular and metabolic processes including secretion of manufactured products including signaling factors e) enhanced biological cellular function of inherent cellular processes f) non-interference with normal cellular metabolics (i.e. signaling) g) increased protection from toxic effects to the cell h) additional benefits to the cellular population which in absence of the additive would be lacking.

Priority:

Inventor: STEELE ANN MARIE [US]; SMITH MARK DARGAN [US]; BOONCHUEN SOMCHAI [TH]


Application No.: US20100035790A1  Published: 11/Feb/2010

Title: Branched Polyorganosiloxanes Modified With Aromatic Substances

Applicant/Assignee: MOMENTIVE PERFORMANCE MATERIALS GMBH

Application No.: 12/531936   Filing Date: 19/Mar/2008

Abstract:The invention relates to fragrance-modified branched polyorganosiloxanes, methods for producing them and their use.

Priority: DE200710012910 Applic. Date: 2007-03-19; WO2008EP53297 Applic. Date: 2008-03-19

Inventor: LANGE HORST [DE]; ROOS CHRISTOPHER [DE]; WAGNER ROLAND [DE]; KROPFGANS MARTIN [DE]


Application No.: US20100035815A1  Published: 11/Feb/2010

Title: SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF

Applicant/Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA

Application No.: 12/522446   Filing Date: 08/Jan/2008

Abstract:A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A preferred heat shock protein is either full-length hsp90alpha or the middle domain plus the charged sequence of hsp90alpha. The composition is topically applied to skin wounds, covering the outer surface of the wound. The heat shock protein acts by promoting migration of both human epidermal keratinocyte and dermal fibroblasts to the wound in order to close, heal, and remodel the wound.

Priority: US20070879150P Applic. Date: 2007-01-08; WO2008US50520 Applic. Date: 2008-01-08

Inventor: LI WEI [US]; CHEN MEI [US]; WOODLEY DAVID T [US]


Application No.: US20100035819A1  Published: 11/Feb/2010

Title: METHOD OF PROMOTING SKIN COLLAGEN PRODUCTION

Applicant/Assignee: SNOW BRAND MILK PRODUCTS CO., LTD

Application No.: 12/579100   Filing Date: 14/Oct/2009

Abstract:It is intended to provide a skin collagen production promoter, foods and drinks for promoting skin collagen production and cosmetics for promoting skin collagen production which are useful in preventing skin chapping, wrinkles, worsening in skin fitness, etc. Namely, a skin collagen production promoter, foods and drinks for promoting skin collagen production and cosmetics for promoting skin collagen production which contain as the active ingredient(s) a milk-origin basic protein fraction and/or a basic peptide fraction obtained by digesting the above-described basic protein fraction with a protein digesting enzyme such as pepsin or pancreatin. The above basic protein fraction and basic peptide fraction have an effect of increasing skin collagen level.

Priority: US2003-553830 Applic. Date: 2003-05-07; WO2003JP05707 Applic. Date: 2003-05-07

Inventor: MORITA YOSHIKAZU [JP]; TAKADA YUKIHIRO [JP]; TOBA YASUHIRO [JP]; OOI WATARU [JP]; KAWAKAMI HIROSHI [JP]


Application No.: US20100035831A1  Published: 11/Feb/2010

Title: ANTI-WRINKLE AGENT AND ADAM INHIBITOR

Applicant/Assignee: SHISEIDO COMPANY, LTD

Application No.: 12/524528   Filing Date: 27/Dec/2007

Abstract:Disclosed is an anti-wrinkle agent for ameliorating a wrinkle (particularly a fine wrinkle) developed when the barrier function is decreased by dryness and the like. Also disclosed is an ADAM inhibitor. The anti-wrinkle agent or the ADAM inhibitor comprises an alkyl glucoside represented by the general formula: (1) [wherein R represents a linear or branched alkyl group having 1 to 18 carbon atoms] or a salt thereof.

Priority: JP20070016535 Applic. Date: 2007-01-26; WO2007JP75120 Applic. Date: 2007-12-27

Inventor: MATSUNAGA YUKIKO [JP]; AMANO SATOSHI [JP]; HIRUMA TAKUYA [JP]; FUKUNISHI HIROTADA [JP]; SUETSUGU MASARU [JP]; SHIBATA MICHIO [JP]


Application No.: US20100035997A1  Published: 11/Feb/2010

Title: KIT FOR APPLYING A POLYMERIZABLE ADHESIVE COMPOSITION TO TISSUES

Applicant/Assignee:

Application No.: 12/579024   Filing Date: 14/Oct/2009

Abstract:The invention relates to a kit for the topical and/or internal application of a polymerisable adhesive composition to tissues, enabling improved control of the polymerisation speed on the surface of the tissue, in addition to the effective disinfection of the wound. The kit consists of at least one receptacle and contains a polymerisable adhesive composition based on cyanacrylate, in addition to a disinfectant composition.

Priority: DE200710019044 Applic. Date: 2007-04-20; WO2008EP54346 Applic. Date: 2008-04-10

Inventor: BROADLEY KENNETH N [IE]; GUTHRIE JOHN [IE]; SWORDS NOELEEN [IE]


Application No.: US20100036280A1  Published: 11/Feb/2010

Title: METHOD OF UTILISING MEASUREMENTS OF THRESHOLD OF PAIN

Applicant/Assignee: ULL METER A/S

Application No.: 12/440438   Filing Date: 10/Sep/2007

Abstract:A method of determining the sympathetic tone and/or level of stress and/or level or warning system sensitivity includes the steps of: measuring an applied stimulation at a threshold value of the stimulation in one or more sympathetic tone-neutral points and measuring an applied stimulation at the same threshold value in one or more sympathetic tone-dependent points. The invention further relates to a system for applying and measuring a stimulation, and the use of a system for applying and measuring a stimulation for determining the sympathetic tone including the steps of: measuring an applied stimulation at a threshold value of the stimulation at one or more sympathetic tone-neutral points and measuring an applied stimulation at the same threshold value of the stimulation at one or more sympathetic tone-dependent points.

Priority: DK20060001159 Applic. Date: 2006-09-08; DK20060001321 Applic. Date: 2006-10-11; DK20070000190 Applic. Date: 2007-02-02; EP20070109765 Applic. Date: 2007-06-06; US20060842984P Applic. Date: 2006-09-08; US20060829068P Applic. Date: 2006-10-11; US20070924986P Applic. Date: 2007-06-07; WO2007EP59471 Applic. Date: 2007-09-10

Inventor: BALLEGAARD SOREN [DK]; MAGNUSSON GISLI [DK]


Application No.: US20100037364A1  Published: 18/Feb/2010

Title: CUT RESISTANT DAMAGE TOLERANT CHEMICAL AND LIQUID PROTECTIVE GLOVE WITH ENHANCED WET AND DRY GRIP

Applicant/Assignee: ANSELL HEALTHCARE PRODUCTS LLC

Application No.: 12/542443   Filing Date: 17/Aug/2009

Abstract:A damage tolerant cut resistant chemical handling glove that is flexible and lightweight comprises a cured, liquid-impervious polymeric latex shell, a knitted cut resistant liner comprising a cotton yarn and at least one cut resistant yarn, the liner being infiltrated with a soft nitrile or polyurethane layer such that the liner bonds to the shell. The soft nitrile or polyurethane layer seals interstices of the cut resistant liner and replicates its rough texture on the external surface of the glove, providing enhanced grip properties. A thin nitrile latex layer applied to and cured together with the polyurethane layer to protect the polyurethane layer from oil or chemical degradation. The intimate seal thus created between the shell and the liner prevents accumulation of liquid there between, which prevents formation of a liquid boundary layer and interference with grip properties of the glove.

Priority: US20080089664P Applic. Date: 2008-08-18

Inventor: SAUNDERS PAUL [GB]; FLATHER MICHAEL [GB]; NARASIMHAN DAVE [US]; BENNETT WILLIAM [US]


Application No.: US20100040561A1  Published: 07/Apr/2005

Title: Penetrating pharmaceutical foam

Applicant/Assignee: FOAMIX LTD FOAMIX, LTD

Application No.: 10/922358   Filing Date: 20/Aug/2004

Abstract:The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.

Priority: IL20020152486 Applic. Date: 2002-10-25; WO2003IB05527 Applic. Date: 2003-10-24; US2004-911367 Applic. Date: 2004-08-04; US20030497648P Applic. Date: 2003-08-25; US20020429546P Applic. Date: 2002-11-29; US20030492385P Applic. Date: 2003-08-04

Inventor: TAMARKIN DOV [IL]; FRIEDMAN DORON [IL]; EINI MEIR [IL]


Application No.: US20100040563A1  Published: 18/Feb/2010

Title: Solubilization of Cyclohexane-Based Carboxamide Derivatives for Use as Sensates in Consumer Products

Applicant/Assignee:

Application No.: 12/541406   Filing Date: 14/Aug/2009

Abstract:Disclosed are methods of solubilizing various coolants, in particular cyclohexane-based carboxamide derivatives to facilitate formulating these coolants into a wide variety of consumer products, including those for oral cavity, throat, skin and hair care applications. Suitable solvents are those that provide at least 5% concentrated solutions of these coolants. Particularly preferred solvents are those used in the perfume and flavor industries and are GRAS materials that do not contribute formulation difficulties or negative aesthetics.

Priority: US20080089093P Applic. Date: 2008-08-15

Inventor: HAUGHT JOHN CHRISTIAN [US]


Application No.: US20100040568A1  Published: 18/Feb/2010

Title: Steroidal compounds as melanogenesis modifiers and uses thereof

Applicant/Assignee: SKINMEDICA, INC

Application No.: 12/587882   Filing Date: 13/Oct/2009

Abstract:Provided are steroidal compounds of formula I, for example, conessine, and the use of such compounds and compositions thereof to modulate (e.g., inhibit) melanogenesis and pigmentation. Also provided are plant extracts containing a compound of formula I, for example, conessine, and the use of such a plant extract to modulate (e.g., inhibit) melanogenesis and pigmentation. The compound or plant extract may be prepared as pharmaceutical and cosmetic compositions, and may be used for the prevention and treatment of conditions that are related to aberrant melanogenesis activity.

Priority: US2009-433322 Applic. Date: 2009-04-30; US20080049114P Applic. Date: 2008-04-30

Inventor: ORLOW SETH J [US]; KOMATSU LI NI [US]


Application No.: US20100040608A1  Published: 18/Feb/2010

Title: Use of HMGB1 antagonists for the treatment of inflammatory skin conditions

Applicant/Assignee:

Application No.: 11/988896   Filing Date: 11/Jul/2006

Abstract:Methods are disclosed for treating an inflammatory skin condition in a subject. The methods comprise administering to a subject an HMGB antagonist, such as a high mobility group box (HMGB) A box or a biologically active fragment thereof, an antibody to HMGB or an antigen-binding fragment thereof, an HMGB small molecule antagonist, an antibody to TLR2 or an antigen-binding fragment thereof, a soluble TLR2 polypeptide, an antibody to RAGE or an antigen-binding fragment thereof, a soluble RAGE polypeptide and a RAGE small molecule antagonist.

Priority: US20050700704P Applic. Date: 2005-07-18; WO2006US27053 Applic. Date: 2006-07-11

Inventor: WAHREN-HERLENIUS MARIE [SE]; NYBERG FILIPPA [SE]; MARCHINI GIOVANNA [SE]


Application No.: US20100040701A1  Published: 18/Feb/2010

Title: COMPOUND FOR EXFOLIATING SKIN

Applicant/Assignee:

Application No.: 12/538212   Filing Date: 10/Aug/2009

Abstract:A novel exfoliating compound and method for treating acne without an irritating cleanser. The compound includes a first subcompound formed from a clay based substance and a second subcompound formed an exfoliating substance selected from the group consisting of crystals, beads, polyethylene, nuts, natural rough products, corundum crystals, crushed almond shells and crushed apricot kernels.

Priority: US20080088147P Applic. Date: 2008-08-12

Inventor: SCHWARTZ NEAL [US]


Application No.: US20100040702A1  Published: 18/Feb/2010

Title: Chemical composition for skin care formulations

Applicant/Assignee:

Application No.: 12/222803   Filing Date: 15/Aug/2008

Abstract:The present invention provides preservative compositions suitable for replacing, partially or in totality, conventional preservatives in skin care and hygiene cosmetic or pharmaceutical products. The preservative formulations include an organic carboxylic acid present in a concentration from about 0.01 to about 30 wt./wt. % of the formulation, an alcohol present in a concentration from about 0.01 to about 60 wt./wt. % of the formulation. The formulations include an inorganic salt present in a concentration from about 0.01 to about 80 wt./wt. % of the formulation, and a chelating agent present in a concentration from about 0.01 to about 20 wt./wt. % of the formulation.

Priority:

Inventor: GRASCHA PIERRE BRUNO [FR]; BATTUT MYLENE [FR]


Application No.: US20100040704A1  Published: 18/Feb/2010

Title: Composition and method for weight reduction

Applicant/Assignee:

Application No.: 12/228845   Filing Date: 18/Aug/2008

Abstract:Disclosed is a composition and method for facilitating weight loss in individuals. The composition is a physiologically effective amount of the herbal substance Bauhinia in a suitable carrier. The carrier can be water, alcohol, mixtures thereof, capsules, powders, tinctures, liposomes, chewing gum, lozenges, candies, food, skin creams, or lotions. The method is to administer a physiologically effective amount of the herbal substance to an individual seeking to lose weight. The preferred herbal substance is obtained from the leaves of a Bauhinia forficata tree.

Priority:

Inventor: TAI PAUL LING [US]


Application No.: US20100040706A1  Published: 18/Feb/2010

Title: METHOD OF ANTI-AGEING COSMETIC CARE BY STIMULATION OF SURVIVIN EXPRESSION

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/477409   Filing Date: 03/Jun/2009

Abstract:The invention relates to a cosmetic care method comprising the delivery of an effective amount of at least one cosmetically acceptable agent that activates or stimulates survivin expression in the stem cells of the basal layer of the epidermis. The invention makes it possible in particular to prevent or delay the appearance of the signs of skin aging or to treat them.

Priority: FR20080053794 Applic. Date: 2008-06-06

Inventor: DUMAS MARC [FR]; BONTE FREDERIC [FR]; RENIMEL ISABELLE [FR]


Application No.: US20100040709A1  Published: 18/Feb/2010

Title: HERBAL COMPOSITION FOR THE PREVENTION OF WRINKLES AND SKIN DISORDERS, METHODS OF PREPARING THE SAME AND USES THEREOF

Applicant/Assignee: HIMALAYA GLOBAL HOLDINGS, LTD

Application No.: 12/440917   Filing Date: 11/Mar/2009

Abstract:Disclosed is a natural herbal composition for preventing wrinkles and other skin disorders due to aging, stress and environmental factors without any side effect. The composition comprises extracts of Rhodomyrtus tomentosa, Cipadessa baccifera, Woodfordia fruticosa and Camellia sinensis.

Priority: WO2006IN00347 Applic. Date: 2006-09-12

Inventor: MITRA SHANKAR KUMAR [IN]; SAXENA EKTA [IN]


Application No.: US20100040710A1  Published: 18/Feb/2010

Title: Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.

Applicant/Assignee: BASF BEAUTY CARE SOLUTIONS FRANCE SAS

Application No.: 12/367299   Filing Date: 06/Feb/2009

Abstract:The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The Invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Priority: FR20030007177 Applic. Date: 2003-06-13

Inventor: PERRIER ERIC [FR]; CENIZO VALERIE [FR]; BOUEZ CHARBEL [FR]; SOMMER PASCAL [FR]; DAMOUR ODILE [FR]; GLEYZAL CLAUDINE [FR]; ANDRE VALERIE [FR]; REYMERMIER CORINNE [FR]


Application No.: US20100040714A1  Published: 18/Feb/2010

Title: Asthma/Allergy Therapy that Targets T-lymphoctyes and/or Eosinophils

Applicant/Assignee:

Application No.: 12/539731   Filing Date: 12/Aug/2009

Abstract:A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa seeds, in a concentration which stimulate Th1 lymphocytes and selectively switch-off the eosinophilic airway inflammation A method of treatment of allergy using Th1 stimulating agents, to be administered to a mammal such as human in need of such treatment in a shot of 5 days only, resulted in significant decrease in symptom score started day 3, and in sputum eosinophils by day 14, followed by long-term clinical remission of a mean of 6 months. The BCG-like Th1 stimulation is also used in treating diseases in which the body defensive mechanism is a Cell Mediated Immunity, including viral infections, as but not limited to influenza and common cold, Chronic and recurrent urinary tract infection, pelvic inflammatory diseases as neuroimmune appendicitis, cancer, crohns disease and facial palsy.

Priority: GB19990004777 Applic. Date: 1999-03-02; US2001-944564 Applic. Date: 2001-09-04

Inventor: NASIF NEDAA ABDUL-GHANI [QA]


Application No.: US20100041603A1  Published: 18/Feb/2010

Title: Method of Promoting Wound Healing

Applicant/Assignee: CORTHERA, INC

Application No.: 12/465613   Filing Date: 13/May/2009

Abstract:The present disclosure relates to methods of administering relaxin to promote wound healing and reduce scar formation. The disclosure further contemplates the use of relaxin in reconstructive and plastic surgery.

Priority: US20080127947P Applic. Date: 2008-05-16

Inventor: STEWART DENNIS R [US]


Application No.: US20100041630A1  Published: 18/Feb/2010

Title: Methods for Treating or Preventing Inflammation Using a Glycerophosphate Salt

Applicant/Assignee: PRELIEF INC

Application No.: 12/526818   Filing Date: 13/Feb/2008

Abstract:Glycerophosphate salts have been found to mitigate the syndromes or conditions of discomfort associated with inflammation. Therefore, methods are provided for treating or preventing an inflammatory condition using a glycerophosphate salt. In particular, methods are provided for treating or preventing an inflammatory condition using calcium glycerophosphate (CGP).

Priority: US20070889765P Applic. Date: 2007-02-14; WO2008US53790 Applic. Date: 2008-02-13

Inventor: KLIGERMAN ALAN E [US]


Application No.: US20100041704A1  Published: 18/Feb/2010

Title: DERMAL COMPOSITIONS OF SUBSTITUTED AMIDES AND THE USE THEREOF AS MEDICATION FOR PAIN AND PRURITUS

Applicant/Assignee:

Application No.: 12/448760   Filing Date: 11/Jan/2008

Abstract:Dermal compositions comprising topical formulations of bupivacaine or ropivacaine, characterized by effective dermal absorption and long duration of dermal anesthetic activity, and intended for use in patients suffering from pruritus and dermal pain, including neuropathic pain, are provided. Compositions containing both bupivacaine and capsaicin are provided. Methods of alleviating pain by the topically administration of these compounds are also provided.

Priority: US20070880227P Applic. Date: 2007-01-12; WO2008US00425 Applic. Date: 2008-01-11

Inventor: ABERG A K GUNNAR [US]; JOHNSON KEITH A [US]


Application No.: US20100041746A1  Published: 18/Feb/2010

Title: NOVEL USE OF ORGANIC COMPOUNDS

Applicant/Assignee:

Application No.: 12/301505   Filing Date: 24/May/2007

Abstract:The present invention refers to compounds of the general formulae Ia to Ie as defined above for use as/in a composition (especially foods and dietary supplements, cosmetic, as well as pharmaceutical compositions) for the prevention and improvement of muscular disorders and for the improvement of muscle function. Other fields of use are disorders connected to impaired lipid metabolism, impaired glucose metabolism and impaired insulin action, obesity, overweight conditions, eating disorders such as bulimia and anorexia nervosa, cardiovascular diseases, atherosclerosis, vascular diseases, heart failure, inflammatory disorders such as arthritis, rheumatoid arthritis, osteoarthritis, gout, gastrointestinal disorders such as inflammatory bowel syndrome, Crohn's disease, gastritis, irritable bowel syndrome and ulcerative colitis, skin related conditions such as psoriasis, eczema, burns, dermatitis, and allergy, respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), allergic diseases, and/or bone disorders such as osteoporosis and osteopenia. The compounds may also be used for bodyshaping, for improving the muscle:fat ratio or for accelerating skin wound healing. The present invention is also directed to dietary compositions such as (fortified) food, beverages, (fortified) feed, food additives, beverage additives, feed additives, clinical nutrition, dietary supplements, functional food, functional feed and nutraceuticals and to pharmaceutical compositions containing such compounds, to methods of treating the above mentioned disorders/diseases in mammals including humans and to the compounds of the formula I themselves. Another object of the present invention is the use of such compounds for the manufacture of a composition for the treatment of such disorders/diseases as mentioned above.

Priority: EP20060010723 Applic. Date: 2006-05-24; WO2007EP04627 Applic. Date: 2007-05-24

Inventor: D ORAZIO DANIEL [CH]; RAEDERSTORFF DANIEL [FR]; SCHUELER GOEDE [DE]; WANG-SCHMIDT YING [CH]; WERTZ KARIN [DE]; WOLFRAM SWEN [DE]


Application No.: US20100041754A1  Published: 18/Feb/2010

Title: Novel natural oil gels and their application

Applicant/Assignee: APPLECHEM, INC

Application No.: 12/589358   Filing Date: 21/Oct/2009

Abstract:The invention is an article of manufacture, comprising a blend of: (A) from 1 to 50 weight percent of at least one block copolymer, wherein the block copolymer has at least one polystyrene block and at least one unsaturated rubber segment

and (B) from 99 to 50 weight percent of a natural oil. The natural oil of this invention is of natural animal, plant or vegetable oils or mixtures thereof, and the block copolymers have a polystyrene block and a rubber block where the rubber blocks are unsaturated rubbers such as polyisoprene, polybutadiene, or mixtures thereof. The block copolymers useful for the present invention are triblock polymers, radial (star) polymers, multiblock polymers, diblock polymers, or mixtures thereof.

Priority: US2007-973826 Applic. Date: 2007-10-09; US20060850586P Applic. Date: 2006-10-10; US20070900512P Applic. Date: 2007-02-09; US20070900518P Applic. Date: 2007-02-09

Inventor: LIN SAMUEL [US]


Application No.: US20100041774A1  Published: 18/Feb/2010

Title: Chemical compositions for skin care emulsions and heavy duty hand cleansers

Applicant/Assignee:

Application No.: 12/222806   Filing Date: 15/Aug/2008

Abstract:The present invention provides preservative compositions suitable for replacing, partially or in totality, conventional preservatives in skin care emulsions and heavy duty hand cleansers comprised of alternative molecular compounds than found in conventional preservative formulations. The preservative formulation for skin care formulations includes a fatty acid and/or ester of fatty acid present in a concentration from about 0.01 wt./wt. % to about 90 wt./wt. % of the formulation, one or more alcohols in a concentration from about 0.01 to about 60 wt./wt. % of the formulation, and a chelating agent present in a concentration from about 0.01 to about 20 wt./wt. % of the blend.

Priority:

Inventor: GRASCHA PIERRE BRUNO [FR]; BATTUT MYLENE [FR]


Application No.: US20100042027A1  Published: 18/Feb/2010

Title: POSITIVE PRESSURE CHAMBER FOR EXTREMITIES

Applicant/Assignee: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY

Application No.: 12/444801   Filing Date: 12/Jun/2009

Abstract:The present invention provides a positive pressure chamber for treating extremities, which is used for treating extremity swelling or edema, rehabilitation, prophylaxis for deep venous thrombosis, relieving extremity pain, improvement of extremity skin, and the like.

Priority: JP20060276735 Applic. Date: 2006-10-10; WO2007JP67078 Applic. Date: 2007-08-24

Inventor: HIRATA HITOSHI [JP]; MATSUMOTO YOSHIKI [JP]; IIDA KENICHI [JP]; MIYAGAWA TAKUYA [JP]


Application No.: US20100042137A1  Published: 18/Feb/2010

Title: ACUPUNCTURE AND ACUPRESSURE THERAPIES

Applicant/Assignee:

Application No.: 12/389248   Filing Date: 19/Feb/2009

Abstract:Described here are devices, methods, and kits for acupuncture or acupressure therapy. The devices may include a tissue-piercing member and a reservoir containing an agent. The devices and agents may be packaged as kits useful for relieving pain and/or treating various medical conditions. The devices, methods, and kits may enable less skilled practitioners to administer acupuncture or acupressure therapy, and may extend the duration of pain relief or other symptom relief.

Priority: US20080066327P Applic. Date: 2008-02-19; US20080061532P Applic. Date: 2008-06-13

Inventor: ORONSKY BRYAN T [US]; ORONSKY NEIL C [US]; ORONSKY ARNOLD L [US]


Application No.: US20100047185A1  Published: 25/Feb/2010

Title: ACTVIE SUBSTANCE COMBINATION

Applicant/Assignee: ISDIN S.A

Application No.: 12/522890   Filing Date: 11/Jan/2008

Abstract:The present invention refers to a combination of at least 2 UV-absorbing active substances (A) and (B), wherein the UV-absorbing active substance (A) is at least one heptaazaphenalene compound of the general formula (I), which is defined in the description and the UV-ab-sorbing active substance (B) is at least one compound which has its ab-sorption maximum [lambda]maX(B) in the range of UV-A or UV-B radiation.

Priority: EP20070000631 Applic. Date: 2007-01-12; WO2008EP00172 Applic. Date: 2008-01-11

Inventor: GORCHS CAPA OLGA [ES]; JIMENEZ ALONSO OSCAR [ES]; TRULLAS CABANAS CARLOS RAMON [ES]; CORBERA ARJONA JORDI [ES]; PANYELLA COSTA DAVID [ES]


Application No.: US20100047192A1  Published: 25/Feb/2010

Title: Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents

Applicant/Assignee: L.V.M.H. RECHERCHE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) MUSEUM NATIONAL D'HISTOIRE NATURELLE

Application No.: 11/991317   Filing Date: 01/Sep/2006

Abstract:The present invention relates to an anti-gene oligonucleotide which hybridizes specifically with the gene encoding human tyrosinase by Hoogsteen pairing between the complementary bases, said oligonucleotide forming a triple helix structure with the human tyrosinase gene. The invention also relates to the use of said oligonucleotide as a skin-depigmenting or skin-bleaching agent in a cosmetic composition or in a dermatological composition.

Priority: FR20050008981 Applic. Date: 2005-09-01; WO2006EP65902 Applic. Date: 2006-09-01

Inventor: KURFUERST ROBIN [FR]; BONNET-DUQUENNOY MATHILDE [FR]; LAZOU KRISTELL [FR]; GIOVANNANGELI CARINE [FR]


Application No.: US20100047219A1  Published: 25/Feb/2010

Title: MARINE EXTRACTS AND BIOFERMENTATIONS FOR USE IN COSMETICS

Applicant/Assignee: BASF BEAUTY CARE SOLUTIONS LLC

Application No.: 12/442769   Filing Date: 26/Sep/2007

Abstract:An extract of the marine algae, Sarcodiotheca, and more particularly Sarcodiotheca gaudichaudii, is described for use in cosmetic compositions. A biofermentation of Sarcodiotheca, such as for example S. gaudichaudii, is also described. This marine bioferment is useful as a skin care active ingredient for anti-aging cosmetic applications, and particularly useful when used in combination with an extracts of red algae, such as Chondrus crispus.

Priority: US20060847236P Applic. Date: 2006-09-26; WO2007US20854 Applic. Date: 2007-09-26

Inventor: CECCOLI JOSEPH D [US]; COSTELLO BRIAN [US]; PILLAI SREEKUMAR [US]


Application No.: US20100047291A1  Published: 25/Feb/2010

Title: COSMETIC FORMULATIONS WITH IR PROTECTION

Applicant/Assignee:

Application No.: 11/993607   Filing Date: 21/Jun/2006

Abstract:The present invention relates to cosmetic formulations with IR protection which are distinguished by the fact that they comprise functional pigments. The invention furthermore relates to cosmetic formulations which, besides the IR pigment, comprise colorants, fillers, cosmetic active compounds and cosmetic raw materials and auxiliaries, and to the use thereof in care and decorative cosmetics.

Priority: DE200510029647 Applic. Date: 2005-06-23; WO2006EP05949 Applic. Date: 2006-06-21

Inventor: HOCHSTEIN VERONIKA [DE]; SCHMIDT CHRISTOPH [DE]; SCHOEN SABINE [DE]


Application No.: US20100047294A1  Published: 25/Feb/2010

Title: SEMI-FINISHED PRODUCT IN THE MANUFACTURE OF A COMPOSITION FOR SKIN OR HAIR CARE

Applicant/Assignee: OY GRANULA AB LTD

Application No.: 12/377515   Filing Date: 14/Aug/2007

Abstract:A semi-finished product is manufactured from raw liquid, extract or powder obtained from wood material, an end product composition for skin or hair care being obtained from the semi-finished product by adding one or more components thereto. The semi-finished product optionally contains a UV protector, and is a liquid, emulsion, microemulsion or nanoemulsion or a dispersion, suspension, wax, lotion or gel or a solid substance. The semi-finished product further contains an active ingredient mixture which contains phenolic compounds having antioxidative and/or microbicidal properties and/or abilities to capture free radicals. The active ingredient mixture contains as phenolic compounds at least one oligolignan, and at least two lignans, tannins or flavonoids selected from a group consisting of hydroxymatairesinol, matairesinol, oxomatairesinol, lariciresinol, cyclolariciresinol, secoisolariciresinol nortrachelogenin, pinoresinol, pinosylvine, conidendrine, melacasidine, teracasidine, ellaga-tannin or a reaction product, stereoisomer or derivative of these compounds.

Priority: FI20060000729 Applic. Date: 2006-08-14; WO2007FI00201 Applic. Date: 2007-08-14

Inventor: AHLNAS THOMAS [FI]


Application No.: US20100047295A1  Published: 25/Feb/2010

Title: SKIN CARE COMPOSITION

Applicant/Assignee:

Application No.: 12/450596   Filing Date: 16/Apr/2008

Abstract:Skin care emulsion compositions are disclosed comprising an oil-in-water emulsion comprising phospholipid-stabilized, submicron triglyceride particles, botanical material selected from the group consisting of a vegetal material, a marine material and combinations thereof

a polycarboxylate polymer and a phosphate ester-type emulsifier. The skin care compositions can be topically applied to the skin before, and surprisingly, together with, and/or after applying a skin colorant (i.e., pigmented) cosmetic composition to moisturize the skin and achieve, augment, and/or maintain a visibly desirable cosmetic appearance.

Priority: US20070926643P Applic. Date: 2007-04-27; WO2008US04893 Applic. Date: 2008-04-16

Inventor: GIAGNORIO GERALYNN [US]


Application No.: US20100047296A1  Published: 25/Feb/2010

Title: Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III

Applicant/Assignee: HENKEL AG & CO. KGAA

Application No.: 12/465983   Filing Date: 14/May/2009

Abstract:Cosmetic or dermatological sticks, especially deodorant or antiperspirant sticks, based on an oil-in-water dispersion/emulsion to be applied to the skin.

Priority: DE200610053886 Applic. Date: 2006-11-14; WO2007EP62236 Applic. Date: 2007-11-13

Inventor: BANOWSKI BERNHARD [DE]; CLAAS MARCUS [DE]; BUSE NADINE [DE]


Application No.: US20100047297A1  Published: 25/Feb/2010

Title: NANOCRYSTALS FOR USE IN TOPICAL COSMETIC FORMULATIONS AND METHOD OF PRODUCTION THEREOF

Applicant/Assignee: ABBOTT GMBH & CO. KG

Application No.: 12/514621   Filing Date: 19/Nov/2007

Abstract:Provided are cosmetic preparations for topical application containing nanocrystals of cosmetic actives leading to an increased bioactivity of the molecules in the skin and methods of making the cosmetic preparations. The nanocrystals can be added to any cosmetic topical formulation, e. g. creams, lotions and liposomal dispersions. The drug nanocrystals are produced by a combination process of low energy pearl milling followed by a high energy high-pressure homogenization leading to nanocrystal suspensions (nanosuspensions) of improved physical stability.

Priority: US20060866233P Applic. Date: 2006-11-17; WO2007EP09943 Applic. Date: 2007-11-19

Inventor: PETERSEN ROLF [DE]


Application No.: US20100047298A1  Published: 25/Feb/2010

Title: PROCESS FOR TREATING THE SKIN BY APPLYING SILICONE COMPOUNDS

Applicant/Assignee: L'OREAL

Application No.: 12/519271   Filing Date: 19/Dec/2007

Abstract:The invention relates to a cosmetic treatment method for improving the superficial appearance of the skin, and especially for reducing the visible and/or tactile irregularities of the skin, such as cutaneous microrelief. According to said method, a filling product is applied to the irregularities, said product resulting from a hydrosilylation reaction, in the presence of a catalyst, between two compounds X and Y, at least one of said compounds being a silicone compound, and both compounds being brought into contact with each other in the presence of a catalyst such that the reaction occurs at least partially on the skin.

Priority: FR20060055727 Applic. Date: 2006-12-20; US20070883171P Applic. Date: 2007-01-03; WO2007FR52563 Applic. Date: 2007-12-19

Inventor: CASSIN GUILLAUME [FR]


Application No.: US20100047299A1  Published: 25/Feb/2010

Title: USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE

Applicant/Assignee: BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH

Application No.: 12/524229   Filing Date: 24/Jan/2008

Abstract:The present invention is directed to novel methods and compositions containing growth factor proteins. Said compositions are specifically designed to optimize the amount of crucial structural elements of mammalian tissues. The invention is especially useful for the preservation and improvement of dermal tissue appearance.

Priority: EP20070001658 Applic. Date: 2007-01-25; WO2008EP00552 Applic. Date: 2008-01-24

Inventor: POHL JENS [DE]


Application No.: US20100047300A1  Published: 25/Feb/2010

Title: PEARLESCENT PIGMENTS CONTAINING COSMETIC COMPOSITIONS

Applicant/Assignee:

Application No.: 12/594509   Filing Date: 04/Apr/2008

Abstract:The present invention is directed to a cosmetic composition comprising an effect pigment based on a glass flake as a substrate with a coating, said coating comprising at least one layer of at least one high refractive material, said material having a refractive index of at least 1.8, and/or a semitransparent metal coating wherein said glass flakes comprising the following composition: 65-75 wt.-% silicon oxide, preferably SiO2 2-9 wt.-% aluminium oxide, preferably Al2O3 0.0-5 wt.-% calcium oxide, preferably CaO 5-12 wt.-% sodium oxide, preferably Na2O 8-15 wt.-% boron oxide, preferably B2O3 0.1-5 wt.-% titanium oxide, preferably TiO2 0.0-5 wt.-% zirconium oxide, preferably ZrO2 based on the weight of said glass flakes. The invention is also directed to the use of the cosmetic composition.

Priority: EP20070007257 Applic. Date: 2007-04-05; WO2008EP02712 Applic. Date: 2008-04-04

Inventor: KAUPP GUENTER [DE]; SCHMIDT ULRICH [DE]; STEINBACH KATRIN [DE]; SCHUMACHER DIRK [DE]


Application No.: US20100047305A1  Published: 25/Feb/2010

Title: Extracellular Matrix Compositions

Applicant/Assignee:

Application No.: 12/363488   Filing Date: 30/Jan/2009

Abstract:The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Priority: US20080024854P Applic. Date: 2008-01-30; US20080034361P Applic. Date: 2008-03-06; US20080050940P Applic. Date: 2008-05-06

Inventor: NAUGHTON GAIL K [US]; ZIEGLER FRANK [US]; BAUMGARTNER MARK [US]; NICKEY KYLE [US]


Application No.: US20100047327A1  Published: 25/Feb/2010

Title: Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same

Applicant/Assignee:

Application No.: 12/524748   Filing Date: 31/Jan/2008

Abstract:It is intended to provide a low molecular weight adjuvant which can be administered safely without inducing skin irritation or the like by transdermal or transmucosal administration and is for enhancing immunogenicity of an antigen efficiently. It can be achieved by an immunostimulant adjuvant containing at least one substance selected from the group consisting of aliphatic alcohols, free fatty acids and fatty acid derivatives but does not contain a substance represented by the following formula. (In the formula, R3 and R4 may be combined to form a cyclic ring, and R1 and R2 independently represent an alkyl side chain having 1 to 16 carbon atoms.)

Priority: JP20070022061 Applic. Date: 2007-01-31; WO2008JP51499 Applic. Date: 2008-01-31

Inventor: KUWAHARA TETSUJI [JP]; TOKUMOTO SEIJI [JP]; MATSUDO TOSHIYUKI [JP]


Application No.: US20100047328A1  Published: 25/Feb/2010

Title: Adhesive preparation

Applicant/Assignee: HISAMITSU PHARMACEUTICAL CO., INC

Application No.: 12/588721   Filing Date: 26/Oct/2009

Abstract:An adhesive preparation comprising a stretchable support and an adhesive layer laminated on at least one side of the support, wherein the stretchable support comprises a interlock woven fabric subjected to crimping processing, the adhesive layer contains 10% by mass or more of methyl salicylate with respect to the total mass of the layer, the whole adhesive preparation has moisture permeability of 1 to 350 g/m224 hr measured at a temperature of 40 DEG C. and a relative humidity of 90%, and the methyl salicylate has a plasma AUC0-24 ranging from 3.0 to 60.0 nghr/mL in terms of a mean+-standard deviation, and salicylic acid as a metabolite of the methyl salicylate has a plasma AUC0-24 ranging from 5000 to 13000 nghr/mL in terms of a mean+-standard deviation, when the adhesive preparation is applied to a human skin for 8 hours such that an application amount of the adhesive layer applied is 50 to 300 g/m2 and a contact area is 280 cm2.

Priority: JP20060213670 Applic. Date: 2006-08-04; US2008-227066 Applic. Date: 2008-11-06; WO2007JP65067 Applic. Date: 2007-08-01

Inventor: TSURUDA KIYOMI [JP]; YAMASOTO SHINJI [JP]; SHOHO KOUKI [JP]; NAKANISHI MASARU [JP]


Application No.: US20100047357A1  Published: 25/Feb/2010

Title: COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID

Applicant/Assignee: SOL-GEL TECHNOLOGIES LTD

Application No.: 12/525329   Filing Date: 03/Feb/2008

Abstract:The invention relates to a composition for topical application comprising as an active ingredient a peroxide and a retinoid wherein one of said peroxide and retinoid is in the form of first microparticles comprising a solid particulate matter of the active ingredient coated by a metal oxide layer and the other of said peroxide and retinoid is present in an uncoated free form or in a coated form of the active ingredient. The invention further relates to method for treating a surface condition in a subject using said composition, a method for preparing a composition exhibiting improved stability, and a kit comprising: (a) a first composition comprising a peroxide as a first active ingredient

and (b) a second composition comprising a retinoid as a second active ingredient

at least one of said first and said second active ingredient being coated by a metal oxide layer.

Priority: US20070898701P Applic. Date: 2007-02-01; WO2008IL00140 Applic. Date: 2008-02-03

Inventor: TOLEDANO OFER [IL]; SERTCHOOK HANAN [IL]; LOBODA NATALIA [IL]; BAR-SIMANTOV HAIM [IL]; SHAPIRO LEORA [IL]; ABU-REZIQ RAED [IL]


Application No.: US20100047361A1  Published: 25/Feb/2010

Title: Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb

Applicant/Assignee: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S LABORATOIRE DE DERMOCOSMETIQUE

Application No.: 12/613964   Filing Date: 06/Nov/2009

Abstract:The invention relates to active principles which are capable of inducing the conversion of inactive TGFb-Latent into active TGFb. The invention relates in particular to the use of such an extract for the manufacture of a composition for increasing the concentration of active TGFb1 in the skin, notably in the dermis. The present invention also relates to the uses which are derived from said use, as well as to cosmetic or pharmaceutical compositions which comprise said extract.

Priority: FR20040006047 Applic. Date: 2004-06-04; US2004-966168 Applic. Date: 2004-10-04

Inventor: PERRIER ERIC [FR]; ALTOBELLI CECILE [FR]; CLEMENT ANNE [FR]; REYMERMIER CORINNE [FR]; ABDUL MALAK NABIL [FR]


Application No.: US20100048515A1  Published: 25/Feb/2010

Title: Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

Applicant/Assignee: VASCULAR BIOGENICS LTD

Application No.: 12/588371   Filing Date: 14/Oct/2009

Abstract:Novel synthetic oxidized lipids and methods utilizing oxidized lipids for treating and preventing an inflammation associated with an endogenous oxidized lipid are provided.

Priority: US2006-528657 Applic. Date: 2006-09-28; US2008-567543 Applic. Date: 2008-04-25; WO2004IL00453 Applic. Date: 2004-05-27; US2003-445347 Applic. Date: 2003-05-27

Inventor: HARATS DROR [IL]; GEORGE JACOB [IL]; HALPERIN GIDEON [IL]; MENDEL ITZHAK [IL]


Application No.: US20100048598A1  Published: 25/Feb/2010

Title: TOPICAL COMPOSITIONS COMPRISING 5-ALPHA REDUCTASE INHIBITORS

Applicant/Assignee:

Application No.: 12/544737   Filing Date: 20/Aug/2009

Abstract:The present invention relates to topical compositions comprising 5[alpha]-reductase inhibitors. The present invention also includes processes for preparation of such topical compositions and methods of using them.

Priority: IN2008CH02033 Applic. Date: 2008-08-21; US20080106733P Applic. Date: 2008-10-20

Inventor: KANDAVILLI SATEESH [IN]; NALAMOTHU VIJENDRA [US]; PANDYA VISHVABHAVAN [IN]


Application No.: US20100048624A1  Published: 25/Feb/2010

Title: USE OF PIPERIDINE DERIVATIVES AS DERMO-DECONTRACTING AGENTS

Applicant/Assignee: L'OREAL

Application No.: 12/607824   Filing Date: 28/Oct/2009

Abstract:The present invention relates to a cosmetic process for treating wrinkled skin, in particular the skin of the face and/or of the forehead, through a dermo-decontracting effect, comprising the topical application to said skin of a composition comprising, in a physiologically acceptable medium, at least one piperidine derivative chosen from the compounds of formula (I): These compounds make it possible to combat expression wrinkles according to a mechanism of dermo-decontraction.

Priority: FR20040051396 Applic. Date: 2004-07-01; US2007-631391 Applic. Date: 2007-02-02; WO2005EP07975 Applic. Date: 2005-06-15; US20040589563P Applic. Date: 2004-07-21

Inventor: CAVEZZA ALEXANDRE [FR]; ROZOT ROGER [FR]


Application No.: US20100048686A1  Published: 25/Feb/2010

Title: Perfume Composition For Temperature Sense Control, Sense Control Article, Sense Control Method, And Perfume Map

Applicant/Assignee: SHISEIDO CO., LTD

Application No.: 12/545914   Filing Date: 24/Aug/2009

Abstract:It is an object of the present invention to discover that a perfume can change a person's temperature sense and humidity sense, to identify a perfume component that can change temperature sense, and to provide a perfume composition for controlling temperature sense that contains this perfume component, and to a sense control method or sense control article such as an aromatic or a cosmetic that is beneficial for controlling temperature sense, and to a perfume map for selecting a perfume suited to controlling temperature sense. The perfume composition is characterized in that a perfume component that changes the temperature subjectively sensed by a person (temperature sense) is contained, and that the perfume component that changes the temperature sense is a perfume component identified on the basis of a temperature image obtained from test subject assessment.

Priority: JP20030314742 Applic. Date: 2003-09-05; US2006-570634 Applic. Date: 2006-03-03; WO2004JP12659 Applic. Date: 2004-09-01

Inventor: SHOJI KEN [JP]; TAGUCHI SUMIE [JP]; TERAJIMA YUSHI [JP]


Application No.: US20100048706A1  Published: 25/Feb/2010

Title: Ethoxylated and/or Hydrogenated Oil Adduct

Applicant/Assignee: COLGATE-PALMOLIVE COMPANY

Application No.: 12/528889   Filing Date: 20/Nov/2008

Abstract:A composition of matter comprising an oil adduct synthesized by an oil and an addition material, wherein the oil includes at least one member chosen from an ethoxylated oil, a hydrogenated oil, and an ethoxylated and hydrogenated oil: wherein the average degree of ethoxylation in the ethoxylated (optionally hydrogenated) oil is less than about 10 based on moles of ethylene oxide per mole of oil: wherein the hydrogenated (optionally ethoxylated) oil has an iodine value of less than about 75: wherein the oil is capable of undergoing reaction with the addition material through a hydroxyl group of tile oil

and wherein the addition material includes at least one member chosen from carboxylic acid anhydrides, maleic anhydride, dicarboxylic acids, fumaric acid, maleic acid, succinic acids alpha hydroxy acids, beta hydroxy acids, lactic acid, glycolic acid, lactobionic acid, carnitine, salicylic acid, and (meth)acrylic acid.

Priority: US20070990801P Applic. Date: 2007-11-28; WO2008US84178 Applic. Date: 2008-11-20

Inventor: SUBRAMANYAM RAVI [US]; MATTAI JAIRAJH [US]; POTNIS SHASHANK [IN]; WU QIANG [US]; XU GUOFENG [US]


Application No.: US20100048725A1  Published: 15/Apr/2004

Title: Use of cyclopamine in the treatment of basal cell carcinoma and other tumors

Applicant/Assignee:

Application No.: 10/682584   Filing Date: 09/Oct/2003

Abstract:This invention concerns the use of cyclopamine in vivo on basal cell carcinomas (BCC's) to achieve therapeutic effect by causing differentiation of the tumor cells and, at the same time, apoptotic death and removal of these tumor cells while preserving the normal tissue cells, including the undifferentiated cells of the normal epidermal basal layer and hair follicles. Causation of apoptosis by cyclopamine is by a non-genotoxic mechanism and thus unlike the radiation therapy and most of the currently used cancer chemotherapeutics which act by causing DNA-damage. These novel effects, previously unachieved by a cancer chemotherapeutic, make the use of cyclopamine highly desirable in cancer therapy, in the treatment of BCC's and other tumors that use the hedgehog/smoothened signal transduction pathway for proliferation and prevention of apoptosis.

Priority: WO2001TR00027 Applic. Date: 2001-07-02; WO2002TR00017 Applic. Date: 2002-04-19

Inventor: TAS SINAN [TR]; AVCI OKTAY [TR]


Application No.: US20100048729A1  Published: 25/Feb/2010

Title: Composition based on xanthoxyline and its use in cosmetic

Applicant/Assignee: PIERRE FABRE DERMO-COSMETIQUE

Application No.: 12/310960   Filing Date: 11/Sep/2007

Abstract:The present invention relates to the use of xanthoxyline, and of plant extracts containing it, in cosmetic compositions.

Priority: FR20060008129 Applic. Date: 2006-09-15; WO2007FR01467 Applic. Date: 2007-09-11

Inventor: CHARVERON MARIE [FR]; BELAUBRE FRANCOISE [FR]; BELLE RENE [FR]; DUNOUAU CHRISTOPHE [FR]


Application No.: US20100048737A1  Published: 25/Feb/2010

Title: COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS

Applicant/Assignee: BASF SE

Application No.: 12/441757   Filing Date: 14/Sep/2007

Abstract:The present invention relates to cosmetic or dermatological formulations comprising at least one active compound, at least one polymer which is molecularly imprinted in the presence of this active compound and at least one fatty phase.

Priority: EP20060120922 Applic. Date: 2006-09-19; WO2007EP59683 Applic. Date: 2007-09-14

Inventor: WENDEL VOLKER [DE]; BRUEGGEMANN OLIVER [DE]; PTOCK ARNE [DE]


Application No.: US20100049039A1  Published: 25/Feb/2010

Title: System and Method of Treating Skin Imperfections Including a Diagnostic Tool

Applicant/Assignee:

Application No.: 12/615797   Filing Date: 10/Nov/2009

Abstract:A system and method of treating skin imperfections including a diagnostic tool is disclosed. In a particular embodiment the system includes a diagnostic tool to scan a preselected area of skin of a client to detect at least one skin imperfection and an associative module to associate a skin value to the client. Further, the system includes that a first unadulterated ingredient of alpha lipoic acid, dimethylaminoethenol, vitamin A, vitamin C, and vitamin E, or any combination thereof, is selected based on the skin value, and a second unadulterated ingredient of retinol, alpha and beta hydroxyl acids, or any combination thereof, is selected based on the skin value. In addition, a customized product is compounded using selected first and second unadulterated ingredients and the product is compounded manually by a technician at a point of sale.

Priority: US2004-007904 Applic. Date: 2004-12-08

Inventor: HEEHLER CHARLES R [US]


Application No.: US20100049148A1  Published: 25/Feb/2010

Title: Expansion Units for Attachment to Custom Patterned Wound Dressings and Custom Patterned Wound Dressings Adapted to Interface With Same

Applicant/Assignee:

Application No.: 12/196908   Filing Date: 22/Aug/2008

Abstract:A custom fabricated (e.g. custom shaped and dimensioned) primary wound dressing part that matches a corresponding, pre-mapped integumentary wound is combined with dressing extension parts to form a composite wound dressing system. The primary wound dressing part may include one or more liquid flow barriers composed for example of a hydrophobic and high viscosity liquid embedded in a layer of the primary wound dressing part. The dressing extension parts may include interconnect portals for operatively interconnecting with the primary wound dressing part so that liquids may be securely moved between primary wound dressing part and the extension parts.

Priority:

Inventor: SINIAGUINE OLEG [US]


Application No.: US20100050316A1  Published: 04/Mar/2010

Title: SYNTHETIC WOVEN PATIENT GOWN FOR PREVENTING AND REDUCING SKIN WOUNDS

Applicant/Assignee: PRECISION FABRICS GROUP, INC

Application No.: 12/501915   Filing Date: 13/Jul/2009

Abstract:A patient gown comprised of therapeutic fabric for the prevention and treatment of skin wounds, and pressure wounds in particular, which includes a woven fabric having warp yarns and filling yarns woven to provide a smooth fabric surface. One of the warp or filling yarns is at least about 40% by weight of the fabric of continuous filament nylon, and the other of the warp or filling yarns is from about 0% to about 60% by weight of the fabric of continuous filament polyester or nylon having non-round filament cross sections. The fabric includes a conductive yarn at about 1% to about 2% by weight to control static dissipation, and an antimicrobial substance is topically applied or inherently available in the fabric. A method of using the patient gown to prevent and treat skin wounds, and pressure wounds in particular, is also disclosed.

Priority: US2005-152914 Applic. Date: 2005-06-13; US2004-985739 Applic. Date: 2004-11-10

Inventor: LEONARD W ALLEN [US]; BLANTON NEIL [US]; MONTGOMERY TERRY [US]; MCCALL JONES [US]


Application No.: US20100054501A1  Published: 04/Mar/2010

Title: FACE PLATE, VIBRATION SPEAKER HAVING FACE PLATE, AND PORTABLE TERMINAL INCLUDING THE SAME

Applicant/Assignee:

Application No.: 12/312758   Filing Date: 27/Nov/2007

Abstract:A vibration speaker with facial plate has developed for delivering sound in a form of vibrational movement to a user's skin. The vibration speaker includes a voice coil to generate a magnetic force in response to application of a sound signal from an exterior, a magnet having a predetermined magnetic force to interact with the magnetic force from the voice coil, a basket to receive the magnet, a face plate to deliver upward and downward movement of the voice coil or the magnet to the user's skin, and a rear cover coupled to the face plate to constitute an appearance of the vibration speaker. The face plate is provided with a plate-shaped tensioner providing a predetermined tension for maintaining the face plate in a horizontal state to control upward and downward vibrational movement delivered from the vibration speaker.

Priority: KR20060118312 Applic. Date: 2006-11-28; WO2007KR06018 Applic. Date: 2007-11-27

Inventor: CHOI SEONG SIK [KR]


Application No.: US20100055053A1  Published: 04/Mar/2010

Title: COMBINATIONS FOR ORAL COMPOSITIONS, THEIR PREPARATION AND USE

Applicant/Assignee: ORALDENT LIMITIED

Application No.: 12/374443   Filing Date: 20/Jul/2007

Abstract:A composition having a pH in the range of from 3 to 8.5, comprising: (a) in the range of from 0.1% to <10% w/w (based on the total weight of the composition) of a stock solution comprising a mixture of bioflavonoids and fruit acids or salts thereof

(b) sodium hyaluronate

and (c) water

and, optionally, (d) a pharmaceutically acceptable carrier therefor

wherein the sodium hyaluronate has an average molecular weight of between 800,000 and 4,000,000.

Priority: GB20060014353 Applic. Date: 2006-07-20; WO2007GB02756 Applic. Date: 2007-07-20

Inventor: RIPLEY IAN [GB]; THOMAS HOWARD [GB]


Application No.: US20100055055A1  Published: 04/Mar/2010

Title: TOPICAL FORMULATIONS OF TELLURIUM-CONTAINING COMPOUNDS

Applicant/Assignee: BIOMAS LTD

Application No.: 12/440727   Filing Date: 10/Sep/2007

Abstract:Novel formulations of tellurium-containing compounds, which are suitable for topical application, are disclosed. The formulations are characterized by high chemical and physical stability and are easy to handle and use.

Priority: US20060843402P Applic. Date: 2006-09-11; WO2007IB04220 Applic. Date: 2007-09-10

Inventor: ALBECK MICHAEL [IL]; SREDNI BENJAMIN [IL]; FIREDMAN DORON [IL]


Application No.: US20100055059A1  Published: 04/Mar/2010

Title: ASSOCIATION OF COMPOUNDS INHIBITING MELANOGENESIS AND USE THEREOF IN COSMETICS AND DERMATOLOGY

Applicant/Assignee: LABORATOIRES MAYOLY SPINDLER

Application No.: 12/522261   Filing Date: 15/Jan/2008

Abstract:The invention relates to an association including at least : a MC1-R receptor inhibitor

a tyrosinase inhibitor derived from vitamin C

an inhibitor of the transfer of melanosomes to the keratinocytes

the invention also relates to the use thereof in cosmetics and dermatology for preparing whitening and/or bleaching depigmentation compositions.

Priority: FR20070000279 Applic. Date: 2007-01-16; WO2008FR00040 Applic. Date: 2008-01-15

Inventor: CRITON MARC [FR]; LEMELLAY HAMON VERONIQUE [FR]; LEBLOND YVES [FR]


Application No.: US20100055060A1  Published: 04/Mar/2010

Title: COSMETIC COMPOSITION

Applicant/Assignee:

Application No.: 12/516347   Filing Date: 27/Nov/2007

Abstract:The problem of the present invention is to provide a cosmetic composition, which has a moisturizing effect, and whose ability to inhibit hyaluronidase activity is high. According to the present invention, by using one or more substances selected from sulfated cellulose and a salt thereof in combination with polyhydric alcohol, the moisturizing effect of sulfated cellulose and the ability to inhibit hyaluronidase activity can be further improved, and thereby the above-described problem can be solved. In addition, the present invention can provide a cosmetic composition having excellent stability through inclusion of an electrolyte having pH buffering ability.

Priority: JP20060317992 Applic. Date: 2006-11-27; WO2007JP73275 Applic. Date: 2007-11-27

Inventor: YOSHIDA NAOYUKI [JP]; YAMAMOTO YUICHI [JP]; ISHIDA KAZUSHI [JP]; YODA AKIKO [JP]; SASAKI SYUJI [JP]


Application No.: US20100055064A1  Published: 04/Mar/2010

Title: BLOCK COPOLYMER, COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS

Applicant/Assignee: L'OREAL S.A

Application No.: 12/612554   Filing Date: 04/Nov/2009

Abstract:The present invention relates to a linear ethylenic block copolymer comprising in each block at least one ionic hydrophilic unit, which may be different from one block to another, the said ionic hydrophilic unit being present in each block in a proportion of from 2% to 100% by weight relative to the weight of the said block. The invention also relates to a cosmetic or pharmaceutical composition comprising such a copolymer, and also to a cosmetic process for making up or caring for keratin materials using the said composition.

Priority: FR20040050718 Applic. Date: 2004-04-09; US2005-101648 Applic. Date: 2005-04-08; US20040562255P Applic. Date: 2004-04-15

Inventor: BOUPAT NICOLAS PASSADE [FR]; GUERRET OLIVIER [FR]; MOUGIN NATHALIE [FR]; SCHULTZE XAVIER [FR]; HERNANDEZ FRANCK [FR]


Application No.: US20100055081A1  Published: 04/Mar/2010

Title: LONG-LASTING ABSORPTION OF FLAVONOIDS

Applicant/Assignee: NESTEC S.A

Application No.: 12/438501   Filing Date: 22/Aug/2007

Abstract:The present invention relates to methods for a long-term and sustained release of flavonoids, in particular rhamnose-containing flavonoids, and for prolonging the uptake of said flavonoids in the gastro-intestinal tract. It further relates to compositions comprising said flavonoid and [alpha]-rhamnosidase. It also encompasses compositions comprising hesperidin and hesperetin-7-glucoside.

Priority: EP20060017678 Applic. Date: 2006-08-24; WO2007EP07394 Applic. Date: 2007-08-22

Inventor: RICHELLE MYRIAM [CH]; WILLIAMSON GARY [GB]; JANKOVIC IVANA [CH]; REIN MAARIT [CH]


Application No.: US20100055088A1  Published: 04/Mar/2010

Title: CXCR4 Antagonists for Wound Healing and Re-Epithelialization

Applicant/Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENTLTD KYOTO UNIVERSITY

Application No.: 11/915428   Filing Date: 21/May/2006

Abstract:The present invention provides novel uses for CXCR4 antagonists, including specifically peptides of the T-140 family, in the treatment of skin burns and other injuries. The invention further provides methods for increasing epithelialisation in a subject in need thereof, and for preventing or inhibiting fibrosis and excessive scar formation, using peptide inhibitors of the T-140 family as well as other CXCR4 antagonists.

Priority: US20050684160P Applic. Date: 2005-05-25; WO2006IL00596 Applic. Date: 2006-05-21

Inventor: PELED AMNON [IL]; FUJII NOBUTAKA [JP]


Application No.: US20100055138A1  Published: 04/Mar/2010

Title: METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS

Applicant/Assignee:

Application No.: 12/488502   Filing Date: 19/Jun/2009

Abstract:In preferred embodiments, the present invention relates to compositions comprising colloidal metals and/or metals for the treatment and prevention of skin conditions and/or diseases. More specifically, the disclosed metal containing compositions are useful as antioxidants, anti-aging agents, anti-wrinkle agents, anti-peroxidation agents, antimicrobial agents, anti-inflammatory agents, pain-relieving agents, wound recovery agents, sun-screens, sunblocks, and integument and skin-supporting agents when applied to the skin/integument, or administered generally to an animal or human body.

Priority: WO2007US88218 Applic. Date: 2007-12-19; US20060875998P Applic. Date: 2006-12-20

Inventor: MARGULIES JOEL [US]; JACOBS TERRY [US]


Application No.: US20100055161A1  Published: 04/Mar/2010

Title: HYDROGEL FACE MASK FOR DELIVERING SKIN CARE AGENTS

Applicant/Assignee:

Application No.: 12/199751   Filing Date: 27/Aug/2008

Abstract:Skin care can be provided by the skin care devices and compositions described herein. Such a skin care device can be configured to include a biocompatible hydrogel layer including one or more treatment agents, and an associated backing layer associated with the hydrogel layer.

Priority:

Inventor: AHN DONG JUNE [KR]


Application No.: US20100055210A1  Published: 04/Mar/2010

Title: COSMETIC COMPOSITION FOR PROTECTING SKIN AGAINST UV LIGHT AND WRINKLE IMPROVEMENT CONTAINING THE EXTRACT OF MAGNOLIA SIEBOLDII FLOWER EXTRACTS

Applicant/Assignee:

Application No.: 12/448751   Filing Date: 13/Dec/2007

Abstract:Disclosed herein is a cosmetic composition for preventing photoaging, containing an extract of Magnolia sieboldii as an active ingredient. Also disclosed is a cosmetic composition for reducing skin wrinkles containing an extract of Magnolia sieboldii as an active ingredient. The extract of Magnolia sieboldii can protect the skin against UV lights and skin damage by suppressing skin cell death and cell DNA damage, and can reduce skin wrinkles by promoting the biosynthesis of collagen and suppressing the synthesis of collagenases. Also, the cosmetic composition containing the extract of Magnolia sieboldii has an excellent effect of inhibiting skin damage caused by UV lights, and an excellent effect of reducing skin wrinkles.

Priority: KR20070001833 Applic. Date: 2007-01-08; WO2007KR06509 Applic. Date: 2007-12-13

Inventor: LEE GHANG TAI [KR]; LEE JUNG NOH [KR]; YOU YOUNG KYOUNG [KR]; LEE SEUNG JI [KR]; LEE KUN KOOK [KR]


Application No.: US20100055217A1  Published: 04/Mar/2010

Title: COSMETIC COMPOSITION COMPRISING A COMBINATION OF LIPOCHROMAN-6 AND AN EXTRACT OF LONGOZA, AND ITS USE

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/533106   Filing Date: 31/Jul/2009

Abstract:The invention relates to a cosmetic composition formulated for topical application to the skin, comprising as active agent a combination of lipochroman-6 and an extract of Longoza (Aframomum angustifolium). It also relates to the use of this combination in a cosmetic composition compatible with topical application, or for preparing such a composition, as an active agent intended for preventing or retarding the appearance of signs of skin ageing, such as the appearance of wrinkles or a decrease in the firmness and the elasticity of the skin, or for attenuating the effects thereof and/or for enhancing the radiance of the complexion of the skin, especially of the skin of the face, or for giving it back its natural radiance. It also relates to a method of cosmetic care of the skin, intended to prevent or to retard the appearance of signs of skin ageing, such as the appearance of wrinkles or a decrease in the firmness and elasticity of the skin, or to attenuate the effects thereof, comprising applying to at least one part of the skin of the body or the face a cosmetic composition comprising said combination.

Priority: FR20080055370 Applic. Date: 2008-08-01

Inventor: NIZARD CARINE [FR]; NOBLESSE EMMANUELLE [FR]; SCHAEFFER PHILIPPE [FR]


Application No.: US20100055218A1  Published: 04/Mar/2010

Title: NOVEL COMPOSITIONS

Applicant/Assignee:

Application No.: 12/373617   Filing Date: 12/Jul/2007

Abstract:The present invention relates to novel compositions comprising rosehip and at least one additional component e.g. selected from ligustilide, oleuropein (I), oleuropein aglycone (II), hydroxytyrosol, genistein, magnolol, honokiol, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.

Priority: EP20060014642 Applic. Date: 2006-07-14; WO2007EP06201 Applic. Date: 2007-07-12

Inventor: RAEDERSTORFF DANIEL [FR]; SCHWAGER JOSEPH [CH]; WERTZ KARIN [DE]


Application No.: US20100055697A1  Published: 04/Mar/2010

Title: POSITIVE SELECTION OF SERUM PROTEINS FOR PROTEOMIC ANALYSIS

Applicant/Assignee: CEDARS-SINAI MEDICAL CENTER APPLIED MINDS, INC

Application No.: 12/515388   Filing Date: 30/Nov/2007

Abstract:This invention relates to methods and kits for positive selection of species of interest based on peptide/protein sequence from a biological sample. The species of interest may be proteins and/or peptides of interest which may be placed through a mass spectrometer to obtain a blood peptide/protein signature. The blood peptide/protein signature may be used in proteomic analysis. The techniques include but are not limited to the use of collectors comprising nucleic acid molecules to extract a composition that has a lower concentration of a high abundance species of interest from a sample. This limits the level of influence that any collectors species may have on the results of a mass spectra.

Priority: US20060868266P Applic. Date: 2006-12-01; WO2007US86153 Applic. Date: 2007-11-30

Inventor: AGUS DAVID B [US]; HILLIS WILLIAM DANIEL [US]


Application No.: US20100056424A1  Published: 04/Mar/2010

Title: COSMETIC USE OF CHITINASE-TYPE PROTEINS

Applicant/Assignee: L'OREAL

Application No.: 12/515161   Filing Date: 19/Nov/2007

Abstract:The present invention relates to the use, notably cosmetic and/or therapeutic, of the YKL-40 protein belonging to the family of chitinase-type proteins, of polypeptides derived from this protein or analogs thereof of a nucleic acid sequence encoding such a polypeptide or of an agent that modulates the activity or expression of such a polypeptide notably for stimulation of terminal epithelial differentiation.

Priority: FR20060054986 Applic. Date: 2006-11-20; US20060874283P Applic. Date: 2006-12-12; WO2007FR01896 Applic. Date: 2007-11-19

Inventor: BERNARD DOMINIQUE [FR]; DONOVAN MARK [FR]


Application No.: US20100056430A1  Published: 04/Mar/2010

Title: Treatment and Method for Eliminating or Reducing Foot Odor

Applicant/Assignee:

Application No.: 12/199088   Filing Date: 27/Aug/2008

Abstract:A method of treating a person having a foot odor comprises administering an effective foot odor treatment amount of an antimicrobial preparation, such as Polymyxin B. Sulfate, Bacitracin Zinc, and an antimicrobial such as Miconazole Nitrate, terbinafine hydrochloride, undecylenic acid, tolnaftate, clotrimazole, or butenafine hydrochloride, to eliminate or reduce the symptoms of foot odor. The present invention is a topical skin preparation for treatment of foot odor. The preparation comprises Polymyxin B Sulfate and Bacitracin Zinc in combination with an antimicrobial agent. In a preferred form, the preparation further comprises, an antimicrobial such as Miconazole Nitrate. The concentrations of these constituents are 10,000 units of Polymyxin B Sulfate, 500 units of Bacitracin Zinc and 1.0 to 2.0% concentration of Miconazole Nitrate, in one preferred embodiment. Other compounds, such as herbal and fragrance additives may also be added to the preparation, for example Rose Water, Colors, Vitamin E, Aloe, Vitamin C, and Collagen. Further, other antimicrobial agents such as terbinafine hydrochloride, undecylenic acid, tolnaftate, clotrimazole, butenafine hydrochloride may be substituted for the antimicrobial agent Miconazole Nitrate. The topical skin preparation may further include Topical Erythromycin, Topical Aluminum Chloride Hexahydrate, or Tea Tree Oil. Topical Erythromycin may be used as a gel or solution with a 2.0% concentration. Topical Aluminum Chloride Hexahydrate may be used in a concentration of about 5.0% to 20.0%. Tea Tree Oil may be used in a concentration of about 0.10% to 10%.

Priority:

Inventor: LESTER ARNOLD [US]


Application No.: US20100056432A1  Published: 04/Mar/2010

Title: TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY

Applicant/Assignee: POLYPHOR LTD UNIVERSITAET ZUERICH

Application No.: 12/506794   Filing Date: 21/Jul/2009

Abstract:Template-fixed [beta]-hairpin peptidomimetics of the general formula (I) wherein Z is a template-fixed chain of 12 [alpha]-amino acid residues which, depend on their positions in the chain (counted starting from the N-terminal amino acid) are Gly, or Pro, or of certain types which, as the remaining symbols in the above formula, are defined in the description and the claims, and salts thereof, have the property to selectively inhibit the growth of or to kill microorganisms such as Pseudomonas aeruginosa and Acinetobacter. They can be used as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials, or as medicaments to treat or prevent infections. In a specific embodiment, the template is based on the D-Pro-L-Pro dipeptides. These [beta]-hairpin peptidomimetics can be manufactured by processes which are based on a mixed solid-and solution phase synthetic strategy.

Priority: US2005-062021 Applic. Date: 2005-02-18; WO2002EP09278 Applic. Date: 2002-08-20

Inventor: VRIJBLOED JAN WIM [CH]; OBRECHT DANIEL [CH]; ROBINSON JOHN ANTHONY [CH]; SELLIER ODILE [FR]; KESSLER MARC [FR]


Application No.: US20100056463A1  Published: 04/Mar/2010

Title: NOVEL COMPOSITIONS

Applicant/Assignee:

Application No.: 12/373584   Filing Date: 12/Jul/2007

Abstract:The present invention relates to novel compositions comprising hydroxytyrosol and/or oleuropein (I) and at least one additional component e.g. selected from the group of ligustilide, oleuropein aglycone, magnolol, honokiol, genistein, resveratrol, EGCG, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.

Priority: EP20060014645 Applic. Date: 2006-07-14; WO2007EP06188 Applic. Date: 2007-07-12

Inventor: RAEDERSTORFF DANIEL [FR]; RICHARD NATHALIE [FR]; SCHWAGER JOSEPH [CH]; WERTZ KARIN [DE]


Application No.: US20100056615A1  Published: 04/Mar/2010

Title: USE OF TRICYCLIC DITERPENES AND THEIR DERIVATIVES FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS AND/OR JOINT DISORDERS

Applicant/Assignee:

Application No.: 12/515329   Filing Date: 21/Nov/2007

Abstract:The present invention refers to the use of at least one tricyclic diterpenes for the manufacture of a nutraceutical or pharmaceutical for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders.

Priority: EP20060024382 Applic. Date: 2006-11-24; WO2007EP10071 Applic. Date: 2007-11-21

Inventor: RAEDERSTORFF DANIEL [FR]; SCHUELER GOEDE [DE]; SCHWAGER JOSEPH [CH]; WEHRLI CHRISTOF [CH]


Application No.: US20100056628A1  Published: 04/Mar/2010

Title: Preservative compositions

Applicant/Assignee:

Application No.: 12/589155   Filing Date: 19/Oct/2009

Abstract:Green and naturally derived biocides such as N[alpha]-(C1-C22) alkanoyl di basic amino acid alkyl (C1 to C22) ester salt cationic molecules can be combined with an anionic molecule not generally considered as having significant biocidal activity to provide antimicrobial, antibacterial, and/or antifungal properties with multifunctional benefits including preservative or self-preserving activity.

Priority: US2006-517147 Applic. Date: 2006-09-07; US2006-633231 Applic. Date: 2006-12-04; US2009-585695 Applic. Date: 2009-09-22; US2009-583919 Applic. Date: 2009-08-27; US20080196455P Applic. Date: 2008-10-17

Inventor: STOCKEL RICHARD F [US]; SAWYER ANTHONY JOSEPH [US]


Application No.: US20100056636A1  Published: 04/Mar/2010

Title: N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof

Applicant/Assignee:

Application No.: 12/519801   Filing Date: 30/Nov/2007

Abstract:The present invention relates to substances and compositions having a physiological cooling effect on the skin and the mucosa of the body, especially of the oral cavity, throat and nose. More in particular, the present invention relates to N-substituted-p-menthane-3-carboxamides represented by the following formula (I): and esters thereof. These substances are capable of imparting and/or enhancing a physiological cooling effect in a product in which they are incorporated, much more effectively than the heretofore known N-substituted-p-menthane-3-carboxamides.

Priority: EP20060126622 Applic. Date: 2006-12-20; US20070982464P Applic. Date: 2007-10-25; WO2007NL50609 Applic. Date: 2007-11-30

Inventor: FURRER STEFAN MICHAEL [US]; TONDEUR SANDER [NL]; WINKEL CHRIS [NL]; RENES HARRY [NL]; DE KLERK ADRI [NL]


Application No.: US20100056642A1  Published: 04/Mar/2010

Title: HEPATITIS A VIRICIDE

Applicant/Assignee: ECOLAB INC

Application No.: 12/617468   Filing Date: 12/Nov/2009

Abstract:The invention relates to agents which combat the hepatitis A virus, containing only minimal amounts of chlorine-containing and/or chlorine cleaving active ingredients, or none of said substances. The inventions also relates to the use of these agents and to a method for their production.

Priority: DE19991062353 Applic. Date: 1999-12-23; US2002-168442 Applic. Date: 2002-09-18; WO2000EP12688 Applic. Date: 2000-12-14

Inventor: VON RHEINBABEN FRIEDRICH [DE]; BIERING HOLGER [DE]; BANSEMIR KLAUS-PETER [DE]; GLAESER SABINE [DE]


Application No.: US20100056647A1  Published: 04/Mar/2010

Title: Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers

Applicant/Assignee: CIBA CORPORATION

Application No.: 12/548924   Filing Date: 27/Aug/2009

Abstract:The present invention relates to aqueous personal care, household care, and/or fabric care compositions comprising the instant copolymers. Also disclosed are methods for the rheological modification of aqueous personal care, household care, and/or fabric care compositions comprising the instant copolymers.

Priority: US20080190785P Applic. Date: 2008-09-02

Inventor: GRAHAM KEITH [GB]; NORMINGTON DAVID [GB]; DUNGWORTH HOWARD R [GB]; PLONKA JOHN M [GB]


Application No.: US20100057026A1  Published: 04/Mar/2010

Title: ABSORBENT ARTICLES COMPRISING A BODILY EXUDATE MODIFYING AGENT AND A SKIN CARE FORMULATION

Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC

Application No.: 12/537334   Filing Date: 07/Aug/2009

Abstract:Absorbent articles having enhanced absorption of bodily exudates are disclosed. The absorbent articles comprise a bodily exudate modifying agent and a skin care formulation. The bodily exudate modifying agent is capable of reducing the viscosity of bodily exudates such as feces and menses. The skin care formulation comprises a bodily exudate modifying agent neutralizer to neutralize the possible negative effects on skin barrier function caused by the bodily exudate modifying agents coming into direct contact with the wearer's skin.

Priority: US2004-915642 Applic. Date: 2004-08-10

Inventor: COHEN JASON C [US]; KOENIG DAVID W [US]; BROCK EARL DAVID [US]; BARATIAN STEPHEN A [US]; CUNNINGHAM COREY [US]; BALDWIN STEPHEN [US]


Application No.: US20100057034A1  Published: 04/Mar/2010

Title: DYNAMIC FITTING BODY ADHERING ABSORBENT ARTICLE

Applicant/Assignee:

Application No.: 12/507703   Filing Date: 22/Jul/2009

Abstract:A disposable personal care article comprises a shell having a unitary structure for disposition adjacent a wearer's vulva region, where the shell has a first side and a second side, the first side having a first area and a second area. The first area of the shell contacts to the wearer's skin and/or hair surrounding the vulva region. At least a portion of the first area comprises a body attachment means for adhering the shell directly to the skin and/or hair of the wearer. In addition, the shell has an anterior half and a posterior half where the posterior half exhibits a higher extension relative to the anterior half when a stretching force of 454 grams is applied. In some aspects, the article further includes an absorbent structure.

Priority: US2009-364486 Applic. Date: 2009-02-02; US2007-890093 Applic. Date: 2007-08-03; US2007-005793 Applic. Date: 2007-12-28

Inventor: DENNIS MELISSA [US]; ROSS RUSSELL FREDERICK [US]; HAGAN LUKE [US]; LUTZOW THOMAS ANDREW [US]; FOELSCHE GERHARD ANDREW [US]; PETRIE AIDAN J [US]; SCHINAZI ALAN [US]


Application No.: US20100058488A1  Published: 04/Mar/2010

Title: PROTEIN FORMULATIONS COMPRISING S1-5

Applicant/Assignee: LOCOMOGENE, INC

Application No.: 11/994327   Filing Date: 28/Dec/2005

Abstract:The present inventors discovered that knockout mice whose S1-5 gene function is lost develop age-related diseases or symptoms. In such knockout mice, bone mineral content, bone mineral density, and bone strength were found to be decreased, and the number of osteoclasts in bone tissues was found to be increased. Analysis of osteoclast-forming ability using bone marrow cells derived from the knockout mice revealed that osteoclast-forming ability is enhanced and osteoclasts are larger in the knockout mice than in wildtype mice. When purified S1-5 protein was added to this in vitro system, osteoclast-forming ability was inhibited. Furthermore, administration of purified S1-5 protein to osteoporotic model mice showed that this protein has the effect of improving osteoporosis. The above findings demonstrate that S1-5 protein is useful for treating and preventing age-related diseases such as osteoporosis.

Priority: WO2005JP12251 Applic. Date: 2005-07-01; WO2005JP24137 Applic. Date: 2005-12-28

Inventor: NAKAJIMA TOSHIHIRO [JP]; YAGISHITA NAOKO [JP]; AMANO TETSUYA [JP]


Application No.: US20100058509A1  Published: 11/Mar/2010

Title: ITEM OF CLOTHING

Applicant/Assignee:

Application No.: 12/450535   Filing Date: 06/Sep/2007

Abstract:The invention relates to an item of clothing, in particular to be worn during sports such as jogging, skating, cycling or similar. Said item of clothing is made of at least one yarn (3) that comprises a heat-reflecting covering (5).

Priority: DE200720005259U Applic. Date: 2007-04-10; WO2007DE01613 Applic. Date: 2007-09-06

Inventor: LAMBERTZ BODO W [CH]


Application No.: US20100058551A1  Published: 11/Mar/2010

Title: Personal hygiene devices to aid physically impaired users to clean their recto-genital area

Applicant/Assignee:

Application No.: 11/015768   Filing Date: 20/Dec/2004

Abstract:Personal hygiene devices designed to aid physically impaired persons to clean their own recto-genital area following urination, defecation, menstruation, or sweating. The devices include an elongated flexible strip made from one or two elongated individual sheets affixed together and of a length sufficient to extend between the user's legs and of a width sufficient to generally cover the recto-genital area. The strip has an absorbent middle portion for engaging the user's recto-genital area and respective dependent end portions having respective thumb holes therethrough for easy gripping in-hand. An absorbent pad is positioned at the middle portion retained by the individual sheets to increase the absorbency thereof. The device is used by gripping the end portions in-hand optionally using the thumb holes with the middle portion extending between the user's legs. The middle portion is moved into engagement with the user's recto-genital area and the end portions moved longitudinally while maintaining tension thereon to wipe the middle portion along the recto-genital area to remove excrement therefrom. The device is made of flushable materials for disposal down toilets following use. The devices are preferably manufactured in device sheets from rolls of raw materials using automated manufacturing equipment in which the devices are initially interconnected at perforated tear lines and subsequently separated, folded or wrapped, and individually wrapped or otherwise packaged for individual use thereof.

Priority:

Inventor: MCDOWELL KAREN S [US]


Application No.: US20100058979A1  Published: 11/Mar/2010

Title: SHEATHLIKE APPLICATOR AND PROCESS FOR PRODUCING THE SAME

Applicant/Assignee:

Application No.: 12/303644   Filing Date: 28/May/2007

Abstract:A sheath-shaped application implement, as well as a manufacturing method thereof, where said sheath-shaped application implement comprises a base sheet(s) and a protective film(s) that are sealed together in a manner providing an empty area in which to insert the palm or fingers, and at least one base sheet mentioned above is constituted by a retention layer having at least one type of application composition on it, and by a barrier layer, where the barrier layer prevents permeation or leakage of the application composition, while the protective film is structured in such a way as to protect the application composition from exposure to the outside. This application implement can be stored in a manner retaining the quality of the application composition, is not bulky, can be carried with ease, and when used the application implement allows the protective film to be removed with ease and the application composition to be applied to desired locations at various parts of the body.

Priority: JP20060157012 Applic. Date: 2006-06-06; WO2007JP60775 Applic. Date: 2007-05-28

Inventor: NAKAMURA KOJI [JP]; PAUCHET BERNARD [FR]; GUIMARD MICHEL [FR]


Application No.: US20100062052A1  Published: 11/Mar/2010

Title: PEPTIDE-BASED COMPOUNDS AS NEW INHIBITORS OF METALLOECTOPEPTIDASES, COMPOSITIONS COMPRISING SAID COMPOUNDS AND THEIR PHARMACEUTICAL AND COSMETIC USES

Applicant/Assignee: GREENPHARMA

Application No.: 12/524955   Filing Date: 04/Feb/2008

Abstract:The invention relates to a compound that inhibits a metallo-ectopeptidase, selected in the group consisting of x-aa2-aa1-z, x-aa3-aa2-aa1-z, x-aa4-aa3-aa2-aa1-z and x-aa5-aa4-aa3-aa2-aa1-z, wherein: aa1 and aa4, independently from each other, represent an arginine amino acid, an histidine amino acid, an asparagine amino acid or a lysine amino acid, aa2 represents a serine amino acid, a glycine amino acid, a threonine amino acid or an alanine amino acid, aa3 represents a phenylalanine amino acid, a leucine amino acid, an isoleucine amino acid, a tyrosine amino acid or a tryptophan amino acid, aa5 represents a glutamine amino acid, a glutamic acid amino acid, an asparagines amino-acid or a lysine amino acid, x and z, independently from each other, represent: -H

-OH1 SH

-a halogen atom, -an amino group, -an alkyl, haloalkyl or heteroalkyl group containing from 1 to 30 carbon atoms, linear or branched, -an alkenyl or alkynyl group containing from 2 to 30 carbon atoms, linear or branched, -a cycloalkyl, cycloakenyl, cycloalkynyl or an heterocyclic group containing from 3 to 30 carbon atoms, linear or branched, -one or more aryl or heteroaryl groups containing from 3 to 10 carbon atoms per cycle, -a alkoxy, thioalkyl, sulfonylalkyl, aminoalkyl containing from 1 to 30 carbon atoms, linear or branched, -one or more heterocyclic group, containing from 5 to 10 carbon atoms per cycle, said groups being optionally substituted by one or more halogen atoms, alkyl groups, hydroxy groups, alkoxy groups, aryloxy groups, acyloxy groups, carbamoyloxy groups, carboxy groups, mercapto groups, alkylthio groups, acylthio groups, arylthio groups, aryl groups, heterocyclic groups, heteroaryl groups or amino groups.

Priority: US20070899033P Applic. Date: 2007-02-02; WO2008IB01328 Applic. Date: 2008-02-04

Inventor: BERNARD PHILIPPE [FR]


Application No.: US20100062085A1  Published: 11/Mar/2010

Title: TREATMENT OF DAMAGED SKIN

Applicant/Assignee:

Application No.: 12/554364   Filing Date: 04/Sep/2009

Abstract:A medicament for treating skin is described. It comprises essentially of bulbine frutescens, centella asiatica and a phenol derived from olive oil preferably oleuropein. The medicament may be used in the treatment of scars formed during surgery. It may also be used cosmeceutically in the treatment of aged skin where it may be used with phosphatidylserine. The medicament can also act in conjunction with anti-acne treatment to diminish scarring from the acne condition.

Priority: ZA20080008004 Applic. Date: 2008-09-18; ZA20090004000 Applic. Date: 2009-06-08; US20080094170P Applic. Date: 2008-09-04

Inventor: WIDGEROW ALAN DAVID [ZA]


Application No.: US20100062086A1  Published: 11/Mar/2010

Title: Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/621027   Filing Date: 18/Nov/2009

Abstract:The present invention relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents, or synthetic equivalents thereof, which inhibit or decrease expression of C-reactive protein expression, production or secretion, thereby reducing, inhibiting, or ameliorating dermatological signs of aging. The compositions of the invention may be topically applied to the skin, or are delivered by directed means to a site in need thereof, in an amount effective in improving the condition and aesthetic appearance of skin.

Priority: US2006-647648 Applic. Date: 2006-12-29

Inventor: DRYER LAURENCE [US]; TAFURI SHERRIE R [US]; PTCHELINTSEV DMITRI S [US]


Application No.: US20100062088A1  Published: 11/Mar/2010

Title: COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT

Applicant/Assignee: MARY KAY INC

Application No.: 12/620410   Filing Date: 17/Nov/2009

Abstract:A topical skin care composition comprising kakadu plum extract or acai berry extract, or a combination of both, is disclosed. The composition can include a high oxygen radical absorbance capacity (ORAC) value. The composition can improve the skin's visual appearance, physiological functions, clinical properties, and/or biophysical properties.

Priority: US2007-624985 Applic. Date: 2007-01-19; US20060760103P Applic. Date: 2006-01-19; US20060760977P Applic. Date: 2006-01-20; US20060760979P Applic. Date: 2006-01-20

Inventor: GAN DAVID [US]; HINES MICHELLE [US]; ARAVENA JAVIER [US]; JONES BRIAN [US]


Application No.: US20100063011A1  Published: 11/Mar/2010

Title: Organic compounds

Applicant/Assignee: GIVAUDAN SA

Application No.: 12/066518   Filing Date: 08/Sep/2006

Abstract:The invention relates to organic compounds having the ability to reduce or suppress the onset of skin irritation induced by extraneous cause selected from the group of 2-heptylcyclopentanone, 2-ethoxynaphthalene

2-methoxynaphthalene

1-methoxy-4-(prop-1-enyl)benzene

1-(cyclopropylmethyl)-4-methoxybenzene

wherein X, Y, and R1 to R11 have the same meaning as given in the description. Furthermore the invention refers to compositions for topical application to the skin comprising them. It further relates to a method of reducing or suppressing the formation of skin irritation.

Priority: GB20050018558 Applic. Date: 2005-09-12; WO2006CH00481 Applic. Date: 2006-09-08

Inventor: NATSCH ANDREAS [CH]; WASESCHA MICHAEL [CH]


Application No.: US20100063015A1  Published: 11/Mar/2010

Title: SKIN-CARE PREPARATIONS CONTAINING MUPIROCIN AND BETAMETHASONE DIPROPIONATE

Applicant/Assignee:

Application No.: 12/065352   Filing Date: 18/Mar/2009

Abstract:The present invention relates to a topical skin-care preparation in the form of an ointment containing mupirocin and betamethasone dipropionate as active principles and a carrier formulated with all or some of the following components: hydrogenated castor oil, polyethylene glycols and preservatives. The inventive preparation is advantageous over prior art compositions in that it has a specific therapeutic effect on primary and secondary skin infections, such as relief of pruritic inflammatory manifestations of dermatosis, a wide range of activity against the majority of bacterial species involved in skin infections, and a high level of activity against Staphylococcus and Streptococcus, including multi-resistant strains. In addition, the therapeutic effect of the preparation is not affected by the size of the inoculum and the preparation has no sensitization potential, thereby providing the product with an excellent safety profile for use by the patient. Moreover, the preparation can counteract the possible secondary effects of one of the components with the effect of another.

Priority: MX2005PA09381 Applic. Date: 2005-09-02; WO2005MX00084 Applic. Date: 2005-09-28

Inventor: AHUMADA AYALA FERNANDO [MX]


Application No.: US20100063490A1  Published: 11/Mar/2010

Title: DEVICE AND METHOD FOR THE TREATMENT OF SKIN, AND USE OF THE DEVICE

Applicant/Assignee: KONINKLIJKE PHILIPS ELECTRONICS N.V

Application No.: 12/305438   Filing Date: 21/Jun/2007

Abstract:The invention provides a skin treatment device comprising a laser source (40) and focusing optics (50), such that a focal spot (18) is positioned in a dermis layer (24) of the skin to be treated. The laser beam (42) is powered and focused (16) such that a LIOB (laser induced optical breakdown) phenomenon is obtained, which affects the skin in order to stimulate re-growth of tissue. This in turn reduces wrinkles (30). The device may comprise wrinkle-determining means (52, 54, 56, 58). The focusing optics (50) may have a numerical aperture of at least 0.4. The invention also provides a corresponding method to treat skin, in particular to reduce wrinkles (30), by providing a focused laser beam (16) that causes LIOB in the dermis layer (24) of the skin. The advantage is that damage to overlaying epidermis layers may be avoided by the use of the very local LIOB phenomenon.

Priority: EP20060116057 Applic. Date: 2006-06-26; WO2007IB52399 Applic. Date: 2007-06-21

Inventor: VERHAGEN RIEKO [NL]; VAN HAL ROBBERT A M [NL]; GOTTENBOS BART [NL]; JANSSEN JOZEF J M [NL]; ACKERMANS PAUL A J [NL]; MORALES SERRANO FRANCISCO [NL]; NERKEN SIEGLINDE [NL]; BROKKEN DIRK [NL]; ROOSEN GUIDO [NL]


Application No.: US20100065445A1  Published: 18/Mar/2010

Title: Pre-Packaged, Customized, Woven, Wet Towel

Applicant/Assignee: HUCKLEBERRY TOYS

Application No.: 12/233242   Filing Date: 18/Sep/2008

Abstract:The invention relates to a pre-packaged, pre-moistened towel, which is customized. The towel is made from a woven cloth material, which can be customized by printing logos, designs or words on the towel. The towel can be either disposable or reusable.

Priority:

Inventor: STEVENSON HUGO [US]


Application No.: US20100065655A1  Published: 18/Mar/2010

Title: Lotion Application Compartment

Applicant/Assignee:

Application No.: 12/086098   Filing Date: 04/Dec/2006

Abstract:A lotion application compartment (10) consisting of apparatus for topical application of a fluid to a human or animal body, the apparatus comprising a spray nozzle (20) and a support (80) for the body. The apparatus further comprises of one or more of the following: means for moving the support, so as to change the distance between the body and the spray nozzle (20)

means for varying the spray pattern, spray pressure, spray frequency and/or spray duty cycle of the nozzle (20)

means for varying the rotational speed of the support (80)

and means for raising the body's skin temperature directly by radiation.

Priority: GB20050024800 Applic. Date: 2005-12-05; WO2006GB04524 Applic. Date: 2006-12-04

Inventor: HIPPERSON GERALD [RU]


Application No.: US20100066026A1  Published: 18/Mar/2010

Title: MAIN SEAL SYSTEM AND METHOD FOR USE IN AN ELECTRONIC DEVICE

Applicant/Assignee: MOTOROLA, INC

Application No.: 12/210638   Filing Date: 15/Sep/2008

Abstract:A main sealing system (500) for use in an electronic device comprises a first half housing (501) and a second half housing (516) such that a sympathetic seal (525) is attached integrally with the first half housing (501). The second half housing (516) comprises an integrally formed compression surface (511) for biasing the sympathetic seal (525) in an outwardly manner to prevent fluid from entering a cavity (618) formed when the first half housing (501) and second half housing (516) are joined to form an enclosure for the electronic device.

Priority:

Inventor: GARCIA JORGE L [US]; MAGANA SALVADOR P [US]


Application No.: US20100068156A1  Published: 18/Mar/2010

Title: AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS

Applicant/Assignee: BASF SE

Application No.: 12/441288   Filing Date: 14/Sep/2007

Abstract:The present invention relates to an ampholytic copolymer based on quaternized nitrogen-containing monomers which has a molar excess of cationogenic/cationic groups compared to anionogenic/anionic groups, to cosmetic or pharmaceutical compositions which comprise at least one such ampholytic copolymer, and to further uses of these copolymers.

Priority: EP20070111467 Applic. Date: 2007-06-29; EP20060120778 Applic. Date: 2006-09-15; WO2007EP59725 Applic. Date: 2007-09-14

Inventor: KIM SON NGUYEN [DE]


Application No.: US20100068161A1  Published: 18/Mar/2010

Title: TOPICAL COMPOSITION FOR THE PROTECTION AND/OR TREATMENT OF RADIATION RELATED SKIN DAMAGES

Applicant/Assignee:

Application No.: 12/559954   Filing Date: 15/Sep/2009

Abstract:There is provided a topical composition for the protection and/or treatment of radiation related skin damages comprising from 18.4% to 68% by volume of active principles comprising anti-oxidants, moisturizers, humectants, emollients, anti-inflammatory agents, healing promoting agents and dermal circulation enhancers in from 81.6% to 32% by volume of a pharmaceutically acceptable carrier.

Priority: CA20082639525 Applic. Date: 2008-09-16

Inventor: TODARY MICHAEL FAYEK [CA]


Application No.: US20100068162A1  Published: 18/Mar/2010

Title: Compositions Having Silicone Properties

Applicant/Assignee: LIPO CHEMICALS INC

Application No.: 12/561465   Filing Date: 17/Sep/2009

Abstract:Silicone-free, carbon-based replacements for volatile silicones, such as cyclomethicones, are disclosed. The compositions can be used as is or in dermatological products.

Priority: US20080098077P Applic. Date: 2008-09-18

Inventor: GREENBERG STEPHEN [US]; RIEMER JED A [US]


Application No.: US20100068232A1  Published: 18/Mar/2010

Title: Methods for treating skin lines and wrinkles and improving skin quality

Applicant/Assignee:

Application No.: 12/583944   Filing Date: 27/Aug/2009

Abstract:Methods and compositions for improving skin quality are disclosed. The methods include applying a solution of about 20-30% pre-wetting agent, such as hyaluronic acid, and/or Botulinum toxin to a skin surface with concurrent particle-free dermabrasion treatment, such as particle-free microdermabrasion treatment. These methods lead to significant improvement in the treatment of skin aging. Compositions for improving skin quality are also disclosed. These compositions comprise a pre-wetting agent and a Botulinum toxin agent.

Priority: US20080190562P Applic. Date: 2008-08-28

Inventor: KEY DOUGLAS J [US]


Application No.: US20100068247A1  Published: 18/Mar/2010

Title: Method And System For Providing Targeted And Individualized Delivery Of Cosmetic Actives

Applicant/Assignee:

Application No.: 12/533107   Filing Date: 31/Jul/2009

Abstract:A system and method are provided for targeted and individualized delivery of multiple skin benefit agents to the skin of a user. The image of a predetermined treatment area of the user's skin is first captured by an imaging device. The captured image data is then analyzed by a computing device to generate a unique skin profile for the user, which is indicative of the skin conditions at the predetermined treatment area. Based on such skin profile, a printing device prints out one or more cosmetic delivery sheets that can be applied to the predetermined treatment area. Each of the cosmetic delivery sheets contains a substrate with multiple isolate, discrete regions, while at least two of the regions are imprinted with different skin benefit agents for treating different skin conditions of the predetermined treatment area according to the unique skin profile of the user.

Priority: US20080097273P Applic. Date: 2008-09-16

Inventor: MOU TSUNG-WEI ROBERT [US]; MOHAMMADI FATEMEH [US]; QU LISA [US]; CZARNOTA ANNA [US]; KAMEN TAMAR LARA [US]


Application No.: US20100068253A1  Published: 18/Mar/2010

Title: BLEOMYCIN PREPARATION FOR USE AGAINST SKIN TUMOURS

Applicant/Assignee:

Application No.: 12/312526   Filing Date: 26/Nov/2007

Abstract:A preparation for use against skin tumours, which preparation has a semi-solid consistency for enabling the preparation to be applied to and remain on a patient's skin during treatment of a tumour on the patient's skin

which preparation comprises bleomycin which acts against the tumour, an elastic liposome which entraps the bleomycin

and a bleomycin containing carrier which contains the bleomycin in the elastic liposome

and which preparation is such that: (i) the concentration of the bleomycin in the bleomycin containing carrier is not less than the concentration of the bleomycin in the elastic liposome

(ii) the concentration of the bleomycin in the bleomycin containing carrier is not so great as to cause the bleomycin in the bleomycin containing carrier to leak into the elastic liposome and cause the elastic liposome to burst

and (iii) the external concentration of the bleomycin in the bleomycin containing carrier is such that it maintains an osmotic balance between internal and external environments of the elastic liposome whereby the internal concentration of the bleomycin in the elastic liposome is kept constant.

Priority: GB20060023768 Applic. Date: 2006-11-28; WO2007GB04517 Applic. Date: 2007-11-26

Inventor: CHOPRA SUNIL [GB]


Application No.: US20100068259A1  Published: 18/Mar/2010

Title: NATURAL PRODUCT INHIBITORS OF 3DG

Applicant/Assignee:

Application No.: 12/474904   Filing Date: 29/May/2009

Abstract:Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.

Priority: US20080057398P Applic. Date: 2008-05-30

Inventor: TOBIA ANNETTE [US]; ALICE MARCY [US]; SU BANGYING [US]; NIWA TAKESHI [JP]


Application No.: US20100068295A1  Published: 18/Mar/2010

Title: LOW FOAMING ENHANCED BIOCIDAL HYDROGEN PEROXIDE COMPOSITION

Applicant/Assignee: CENTENNIAL VENTURES B.V

Application No.: 12/226657   Filing Date: 27/Apr/2007

Abstract:The present invention discloses a biocidal composition comprising hydrogen peroxide in a concentration of 0.05-50% (w/w) and a compound with a structure according to Formula 1: R-O-(CH(Y)-CH2-O)n-CH2-COOH, wherein R is an alkyl or alkenylene radical containing 6-12 carbon atoms, Y is H or CH3, and n is 3-10, in a concentration of 0.01-60% (w/w). An especially preferred compound according to Formula 1 is R is 6 or 8 and n is 3-8.

Priority: EP20060113228 Applic. Date: 2006-04-27; WO2007EP54164 Applic. Date: 2007-04-27

Inventor: BOBBERT ILJA [NL]


Application No.: US20100068318A1  Published: 18/Mar/2010

Title: Coffee Cherry Cosmetic Composition and Methods

Applicant/Assignee: VDF FUTURECEUTICALS, INC

Application No.: 12/631119   Filing Date: 04/Dec/2009

Abstract:A cosmetic composition comprises a coffee cherry preparation, and most preferably an extract from a sub-ripe quick-dried coffee cherry. Particularly contemplated cosmetic compositions are formulated as a shampoo, lotion, cream, balm, or ointment, and will have at least one of an antioxidant effect, an anti-inflammatory effect, a UV-protective effect, an antimutagenic effect, a chemoprotective effect, a scar reducing effect, a skin-lightening effect, a moisturizing effect, a wrinkle reduction effect, and an antibacterial effect.

Priority: WO2003US11950 Applic. Date: 2003-04-16; WO2003US11951 Applic. Date: 2003-04-16; US2007-599663 Applic. Date: 2007-07-20; WO2004US36630 Applic. Date: 2004-11-03; US20040560865P Applic. Date: 2004-04-08; US20040618900P Applic. Date: 2004-10-12

Inventor: MILJKOVIC DUSAN [US]


Application No.: US20100069311A1  Published: 18/Mar/2010

Title: MEDICAMENT COMPRISING A REDUCING ALKYL-SUGAR MONOMER FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Applicant/Assignee:

Application No.: 12/559107   Filing Date: 14/Sep/2009

Abstract:The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40, said medicament being preferably intended to regulate inflammatory mechanisms. The reducing sugar is preferably selected from the group containing rhamnose, fucose and glucose. The invention also relates to a cosmetic treatment method involving the topical application of a composition comprising at lest one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40.

Priority: FR20030012798 Applic. Date: 2003-10-31; US2006-577444 Applic. Date: 2006-04-27; WO2004FR02794 Applic. Date: 2004-10-29

Inventor: HOULMONT JEAN-PHILIPPE [FR]; RICO-LATTES ISABELLE [FR]; PEREZ EMILE [FR]; BORDAT PASCAL [FR]


Application No.: US20100069338A1  Published: 18/Mar/2010

Title: PHARMACEUTICAL COMPOSITIONS

Applicant/Assignee: YORK PHARMA PLC

Application No.: 12/439023   Filing Date: 31/Aug/2007

Abstract:The present invention provides a composition for topical administration to the skin for treating and/or preventing a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells comprising a zinc salt which is at least partially soluble in water and an acid, wherein the composition has a pH less than or equal to 6. The dermatological condition is generally selected from eczema, dermatitis, atopic eczema, atopic dermatitis, non-atopic eczema, non-atopic dermatitis, seborrheic eczema, irritant contact dermatitis, allergic contact dermatitis, pruritus and sensitive skin. A preferred composition comprises zinc lactate, lactic acid and has a pH of about 4.0 to 5.0.

Priority: GB20060017191 Applic. Date: 2006-08-31; WO2007EP59102 Applic. Date: 2007-08-31

Inventor: WARD SIMON J [GB]; MACGOWAN ALICE [GB]; CORK MICHAEL J [GB]; DAVIS ADRIAN [GB]


Application No.: US20100069400A1  Published: 18/Mar/2010

Title: METHODS FOR TREATING INFLAMMATION AND RELATED CONDITIONS

Applicant/Assignee: ORE PHARMACEUTICALS INC

Application No.: 12/500761   Filing Date: 10/Jul/2009

Abstract:A method for treating an inflammatory condition or immune disorder comprises administering to a subject having such a condition or disorder a therapeutically effective amount of at least one compound selected from irindalone, physiologically active enantiomers thereof, and pharmaceutically acceptable salts thereof. The invention further provides a method for elevating levels of anti-inflammatory cytokines such as IL-10 and IL-13 while inhibiting expression of pro-inflammatory cytokines. A pharmaceutical composition, useful for example in topical treatment of psoriasis, comprises a therapeutically effective amount of at least one compound selected from irindalone, physiologically active enantiomers thereof, and pharmaceutically acceptable salts thereof, in a vehicle comprising at least one pharmaceutically acceptable excipient, the vehicle being adapted for topical administration to skin of a subject.

Priority: US20080079808P Applic. Date: 2008-07-10

Inventor: MALSTROM SCOTT [US]; AMUGUNI HELLEN MULOMI [US]; CLISH CLARY [US]; DEIK AMY ANDERSON [US]; WHITE DAVID [US]


Application No.: US20100069511A1  Published: 18/Mar/2010

Title: STABLE MIXED EMULSIONS

Applicant/Assignee: COMBE

Application No.: 12/608391   Filing Date: 29/Oct/2009

Abstract:Stable mixed emulsion systems containing at least two discrete and distinctly different dispersed particle size ranges, i.e., both nanoemulsion and macroemulsion semisolid dispersions, as well as a method of making the same, are disclosed. The stable mixed emulsions may be used for cosmetic and dermatological applications and provide unique benefits.

Priority: US2006-369831 Applic. Date: 2006-03-08; US20050659410P Applic. Date: 2005-03-09

Inventor: SPENGLER ERIC [US]; PETRAIA TERESA [US]


Application No.: US20100069860A1  Published: 18/Mar/2010

Title: AGENT

Applicant/Assignee: SCA HYGIENE PRODUCTS AB

Application No.: 12/515252   Filing Date: 15/May/2009

Abstract:A novel strain of Lactobacillus fermentum, denoted strain Ess-1, which has been deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH and has been assigned accession number DSM17851. Lactobacillus fermentum, strain Ess-1, has shown valuable properties in the inhibition of Candida, and has medical uses, in particular for the treatment and/or prevention of candidasis and urinary tract infections. In addition, pharmaceutical products and articles include the novel bacterial strain.

Priority: WO2006SE01311 Applic. Date: 2006-11-17

Inventor: FORSGREN BRUSK ULLA [SE]; HUSMARK ULRIKA [SE]; GRAHN HAAKANSSON EVA [SE]; ROENNQVIST DANIEL [SE]


Application No.: US20100070197A1  Published: 18/Mar/2010

Title: SPECTRALLY SENSING CHEMICAL AND BIOLOGICAL SUBSTANCES

Applicant/Assignee:

Application No.: 12/625970   Filing Date: 25/Nov/2009

Abstract:A sensor-network system for spectrally sensing a chemical or biological substance includes a plurality of probe assemblies that each includes a sensor comprising a nano structured surface, wherein the nano structured surface can adsorb molecules of a sample material captured adjacent to the sensor

a laser configured to emit a laser beam to illuminate the molecules adsorbed to the nano structured surface, and a spectrometer that can obtain spectral data from light scattered by the molecules adsorbed to the nano structured surface. A control center includes a computer storage configured to store spectral signatures each associated with a chemical or biological substance and a spectral analyzer that can determine a spectral signature matching at least one of the spectral signatures stored in the computer storage thereby to identify, in the sample material, the chemical or biological substance associated with the one of the spectral signatures.

Priority: US2009-403522 Applic. Date: 2009-03-13; US2008-246616 Applic. Date: 2008-10-07; US2008-176383 Applic. Date: 2008-07-20; US2007-681157 Applic. Date: 2007-03-01; US2004-987842 Applic. Date: 2004-11-12; US2004-852787 Applic. Date: 2004-05-24; US20030473283P Applic. Date: 2003-05-27; US20030473287P Applic. Date: 2003-05-27; US20030520222P Applic. Date: 2003-11-17

Inventor: WANG HONG [US]; GUO XUN [US]; LIU CHUNWEI [CN]


Application No.: US20100070291A1  Published: 18/Mar/2010

Title: Business_on_a_page

Applicant/Assignee:

Application No.: 12/584558   Filing Date: 08/Sep/2009

Abstract:Enterprise architecture is an emerging discipline that cuts across arts, science and religion. Enterprise architecture is increasingly seen as the best way to optimize existing IT investment while planning for future growth in areas like green IT, healthcare IT and medical tourism. Only by establishing a blueprint with which to operate can companies comply with corporate and government mandates requiring closer alignment of business processes with IT investment. Further, since change is a constant in IT, the blueprint must be dynamic enough to anticipate and adapt to evolving business models and economic trends. The blueprints are built on the Beijing Olympics with the One World theme. They cover people, plants and animals, can be applied to person and product complaints and provides the foundation for globalization, mass customization and personalized medicine.

Priority: US20080095693P Applic. Date: 2008-09-10

Inventor: HANDY ASLAM TAHER [US]


Application No.: US20100070455A1  Published: 18/Mar/2010

Title: Methods and Systems for Incorporating Multiple Environmental and Genetic Risk Factors

Applicant/Assignee: NAVIGENICS, INC

Application No.: 12/558345   Filing Date: 11/Sep/2009

Abstract:The present disclosure provides methods and systems for incorporating multiple environmental and genetic risk factors into an individual's genomic profile. Methods include assessing the association between an individual's genotype and at least one disease or condition by incorporating multiple genetic risk factors, environmental risk factors, or a combination of both.

Priority: US20080096758P Applic. Date: 2008-09-12

Inventor: HALPERIN ERAN [US]; WESSEL JENNIFER [US]; CARGILL MICHELE [US]; STEPHAN DIETRICH A [US]


Application No.: US20100071112A1  Published: 25/Mar/2010

Title: WATERPROOF MOISTURE-PERMEABLE FABRIC FOR CLOTHING AND CLOTHING

Applicant/Assignee: TEIJIN FIBERS LIMITED

Application No.: 12/527321   Filing Date: 24/Oct/2007

Abstract:The invention provides a waterproof moisture-permeable fabric for clothing which includes, on one side of a polyester fabric A, a waterproof moisture-permeable layer B including a colorless transparent polyester film stacked, and a white or gray resin C partially stacked, and clothing including the waterproof moisture-permeable fabric. Preferably, a moisture-permeable polymer resin D containing inorganic fine particles is stacked on the waterproof moisture-permeable layer B, and the white or gray resin C is partially stacked thereon.

Priority: JP20070040334 Applic. Date: 2007-02-21; WO2007JP71162 Applic. Date: 2007-10-24

Inventor: IWASHITA KENJI [JP]; ITAI HITOSHI [JP]; YAMAZAWA MOTOKI [JP]


Application No.: US20100074851A1  Published: 25/Mar/2010

Title: COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIC ACID

Applicant/Assignee: AURIGA INTERNATIONAL S.A

Application No.: 12/375857   Filing Date: 01/Aug/2007

Abstract:A cosmetic or pharmaceutical composition includes particles of hyaluronic acid having a molecular weight between 20000 Da and 3000000 Da, combined with a polyamine.

Priority: EP20060118270 Applic. Date: 2006-08-01; US20060841656P Applic. Date: 2006-08-30; WO2007EP57987 Applic. Date: 2007-08-01

Inventor: DUBOIS JACQUES [BE]; MARCHAL ALFRED [BE]


Application No.: US20100074853A1  Published: 25/Mar/2010

Title: Compositions Comprising Kakadu Plum Extract Or Acai Berry Extract

Applicant/Assignee: MARY KAY INC

Application No.: 12/624980   Filing Date: 24/Nov/2009

Abstract:A topical skin care composition comprising kakadu plum extract or acai berry extract, or a combination of both, is disclosed. The composition can include a high oxygen radical absorbance capacity (ORAC) value. The composition can improve the skin's visual appearance, physiological functions, clinical properties, and/or biophysical properties.

Priority: US2007-624985 Applic. Date: 2007-01-19; US20060760103P Applic. Date: 2006-01-19; US20060760977P Applic. Date: 2006-01-20; US20060760979P Applic. Date: 2006-01-20

Inventor: GAN DAVID [US]; HINES MICHELLE [US]; ARAVENA JAVIER [US]; JONES BRIAN [US]


Application No.: US20100074856A1  Published: 25/Mar/2010

Title: EXTERNAL PREPARATION COMPOSITION

Applicant/Assignee: LION CORPORATION

Application No.: 12/605294   Filing Date: 23/Oct/2009

Abstract:An external preparation composition used for preventing or treating symptoms or diseases related to dermatopathy caused by dryness, UV rays and aging such as wrinkles and sags of the skin, pigmentation of the skin, skin roughness and coarse texture and skin diseases such as psoriasis, lichen, ichthyosis, keratosis, Darier's disease, pustulosis, acne, eczema and atopic dermatitis. The external preparation composition comprises at least one of acyl glucosamine derivatives represented by the following Formula (I): wherein R1, R2, R3, R4 and R5 are defined

and X is any one of groups represented by the following Formulas (A) to (C): wherein Y, n and R6 are also defined.

Priority: US2008-257853 Applic. Date: 2008-10-24; US2005-522032 Applic. Date: 2005-01-21; WO2002JP07549 Applic. Date: 2002-07-25

Inventor: KAMBAYASHI HIROAKI [JP]; KONTA HIROSHI [JP]


Application No.: US20100074857A1  Published: 25/Mar/2010

Title: COMPOSITIONS AND METHODS TO TREAT EPITHELIAL-RELATED CONDITIONS

Applicant/Assignee:

Application No.: 12/565335   Filing Date: 23/Sep/2009

Abstract:The described invention relates to the formulation and delivery of compositions to treat an epithelial-related condition selected from the group consisting of sparse hair growth, short hair growth, thin hair growth, alopecia and hair depigmentation and methods for their use. In some embodiments, the composition contains a first component and a second component wherein the first component is at least one prostaglandin analog and the second component is at least one imidazole analog, such that the at least one imidazole analog improves the efficacy of the at least one prostaglandin analog when delivered to a subject refractory to the effect of the prostaglandin analog alone.

Priority: US20080099226P Applic. Date: 2008-09-23

Inventor: LIPKIN PAMELA [US]; LUBIT BEVERLY [US]


Application No.: US20100074859A1  Published: 25/Mar/2010

Title: SKIN CARE COMPOSITIONS AND RELATED METHODS

Applicant/Assignee:

Application No.: 11/996557   Filing Date: 22/Aug/2007

Abstract:A skin care composition comprising an acrylate polymer

a yield value increaser, and a surfactant. The composition has a yield value of at least about 4. Also included within the scope of the invention are related methods, such as methods of depositing a hydrophobic material on an epidermal surface and methods of incorporating a hydrophobic material into a skin care composition.

Priority: US2007-683801 Applic. Date: 2007-03-08; US20060823305P Applic. Date: 2006-08-23; WO2007US76494 Applic. Date: 2007-08-22

Inventor: HASKEL ARIEL [US]; PIMENTA PALOMA [US]


Application No.: US20100074877A1  Published: 25/Mar/2010

Title: COMPOSITION FOR IMPROVING SKIN QUALITY AND A PROCESS FOR PREPARING THE SAME

Applicant/Assignee: COMPAGNIE GERVAIS DANONE

Application No.: 12/445205   Filing Date: 12/Oct/2007

Abstract:The present invention relates to a composition including, as active substance, a mixture of at least one polyunsaturated fatty acid, different from polyunsaturated fatty acid derived from milk, polyphenols, milk proteins and lactic bacteria, and the composition having a water content of at least 50% by weight

and wherein the polyunsaturated fatty acid presents an increased bioavailability compared with the one of the polyunsaturated fatty acid alone.

Priority: EP20060291607 Applic. Date: 2006-10-13; WO2007EP60922 Applic. Date: 2007-10-12

Inventor: GUYONNET DENIS [FR]; LASSEL TAOUS [FR]; SAMSON-VILLEGER SANDRINE [FR]; TRGO CHRISTIAN [FR]; RAWLINGS ANTHONY [GB]


Application No.: US20100074879A1  Published: 25/Mar/2010

Title: SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME

Applicant/Assignee: SHOWA DENKO K.K

Application No.: 12/445184   Filing Date: 15/Oct/2007

Abstract:A skin agent for external use and a cosmetic agent are provided, by transdermal administration of which expected actions and effects of ubiquinone derivatives, salts thereof, ubiquinones and ubiquinols are effectively obtained. The skin agent for external use includes a ubiquinone derivative or a salt thereof as an active ingredient. The ubiquinone derivative is represented by the formula (1): wherein R1 and R2 are each a hydrogen atom or a phosphoric group, at least one of R1 and R2 is a phosphoric group, and n is an integer in the range of 1 to 9.

Priority: WO2007JP70385 Applic. Date: 2007-10-12; JP20060280112 Applic. Date: 2006-10-13; JP20070264317 Applic. Date: 2007-10-10

Inventor: AOKI HIROBUMI [JP]; KURATA YOHEI [JP]; KAMACHI HARUMI [JP]; NAKANISHI HIROTSUGU [JP]


Application No.: US20100074965A1  Published: 25/Mar/2010

Title: COSMETIC COMPOSITION COMPRISING A METEORITE EXTRACT, AND USE OF THE EXTRACT AS COSMETIC AGENT SUITABLE FOR STIMULATING THE DIFFERENTIATION OF HUMAN KERATINOCYTES

Applicant/Assignee: GATTEFOSSE SAS

Application No.: 12/418854   Filing Date: 06/Apr/2009

Abstract:The present invention relates to a cosmetic composition comprising a meteorite extract. The present invention also relates to methods of using the extract as a cosmetic agent suitable for stimulating the differentiation of human keratinocytes.

Priority: FR20080056344 Applic. Date: 2008-09-22

Inventor: ERISSON NEE CONRY MURIELLE [FR]; GUICHON ALAIN [FR]; LENNON PAULA [FR]


Application No.: US20100075016A1  Published: 25/Mar/2010

Title: METHOD AND APPARATUS FOR TEMPERING OF MEAT, TEMPERED MEAT TREATED BY THE METHOD, AND REFRIGERATED MEAT STORAGE

Applicant/Assignee: MAYEKAWA MFG. CO., LTD

Application No.: 12/563783   Filing Date: 21/Sep/2009

Abstract:A tempering treatment method whereby the temperature of meat, which involves carcass prepared by slaughtering cattle or poultry and sterilizing and washing, is lowered as close to the ice storage temperature as possible to prevent a temperature rise caused by the actions of enzymes contained within the meat before transporting the meant to a refrigerated storage, which comprises surface-freezing the meat by blowing a cold air stream at about -20 to about -40 DEG C. to the meant before conducting the tempering treatment, thus allowing the generation of freezing latent heat in the subcutaneous part owing to the surface-freezing (freezing the subcutaneous tissue), and then rapidly lowering the core temperature inside the meat due to the latent heat released at the melting of the freezing latent heat to thereby conduct the tempering treatment at a temperature of 0 to +15 DEG C.

Priority: WO2008JP54340 Applic. Date: 2008-03-11; US20070895886P Applic. Date: 2007-03-20

Inventor: OKAMOTO NAOTO [JP]; SAKURAMOTO SUGURU [JP]; ARAI TAKAHIRO [JP]; TSUBATA KOUICHI [JP]; TANIYAMA AKIRA [JP]


Application No.: US20100075914A1  Published: 25/Mar/2010

Title: METHODS FOR TREATING HERPES VIRUS INFECTIONS

Applicant/Assignee: NANOBIO CORPORATION

Application No.: 12/425984   Filing Date: 17/Apr/2009

Abstract:The present invention relates to methods for treating, killing, and/or inhibiting the growth of Herpes viruses in human subjects comprising topically administering to a human subject in need thereof a nanoemulsion composition having antiviral properties.

Priority: US20080046262P Applic. Date: 2008-04-18

Inventor: FLACK MARY R [US]; CIOTTI SUSAN MARIE [US]; HAMOUDA TAREK [US]; SUTCLIFFE JOYCE A [US]; BAKER JR JAMES R [US]


Application No.: US20100076071A1  Published: 25/Mar/2010

Title: USE OF EQUOL FOR TREATING SKIN DISEASES

Applicant/Assignee:

Application No.: 12/533169   Filing Date: 31/Jul/2009

Abstract:Equol (7-hydroxy-3(4'hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5[alpha]-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies of skin and hair. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes affecting skin and hair.

Priority: US2005-059951 Applic. Date: 2005-02-17; US2005-533045 Applic. Date: 2005-10-20; WO2003US34441 Applic. Date: 2003-10-29; US2003-625989 Applic. Date: 2003-07-24; US2008-167813 Applic. Date: 2008-07-03; US2003-625934 Applic. Date: 2003-07-24; US20040521457P Applic. Date: 2004-04-28; US20020422469P Applic. Date: 2002-10-29; US20020398270P Applic. Date: 2002-07-24

Inventor: LEPHART EDWIN DOUGLAS [US]; LUND TRENT D [US]; SETCHELL KENNETH DAVID REGINALD [US]; HANDA ROBERT J [US]


Application No.: US20100076077A1  Published: 25/Mar/2010

Title: ESTERS OF 4,5-DISUBSTITUTED-OXY-2-METHYL-3,6-DIOXO-CYCLOHEXA-1,4-DIENYL ALKYL ACIDS AND PREPARATION THEREOF

Applicant/Assignee: EASTMAN CHEMICAL COMPANY

Application No.: 12/236171   Filing Date: 23/Sep/2008

Abstract:Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids were prepared chemically and/or enzymatically. Depending upon the ester, improved melanocyte cytotoxicity was achieved. Improved cytotoxicity characteristics are consistent with ester analogs being more physiologically compatible and less irritating to skin than their corresponding acids.

Priority:

Inventor: WEMPE MICHAEL FITZPATRICK [US]; DENG LIU [US]; CLENDENNEN STEPHANIE KAY [US]; BOAZ NEIL WARREN [US]


Application No.: US20100076080A1  Published: 25/Mar/2010

Title: Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products

Applicant/Assignee:

Application No.: 12/541428   Filing Date: 14/Aug/2009

Abstract:The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect. Preparation schemes for neoisomers of other menthyl derivatives which are useful as coolants, including esters, ethers, carboxy esters and other N-substituted carboxamides are also provided.

Priority: US20080089094P Applic. Date: 2008-08-15

Inventor: YELM KENNETH EDWARD [US]; BUNKE GREGORY MARK [US]; HAUGHT JOHN CHRISTIAN [US]


Application No.: US20100076089A1  Published: 25/Mar/2010

Title: ANTIMICROBIAL GEL FORMULATIONS

Applicant/Assignee: NOVABAY PHARMACEUTICALS, INC

Application No.: 12/540251   Filing Date: 12/Aug/2009

Abstract:Disclosed herein are formulations comprising an N-halogenated or N,N-dihalogenated amine compound dispersed in a water-swellable polymer, wherein the compound is 90% stable for at least 30 days at about 25 DEG C. Also disclosed are methods of treating or preventing infections caused by a bacterial, a microbial, a sporal, a fungal or a viral activity using such formulations.

Priority: US20080088302P Applic. Date: 2008-08-12; US20090229624P Applic. Date: 2009-07-29

Inventor: WANG LU [US]; NAJAFI AZAR [US]; MEMARZADEH BAHRAM [US]; SHARMA KULDEEPAK [US]; HO KIM PHUONG [US]


Application No.: US20100076090A1  Published: 25/Mar/2010

Title: Topical skin care formulations

Applicant/Assignee:

Application No.: 12/284398   Filing Date: 22/Sep/2008

Abstract:A topical anti-aging skin care formulation comprising an effective amount of a benzoquinone, such as CoQ10, plus a synergistic pair of stabilizers and a synergistic pair of whiteners. The stabilizers are octyl salicylate and octyl methoxycinnamate. The whiteners are titanium dioxide and zinc oxide. When proper amounts of these ingredients are used in an aqueous based emulsion formulation, the product will be initially white, and will remain white for an extended period of time.

Priority:

Inventor: HOLYFIELD LOUISE [US]


Application No.: US20100080761A1  Published: 01/Apr/2010

Title: Extracts of Isochrysis sp.

Applicant/Assignee: SYMRISE GMBH & CO. KG

Application No.: 12/568475   Filing Date: 28/Sep/2009

Abstract:The present invention relates to extracts of Isochrysis sp., preferably Tahitian Isochrysis, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Isochrysis sp., preferably Tahitian Isochrysis.

Priority: US20080101228P Applic. Date: 2008-09-30

Inventor: HERRMANN MARTINA [DE]; JOPPE HOLGER [DE]; PERTILE PAOLO [IT]; ZANELLA LORENZO [IT]


Application No.: US20100080762A1  Published: 01/Apr/2010

Title: SKIN CARE COMPOSITION

Applicant/Assignee:

Application No.: 12/440342   Filing Date: 05/Sep/2007

Abstract:The present invention relates to an oral composition containing an optimal combination of nutritional ingredients at high concentrations and at optimal ratios in order to maintain and/or achieve health and/or beautiful look of the skin.

Priority: EP20060018843 Applic. Date: 2006-09-08; EP20060026413 Applic. Date: 2006-12-20; WO2007EP07719 Applic. Date: 2007-09-05

Inventor: GORALCZYK REGINA [DE]


Application No.: US20100080763A1  Published: 01/Apr/2010

Title: ACRYLIC-BASED COPOLYMER COMPOSITIONS FOR COSMETIC AND PERSONAL CARE

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/632228   Filing Date: 07/Dec/2009

Abstract:A composition for nails, skin and hair in the form of an aqueous emulsion or dispersion is provided. The composition comprises: (a) at least one copolymer comprising (i) about 10 to 85 weight percent of (meth)acrylate ester of C4 to C18 straight and/or branched chain alkyl alcohol, (ii) about 10 to 70 weight percent of (meth)acrylate ester of a saturated or unsaturated cyclic alcohol containing 6 to 20 carbon atoms

and (b) an aqueous carrier, solvent, or vehicle component. When used in hair applications, the inventive composition is not a reshapable composition.

Priority: US2001-887751 Applic. Date: 2001-06-22; US2000-696468 Applic. Date: 2000-10-25

Inventor: KANTNER STEVEN S [US]; EVERAERTS ALBERT I [US]; NGUYEN LANG N [US]


Application No.: US20100080767A1  Published: 01/Apr/2010

Title: COMPOUNDS

Applicant/Assignee: CRODA UNIQEMA, INC

Application No.: 12/312430   Filing Date: 12/Nov/2007

Abstract:The present invention relates to compounds according to Formula 1

wherein R represents a hydrocarbon group, Z represents an oxyethylene group, B represents an alkyl chain comprising 1 to 5 carbon atoms, Y represents 0 or 1, X represents a number greater than zero, and their use as surfactants, and in particular as surfactants which act as foam promoting agents.

Priority: US20060858364P Applic. Date: 2006-11-13; WO2007US23844 Applic. Date: 2007-11-12

Inventor: QUEEN CRAIG BARTLETT [US]


Application No.: US20100080768A1  Published: 01/Apr/2010

Title: Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin

Applicant/Assignee:

Application No.: 12/238481   Filing Date: 26/Sep/2008

Abstract:The present invention relates to a composition used as a vehicle for percutaneous absorption of Pharmaceutical and Cosmaceutical active agents that comprises Dimethiconol (hydroxyl-terminated polydimethydimethylsiloxane), dimethicone-350 (polydimethylsiloxane-350), cyclomethicone-5 nf (decamethylcyclopentasiloxane), alkymeth siloxane copolyol-lauryl peg/ppg 18/18 methicone (alkymethyl siloxane copolyol), cyclopentasiloxane and dimethicone Crosspolymer (silicone elastomer and decamethylcyclopentasiloxane), stearoxytrimethylsilane and stearyl alcohol (silicone wax), and deionized water. This composition serves several key applications: (1) it is a vehicle for percutaneous absorption of Pharmaceutical and Cosmaceutical active agents

(2) it acts as a method for utilizing other compositions in the treatment of inflammatory conditions of the skin including, but by no means limited to, atopic dermatitis (eczema), allergic contact dermatitis, seborrheic dermatitits, psoriasis, xerosis and atopia

(3) it is a treatment of inflammatory conditions of mucosae

(4) it relates to other compositions and methods for protecting and enhancing the barrier function of the skin.

Priority:

Inventor: MCGRAW THOMAS L [US]; MCGRAW DONALD M [US]; MCGRAW KELI C [US]; MCGRAW DONALD V [US]


Application No.: US20100080782A1  Published: 01/Apr/2010

Title: Use of probiotic lactic acid bacteria for balancing the skin's immune system

Applicant/Assignee: NESTEC S.A

Application No.: 12/454722   Filing Date: 07/Aug/2009

Abstract:The present invention pertains to the use of probiotics for the preparation of a carrier for balancing the skin's immune function. In particular, the present invention pertains to the use of probiotic micro-organisms for balancing the skin's immune function under stress conditions, such as a exposure to ultraviolet radiation, specifically for enhancing the skin's immune activity and reducing the tendency to develop allergic reactions under such conditions.

Priority: EP20000121865 Applic. Date: 2000-10-06; US2003-381911 Applic. Date: 2003-08-12; WO2001EP11475 Applic. Date: 2001-10-04

Inventor: BAUR MARKUS [DE]; BRETON LIONEL [FR]; COUZY FRANCOIS [CH]; GUENICHE AUDREY [FR]


Application No.: US20100080834A1  Published: 01/Apr/2010

Title: Film Material With Antimicrobial And/Or Odor-Absorbing Coating and Sanitary Article

Applicant/Assignee: NUOVA PANSAC S.P.A

Application No.: 12/515191   Filing Date: 26/Jun/2009

Abstract:A film material (1) is disclosed herein, particularly a polyolefin-based film material, coated on one side with a water resoluble resin-containing skin (2), and containing antimicrobial and/or odor-absorbing agents susceptible of being activated by organic liquids and blood liquids, such film material is particularly designed to form a disposable sanitary article (4) comprising a liquid-pervious topsheet (5), a liquid-impervious backsheet (6) and an absorbent layer (7) sandwiched between the topsheet (5) and the backsheet (6).

Priority: IT2006MI02253 Applic. Date: 2006-11-24; WO2007IB03588 Applic. Date: 2007-11-22

Inventor: LORI FABRIZIO [IT]; DELLA ZASSA SANTE AURELIO [IT]


Application No.: US20100080845A1  Published: 01/Apr/2010

Title: Cosmetic Methods And Compositions For Repairing Human Skin

Applicant/Assignee:

Application No.: 12/631585   Filing Date: 04/Dec/2009

Abstract:The present invention relates to methods and compositions for repairing adverse effects of the environment, daily stress, sun exposure, or pre-mature aging on human skin, comprising applying to the skin, prior to a period of bodily rest, a topical composition that contains resveratrol or a derivative thereof and at least one DNA repair enzyme.

Priority: US2007-837658 Applic. Date: 2007-08-13

Inventor: MAES DANIEL H [US]; MAMMONE THOMAS [US]; GOLDGRABEN KERRI [US]


Application No.: US20100080853A1  Published: 01/Apr/2010

Title: Use of Spongilla Spicules as a Dermabrasion Device or Resurfacing Modality

Applicant/Assignee:

Application No.: 12/444495   Filing Date: 05/Oct/2007

Abstract:Dermabrasive compositions for skin resurfacing are disclosed. Therapeutic compositions disclosed are derived from Porifera species, specifically sponges, and more specifically fresh water sponges. One disclosed embodiment is derived from Spongilla species and is formulated with pharmaceutically acceptable excipients.

Priority: US20060828324P Applic. Date: 2006-10-05; WO2007US80587 Applic. Date: 2007-10-05

Inventor: VILLANI MARIA [US]


Application No.: US20100080861A1  Published: 01/Apr/2010

Title: COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING A MIXTURE OF ESSENTIAL OILS, AND ITS USES THEREOF, PARTICULARLY FOR THE CARE OF SENSITIVE OR SENSITIZED SKIN

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/553200   Filing Date: 03/Sep/2009

Abstract:The present invention relates to cosmetic or dermatological compositions comprising a combination of a cannabis essential oil substantially free of cannabinoids and a helichrysum essential oil, and to their uses thereof, particularly for the care of sensitive or sensitized skin.

Priority: FR20080055994 Applic. Date: 2008-09-05

Inventor: ANDRE PATRICE [FR]; RENIMEL ISABELLE [FR]; JOLY FRANCINE [FR]


Application No.: US20100080864A1  Published: 01/Apr/2010

Title: TREATMENT AND COMPOSITION FOR ACHIEVING SKIN ANTI-AGING BENEFITS BY CORNEUM PROTEASE ACTIVATION

Applicant/Assignee: MARY KAY INC

Application No.: 12/632554   Filing Date: 07/Dec/2009

Abstract:Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's stratum corneum. The disclosed treatment methods involve topical application of a novel cosmetic composition containing a combination of a cationic surfactant such as N,N,-dimethyldodecyl amine oxide (DMDAO), an anionic surfactant such as sodium dodecyl sulfate (SDS), or monoalkyl phosphate (MAP) and a chelating agent such as ethylene diamine tetraacetate (EDTA) to stimulate a chronic increase in the replacement rate of the skin's stratum corneum by means of corneum protease activation. This chronic, low level stimulation is effective to induce repair and replacement of the stratum corneum, epidermis, and dermis of the skin and improvements in the appearance, function, and anti-aging properties of the skin.

Priority: US2008-202924 Applic. Date: 2008-09-02; US2007-624840 Applic. Date: 2007-01-19; US2002-273649 Applic. Date: 2002-12-12; US1999-357288 Applic. Date: 1999-07-20

Inventor: SCHILTZ JOHN R [US]


Application No.: US20100081162A1  Published: 01/Apr/2010

Title: METHOD OF EVALUATING ANTIWRINKLE SUBSTANCE AND METHOD OF ASSESSING THE SKIN

Applicant/Assignee: POLA CHEMICAL INDUSTRIES INC

Application No.: 12/529505   Filing Date: 18/Feb/2008

Abstract:It is intended to provide a method whereby the skin conditions (for example, loss in the skin elasticity, wrinkle formation possibility, insufficient tightness in dermal collagen fiber bundles, or the like) can be exactly and conveniently assessed. It is also intended to provide a method whereby the wrinkle-improvement effect of a test substance can be exactly and conveniently evaluated. The skin conditions are assessed by using the expression amount of an adhesion factor in skin cells as an indication. The wrinkle reducing effect of a test substance is evaluated by using the expression amount of an adhesion factor in skin cells in the presence of the test substance as an indication.

Priority: JP20070051025 Applic. Date: 2007-03-01; WO2008JP52626 Applic. Date: 2008-02-18

Inventor: KIDA NAOKO [JP]; TADA AKIHIRO [JP]


Application No.: US20100081411A1  Published: 01/Apr/2010

Title: Multifunctional telemetry alert safety system (MTASS)

Applicant/Assignee:

Application No.: 12/286210   Filing Date: 29/Sep/2008

Abstract:A personnel accountability and situational awareness monitoring communications system for emergency personnel that comprises wireless network-adaptable monitoring devices, peripherals and base station console software for telemetry monitoring of real-time information at a plurality of personnel accountability and situational awareness parameters of critical data about the safety, health and whereabouts of first responders deployed in typically hazardous environments. Exterior incident command, including fire, rescue, safety and other emergency agencies achieve real-time command view and control over a variety of personnel accountability and safety parameters during emergency response activities of personnel wearing the system of the present invention portable device while operating within the wireless network of an emergency incident scene. Configured to be carried by emergency services personnel while deployed on scene, the portable device is a multi-functional sensing and communicating integration of accountability and situational awareness technologies consolidated into one portable, telemetry device. The portable device's multifunctional integrated technology includes the monitoring, telemetry and alert notification of accountability identification, location, assignment notification, vital signs, ambient vicinity temperature, SCBA status, combustible gas sensing, video streaming, "evacuation" recall signaling, signal tracking and multi-alarm signaling if the wearer has either low remaining air pressure/time, impending thermal breakthrough, low battery power, exceeds the safety threshold for safe heart rate or external body temperature readings, or becomes motionless for a predetermined time period.

Priority:

Inventor: MONTENERO JOHN MATHEW [US]


Application No.: US20100081637A1  Published: 01/Apr/2010

Title: Eczema treatment with vitamin D and analogs thereof method, composition and cream

Applicant/Assignee: INNOVIA SKINCARE CORP

Application No.: 12/587070   Filing Date: 30/Sep/2009

Abstract:An eczema treatment method comprises application of a therapeutically effective composition in the form of an aqueous topical cream to an affected area of an exterior skin region of a patient, the aqueous topical cream comprising water, a water-soluble organic liquid, a surface active agent, and vitamin D3 compound or another claimed analog thereof, the vitamin D3 compound or the analog constituting at least approximately 10 international units per gram (IU/gram), and, most preferably at least approximately 400 IU/gram. An eczema treatment composition comprises a therapeutically effective formulation comprising at least approximately 50%-90% water, between approximately 1-5% PEG-40 stearate, between approximately 1-5% steareth-2, and cholecalciferal at a concentration of at least approximately 50 international units per gram (IU/g) of composition, and, most preferably at least approximately 400 IU/g. A topical vitamin D cream for therapeutic treatment of eczema includes vitamin D or an analog thereof chosen from the group consisting of cholecalciferol, alfacalcidol, calcifedol, and ergocalciferol

water

a water-soluble organic liquid

and a surface active agent, the vitamin D or analog being in a concentration of at least approximately 50 international units per gram (IU/g) of cream. Remarkably, relief from eczema conditions occurs immediately or in less than 3 days.

Priority: US20080194963P Applic. Date: 2008-10-01

Inventor: STRUBE MARILYN [US]


Application No.: US20100081716A1  Published: 01/Apr/2010

Title: PROCESS FOR PRODUCTION OF ETHER CARBOXYLATES

Applicant/Assignee: KAO CORPORATION

Application No.: 12/597019   Filing Date: 03/Apr/2008

Abstract:The present invention relates to a process for producing an ether carboxylate which includes the steps of (1) reacting an aliphatic monohydric alcohol with an alkylene oxide in the presence of an alkali catalyst

(2) neutralizing a reaction solution obtained in the step (1) with an acid such as hydroxycarboxylic acids to obtain an ether alcohol

and (3-1) reacting the obtained ether alcohol with a monohalogenofatty acid or a salt thereof and an alkali metal hydroxide, or (3-2) subjecting the obtained ether alcohol to catalytic oxidation reaction in the presence of a catalyst. The obtained ether carboxylate has a less odor and a high quality and is therefore suitably used in the applications such as cosmetics and toiletries.

Priority: JP20070122572 Applic. Date: 2007-05-07; WO2008JP56705 Applic. Date: 2008-04-03

Inventor: MATSUNAGA AKIRA [JP]; OHMAE KAORU [JP]


Application No.: US20100082006A1  Published: 01/Apr/2010

Title: DEVELOPMENTALLY DESIGNED DIAPER

Applicant/Assignee:

Application No.: 12/589514   Filing Date: 28/Apr/2009

Abstract:The present disclosure provides a developmentally designed diaper for LBW infants that is based on NIDCAP principals to allow for the proper positioning of a LBW infants limbs while wearing the diaper.

Priority: US20080127209P Applic. Date: 2008-05-09; US20080127210P Applic. Date: 2008-05-09; US20080127211P Applic. Date: 2008-05-09

Inventor: ROGONE MARY S [US]; ROGONE PHILIP N [US]; CROTEAU KENNETH S [US]; CROTEAU WINNIFRED D [US]


Application No.: US20100083443A1  Published: 08/Apr/2010

Title: Depilatory Composition

Applicant/Assignee: RECKITT & COLMAN (OVERSEAS) LIMITED

Application No.: 12/530426   Filing Date: 03/Mar/2008

Abstract:A depilatory cream composition comprising, a depilatory active, an emollient selected from at least one of mineral oil, silicone oil and emollient esters, and a silicone wax, a talc and/or polyamide resin.

Priority: GB20070004599 Applic. Date: 2007-03-09; WO2008GB00731 Applic. Date: 2008-03-03

Inventor: TINDAL ANNE [GB]; MANGASSI OUMOU [GB]


Application No.: US20100085564A1  Published: 08/Apr/2010

Title: SYSTEMS AND METHODS FOR DETECTING CHEMICAL AND BIOLOGICAL SUBSTANCES

Applicant/Assignee:

Application No.: 12/403522   Filing Date: 13/Mar/2009

Abstract:A method for detecting an ingredient in a food product or detecting a disease includes allowing a food sample solution obtained from a food product or a body fluid from an individual to come to contact with a nano-scale surface structure in a sensor, wherein the nano-scale surface structure comprises a plurality of columns over a substrate or a plurality of holes in a substrate. The method includes illuminating the food sample solution or the body fluid on the nano-scale surface structure on the sensor by a laser beam

obtaining a Raman spectrum from the scattered light using a spectral analyzer

and identifying the spectral signature in the Raman spectrum to determine the existence of the chemical substance in the food product or identifying a disease in the individual.

Priority: US2008-246616 Applic. Date: 2008-10-07

Inventor: GUO XUN [US]; WANG HONG [US]; LIU CHUNWEI [CN]


Application No.: US20100086494A1  Published: 08/Apr/2010

Title: SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF

Applicant/Assignee: PCR TECHNOLOGY HOLDINGS, LC

Application No.: 12/574135   Filing Date: 06/Oct/2009

Abstract:The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted idebenone derivatives, methods of treating skin changes by topical application of these carboxylic acid-substituted idebenone derivatives, and their methods of synthesis. The carboxylic acid-substituted idebenone derivatives of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the carboxylic acid-substituted idebenone derivatives of the present invention have an antioxidant effect that is useful in treating a skin change.

Priority: US20080103043P Applic. Date: 2008-10-06

Inventor: DIEDRICH FALKO [DE]; LEWIS II JOSEPH A [US]; DINARDO JOSEPH C [US]; NEUDECKER BIRGIT [DE]; WIELAND EBERHARD [DE]


Application No.: US20100086498A1  Published: 08/Apr/2010

Title: Personal Care Compositions Providing Enhanced Cooling Sensation

Applicant/Assignee:

Application No.: 12/636096   Filing Date: 11/Dec/2009

Abstract:Disclosed are personal care compositions for use on hair, skin, oral cavity, throat and other mucosal surfaces containing a flavor/perfume system comprising one or more coolants, wherein the pleasant cool and refreshing sensation provided by the coolant is enhanced in terms of quicker onset, greater intensity or impact and/or longer duration, thereby improving appeal and acceptability of the compositions to consumers. In one embodiment the invention provides oral care compositions comprising (a) a flavor composition comprising one or more non-menthol coolants and optionally one or more additional flavor ingredients, (b) a calcium ion source and/or a calcium transport agent sufficient to potentiate and/or modulate the cooling and refreshing sensation provided by the coolant(s), and (c) an orally-acceptable carrier. Upon application to the oral cavity, the compositions provide an immediate onset of cooling sensation which lasts longer than about 15 minutes thereby providing long-lasting clean and fresh mouth impression and encouraging user compliance and repeated use of the compositions.

Priority: US2008-274467 Applic. Date: 2008-11-20; US20070003863P Applic. Date: 2007-11-20

Inventor: HAUGHT JOHN CHRISTIAN [US]; GLANDORF WILLIAM MICHAEL [US]; JOHNSON CHRISTINE LULA [US]; SANKER LOWELL ALAN [US]


Application No.: US20100086501A1  Published: 08/Apr/2010

Title: Determining Age Ranges of Skin Samples

Applicant/Assignee: DERMTECH INTERNATIONAL

Application No.: 12/550060   Filing Date: 28/Aug/2009

Abstract:The present invention provides methods for characterizing a skin sample of a subject as belonging to an age range by analyzing nucleic acid or protein molecules obtained from the subject. The methods include analyzing expression or mutations in epidermal samples, of one or more skin markers. The methods can include the use of a microarray to analyze gene or protein profiles from a sample and compare them with a known skin age index. Therapeutic and cosmetic formulations are also provided herein.

Priority: US20080092687P Applic. Date: 2008-08-28

Inventor: CHANG SHERMAN H [US]; NAUGHTON GAIL K [US]


Application No.: US20100086504A1  Published: 08/Apr/2010

Title: METHODS OF ADMINISTERING TOPICAL ANTIFUNGAL FORMULATIONS FOR THE TREATMENT OF FUNGAL INFECTIONS

Applicant/Assignee:

Application No.: 12/508537   Filing Date: 23/Jul/2009

Abstract:The present invention relates to topical antifungal formulations comprising one or more antifungal (e.g., terbinafine), a lipid and a surfactant, and uses thereof for the treatment of skin and nail fungal infections.

Priority: US20080083115P Applic. Date: 2008-07-23; US20080102111P Applic. Date: 2008-10-02; US20090150187P Applic. Date: 2009-02-05; US20090168122P Applic. Date: 2009-04-09

Inventor: CEVC GREGOR [DE]; VIERL ULRICH [DE]


Application No.: US20100086581A1  Published: 08/Apr/2010

Title: METHOD FOR PURPURA REDUCTION AND PREVENTION

Applicant/Assignee:

Application No.: 12/246528   Filing Date: 07/Oct/2008

Abstract:A method for reducing or eliminating skin discoloration caused by purpura or similar conditions uses corticosteroids, particularly glucocorticoids, in a long term cutaneous treatment. A cream, ointment, spray or other means is used to apply a glucocorticoid, for example, hydrocortisone to warmed skin having a red or purple discoloration. Application is continued daily for several months or years to reduce, eliminate and prevent discoloration.

Priority:

Inventor: BOVE ERNEST [US]


Application No.: US20100086605A1  Published: 08/Apr/2010

Title: MATERIAL, ITEM AND PRODUCTS COMPRISING A COMPOSITION HAVING ANTI-MICROBIAL PROPERTIES

Applicant/Assignee: NM TECH NANOMATERIALS MICRODEVICE TECHNOLOGY LTD

Application No.: 12/445307   Filing Date: 14/Oct/2009

Abstract:A coating product composition has the general formula AOx-(L-Men+)i, wherein AOx is a metal or metalloid oxide in which x indicates the number of the Oxygen atom(s) (O) bonded to the metal (A) atom, Men+ is a metal ion, L is a bifunctional molecule that could bind both metal oxide or metalloid oxide (AOx) and the metal ion (Men+), i is the number of the (L-Men+) groups bound to the metal oxide AOx. The value of the parameter i depends on various factors, such as the size of the nanoparticle of AOx, and the nature of the molecule L.

Priority: WO2006EP67361 Applic. Date: 2006-10-12

Inventor: BIGNOZZI CARLO ALBERTO [IT]; DISSETTE VALERIA [IT]


Application No.: US20100086625A1  Published: 08/Apr/2010

Title: METHODS FOR TREATING SKIN LESIONS

Applicant/Assignee:

Application No.: 12/575232   Filing Date: 07/Oct/2009

Abstract:The present invention relates to the treatment of skin lesions such as cold sores and other complications resulting from disorders such as herpes and the like. The invention relates to the use of a composition comprising one or more aluminum salts for treatment purposes.

Priority: US20080103854P Applic. Date: 2008-10-08

Inventor: ABUKURAH ABDUL R [US]


Application No.: US20100087389A1  Published: 08/Apr/2010

Title: Sensory Modifier

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/247478   Filing Date: 08/Oct/2008

Abstract:Sensory modifiers and compositions comprising sensory modifiers are described. The sensory modifiers comprise polysaccharide carbohydrate having at least about 75% by weight amylopectin and the polysaccharide carbohydrate has been treated and swollen with a substantially anhydrous solvent.

Priority:

Inventor: POLONKA JACK [US]


Application No.: US20100087390A1  Published: 08/Apr/2010

Title: Universal Sensory Structurant

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/247488   Filing Date: 08/Oct/2008

Abstract:Universal sensory structurants and compositions comprising the same are described. The universal sensory structurants comprise polysaccharide carbohydrate having at least about 75% by weight amylopectin and the polysaccharide carbohydrate has been treated and swollen with a solvent comprising hydroxylated polymer comprising less than about 100 silane repeat units.

Priority:

Inventor: POLONKA JACK [US]


Application No.: US20100087394A1  Published: 08/Apr/2010

Title: Compositions Containing Betaine and Hydrophobic Silica

Applicant/Assignee:

Application No.: 12/567002   Filing Date: 25/Sep/2009

Abstract:A free-flowing, substantially dry-to-the-touch, particulate composition comprises (A) finely particulate hydrophobic silicone-treated silica having a surface area of from 80 to 300 m2/g, (B) trimethylglycine, and (C) water, wherein the content of component (A) is greater than 2% and less than 8% by weight based on the total weight of components (A), (B) and (C) and wherein the content of component (B) is greater than 30% and less than 65% by weight based on the total weight of components (A), (B) and (C), said composition being in the form of particles of an aqueous solution of component (B) the surfaces of which particles are coated with a coating of component (A). The particulate composition is useful as a moisturising component in skin-care or cosmetic formulations.

Priority: US20080102777P Applic. Date: 2008-10-03

Inventor: TWYDELL ROLAND [GB]


Application No.: US20100087498A1  Published: 08/Apr/2010

Title: USE OF BIOTIN TO PREVENT PHOTOAGING

Applicant/Assignee:

Application No.: 12/597959   Filing Date: 07/May/2008

Abstract:Use of biotin, preferably in a combination of biotin and (-)-epigallocatechin gallate (EGCG) in a specific ratio, to prevent sunlight-induced aging (photoaging) of the skin.

Priority: EP20070009371 Applic. Date: 2007-05-10; WO2008EP03648 Applic. Date: 2008-05-07

Inventor: GORALCZYK REGINA [DE]; SCHWAGER JOSEPH [CH]


Application No.: US20100087701A1  Published: 08/Apr/2010

Title: Systems and Methods for Optimization of Sleep and Post-Sleep Performance

Applicant/Assignee: ADVANCED BRAIN MONITORING, INC

Application No.: 12/574631   Filing Date: 06/Oct/2009

Abstract:Systems and methods for optimizing the sleep and post-sleep performance of individuals regardless of their environment and time available for sleep are provided. The systems and methods take into account factors that determine the effects of a sleep episode on dexterity, cognitive functions and the subjective feeling of fatigue after sleeping: duration and sleep architecture of the sleep episode, point on the circadian cycle at which the episode occurred, the amount of sleep debt accumulated prior to the episode and the subject's susceptibility to sleep deprivation. The systems and methods include monitoring of sleep architecture over a longer period of time, measurement of accumulated sleep debt and assessment and/or tailoring of the sleep architecture for each subsequent sleep episode, determining a desired sleep state in which the subject should be in, and generating sensory stimuli for guiding the subject to the desired sleep state.

Priority: US20080103512P Applic. Date: 2008-10-07

Inventor: BERKA CHRIS [US]; POPOVIC DJORDJE [US]; DAVIS GENE [US]; YANAGI MATTHEW A [US]


Application No.: US20100092401A1  Published: 15/Apr/2010

Title: IMMUNE RESPONSE MODIFIER FORMULATIONS

Applicant/Assignee: GRACEWAY PHARMACEUTICALS, LLC

Application No.: 12/309367   Filing Date: 12/Jul/2007

Abstract:The present invention provides a pharmaceutical foam formulation. Generally, the formulation includes a therapeutically effective amount of imiquimod and a fatty acid.

Priority: US20060807669P Applic. Date: 2006-07-18; WO2007US16029 Applic. Date: 2007-07-12

Inventor: VALLEJO JANET A [US]; LEUNG SUZANNE S [US]; RODDY PATRICK J [US]; BUSCH TERRI F [US]


Application No.: US20100092404A1  Published: 15/Apr/2010

Title: HYDROGENATION OF CARYOPHELLENE

Applicant/Assignee: E.I. DU PONT DE NEMOURS AND COMAPNY

Application No.: 12/519614   Filing Date: 20/Dec/2007

Abstract:A process for the hydrogenation of a mixture of caryophyllenes by contact with hydrogen in the presence of a supported catalyst. The resulting products are useful for the application to skin.

Priority: US20060876555P Applic. Date: 2006-12-21; WO2007US25983 Applic. Date: 2007-12-20

Inventor: HUTCHENSON KEITH W [US]; JACKSON SCOTT CHRISTOPHER [US]; MANZER LEO ERNEST [US]; SCIALDONE MARK A [US]; SEAPAN MAYIS [US]


Application No.: US20100092408A1  Published: 15/Apr/2010

Title: RESILIENT PERSONAL CARE COMPOSITION COMPRISING POLYALKYL ETHER CONTAINING SILOXANE ELASTOMERS

Applicant/Assignee:

Application No.: 12/251154   Filing Date: 14/Oct/2008

Abstract:A stable personal care composition in the form of a water-in-oil emulsion may comprise a silicone elastomer comprising a polyalkyl ether pendant or a polyalkyl ether crosslink, wherein the alkyl group contains three or more carbon atoms

a non-emulsifying silicone elastomer

an emulsifier

a polar oil

and water. The personal care composition allows for previously unattainable levels of polar oils and/or aqueous phase within a water-in-oil emulsion.

Priority:

Inventor: BREYFOGLE LAURIE ELLEN [US]; TANNER PAUL ROBERT [US]; AISTRUP ELIZABETH REBECCA [US]


Application No.: US20100092409A1  Published: 15/Apr/2010

Title: PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS

Applicant/Assignee: DANISCO US INC

Application No.: 12/252032   Filing Date: 15/Oct/2008

Abstract:The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses the compositions comprising the modified variant BBPIs, and the methods for making and using the compositions in personal care.

Priority:

Inventor: AMIN NEELAM S [US]; COLLIER KATHERINE D [US]; ESTABROOK MELODIE [US]; ESTELL DAVID A [US]; FOX BRYAN P [US]; POWER SCOTT D [US]; SCHMIDT BRIAN F [US]; VOGTENTANZ GUDRUN [US]


Application No.: US20100092412A1  Published: 15/Apr/2010

Title: SELF TANNING COMPOSITIONS CONTAINING DIHYDROXYACETONE, A RETINOID AND ASCORBIC ACID GLUCOSIDE AS A STABILIZER

Applicant/Assignee:

Application No.: 12/576382   Filing Date: 09/Oct/2009

Abstract:The invention concerns a composition comprising dihydroxyacetone, a retinoid and a glycosylated ascorbic acid.

Priority: EP20080305675 Applic. Date: 2008-10-13

Inventor: GOHIER ANNIE [FR]; JOETZJER PASCALE [FR]; MARCHELIDON HERVE [FR]


Application No.: US20100092414A1  Published: 15/Apr/2010

Title: Guar Protein Extracts and Compositions Comprised Thereof as Surface Treating and/or Modifying Agents

Applicant/Assignee: RHODIA CHIMIE

Application No.: 11/989997   Filing Date: 07/Aug/2006

Abstract:Surface treating and/or modifying compositions, for example cosmetic or pharmaceutical or plant protective compositions or domestic care compositions contain a guar protein extract, or derivative thereof, such guar protein extract containing at least 65% by weight of proteins and are particularly suitable as surface treating and/or modifying agents, wherein these surfaces are, for example, the skin, hairs, domestic care and textile surfaces and plant leaf surfaces.

Priority: FR20050008381 Applic. Date: 2005-08-05; WO2006FR01914 Applic. Date: 2006-08-07

Inventor: KARAGIANNI KATERINA [FR]; MONIN VINCENT [US]; SASSI JEAN-FRANCOIS [FR]


Application No.: US20100092454A1  Published: 15/Apr/2010

Title: NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS

Applicant/Assignee:

Application No.: 12/520503   Filing Date: 20/Dec/2007

Abstract:What is described is a use of an antidepressant compound, preferably belonging to the class of selective serotonin reuptake inhibitors (SSRI), for regenerating the integumentary system and/or for stimulating the growth, the original trophism and/or original pigmentation of the corresponding cutaneous appendages, particularly body hair and/or head hair, in mammals. For this purpose, the antidepressant can be formulated in a cosmetic preparation, a pharmaceutical composition, a medical device, or in the form of a culture medium, alone or in combination with a further active ingredient such as a proteolytic enzyme and/or a vitamin.

Priority: IT2006TO00918 Applic. Date: 2006-12-22; IT2006TO00920 Applic. Date: 2006-12-22; IT2007TO00603 Applic. Date: 2007-08-20; WO2007IT00891 Applic. Date: 2007-12-20

Inventor: DE VIVO ENRICO [IT]; PONZETTO ANTONIO [IT]; CESANO CHIARA [IT]; GENNERO LUISA [IT]; MERIZZI GIANFRANCO [IT]; MORRA EMANUELLA [IT]


Application No.: US20100092506A1  Published: 15/Apr/2010

Title: USE OF PHAEODACTYLUM ALGAE EXTRACT FOR DEPIGMENTING THE SKIN

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/530266   Filing Date: 07/Mar/2008

Abstract:The invention relates to the use in a cosmetic composition of an extract of the alga Phaeodactylum tricornutum, as a depigmenting active agent intended in particular for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair. The extract is preferably a lipid extract. The invention also relates to a cosmetic care method for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair, characterized in that it comprises the application, to at least one concerned area of the skin, of a cosmetic composition containing this extract.

Priority: FR20070053728 Applic. Date: 2007-03-08; WO2008FR50394 Applic. Date: 2008-03-07

Inventor: NIZARD CARINE [FR]; MOREAU MARIELLE [FR]; KURFURST ROBIN [FR]; FRIGUET BERTRAND [FR]; BULTEAU ANNE-LAURE [FR]; GAREIL MONIQUE [FR]


Application No.: US20100092546A1  Published: 15/Apr/2010

Title: Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds

Applicant/Assignee:

Application No.: 12/577006   Filing Date: 09/Oct/2009

Abstract:Compositions and methods are provided for the treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1[alpha] in the wound. Agents that increase HIF-1[alpha] activity include, without limitation, agents that stabilize HIF-1[alpha], e.g. deferoxamine, deferiprone, deferasirox, etc.

agents that upregulate expression of HIF-1[alpha], e.g. dimethyloxalylglycine, etc., HIF-1[alpha] polypeptide or coding sequences

and combinations thereof. Such agents may be referred to herein as HIF-1[alpha] potentiating agents.

Priority: US20080104599P Applic. Date: 2008-10-10

Inventor: GURTNER GEOFFREY C [US]; RAJADAS JAYAKUMAR [US]; GALVEZ MICHAEL GABRIEL [US]; NEOFYTOU EVGENIOS [US]


Application No.: US20100092577A1  Published: 15/Apr/2010

Title: TOPICAL COMPOSITIONS CONTAINING MAGALDRATE

Applicant/Assignee:

Application No.: 12/593299   Filing Date: 28/Mar/2008

Abstract:Disclosed are topical compositions containing the active ingredient magaldrate mixed with suitable vehicles and excipients.

Priority: IT2007MI00644 Applic. Date: 2007-03-29; WO2008IB02047 Applic. Date: 2008-03-28

Inventor: GUASTI PIER LUIGI [SM]


Application No.: US20100092585A1  Published: 15/Apr/2010

Title: PLANT EXTRACTION METHOD AND COMPOSITIONS

Applicant/Assignee: NERIUM BIOTECHNOLOGY, INC

Application No.: 12/578436   Filing Date: 13/Oct/2009

Abstract:The present invention pertains to methods of extracting cardiac glycosides from cardiac glycoside containing plant material, such as Nerium oleander, through use of aloe. It further provides for compositions resulting from such extractions, pharmaceutical compositions, cosmetic compositions, and methods of treating skin conditions.

Priority: US20080105133P Applic. Date: 2008-10-14

Inventor: SMOTHERS DONALD L [US]


Application No.: US20100093582A1  Published: 15/Apr/2010

Title: METHOD FOR USING HYDROPHOBICALLY MODIFIED POLYMERS IN CONSUMER AND INDUSTRIAL APPLICATIONS

Applicant/Assignee:

Application No.: 12/575966   Filing Date: 08/Oct/2009

Abstract:This invention pertains to method of using a composition comprising one or more hydrophobically modified polyacrylamides, wherein the polyacrylamides contain acrylamide, one or more anionic monomers, and excludes a cationic monomer, and the method of combination with other compositions for use in combination for consumer and/or industrial applications.

Priority: US2007-853084 Applic. Date: 2007-09-11

Inventor: HESSEFORT YIN Z [US]; MAREK PATRICK J [US]; CRAMM JEFFREY R [US]; PATEL DAMYANTI J [US]; CARLSON WAYNE M [US]


Application No.: US20100093584A1  Published: 15/Apr/2010

Title: Cleansing Formulations Comprising Non-Cellulosic Polysaccharide With Mixed Cationic Substituents

Applicant/Assignee: HERCULES INCORPORATED

Application No.: 12/576639   Filing Date: 09/Oct/2009

Abstract:The present invention is related to the use of a non-cellulosic cationically modified polysaccharide in cleaning compositions and more particularly to a surfactant based cleansing composition comprising, a surfactant, a non-cellulosic cationically modified polysaccharide and a solvent for use in personal care composition, household care composition or an institutional care composition.

Priority: US20080195698P Applic. Date: 2008-10-09

Inventor: BRAND PIET [NL]; BROWN RICHARD G [US]; CHAN ANITA N [US]; ERAZO-MAJEWICZ PAQUITA [US]; MODI JASHAWANT J [US]


Application No.: US20100093637A1  Published: 15/Apr/2010

Title: PEPTIDES AND USE THEREOF

Applicant/Assignee:

Application No.: 12/089300   Filing Date: 10/Oct/2006

Abstract:The present invention relates to peptides, compositions containing such peptides, and the use thereof. The peptides derived from C-krox binding sequences of three zinc finger domains are effective for stimulating the collagen synthesis of normal human dermal fibroblast, and thus can be used to improve the appearance of the skin.

Priority: EP20050292121 Applic. Date: 2005-10-11; WO2006EP09756 Applic. Date: 2006-10-10

Inventor: ODDOS THIERRY [FR]; BELLEMERE GAELLE [FR]; VON STETTEN OTTO [DE]


Application No.: US20100093674A1  Published: 15/Apr/2010

Title: Skin cancer prevention method and product

Applicant/Assignee:

Application No.: 11/196946   Filing Date: 04/Aug/2005

Abstract:The increased use of sunscreens, while limiting damage to the DNA, may promote cancer growth by preventing vitamin D synthesis in the skin. According to the present invention, the beneficial effects of UV radiation are obtained by incorporating vitamin D into the topical after-sun lotions and creams, applied to the skin after exposure to the sun to prevent its harmful effects. Application of the after-sun product provides vitamin D, which is activated by the skin to calcitriol for cancer prevention. Because calcitriol also promotes cellular growth and differentiation, the topical after-sun product with vitamin D may be of benefit for photoaging.

Priority:

Inventor: PERSON JOHN R [US]


Application No.: US20100093691A1  Published: 15/Apr/2010

Title: TOPICAL FORMULATIONS

Applicant/Assignee: HELPERBY THERAPEUTICS LIMITED

Application No.: 12/513783   Filing Date: 08/Nov/2007

Abstract:There is provided topical pharmaceutical compositions comprising compounds of formula I wherein R1, R2, R3 and X have meanings given in the description. These compositions can be used to treat microbial infections and to kill clinically latent microorganisms.

Priority: WO2006GB04178 Applic. Date: 2006-11-08; GB20070009513 Applic. Date: 2007-05-17; WO2007GB04268 Applic. Date: 2007-11-08

Inventor: BECK PETRA HELGA [GB]; BROWN MARC BARRY [GB]; COATES ANTHONY [GB]; HU YANMIN [GB]; STODDART GERLINDA [GB]


Application No.: US20100093823A1  Published: 15/Apr/2010

Title: STEROIDAL COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF

Applicant/Assignee:

Application No.: 12/433322   Filing Date: 30/Apr/2009

Abstract:A method for the identification of compounds) that control melanin synthesis (melanogenesis), and the preparation and use of such compounds, and compositions and formulations thereof to modify (e.g., inhibit) melanin production are disclosed. A representative compound of the invention is defined by formula I: The compounds may be prepared as pharmaceutical and cosmetic compositions, and in one embodiment, may be prepared in combination with each other, and with other melanogenesis inhibiting formulations. The compounds, compositions and formulations of the invention may be used for the prevention and treatment of conditions that are causally related to aberrant melanogenesis activity including, by way of non-limiting example, hyperpigmentation and others.

Priority: US20080049114P Applic. Date: 2008-04-30

Inventor: ORLOW SETH J [US]; KOMATSU LI NI [US]


Application No.: US20100093827A1  Published: 15/Apr/2010

Title: METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS

Applicant/Assignee: TRISTRATA, INC

Application No.: 12/638505   Filing Date: 15/Dec/2009

Abstract:A method of treating a tar-responsive dermatological disorder includes topically applying an anhydrous tar composition to skin of a mammal, preferably a human, that is involved with the disorder, the composition including a wax and a therapeutically effective amount of tar for topical treatment of the tar-responsive dermatological disorder, the composition being in liquid form when at a temperature selected from room temperature and a temperature of skin of a mammal upon application of the composition to the skin of the mammal.

Priority: US2007-680227 Applic. Date: 2007-02-28; US20060778128P Applic. Date: 2006-03-01

Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]; LEE YALING [US]


Application No.: US20100094054A1  Published: 15/Apr/2010

Title: COMPOSITION FOR EXTERNAL APPLICATION TO SKIN

Applicant/Assignee: SHISEIDO COMPANY LTD

Application No.: 12/449143   Filing Date: 24/Jan/2008

Abstract:The present invention provides a composition for external application to skin containing one type or two or more types of compounds selected from the group consisting of aminoacetoamide compounds represented by the following general formula (1) and salts thereof.

Priority: JP20070015083 Applic. Date: 2007-01-25; WO2008JP51000 Applic. Date: 2008-01-24

Inventor: KAMINUMA MIKIKO [JP]; SUETSUGU MASARU [JP]; OCHIAI NOBUHIKO [JP]; TSUNENAGA MAKOTO [JP]


Application No.: US20100095393A1  Published: 15/Apr/2010

Title: METHOD FOR BREEDING TOMATOES HAVING REDUCED WATER CONTENT AND PRODUCT OF THE METHOD

Applicant/Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, (A.R.O.), VOLCANI CENTER

Application No.: 12/636880   Filing Date: 14/Dec/2009

Abstract:A method for breeding tomato plants that produce tomatoes with reduced fruit water content including the steps of crossing at least one Lycopersicon esculentum plant with a Lycopersicon spp. to produce hybrid seed, collecting the first generation of hybrid seeds, growing plants from the first generation of hybrid seeds, pollinating the plants of the most recent hybrid generation, collecting the seeds produced by the most recent hybrid generation, growing plants from the seeds of the most recent hybrid generation, allowing plants to remain on the vine past the point of normal ripening, and screening for reduced fruit water content as indicated by extended preservation of the ripe fruit and wrinkling of the fruit skin.

Priority: IL19990131509 Applic. Date: 1999-08-19; US2006-506896 Applic. Date: 2006-08-21; US2002-069389 Applic. Date: 2002-06-27; WO2000IL00389 Applic. Date: 2000-07-04

Inventor: SCHAFFER ARTHUR A [IL]


Application No.: US20100098644A1  Published: 22/Apr/2010

Title: SOLUBILIZING SYSTEMS FOR FLAVORS AND FRAGRANCES

Applicant/Assignee: FIRMENICH SA

Application No.: 12/643269   Filing Date: 21/Dec/2009

Abstract:The present invention provides compositions and clear oil-in-water microemulsion containing up to 80% w/w of an oil, a surfactant system, a w/w oil/surfactant system ratio between 1 and 3, and a solubilizing-aid ingredient which is not a surfactant neither a VOC compound, the latter being present in an amount sufficient to ensure that the ratio oil/(surfactant+solubilizing aid) is comprised between 0.1 and 5. The present invention concerns also the articles and products associated the compositions and microemulsions, and the methods to manufacture them.

Priority: EP20040105185 Applic. Date: 2004-10-20; US2007-689635 Applic. Date: 2007-03-22; WO2005IB03329 Applic. Date: 2005-10-19; US2005-245704 Applic. Date: 2005-10-06; WO2004IB01473 Applic. Date: 2004-04-19; US2003-421216 Applic. Date: 2003-04-21; US20040620557P Applic. Date: 2004-10-20

Inventor: VLAD FLORIN JOSEPH [US]; MOUNIER REMY [FR]; WONG KENNETH [CH]; DAUGERON AUDE [FR]; HERD THOMAS [US]


Application No.: US20100098646A1  Published: 22/Apr/2010

Title: Soap-Based Liquid Wash Formulations with Enhanced Deposition of Conditioning and/or Skin Appearance Enhancing Agents

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/255349   Filing Date: 21/Oct/2008

Abstract:The invention relates to soap-based liquid body and facial wash compositions. Using high solvent, low water compositions and incompletely naturalized fatty acids to help structure the compositions, all in combination with modified benefit agents, enhanced deposition of conditioning and/or skin appearance and/or optical enhancing agents is achieved.

Priority:

Inventor: CARNALI JOSEPH ORESTE [US]; SHAH PRAVIN [US]; QIU QIANG [US]


Application No.: US20100098647A1  Published: 22/Apr/2010

Title: Soap-Based Liquid Wash Formulations with Enhanced Deposition of Make-Up Agents

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/255365   Filing Date: 21/Oct/2008

Abstract:The invention relates to soap based liquid body and facial wash compositions. Using high solvent, low water compositions and incompletely neutralized fatty acid to help structure the compositions, all in combination with modified benefit agents, enhanced deposition of make-up agents is achieved.

Priority:

Inventor: CARNALI JOSEPH ORESTE [US]; SHAH PRAVIN [US]; QIU QIANG [US]; LIPS ALEXANDER [GB]


Application No.: US20100098648A1  Published: 22/Apr/2010

Title: COMPOSITIONS CONTAINING AT LEAST ONE OIL STRUCTURED WITH AT LEAST ONE SILICONE-POLYAMIDE POLYMER, AND AT LEAST ONE CRYSTALLINE SILICONE COMPOUND AND METHODS OF USING THE SAME

Applicant/Assignee: L'OREAL

Application No.: 12/648020   Filing Date: 28/Dec/2009

Abstract:The invention relates to a physiologically acceptable composition, in particular a cosmetic composition, containing at least one liquid fatty phase structured with at least one structuring polymer of the silicone-polyamide type, the polymer being solid at room temperature and soluble in the liquid fatty phase at a temperature of from 25 to 250 DEG C., and at least one crystalline silicone compound, said oil having an affinity with said structuring polymer and/or with said crystalline silicone compound, and the liquid fatty phase, the polymer and the crystalline silicone compound forming a physiologically acceptable medium. This composition may be in the form of a stick of lipstick which is stable, which does not exude and whose application produces a glossy deposit with good staying power over time.

Priority: US2002-320601 Applic. Date: 2002-12-17

Inventor: YU WEI [US]


Application No.: US20100098679A1  Published: 22/Apr/2010

Title: PROMOTION OF PEROXISOMAL CATALASE FUNCTION IN CELLS

Applicant/Assignee: WAYNE STATE UNIVERSITY

Application No.: 12/568960   Filing Date: 29/Sep/2009

Abstract:The molecular mechanisms of peroxisome biogenesis have begun to emerge

in contrast, relatively little is known about how the organelle functions as cells age. The present inventors characterized age-related changes in peroxisomes of human cells and showed that aging compromises peroxisomal targeting signal 1 (PTS1) protein import, with the critical antioxidant enzyme, catalase, especially affected. The number and appearance of peroxisomes are altered in these cells, and the organelles accumulate the PTS1-import receptor, Pex5p, on their membranes. Concomitantly, cells produce increasing amounts of the toxic metabolite, H2O2, and this increased load of reactive oxygen species (ROS) may further reduce peroxisomal protein import and exacerbate the effects of aging. Disclosed are novel compositions and methods for restoring catalase in peroxisomes by use of targeted catalase modified at its C-terminus and/or N-terminus, optionally in combination with polypeptides which promote cellular uptake of proteins, to prevent or overcome the changes that follows aging or that are associated with a number of diseases or disorders.

Priority: US2005-533124 Applic. Date: 2005-12-27; WO2003US34512 Applic. Date: 2003-10-30; US20020422100P Applic. Date: 2002-10-30

Inventor: TERLECKY STANLEY R [US]; WALTON PAUL A [CA]


Application No.: US20100098732A1  Published: 22/Apr/2010

Title: METHODS, PROCESSES AND COMPOSITIONS COMPRISING THE PROTEIN CALMODULIN (CAM) FOR TREATMENT OF DAMAGED OR AGING SKIN, AND/OR HAIR LOSS

Applicant/Assignee:

Application No.: 12/449916   Filing Date: 21/Mar/2007

Abstract:The invention relates to compositions comprising the calcium binding protein, calmodulin (CaM), and the use of this protein additive in compositions suitable for topical application for the maintenance and development of healthy skin

for improving the aesthetic appearance of skin

for treating fine lines, and/or wrinkles, and/or age spots, and/or minor wounds and burns, and/or calloused skin-through its facilitation of natural healing processes initiated by disease, injury or aging

for enhancing hair growth

and as a cosmetic treatment process comprising application to the skin the compositions, preferably on a daily basis. The compositions may comprise, but not be limited to, UV blocking agents and/or penetration enhancers and/or one or more bio-active agents. CaM can be formulated into therapeutic compositions as lotions, creams, ointments, sprays, gels, skin coverings and wound dressings.

Priority: WO2007IB02725 Applic. Date: 2007-03-21

Inventor: TIPPENS DORR FELT [US]


Application No.: US20100098734A1  Published: 22/Apr/2010

Title: METHODS FOR PREPARATION OF A THIXOTROPIC MICROEMULSION FOR SKIN CARE FORMULATIONS

Applicant/Assignee:

Application No.: 12/619982   Filing Date: 17/Nov/2009

Abstract:Methods for the preparation of a novel topical gel delivery system are disclosed. The delivery system is an oil-in-water (O/W) type thixotropic microemulsion especially useful as a vehicle for the delivery of botanical actives. The delivery system is comprised of natural starches emulsified with a cationic surfactant and utilizes both synthetic and cosmetically-acceptable oils in a two step process. The resulting microemulsion is a uniform dispersion of oil droplets in a stable starch-oil composite. The method also allows for sequestering volatile fragrances by encapsulating them in the oil phase droplets, drying of liquid emulsions to a thin film, and subsequent moisture-activated release of the entrapped fragrances from dried films. Finally, a wound dressing that undergoes reversible hydration upon contact with wound exudates can be prepared by the methods of this invention.

Priority: US2004-873590 Applic. Date: 2004-06-22; US2006-339419 Applic. Date: 2006-01-25; US20030485058P Applic. Date: 2003-07-07; US20050646896P Applic. Date: 2005-01-25

Inventor: WILLE JR JOHN JACOB [US]


Application No.: US20100098751A1  Published: 22/Apr/2010

Title: Novel Use Of An Extract Of Common Mallow As An Hydrating Agent, And Cosmetic Composition Containing It

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/500824   Filing Date: 10/Jul/2009

Abstract:The present invention relates to a novel use of an extract of common mallow for restoring, maintaining or reinforcing the state of moisturization of the skin

to a cosmetic composition containing it, and also to cosmetic care methods using said composition.

Priority: FR20080054780 Applic. Date: 2008-07-11

Inventor: DUMAS MARC [FR]; NOBLESSE EMMANUELLE [FR]; KRZYCH VALERIE [FR]; CAUCHARD JEAN HUBERT [FR]


Application No.: US20100098752A1  Published: 22/Apr/2010

Title: Materials and Methods for Delivering Antioxidants into the Skin

Applicant/Assignee:

Application No.: 12/523237   Filing Date: 18/Jan/2008

Abstract:Compositions and methods for administering one or more antioxidants to a human subject have been developed. The antioxidant-containing lipid vesicles of the invention provide a delivery system for antioxidants which can be applied topically to the skin.

Priority: US20070885643P Applic. Date: 2007-01-19; US20070885641P Applic. Date: 2007-01-19; US20070885551P Applic. Date: 2007-01-18; US20070885549P Applic. Date: 2007-01-18; US20070885523P Applic. Date: 2007-01-18; US20070885482P Applic. Date: 2007-01-18; WO2008US51437 Applic. Date: 2008-01-18

Inventor: PINSKY MARK A [US]


Application No.: US20100098765A1  Published: 22/Apr/2010

Title: Powder Makeup Compositions And Methods

Applicant/Assignee:

Application No.: 12/255975   Filing Date: 22/Oct/2008

Abstract:An anhydrous powder composition wherein the ratio of platelet to non-platelet particulates is greater than about 5 to 1 respectively, which is preferably talc-free, oil-free, paraben-free, and fragrance-free

and a method for preparing the powder composition of the invention.

Priority:

Inventor: MERCADO CLARA G [US]; LOGALBO JOHN F [US]; DAO KHANH NGOC [US]


Application No.: US20100098769A1  Published: 22/Apr/2010

Title: Synthetic Peptides Reducing or Removing Bags Formed Under the Lower Eye Contour and Their Use in Cosmetic or Dermopharmaceutical Compositions

Applicant/Assignee: LIPOTEC, S.A

Application No.: 11/664574   Filing Date: 22/Sep/2005

Abstract:The invention relates to peptides of general formula (I): that can reduce or remove bags formed under the eyes, their stereoisomers and racemic or non-racemic mixtures thereof, and the cosmetically or dermopharmaceutically acceptable salts thereof, wherein X is cystenyl, seryl, threonyl or aminobutyryl

R1 is H or alkyl, aryl, aralkyl or acyl group

and R2 is amino, hydroxy or thiol, all of them substituted or non-substituted with aliphatic or cyclic groups. The invention also relates to a method of obtaining, cosmetic or dermopharmaceutical compositions containing them and their use for treating skin, preferably for reducing or removing bags formed under the eyes.

Priority: ES20040002364 Applic. Date: 2004-10-05; WO2005ES00514 Applic. Date: 2005-09-22

Inventor: PUIG MONTIEL ARTURO [ES]; CEBRIAN PUCHE JUAN [ES]; PASSERINI ELENA [ES]


Application No.: US20100098776A1  Published: 22/Apr/2010

Title: SOAP-BASED LIQUID WASH FORMULATIONS WITH ENHANCED DEPOSITION OF ANTIMICROBIAL AGENTS

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/255377   Filing Date: 21/Oct/2008

Abstract:The invention relates to soap-based liquid body and facial wash compositions using high solvent, low water compositions and incompletely neutralized fatty acids to help structure the compositions, all in combination with modified benefit agents, enhanced deposition of antimicrobial agents is obtained.

Priority:

Inventor: CARNALI JOSEPH ORESTE [US]; SHAH PRAVIN [US]; QIU QIANG [US]; WEIR ANTHONY JOHN [US]


Application No.: US20100098785A1  Published: 22/Apr/2010

Title: Composition of Ashwagandha and Indian Gooseberry

Applicant/Assignee: NUTRAGENESIS, LLC

Application No.: 12/604092   Filing Date: 22/Oct/2009

Abstract:A therapeutic composition comprising extracts of the plant species ashwagandha (Withania somnifera) and Indian gooseberry (Phyllanthus emblica). A composition of ashwagandha and Indian gooseberry may: (1) lower cortisol and increase DHEA, (2) prevents free radical-induced photoaging, (3) inhibit collagenase activity in vitro, (4) inhibit hyaluronidase activity in vitro, (5) display superior cascading antioxidant activity, (6) reduce C-reactive protein, (7) enhance mood.

Priority: US20080107573P Applic. Date: 2008-10-22

Inventor: MCNEARY PETER [US]


Application No.: US20100098794A1  Published: 22/Apr/2010

Title: Topical anti-wrinkle and anti-aging moisturizing cream

Applicant/Assignee:

Application No.: 12/589088   Filing Date: 19/Oct/2009

Abstract:The present invention relates to a topical anti-wrinkle and anti-aging moisturizing cream designed (formulated) to repair and restore human adult skin to its original youthful state. This has successfully been achieved by using a water based molecular mixture of high molecular weight (0.5 to 2.0 million Daltons) hyaluronic acid (HA) and of low molecular weight hyaluronic acid oligosaccharides (small HA fragments less than 12000 Daltons molecular weight) to create this unique anti-aging moisturizer. An equal mixture of high molecular HA and HA-oligosaccharides at concentrations of 0.1-0.2% was found to be essential for providing our moisturizer its unique ability to repair and rejuvenate adult human skin.

Priority: US20080106413P Applic. Date: 2008-10-17

Inventor: ARMAND GERARD [US]


Application No.: US20100099594A1  Published: 22/Apr/2010

Title: Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof

Applicant/Assignee:

Application No.: 12/289010   Filing Date: 17/Oct/2008

Abstract:An aqueous composition is provided having a pH of from about 2.0 to about 5.7 to about 12.8 and comprising boron or persulfate ion-crosslinked polyvinyl alcohol microcapsules. A method of delivering a fragrance to a substrate is further provided comprising applying to the substrate an aqueous composition comprised of fragrance-containing, boron or persulfate ion-crosslinked, polyvinyl alcohol microcapsules, as well as a method of cleaning a substrate comprising applying to the substrate an aqueous composition comprised of fragrance-containing, boron or persulfate ion-crosslinked, polyvinyl alcohol microcapsules together with at least one cleaning component.

Priority:

Inventor: BOBNOCK ROBERT STANLEY [US]


Application No.: US20100099632A1  Published: 22/Apr/2010

Title: Oligosaccharide Aldonic Acids and Their Topical Use

Applicant/Assignee:

Application No.: 12/643215   Filing Date: 21/Dec/2009

Abstract:Methods for using compositions comprising oligosaccharide aldonic acids for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and/or extrinsic aging, as well as with changes or damage caused by extrinsic factors

general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa

for general oral care, as well as treatment and prevention of oral and gum diseases

and for wound healing of the skin. Methods may comprise using compositions comprising oligosaccharide aldonic acids and additional cosmetic, pharmaceutical or other topical agents to enhance or create synergetic effects.

Priority: US2007-872459 Applic. Date: 2007-10-15; US2004-811998 Applic. Date: 2004-03-30; US2001-987023 Applic. Date: 2001-11-13; US2000-487228 Applic. Date: 2000-01-19; US19990141264P Applic. Date: 1999-06-30

Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]


Application No.: US20100099689A1  Published: 22/Apr/2010

Title: METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/562665   Filing Date: 18/Sep/2009

Abstract:Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

Priority: FR20030007487 Applic. Date: 2003-06-20; US2005-311449 Applic. Date: 2005-12-20; WO2004EP07200 Applic. Date: 2004-06-16; US20030489672P Applic. Date: 2003-07-24

Inventor: CLARY LAURENCE [FR]; THOREAU ETIENNE [FR]; RIVIER MICHEL [FR]; AUBERT JEROME [FR]; CHANTALAT LAURENT [FR]; VOEGEL JOHANNES [FR]


Application No.: US20100099698A1  Published: 22/Apr/2010

Title: Compositions for Improving Skin Conditions Comprising Matrine or Its Oxidized Derivatives

Applicant/Assignee: BIOSPECTRUM INC

Application No.: 12/527237   Filing Date: 21/Feb/2008

Abstract:The present invention relates to a composition for improving skin conditions comprising matrine and oxymatrine as an active ingredient. Matrine and oxymatrine have lower cytotoxicity than retinol used as anti-wrinkle agents and exhibit the inhibition effect on collagenase activity and promotion effect on collagen biosynthesis at a molecular level, contributing to excellent efficacy in improvement of skin wrinkles. In addition, both matrine and oxymatrine exhibit the inhibition effect on melanin production by inhibiting intracellular tyrosinase activity, the improving effects of UV-induced skin damage and the skin growth promotion or hair loss prevention. Therefore, matrine and oxymatrine have the excellent improvement effects on skin conditions. Furthermore, matrine and oxymatrine have the excellent anti-obesity and anti-oxidation effects. The composition of this invention can be applied to cosmetic, pharmaceutical and food composition having no cytotoxicities and side effects.

Priority: KR20070017400 Applic. Date: 2007-02-21; WO2008KR01021 Applic. Date: 2008-02-21

Inventor: PARK DEOK HOON [KR]; JUNG EUN SUN [KR]; LEE JONG SUNG [KR]


Application No.: US20100099727A1  Published: 22/Apr/2010

Title: Amino acid and peptide conjugates of arylalkylic acids for cosmetic use

Applicant/Assignee: DSM IP ASSETS B.V

Application No.: 12/591663   Filing Date: 27/Nov/2009

Abstract:The invention provides novel compounds of general formula I wherein R1, R2 and R3 are independently hydrogen, OR4, C1-C6 alkyl or C2-C6 alkenyl, R4 is hydrogen, C1-C6 alkyl or C2-C6 alkenyl, -N-(AA) represents the residue of an amino acid or of a peptide which is bonded over the N-terminus of the amino acid or the peptide and the peptide is composed of 2 to 6, that means 2, 3, 4, 5 or 6, amino acids, wherein the C-terminus of the amino acid or the peptide is optionally esterified with a C1-C16 hydrocarbon moiety and n is an integer of 1 to 5. The compounds are in particular useful for cosmetic applications.

Priority: EP20040007282 Applic. Date: 2004-03-26; US2005-593484 Applic. Date: 2005-03-23; WO2005EP03116 Applic. Date: 2005-03-23

Inventor: KLOCK JOCHEN [DE]; MAILLAN PHILIPPE EMMANDEL [FR]; VOLLHARDT JUERGEN H [CH]; BEUMER RAPHAEL [DE]


Application No.: US20100100030A1  Published: 22/Apr/2010

Title: Microbe Reductions with Photosensitizers

Applicant/Assignee: CERAMOPTEC INDUSTRIES INC

Application No.: 12/643467   Filing Date: 21/Dec/2009

Abstract:Methods, devices and composition are disclosed for treating oral, skin and nail diseases, including inflammatory periodontal disease, onychomycosis and dermatophytosis. In a preferred embodiment a method for treating oral, skin and nail infections comprises administering a photosensitizing compound in long term effect or timed release formulations, including local highly concentrated formulations, and activating the photosensitizer with radiation to selectively destroy bacteria, fungi and other microbial bodies. In another preferred embodiment, photosensitizers are housed within nanoparticles, and can be gradually released through biodegradation or periodically released by such processes as brushing, irradiation and chemically induced release. The diffusion speed of the photosensitizers can be accelerated by brushing. In another embodiment, the photosensitizer molecule is also modified to more effectively target the molecule to the unwanted oral bacterial and fungal species. In another embodiment devices for treating oral, skin and nail infections includes a laser radiation source and delivery apparatuses such as brush or teethed comb for nail and scalp infections respectively.

Priority: US2006-523203 Applic. Date: 2006-09-19; US2002-241958 Applic. Date: 2002-09-12

Inventor: DRISCOLL TIM [US]; MEGA VERONICA INES [AR]; NEUBERGER WOLFGANG [AE]


Application No.: US20100100063A1  Published: 22/Apr/2010

Title: Device and method for wound therapy

Applicant/Assignee:

Application No.: 12/592049   Filing Date: 18/Nov/2009

Abstract:A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid collector for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid collector. The vacuum connection may be separated from the liquid collector by a liquid barrier.

Priority: US2006-610458 Applic. Date: 2006-12-13; US2006-432855 Applic. Date: 2006-05-11

Inventor: JOSHI ASHOK V [US]; GORDON JOHN HOWARD [US]; BHAVARAJU SAI [US]; DAYTON TROY C [US]; HEISER JEREMY [US]


Application No.: US20100100162A1  Published: 22/Apr/2010

Title: CONTROLLED BIOTHERMOTHERAPY

Applicant/Assignee:

Application No.: 12/256057   Filing Date: 22/Oct/2008

Abstract:A method for thermotherapy of a biological tissue by determining the temperature at which to heat a target site to be treated to provide a temperature to the site to effect therapy, the temperature above body temperature but below a protein denaturation temperature, as determined by a patient's experience of a sensation of pain. Thermotherapy is effected in the absence of coagulative effects by providing oscillatory energy at the predetermined temperature.

Priority:

Inventor: PEYMAN GHOLAM A [US]


Application No.: US20100100392A1  Published: 22/Apr/2010

Title: Methods of Assessing Risk Based on Medical Data and Uses Thereof

Applicant/Assignee: ROTHMAN HEALTHCARE RESEARCH, LLC

Application No.: 12/582942   Filing Date: 21/Oct/2009

Abstract:Methods of assessing risk based on medical data are disclosed herein. In an embodiment, a method of assessing risk associated with medical data includes creating a dataset representing a plurality of patients, the dataset comprising (x,y) pairs for each patient, wherein x represents the medical data collected at a first time, and wherein y is an outcome measurement collected at a second time

binning the (x,y) pairs to form a plurality of binned data sets

computing an average value for x and an average value for y for each binned data set

determining a minimum average value of y based on all of the average values of y

subtracting the minimum average value of y from each average value of y to get a new average value of y for each binned data set

and deriving a function for assessing risk associated with the medical data.

Priority: US20080107021P Applic. Date: 2008-10-21; US20080107028P Applic. Date: 2008-10-21

Inventor: ROTHMAN MICHAEL J [US]; ROTHMAN STEVEN I [US]


Application No.: US20100101722A1  Published: 29/Apr/2010

Title: Composition for matte layer formation, release sheet using the same, and synthetic leather produced using said release sheet

Applicant/Assignee: DAI NIPPON PRINTING CO., LTD

Application No.: 12/654689   Filing Date: 29/Dec/2009

Abstract:There are provided a composition for matte layer formation suitable for the production of a matte synthetic leather having a matte surface with a high level of jet-blackness even without the practice of embossing, raising, etc., and a release sheet for the production of a matte synthetic leather by using the composition. The composition for matte layer formation suitable for the production of a matte synthetic leather comprises a thermosetting resin and a matting agent as indispensable components. The matting agent comprises one or at least two types of organic or/and inorganic porous fine particles. The porous fine particles have a mean particle diameter in the range of 0.5 to 20 [mu]m and a specific surface area in the range of 1 to 1000 m2/g. The release sheet is produced by using the composition.

Priority: JP20020283538 Applic. Date: 2002-09-27; US2008-068633 Applic. Date: 2008-02-08; US2006-519805 Applic. Date: 2006-09-13; US2002-328188 Applic. Date: 2002-12-26

Inventor: SUTO KENICHIRO [JP]; KAWAGOE YOSHIKI [JP]; WATANABE HIROSHI [JP]; KUBOTA TAKESHI [JP]; MATSUDAIRA KOICHIRO [JP]


Application No.: US20100104515A1  Published: 29/Apr/2010

Title: USE OF ALPHA-HYDROXY CARBONYL COMPOUNDS AS REDUCING AGENTS

Applicant/Assignee:

Application No.: 12/159363   Filing Date: 29/Dec/2006

Abstract:There is provided the use as reducing agents of alpha-hydroxycarbonyl compounds capable of forming cyclic dimers. There is also provided corresponding methods of reducing reducible compounds, particularly reduction-activated prodrugs. Examples of the alpha-hydroxycarbonyl compounds used are dihydroxyacetone, glycolaldehyde, glyceraldehyde, erythrose, xylulose, erythrulose or 3-hydroxy-2-butanone.

Priority: GB20050026552 Applic. Date: 2005-12-29; WO2006GB04947 Applic. Date: 2006-12-29

Inventor: KNOX RICHARD J [GB]


Application No.: US20100104522A1  Published: 29/Apr/2010

Title: COMPOSTION FOR SKIN EXTERNAL USE CONTAINING OMEGA-3 FATTY ACID

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 12/683916   Filing Date: 07/Jan/2010

Abstract:Stable preparations containing omega-3 fatty acid as an effective ingredient are disclosed. Further, uses of omega-3 fatty acid in preventing or alleviating skin aging, moisturizing skin, improving skin roughness, restoring or strengthening skin barrier function, improving skin elasticity, recovering or preventing skin damage induced by UV are disclosed.

Priority: KR20060084425 Applic. Date: 2006-09-01; US2007-928669 Applic. Date: 2007-10-30; US2007-840512 Applic. Date: 2007-08-17

Inventor: CHO JUNCHEOL [KR]; KANG CHANKOO [KR]; HAN SANGHOON [KR]; SON EUI-DONG [KR]; KANG HAKHEE [KR]


Application No.: US20100104523A1  Published: 29/Apr/2010

Title: STABILIZATION OF UV-SENSITIVE ACTIVE INGREDIENTS

Applicant/Assignee: CIBA CORPORATION

Application No.: 12/520880   Filing Date: 16/Jan/2008

Abstract:Disclosed is the use of merocyanine derivatives of formula (1) for stabilizing UV-sensitive active ingredients like dibenzoylmethane derivatives.

Priority: EP20070101171 Applic. Date: 2007-01-25; WO2008EP50440 Applic. Date: 2008-01-16

Inventor: WAGNER BARBARA [DE]; HERZOG BERND [DE]; MULLER STEFAN [DE]; EHLIS THOMAS [DE]


Application No.: US20100104524A1  Published: 29/Apr/2010

Title: COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING ARCTIIN, ARCTIGENIN OR THE MIXTURE THEREOF AS ACTIVE

Applicant/Assignee:

Application No.: 12/449727   Filing Date: 25/Feb/2008

Abstract:Present Invention relates to a skin whitening cosmetic composition comprising arctiin, arctigenin or a mixture thereof as an active ingredient. The disclosed composition can control or inhibit the synthesis of melanin by acting on a melanin synthesis route of [alpha]-MSH secreted by UV, and thus show an excellent whitening effect compared to a conventional skin whitening cosmetic. Also, the composition has high formulation stability and low skin irritation.

Priority: KR20070020603 Applic. Date: 2007-02-28; WO2008KR01077 Applic. Date: 2008-02-25

Inventor: LEE JUNG NOH [KR]; CHOI JEONG EUN [KR]; KIM SANG WOO [KR]; LEE KANG TAE [KR]; LEE KUN KOOK [KR]


Application No.: US20100104610A1  Published: 29/Apr/2010

Title: Color cosmetics comprising a random terpolymer

Applicant/Assignee:

Application No.: 12/566273   Filing Date: 24/Sep/2009

Abstract:Topically applicable, water-resistant cosmetic or dermatological compositions well suited for the cosmetic color compositions for human skin and/or hair comprising at least one (a) coloring agent

(b) at least one random terpolymer

and, optionally (c) other cosmetically acceptable ingredients.

Priority: US20080194877P Applic. Date: 2008-10-01

Inventor: DUEVA-KOGANOV OLGA V [US]; JAYNES BINGHAM S [US]; LUPIA JOSEPH A [US]; TERMATEN ARJAN T [NL]; SLUIS MARCELLES VAN DER [NL]; SUURMEIJER MARLEEN [NL]; NORMINGTON DAVID [GB]; SCHNYDER MARCEL [CH]


Application No.: US20100104673A1  Published: 29/Apr/2010

Title: Methods and Compositions for Treatment of Skin Conditions

Applicant/Assignee: JORMAY, INC

Application No.: 12/446946   Filing Date: 24/Oct/2007

Abstract:Topical skin care compositions are described that include effective amounts of anti-inflammatory, antioxidant, silica and sugar compounds. In addition, methods of treating skin conditions are described, which include applying topically to a site of treatment a therapeutically effective amount of a composition comprising anti-inflammatory, antioxidant, silica and sugar compounds.

Priority: US20060853912P Applic. Date: 2006-10-24; WO2007US22523 Applic. Date: 2007-10-24

Inventor: TECCO MICHELLE A [US]


Application No.: US20100104674A1  Published: 29/Apr/2010

Title: COMPOSITION FOR THE TREATMENT OF HYPERTENSION

Applicant/Assignee: AURON INVESTMENTS LTD

Application No.: 12/325845   Filing Date: 01/Dec/2008

Abstract:The present invention is directed to a composition for the treatment of hypertension and/or of the symptoms associated with hypertension and/or of diseases caused by hypertension. This composition contains an extract of at least, one Chamomilla plant and/or of at least one Achillea plant.

Priority: GB20080019635 Applic. Date: 2008-10-27; GB20080020885 Applic. Date: 2008-11-14

Inventor: JAMEL YOUSEF ABDULLATIF [AT]; AHMED AL-DABOONI RAFIDA MOHAMMED [AE]; HAMED AL SARI KARAM MASHAAL [AE]


Application No.: US20100105102A1  Published: 29/Apr/2010

Title: DEVICE, METHOD AND APPARATUS FOR ANALYZING SKIN AND HAIR

Applicant/Assignee: REVEAL SCIENCES, LLC

Application No.: 12/604162   Filing Date: 22/Oct/2009

Abstract:The present invention includes compositions, methods, and systems for the analysis of skin and hair conditions. The system includes a method and apparatus for analyzing skin and hair samples by taking a sample, identifying desired components of the sample, obtaining an image electronically, storing the image, and analyzing the image using analysis software.

Priority: US20080107633P Applic. Date: 2008-10-22; US20080107985P Applic. Date: 2008-10-23

Inventor: HANES ROBERT EUGENE [US]; WINDSOR J BRIAN [US]; BORICH DAMON V [US]; NEESER JASON [US]; RASOULIAN MICHAEL [US]; ESCAMILLA P ROGELIO [US]


Application No.: US20100105638A1  Published: 29/Apr/2010

Title: COSMETIC COMPOSITIONS

Applicant/Assignee:

Application No.: 12/528710   Filing Date: 28/Feb/2008

Abstract:The present invention relates to the use of ascorbyl phosphate and niacinamide to suppress the crystallization of biotin in cosmetic or dermatological compositions. Furthermore, the invention relates to cosmetic or dermatological compositions comprising ascorbyl phosphate, niacinamide, biotin and a cosmetically acceptable carrier.

Priority: EP20070005028 Applic. Date: 2007-03-12; WO2008EP01568 Applic. Date: 2008-02-28

Inventor: DEN-BRAVEN KERSTIN [CH]; SAECKER CHRISTINE [CH]; WESTENFELDER HORST [DE]


Application No.: US20100105741A1  Published: 29/Apr/2010

Title: ADMINISTRATION OF PYRIDINEDICARBOXYLIC ACID COMPOUNDS FOR STIMULATING OR INDUCING THE GROWTH OF HUMAN KERATINOUS FIBERS AND/OR ARRESTING THEIR LOSS

Applicant/Assignee: L'OREAL

Application No.: 12/650777   Filing Date: 31/Dec/2009

Abstract:The invention relates to the use in a composition for caring for human hair or eyelashes of an effective amount of a pyridinedicarboxylic acid derivative of general formula (I) or of one of its salts, in which R1 and R2 represent, independently of one another, OH, OR', -NH2, -NHR' or -NR'R'', and R' and R'' represent, independently of one another, a saturated or unsaturated and linear or branched C1-C18 alkyl radical or an aryl radical, this alkyl or aryl radical optionally being substituted by at least one OH, alkoxy, acyloxy, amino or alkylamino group, or R' and R'' together represent a heterocycle, the composition being intended to induce and/or stimulate the growth of human keratinous fibers, such as the hair and eyelashes, and/or slow down their loss

the invention also relates to a cosmetic treatment intended to stimulate the growth of human keratinous fibers, such as the hair and eyelashes, and/or slow down their loss.

Priority: FR20020004527 Applic. Date: 2002-04-11; US2009-463602 Applic. Date: 2009-05-11; US2003-410402 Applic. Date: 2003-04-10; US20020372414P Applic. Date: 2002-04-16

Inventor: DALKO MARIA [FR]; LOUSSOUARN GENEVIEVE [FR]; RAWADI CHARLES EL [FR]; BOULLE CHRISTOPHE [FR]; BERNARD BRUNO [FR]


Application No.: US20100106046A1  Published: 29/Apr/2010

Title: DEVICE AND METHOD FOR PREDICTING AND PREVENTING PULMONARY EDEMA AND MANAGEMENT OF TREATMENT THEREOF

Applicant/Assignee:

Application No.: 12/258413   Filing Date: 26/Oct/2008

Abstract:A device and a method for preventive treatment of evolving pulmonary edema in patients which are at risk of complication associated with pulmonary edema which is based on the monitoring of internal thoracic impedance of the patient. The device extracts the internal thoracic impedance from measured trans-thoracic impedance and is relatively immune to variations in skin/electrode interface impedance. The method includes identification of a stage of interstitial edema development before the appearance of a clinical indication and the beginning of an appropriate medicinal treatment in accordance to variations of the monitored internal thoracic impedance. The method also indicates the appropriate moment for terminating the medicinal treatment and can be applied when the patient and his treating physician are positioned at remote locations.

Priority:

Inventor: SHOCHAT MICHAEL [IL]; RABINOVICH PAVEL [IL]


Application No.: US20100106117A1  Published: 29/Apr/2010

Title: VACUUM THERAPY AND CLEANSING DRESSING FOR WOUNDS

Applicant/Assignee: KCI MEDICAL RESOURCES

Application No.: 12/618411   Filing Date: 13/Nov/2009

Abstract:Wound treatment apparatuses comprising a vacuum source and a bandage (e.g., a wound-care bandage) configured to be coupled (and/or coupled) to the vacuum source. Some embodiments of the bandage including a wound dressing member configured to be placed in contact with a wound surface, and a suction port associated with the wound dressing member and/or configured to be connected to the vacuum source. Some embodiments of the member including a plurality of spacers configured to contact the wound surface to define suction space between the member and the wound surface. Some embodiments of the member including holes configured to communicate with the suction space, and/or a plurality of passageways between the suction port and the holes.

Priority: US2003-664535 Applic. Date: 2003-09-19; US2000-725352 Applic. Date: 2000-11-29

Inventor: LOCKWOOD JEFFREY S [US]; PETROSENKO ROBERT [US]; RISK JR JAMES ROBERT [US]


Application No.: US20100111833A1  Published: 06/May/2010

Title: Compositions and methods for surface abrasion with frozen particles

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/380557   Filing Date: 26/Feb/2009

Abstract:Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

Priority: US2008-290658 Applic. Date: 2008-10-31

Inventor: BOYDEN EDWARD S [US]; COOK DANIEL B [US]; HYDE RODERICK A [US]; LEUTHARDT ERIC C [US]; MYHRVOLD NATHAN P [US]; SWEENEY ELIZABETH A [US]; WOOD JR LOWELL L [US]


Application No.: US20100111878A1  Published: 06/May/2010

Title: SKIN-CARE COMPOSITIONS AND USES THEREOF

Applicant/Assignee: AHAVA - DEAD SEA LABORATORIES LTD

Application No.: 12/574159   Filing Date: 06/Oct/2009

Abstract:Composition of a Dead Sea extract and at least one plant extract of a Himalayan origin are provided for topical applications.

Priority: US20080136834P Applic. Date: 2008-10-07

Inventor: MAOR ZEEV [IL]; ZIONI TAMAR [IL]


Application No.: US20100111879A1  Published: 06/May/2010

Title: SACCHARIDE FOAMABLE COMPOSITIONS

Applicant/Assignee: FOAMIX LTD

Application No.: 12/646322   Filing Date: 23/Dec/2009

Abstract:A foamable composition, containing a saccharide for use in the treatment of various disorders including: water, a saccharide, about 0.2% to about 5% by weight of a surface-active agent, about 0.01% to about 5% by weight of at least one polymeric agent selected from a bio-adhesive agent, a gelling agent, a film forming agent and a phase change agent, and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.

Priority: US2006-430437 Applic. Date: 2006-05-09; US20050679020P Applic. Date: 2005-05-09; US20060784793P Applic. Date: 2006-03-21

Inventor: TAMARKIN DOV [IL]; FRIEDMAN DORON [IL]; BESONOV ALEX [IL]


Application No.: US20100111881A1  Published: 06/May/2010

Title: Polymeric anti-microbial agents

Applicant/Assignee:

Application No.: 12/383900   Filing Date: 30/Mar/2009

Abstract:Polymeric anti-microbial agents produced by substituting the nitrogen atoms in the backbone of ethylenimine polymers, for example, substitution with aralkyl groups, are provided. The agents are believed to have low human toxicity while being effective against a variety of pathogens and are useful in applications involving human contact, such as cosmetics, hair care products and textiles, as well as in applications with much less human contact, such as coatings.

Priority: US2007-656836 Applic. Date: 2007-01-23; US20060762808P Applic. Date: 2006-01-27

Inventor: HUANG XINYU [US]; DEISENROTH TED [US]; PREUSS ANDREA [CH]; MARQUAIS-BIENEWALD SOPHIE [FR]; HENDRICKS-GUY CARMEN [US]; JENNINGS JOHN [IE]


Application No.: US20100112021A1  Published: 06/May/2010

Title: SUSTAINED-RELEASE COMPOSITION

Applicant/Assignee:

Application No.: 12/532218   Filing Date: 19/Mar/2008

Abstract:A composition which comprises (A) a plurality of cross-linked polymer particles, said polymer being the polymerization product of at least two monomer units selected from the group consisting of monoalkenyl aromatic compounds, alkyl esters derived from a saturated alcohol and acrylic or methacrylic acid, and vinyl esters of an aliphatic carboxylic acid

and said cross-line polymer particles being loaded with (B) an active ingredient, the weight ratio of the active ingredient (B) to the polymer particles (A) being from 0.05 to 50:1, is useful to release the active ingredient over an extended period of time while controlling sebum on skin and hair.

Priority: US20070919222P Applic. Date: 2007-03-21; WO2008US57444 Applic. Date: 2008-03-19

Inventor: ZHANG XIAODONG [US]; MEERBOTE MICHAEL [DE]; BATRA ASHISH [US]; KOSENSKY LINDA A [US]; SCHILLER KLAUS [DE]; NIETER ELKE [DE]


Application No.: US20100112065A1  Published: 06/May/2010

Title: Therapeutic ultrasound gel

Applicant/Assignee:

Application No.: 12/588763   Filing Date: 27/Oct/2009

Abstract:The therapeutic ultrasound gel is a composition that lubricates the abdomen for ultrasound scanning, that enhances the transmission of sound waves during ultrasound diagnostic imaging, and that has beneficial therapeutic effects in preventing the formation of stretch marks. The composition contains effective amounts of aloe vera (Aloe barbadensis), glycerin, and various agents for preventing the formation of stretch marks, with the balance being sufficient water to adjust the consistency of the composition. The composition may also be formulated for home use, chiefly by the addition of vitamin D3 or, alternatively, vitamin K. Either formulation may contain additional excipients, including surfactants, emulsifiers, humectants, stabilizers, thickeners, pH balancers, preservatives, colorants, and scent, if desired.

Priority: US20080193160P Applic. Date: 2008-10-31

Inventor: LAUER SCOTT D [US]


Application No.: US20100112543A1  Published: 06/May/2010

Title: PROCESSING SOFT TISSUE, METHODS AND COMPOSITIONS RELATED THERETO

Applicant/Assignee:

Application No.: 12/534613   Filing Date: 03/Aug/2009

Abstract:In certain embodiments, the present invention relates to a process for preparing skin removed from a human donor, including a living human donor, and removing cellular components and forming a decellular matrix having as major components collagens and elastins while disinfecting the tissue. In other embodiments, the present invention relates to a process for treating a decellularized soft tissue by freezing the same at a plurality of decreasing temperatures at atmosphere or higher such that there is formation of ice crystals having a size greater than 2.0 and lyophilizing the soft tissue under vacuum to remove the water to less than 6% forming a porous matrix.

Priority: WO2008US52882 Applic. Date: 2008-02-04; WO2008US52884 Applic. Date: 2008-02-04; WO2008US52885 Applic. Date: 2008-02-04; US2006-375026 Applic. Date: 2006-03-15; US20070899021P Applic. Date: 2007-02-02; US20070899020P Applic. Date: 2007-02-02; US20070899018P Applic. Date: 2007-02-02; US20070924249P Applic. Date: 2007-05-04; US20050662078P Applic. Date: 2005-03-16

Inventor: NGO MANH-DAN [US]; GERTZMAN ARTHUR [US]; KAWAS MICHAEL [US]; TRUNCALE KATHERINE G [US]; SUNWOO MOON HAE [US]; LEE ALISON [US]; SEEMAN RICHARD [US]; DEPAULA CARL ALEXANDER [US]; CARTMELL JEFFREY S [US]; GOCKE DAVID J [US]; SYRING CARINA [CH]; VERSEN RUDIGER VON [DE]


Application No.: US20100113372A1  Published: 06/May/2010

Title: Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 12/445362   Filing Date: 25/Apr/2007

Abstract:Disclosed is a method for the preparation of kaempferol-3-O-rutinoside and a composition of a skin external application comprising kaempferol-3-O-rutinoside as an active ingredient. The method for isolating kaempferol-3-O-rutinoside through hydrolysis uses an enzyme or microbe that removes the sugar selectively from kaempferol-3-O-rutinoside glycosides in a plant extract. Disclosed also is a composition of a skin external application comprising kaempferol-3-O-rutinoside that prevents skin wrinkle.

Priority: KR20060099725 Applic. Date: 2006-10-13; WO2007KR02030 Applic. Date: 2007-04-25

Inventor: PARK JUN SEONG [KR]; PARK HYE YOON [KR]; RHO HO SIK [KR]; KIM DUCK HEE [KR]; CHANG IH SEOP [KR]


Application No.: US20100113385A1  Published: 06/May/2010

Title: COMPLEX COMBINING AN ORGANIC SILICON DERIVATIVE WITH HYALURONIC ACID CALIBRATED FRAGMENTS, FOR PREVENTIVE AND REPAIRING ACTION OF CUTANEOUS DAMAGES

Applicant/Assignee: EXZYMOL S.A.M

Application No.: 12/572658   Filing Date: 02/Oct/2009

Abstract:The invention concerns a complex based on an organic silicon derivative. The invention is characterized in that said derivative is combined, by weak bonds, with one or several hyaluronic acid calibrated fragments of molecular weight comprised between 150 and 750 kDa, said derivative being of general formula (I): RXSi(OH)4-x (I) wherein: R is a (C1-C4)alkyl, x=1 and 2. The invention also concerns the use of such a complex in the prevention or the repair of cutaneous damages.

Priority: FR20080005479 Applic. Date: 2008-10-03

Inventor: SEGUIN MARIE-CHRISTINE [MC]


Application No.: US20100113386A1  Published: 06/May/2010

Title: N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF

Applicant/Assignee: INOTEK PHARMACEUTICALS CORPORATION

Application No.: 12/622809   Filing Date: 20/Nov/2009

Abstract:The present invention relates to N-Benzyl-Substituted Pyridyl Porphyrin Compounds, compositions comprising an effective amount of an N-Benzyl-Substituted Pyridyl Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive species, erectile dysfunction, urinary incontinence, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, a diabetic complication, cancer, a side effect of cancer chemotherapy, or a radiation-induced injury, and methods for prolonging the half-life of an oxidation-prone compound, comprising administering to a subject in need thereof an effective amount of an N-Benzyl-Substituted Pyridyl Porphyrin Compound.

Priority: US2006-528082 Applic. Date: 2006-09-26; US20050721388P Applic. Date: 2005-09-28

Inventor: WILLIAMS WILLIAM [US]


Application No.: US20100113450A1  Published: 06/May/2010

Title: Agent for Preventing and Alleviating Wrinkles

Applicant/Assignee: SHISEIDO COMPANY LTD

Application No.: 12/530841   Filing Date: 14/Mar/2008

Abstract:The present invention provides an agent for preventing and alleviating wrinkles which has excellent effects of preventing and alleviating wrinkles formed by decreased barrier function of the skin owing to aging or photo aging, that is graphic wrinkles or linear wrinkles. The agent for preventing and alleviating wrinkles consisting of one or more compounds selected from the group consisting of gamma-aminobutyric acid derivatives represented by the following formula (1) or N,N,N-trimethyl gamma-aminobutyric acid represented by the following formula (3) and salts thereof: wherein R1 and R2 independently represent any of a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a benzyloxycarbonyl group, a cyclohexyl group, a cyclohexanemethyl group, a cyclohexanecarbonyl group, a guanidino group formed with nitrogen atom in the formula (1), an ureido group formed with nitrogen atom in the formula (1), and a group represented by following formula (2). Additionally, R1 and R2 may jointly form a piperidine ring, morpholine ring, or pyrrolidine ring. Both of R1 and R2 are not simultaneously a hydrogen atom.

Priority: JP20070069134 Applic. Date: 2007-03-16; WO2008JP54765 Applic. Date: 2008-03-14

Inventor: TSUNENAGA MAKOTO [JP]; KAMINUMA MIKIKO [JP]; SUETSUGU MASARU [JP]; KATAGIRI CHIKA [JP]


Application No.: US20100113576A1  Published: 06/May/2010

Title: Device and Method for Processing or Treating Surfaces By Means of A Dry Ice Granulate

Applicant/Assignee:

Application No.: 12/594598   Filing Date: 07/Apr/2008

Abstract:The invention relates to an apparatus for surface processing or surface treatment by means of dry ice granulate, with a reservoir for receiving a dry ice medium, in particular dry ice pellets, an inlet for the feed of a propellant medium, an outlet for the supply of a mixture of propellant medium and dry ice granulate to a blast gun, and an outflow chamber lying therebetween, there being arranged in the path between the reservoir and the outflow chamber a grinding mechanism, which is formed so as to comminute the dry ice medium to dry ice granulate with a particle size in a prescribed range, and a transport roll (4) being arranged between the grinding mechanism (3) and the outflow chamber (59), the transport roll (4) being operable with a variable speed so as to vary the quantity of the particles of the dry ice granulate per unit time. Furthermore, the invention relates to a corresponding method and the use of the method.

Priority: EP20070105772 Applic. Date: 2007-04-05; WO2008EP54151 Applic. Date: 2008-04-07

Inventor: RAEDER NIELS [DE]; ROTSTEIN ROSA [DE]


Application No.: US20100113616A1  Published: 06/May/2010

Title: INHIBITION OF DISCOLORATION BY WASHING AND CLEANING AGENTS AND/OR COSMETIC AGENTS

Applicant/Assignee:

Application No.: 12/613767   Filing Date: 06/Nov/2009

Abstract:Method of inhibiting discoloration in agents by incorporating iodide salt(s), preferably calcium, potassium and/or sodium iodides into the formulation of those agents. The method is particularly suited for agents comprising vanillin and/or vanillin derivatives, wherein vanillin and/or vanillin derivatives are components of a fragrance mixture and the agents are washing and cleaning agents or cosmetics agents.

Priority: DE200710022069 Applic. Date: 2007-05-08; WO2008EP55242 Applic. Date: 2008-04-29

Inventor: GERKE THOMAS [DE]; VELDMAN GERARD [US]; BAUER ANDREAS [DE]; FABER WERNER [DE]


Application No.: US20100113860A1  Published: 06/May/2010

Title: TEMPORARY TATTOO COVER AND RELATED METHOD

Applicant/Assignee:

Application No.: 12/264204   Filing Date: 03/Nov/2008

Abstract:A cover for protecting a temporary mark on a person's skin includes a transparent layer and an associated opaque layer, wherein the opaque layer features an opening through which the temporary mark may be located as the cover is applied. An adhesive is superimposed upon the transparent layer in order to releasably affix the cover to the temporary mark, and also to permit maintaining the cover on a backing material during transportation or storage. During use, the mark is sighted through the transparent layer and the opening in the opaque layer, and applied to the patient's skin. The opaque layer is then removed from the transparent layer, which remains in place over the temporary mark, permitting the person to bathe or otherwise participate unhindered in his or her life's routines without smudging, wearing or removing the mark.

Priority:

Inventor: TRABOULSI MAEGHAN E [US]; BROYLES MARK [US]


Application No.: US20100113999A1  Published: 06/May/2010

Title: PRESSURE SENSITIVE ADHESIVE COMPOSITION COMPRISING SALT

Applicant/Assignee:

Application No.: 12/448470   Filing Date: 20/Dec/2007

Abstract:The present invention relates to a pressure sensitive adhesive composition comprising a continuous phase and a discontinuous phase wherein a) the continuous phase comprises a water vapour permeable hydrophobic polymer

and b) the discontinuous phase comprises a water soluble salt.

Priority: DK20060001673 Applic. Date: 2006-12-20; DK20070001003 Applic. Date: 2007-07-06; WO2007DK50199 Applic. Date: 2007-12-20

Inventor: LAM PETER KWOK HING [DK]; BACH ANDERS [DK]; LYKKE MADS [DK]; TOFTKAER ASTRID [DK]; HASSE BUUS [DK]; KONGEBO TOM [DK]


Application No.: US20100114007A1  Published: 06/May/2010

Title: DERMATOLOGICAL TREATMENT APPARATUS

Applicant/Assignee: OUANTEL DERMA GMBH

Application No.: 12/444831   Filing Date: 09/Oct/2007

Abstract:An apparatus for dermatological treatments has a base equipment 10 to which differing application heads 14 can be connected, selectively via flexible conduits 12, for the purpose of applying radiation, in particular of an LED and of a laser or of a high-energy flashbulb.

Priority: EP20060021252 Applic. Date: 2006-10-10; WO2007EP08769 Applic. Date: 2007-10-09

Inventor: FISCHER DIETMAR [DE]; HABERER DANIEL [DE]; KAUKEL SEBASTIAN [DE]; PARUSEL HENRY [DE]; PRIBBERNOW ARNOLD [DE]; SCHMIDT UDO [DE]; SCHULZE STEFAN [DE]; WINKLER MARTIN [DE]


Application No.: US20100119456A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/291542   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority: US2008-291537 Applic. Date: 2008-11-10

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL L [US]; WOOD VICTORIA Y H [US]


Application No.: US20100119461A1  Published: 13/May/2010

Title: ANTIMICROBIAL COMPOSITION

Applicant/Assignee: MERCK PATENT GMBH

Application No.: 12/523938   Filing Date: 10/Dec/2007

Abstract:The present invention relates to compositions comprising zinc oxide, barium sulphate and bound silver ions and their use in various applications, such as cosmetics, inks, lacquers or plastics.

Priority: EP20070001366 Applic. Date: 2007-01-23; WO2007EP10733 Applic. Date: 2007-12-10

Inventor: BICARD-BENHAMOU VALERIE [DE]; RUDOLPH THOMAS [DE]; BRUNNER MARCUS [DE]


Application No.: US20100119462A1  Published: 13/May/2010

Title: UV-FILTER COMPOUNDS

Applicant/Assignee:

Application No.: 12/531945   Filing Date: 28/Feb/2008

Abstract:The present invention provides novel diol compounds, novel cosmetic or dermatological sunscreen compositions containing these compounds and the use of the novel compounds as UV-filters. The compounds are particularly advantageous, because they adhere to the skin and therefore provide sunscreen protection for a prolonged period of time.

Priority: EP20070005613 Applic. Date: 2007-03-19; WO2008EP01591 Applic. Date: 2008-02-28

Inventor: VOLLHARDT JURGEN H [CH]; BLYUMIN YEVGEN [CH]; POCHALKO ALEXANDER [CH]


Application No.: US20100119469A1  Published: 13/May/2010

Title: GYNOSTEMMA EXTRACT SURFACTANT/CLEANING AGENT/EMULSIFIER/FOAMING AGENT AND METHOD OF PRODUCING SAME

Applicant/Assignee: DRACO NATURAL PRODUCTS, INC

Application No.: 12/616687   Filing Date: 11/Nov/2009

Abstract:Gynostemma extract compositions containing gynostemma extract and at least a carrier liquid are used as cleaning agents, emulsifiers, skin care products, and foaming agents. The gynostemma extract alone or together with other herbal extracts is mixed with water, glycerin, or a mixture of water and glycerin to produce the surfactant composition. The extracts have distinctive surface tension altering functions, reducing the surface tension of aqueous solutions and allowing foam formation, micelle formation, and emulsification with oil, dirt and water insoluble substances, and may also be used as an emulsification agent with other ingredients in cosmetic or personal care products.

Priority: US20080113888P Applic. Date: 2008-11-12

Inventor: WU JERRY [US]; QUIRK BRIEN [US]


Application No.: US20100119470A1  Published: 13/May/2010

Title: Method Of Reducing The Appearance Of Wrinkles

Applicant/Assignee: SHISEIDO COMPANY, LTD

Application No.: 12/690117   Filing Date: 20/Jan/2010

Abstract:To provide a skin treatment composition for wrinkle reduction that is superior in terms of the wrinkle reduction effect, usability, and the sensation during use. A skin treatment composition having a water dispersion of a polymer in which a non-water soluble film-forming polymer is dispersed in water wherein the main ingredients of said film-forming polymer are polyurethane having a film shrinkage rate of 20% or less and an acrylic type polymer having a film shrinkage rate of 20% or less. Also, a skin treatment composition for wrinkle reduction comprising (a) a non-emulsification type cross-linked silicone, (b) a film forming polymer having a film shrinkage rate of 20% or less containing as a main ingredient a polyurethane having a film shrinkage rate of 20%, (c) a liquid oil component, and (d) water.

Priority: JP20040006285 Applic. Date: 2004-01-14; JP20040245079 Applic. Date: 2004-08-25; US2005-584171 Applic. Date: 2005-01-14; WO2005JP00332 Applic. Date: 2005-01-14

Inventor: OMURA TAKAYUKI [JP]; WATANABE HIROKO [JP]


Application No.: US20100119542A1  Published: 13/May/2010

Title: FOOD EXTRACTS FOR TREATMENT OF LIPOPROTEIN ABNORMALITIES AND SKIN DISEASES AND SKIN DISORDERS

Applicant/Assignee:

Application No.: 12/633227   Filing Date: 08/Dec/2009

Abstract:The present invention is directed to N-methylnicotinamide containing food extracts, and their use in treating lipoprotein abnormalities and skin diseases and disorders.

Priority: US2007-874627 Applic. Date: 2007-10-18; US20060852586P Applic. Date: 2006-10-18

Inventor: GEBICKI JERZY [PL]


Application No.: US20100119560A1  Published: 13/May/2010

Title: NANO-EMULSION, THE USE THEREOF, AND PREPARATION METHOD THEREOF

Applicant/Assignee:

Application No.: 11/682279   Filing Date: 05/Mar/2007

Abstract:Embodiments of the present invention relate to nanoemulsions, the use thereof and preparation method thereof wherein the nanoemulsion contains a crosspolymer comprising at least one of a polyacrylic acid chain and a derivative of the polyacrylic acid chain

and polyoxypropylene-polyoxyethylene compound. According to one embodiment, the nanoemulsion forms a droplet with a diameter in the range of about 43 nm to about 96 nm.

Priority: KR20040070665 Applic. Date: 2004-09-04; WO2005KR02929 Applic. Date: 2005-09-03

Inventor: KIM YOUNG DAE [KR]; PARK KEUN JA [KR]; KIM JUNG SOO [KR]; KIM JI SOO [KR]


Application No.: US20100119561A1  Published: 13/May/2010

Title: Compositions Having a Performance Indicator

Applicant/Assignee: AMCOL INTERNATIONAL CORPORATION

Application No.: 12/443998   Filing Date: 04/Oct/2007

Abstract:Compositions containing a delivery system including polymeric microparticles capable of undergoing a visual change, such as a color change, after application to a substrate are disclosed. The delivery system informs a consumer that the composition has been properly applied and/or has performed its intended function.

Priority: US20060849985P Applic. Date: 2006-10-05; WO2007US80403 Applic. Date: 2007-10-04

Inventor: SPINDLER RALPH [US]; LARIONOVA NATALIYA V [US]


Application No.: US20100119562A1  Published: 13/May/2010

Title: Structured Personal Care Compositions Comprising A Clay

Applicant/Assignee: COLGATE PALMOLIVE COMPANY

Application No.: 12/532178   Filing Date: 21/Mar/2008

Abstract:Structured personal care compositions comprising a clay are contemplated, as well as methods for using such compositions.

Priority: US20070896146P Applic. Date: 2007-03-21; WO2008US57814 Applic. Date: 2008-03-21

Inventor: HILLIARD JR PETER R [US]; HASSAN MAHMOUD [US]; KAPLAN STACEY [US]; SOLIMAN NADIA [US]


Application No.: US20100119566A1  Published: 13/May/2010

Title: USE OF A SYNERGISTIC COMPOSITIONS AS A THERAPEUTIC AGENT OR DISINFECTANT

Applicant/Assignee: BODE CHEMIE GMBH MULTIBIND BIOTEC GMBH

Application No.: 12/452295   Filing Date: 27/Jun/2008

Abstract:The invention relates to the use of a composition comprising a vitamin, a metal ion, and a surfactant, as a therapeutic agent or disinfectant. The composition has been known as a decontaminant because the same efficiently decomposes DNA. It has now been possible to demonstrate that the agent has surprisingly good compatibility while having a wide-ranging disinfecting effect and is therefore also suitable for other purposes, e.g., for disinfecting or dressing wounds.

Priority: DE200710030103 Applic. Date: 2007-06-28; WO2008EP05292 Applic. Date: 2008-06-27

Inventor: KRUG BARBARA [DE]; EGGERSTEDT SVEN [DE]; OSTERMEYER CHRISTIANE [DE]; LISOWSKY THOMAS [DE]; ESSER KARLHEINZ [DE]; BUERGER FRANK [DE]; BLOSS RICHARD [DE]


Application No.: US20100119613A1  Published: 13/May/2010

Title: PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT

Applicant/Assignee: MEDIZINISCHE UNIVERSITAT WIEN

Application No.: 12/594315   Filing Date: 02/Apr/2008

Abstract:The present invention relates to a method for producing an extract which is capable of inducing an antioxidant stress response comprising the step of treating an extract from organic material with UV light, said extract being derived from a non-mammalian cell or a non-mammalian organism and said cell or organism being capable of synthesizing polyunsaturated fatty acids. Furthermore, an extract capable of inducing an antioxidant stress response produced in accordance with the inventive methods, in particular an extract capable of inducing an antioxidant stress response for the preparation of a cosmetic composition is disclosed. The present invention also relates to a cosmetic composition comprising the inventive extract obtainable by the method provided herein.

Priority: EP20070006989 Applic. Date: 2007-04-03; WO2008EP02622 Applic. Date: 2008-04-02

Inventor: GRUBER FLORIAN [AT]; OSKOLKOVA OLGA [AT]; TSCHACHLER ERWIN [AT]; BOCHKOV VALERY [AT]


Application No.: US20100119616A1  Published: 13/May/2010

Title: HIGHLY STABLE ELECTROLYTIC WATER WITH REDUCED NMR HALF LINE WIDTH

Applicant/Assignee: AKUATECH S.R.L

Application No.: 12/597587   Filing Date: 25/Apr/2008

Abstract:Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from -1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.

Priority: US20070926182P Applic. Date: 2007-04-25; WO2008EP03383 Applic. Date: 2008-04-25

Inventor: CHEN YONGGE [CN]; DE NONI ROBERTO [IT]


Application No.: US20100119619A1  Published: 13/May/2010

Title: AQUEOUS GEL HAVING AN ALPHA-HYDROXY ACID AND SUSPENDED PARTICULATES

Applicant/Assignee:

Application No.: 12/607553   Filing Date: 28/Oct/2009

Abstract:A personal care composition in the form of an aqueous gel may comprise an alpha-hydroxy acid, wherein the pH of the composition is less than about 4.5. The personal care composition comprises a gelling agent and an aqueous solvent. The personal care composition further comprises particulates and an effective amount of suspension agent to suspend the particulates. The personal care composition exhibits a consumer desired viscosity and translucency.

Priority: US20080109354P Applic. Date: 2008-10-29

Inventor: GRIFFITHS-BROPHY SUSAN ADAIR [US]; KUHLMAN DENNIS EUGENE [US]


Application No.: US20100119628A1  Published: 13/May/2010

Title: Anti-aging cosmetic composition

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 12/654635   Filing Date: 28/Dec/2009

Abstract:The present invention relates to an anti-aging cosmetic composition, and more particularly, the present invention relates to an anti-aging cosmetic composition containing Hibiscus esculentus extracts and at least one selected from the group consisting of oleanolic acid, ursolic acid, glycyrhetinic acid and retinol, showing high safety to skin and wrinkle-improvement effect.

Priority: KR20050008665 Applic. Date: 2005-01-31; US2007-795875 Applic. Date: 2007-11-20; WO2005KR03770 Applic. Date: 2005-11-08

Inventor: KANG CHAN KOO [KR]; LEE YOUNG JIN [KR]; HAN SANG HOON [KR]; KIM SEUNG HUN [KR]


Application No.: US20100119755A1  Published: 13/May/2010

Title: METHOD OF PATTERNING A SURFACE AND ARTICLES COMPRISING THE SAME

Applicant/Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC

Application No.: 12/616915   Filing Date: 12/Nov/2009

Abstract:An article has a curved surface. Disposed upon the curved surface is a plurality of patterns. Each pattern is defined by a plurality of spaced apart features attached to or projected into the curved surface. The plurality of features each have at least one neighboring feature having a substantially different geometry, wherein an average spacing between adjacent features is about 1 nanometer and about 1 millimeter in at least a portion of the curved surface. The plurality of spaced apart features are represented by a periodic function.

Priority: US20080113278P Applic. Date: 2008-11-11; US20090153135P Applic. Date: 2009-02-17

Inventor: CHUNG KENNETH K [US]; BRENNAN ANTHONY B [US]; BAGAN JOSEPH W [US]; SPIECKER MARK M [US]


Application No.: US20100120042A1  Published: 13/May/2010

Title: METHOD OF SCREENING MATERIAL FOR IMPROVING SKIN FUNCTIONS

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 12/575944   Filing Date: 08/Oct/2009

Abstract:A method of screening a material for improving skin functions includes: (a) treating a skin cell with a candidate material

(b) detecting a change in a relative expression level of membrane-associated protein 17 (MAP17) gene

and (c) selecting a candidate material inducing the change in the expression level of the gene as a material for improving skin functions. That is to say, a material for improving skin functions is screened using MAP17 gene as a marker, on the basis of the change in the expression level of the MAP17 gene. A material for improving skin functions, which is useful in improving skin barrier function, promoting skin moisturization, preventing skin aging, or ameliorating skin troubles, may be effectively screened.

Priority: KR20080110377 Applic. Date: 2008-11-07

Inventor: NOH MINSOO [KR]; YEO HYEONJU [KR]; PARK SEON MI [KR]; SHIN DONG WOOK [KR]; LEE HYOUNG HO [KR]; KIM HAN-KON [KR]


Application No.: US20100120646A1  Published: 13/May/2010

Title: STOMA WIPE AND ADHESIVE REMOVER AND METHOD

Applicant/Assignee: SAFE N' SIMPLE LLC

Application No.: 12/597437   Filing Date: 23/Oct/2009

Abstract:A stoma wipe and adhesive remover is for use by an ostomy patient in cleaning a stoma and the area of skin surrounding the stoma, also known as the peristomal skin. The stoma wipe includes a convenient, pre-moistened and disposable towelette. The towelette includes an absorbent fibrous web of material into which is absorbed a liquid cleaning solution having a soap component, an emulsifying component, a water component and an antifungal component. The wipes can be packaged in a convenient, portable, re-sealable package. The stoma wipe is suitable for cleaning a stoma and its surrounding skin area without causing irritation to the stoma and the surrounding skin area, while at the same time removing adhesive residue from an ostomy appliance. The cleaning of the skin and removing old adhesive residue improves adherence of the stoma pouch to the skin area surrounding the stoma.

Priority: US20070913339P Applic. Date: 2007-04-23; WO2008US05158 Applic. Date: 2008-04-22

Inventor: LEROY JOHN L [US]


Application No.: US20100120657A1  Published: 13/May/2010

Title: Reactive Polyorganosiloxanes Modified With Aromatic Substances

Applicant/Assignee: MOMENTIVE PERFORMANCE MATERIALS GMBH

Application No.: 12/531894   Filing Date: 19/Mar/2008

Abstract:The invention relates to polyorganosiloxanes modified with fragrances and having reactive groups, to a method for coating a substrate using the polyorganosiloxanes according to the invention, use of the polyorganosiloxanes according to the invention for releasing the fragrance, to a method for producing the polyorganosiloxanes according to the invention as well as to their use, for example, in detergents or laundry detergents, in care products, in surface treatment agents and in cosmetics.

Priority: DE200710012909 Applic. Date: 2007-03-19; WO2008EP53287 Applic. Date: 2008-03-19

Inventor: LANGE HORST [DE]; ROOS CHRISTOPHER [DE]; WAGNER ROLAND [DE]; KROPFGANS MARTIN [DE]


Application No.: US20100120696A1  Published: 13/May/2010

Title: Peptides Having Activities of Epidermal Growth Factor and Its Uses

Applicant/Assignee: CAREGEN CO., LTD

Application No.: 12/444874   Filing Date: 08/Oct/2007

Abstract:The present invention relates to peptides comprising the amino acid sequence represented by the following formula 1 and having the activities of epidermal growth factor and their uses: Cys-Met-Tyr-Ile-Glu-Linker-Arg-Gly-Asp (1) The EGF-mimicking peptides of the present invention possess identical functions or activities to natural-occurring human EGF and are able to promote the generation of autocrine EGF in cells. In addition the peptides of the present invention are much higher stability and skin penetration potency than natural-occurring EGF. Therefore, the composition containing the peptide exhibits excellent treatment and prevention efficacies on diseases or conditions demanding EGF activities, and can be advantageously applied to pharmaceutical compositions, quasi-drugs and cosmetics.

Priority: KR20060098368 Applic. Date: 2006-10-10; WO2007KR04895 Applic. Date: 2007-10-08

Inventor: CHUNG YONG-JI [KR]; KIM YOUNG DEUG [KR]; KIM EUN MI [KR]; CHOI JUN YOUNG [KR]; SONG SANG SU [KR]


Application No.: US20100120720A1  Published: 13/May/2010

Title: USE OF HMG-COA REDUCTASE AND FARNESYL-PYROPHOSPHATE SYNTHASE INHIBITORS FOR THE PREPARATION OF A MEDICINE

Applicant/Assignee: UNIVERSITE DE LA MEDITERRANEE AIX-MAR SEILLE II

Application No.: 12/307220   Filing Date: 05/Jul/2007

Abstract:The invention relates to the use of a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor and of a farnesyl-pyrophosphate synthase inhibitor, or of one of their associated physiologically acceptable salts, in the preparation of a composition, particularly a pharmaceutical composition, for use in the treatment of human or animal, pathological or nonpathological situations related to the accumulation and/or the persistence of prenylated proteins in cells, such as during progeria (Hutchinson-Gilford syndrome), restrictive dermopathy or physiological aging.

Priority: FR20060006097 Applic. Date: 2006-07-05; WO2007FR01144 Applic. Date: 2007-07-05

Inventor: LEVY NICOLAS [FR]; CAU PIERRE [FR]; LOPEZ-OTIN CARLOS [ES]


Application No.: US20100120768A1  Published: 13/May/2010

Title: METHODS, KITS, AND COMPOSITIONS FOR GENERATING NEW HAIR FOLLICLES AND GROWING HAIR

Applicant/Assignee:

Application No.: 12/443122   Filing Date: 27/Sep/2007

Abstract:The invention features methods, kits, and compositions for generating new hair follicles and growing hair on a subject.

Priority: US20060847854P Applic. Date: 2006-09-28; WO2007US20842 Applic. Date: 2007-09-27

Inventor: STEINBERG DAVID [US]; POJASEK KEVIN [US]; PROUTY STEPHEN [US]; COTSARELIS GEORGE [US]; ITO MAYUMI [US]


Application No.: US20100120778A1  Published: 13/May/2010

Title: QUINOXALINE-BASED LXR MODULATORS

Applicant/Assignee: WYETH

Application No.: 12/614167   Filing Date: 06/Nov/2009

Abstract:Disclosed are quinoxaline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): wherein: each of L1 and L2 is, independently, a bond, -O- or -NH-

R2 is C6-C10 aryl or heteroaryl including 5-10 atoms, each of which is (i) substituted with 1 R9, and (ii) optionally further substituted with from 1-4 Re

and each of R4 and R5 is, independently (i) hydrogen

or (ii) halo

or (iii) C1-C6 alkyl or C1-C6 haloalkyl, each of which is optionally substituted with from 1-3 Ra

and R1, R3, R6, R9, Ra and Re are defined herein. In general, these compounds can be used for treating or preventing one or more diseases, disorders, conditions or symptoms mediated by LXRs.

Priority: US20080112456P Applic. Date: 2008-11-07

Inventor: HU BAIHUA [US]; WROBEL JAY EDWARD [US]; JETTER JAMES WINFIELD [US]; O'NEILL DAVID JOHN [US]; MANN CHARLES WILLIAM [US]; UNWALLA RAYOMAND JAL [US]


Application No.: US20100120820A1  Published: 13/May/2010

Title: METHOD OF TREATING ACTINIC KERATOSIS

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697185   Filing Date: 29/Jan/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120821A1  Published: 13/May/2010

Title: METHOD OF TREATING GENITAL OR PERI-ANAL WARTS

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697210   Filing Date: 30/Jan/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120823A1  Published: 13/May/2010

Title: METHOD OF TREATING BASAL CELL CARCINOMA

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697246   Filing Date: 30/Jan/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120825A1  Published: 13/May/2010

Title: METHOD OF TREATING MOLLESCUM CONTAGIOSUM

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697294   Filing Date: 31/Jan/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120826A1  Published: 13/May/2010

Title: METHOD OF INDUCING CYTOKINE BIOSYNTHESIS

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697296   Filing Date: 31/Jan/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120828A1  Published: 13/May/2010

Title: METHOD OF INDUCING INTERFERON BIOSYNTHESIS

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/697415   Filing Date: 01/Feb/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120836A1  Published: 13/May/2010

Title: METHOD OF TREATING A DERMAL AND/OR MUCOSAL ASSOCIATED CONDITION

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/698011   Filing Date: 01/Feb/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100120837A1  Published: 13/May/2010

Title: METHOD OF TREATING A MUCOSAL AND/OR DERMAL ASSOCIATED CONDITION

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/698039   Filing Date: 01/Feb/2010

Abstract:Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Priority: US2008-334255 Applic. Date: 2008-12-12; US2006-276324 Applic. Date: 2006-02-24; US2005-303659 Applic. Date: 2005-12-16; US20040636916P Applic. Date: 2004-12-17

Inventor: STATHAM ALEXIS S [US]; NELSON ROBERT J [US]


Application No.: US20100121160A1  Published: 13/May/2010

Title: REMOTE PSYCHOLOGICAL EVALUATION

Applicant/Assignee: IZEX TECHNOLOGIES, INC

Application No.: 12/689568   Filing Date: 19/Jan/2010

Abstract:Instrumented orthoses with more sophisticated structures provide for coordinated support and rehabilitation of complex joints and multiple injured joints. Improved instrumented orthoses can include hinges that can rotate in multiple different planes. Particularly preferred embodiments include a shoulder brace with a hand hold and a lower extremities brace. Preferably, a control unit monitors the output Of transducers used to instrument the brace. A patient can be prompted by the control unit for the performance of a variety of different monitored exercises.

Priority: US2004-997737 Applic. Date: 2004-11-24; US1999-339071 Applic. Date: 1999-06-23

Inventor: STARK JOHN G [US]; OYEN DUANE [US]; MOWERY BLAIR P [US]


Application No.: US20100121176A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/291541   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority:

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL L [US]; WOOD VICTORIA Y H [US]


Application No.: US20100121185A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/291507   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority:

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL L [US]; WOOD VICTORIA Y H [US]


Application No.: US20100121186A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE DELAWARE

Application No.: 12/291509   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority:

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL L [US]; WOOD VICTORIA Y H [US]


Application No.: US20100121187A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/291534   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority:

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL I [US]; WOOD VICTORIA Y H [US]


Application No.: US20100121300A1  Published: 13/May/2010

Title: Nursing Bra Pad

Applicant/Assignee: PERSIMMON SCIENTIFIC, INC

Application No.: 12/618584   Filing Date: 13/Nov/2009

Abstract:A nursing bra pad has a concave, cup-shape formed from a rounded section of multi-layer composite textile having a first, skin contact layer formed from a non-shearing, moisture vapor permeable woven fabric of synthetic filament yarns. A second layer and optional third layer are formed from moisture absorbing and retaining fabrics. The second layer is a breathable fabric that draws moisture from the inner to the outer surface of the fabric. The optional third microfiber layer provides moisture retention and may be positioned between the first layer and the second layer or between the second and fourth layers. The fourth layer, which may optionally be coated with polyurethane, is formed from a breathable, waterproof fabric woven from synthetic yarn to allow moisture vapor transfer away from the skin. The three or four layers are stitched together along their edges. The layers are stitched to generally conform to the shape of the breast.

Priority: US20080114067P Applic. Date: 2008-11-13

Inventor: HANN ELLY [US]


Application No.: US20100121581A1  Published: 13/May/2010

Title: Administering a therapeutic agent with more than one taggant

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/291536   Filing Date: 10/Nov/2008

Abstract:A system may include a means for administering a therapeutic agent to a subject

a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile

and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.

Priority:

Inventor: HYDE RODERICK A [US]; ISHIKAWA MURIEL Y [US]; KARE JORDIN T [US]; LEUTHARDT ERIC C [US]; RIVET DENNIS J [US]; WOOD JR LOWELL L [US]; WOOD VICTORIA Y H [US]


Application No.: US20100124538A1  Published: 20/May/2010

Title: TOPICAL APPLICATION OF FLUOCINOLONE ACETONIDE FOR DEPIGMENTATION OF THE SKIN

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/541393   Filing Date: 14/Aug/2009

Abstract:Topically applicable compositions useful for the depigmentation of the skin contain a fluocinolone acetonide depigmenting agent, at a concentration of from 0.0001% to 0.02% by weight, of the total weight of the composition, formulated into physiologically acceptable carrier therefor.

Priority: WO2008EP52298 Applic. Date: 2008-02-26; US20070903311P Applic. Date: 2007-02-26

Inventor: PELISSON ISABELLE [FR]; JOMARD ANDRE [FR]


Application No.: US20100124539A1  Published: 20/May/2010

Title: COSMETIC PREPARATIONS

Applicant/Assignee: HANSON MEDICAL, INC

Application No.: 12/691010   Filing Date: 21/Jan/2010

Abstract:According to an aspect of the invention, a cosmetic preparation comprises about 1% to about 80% by weight of the finished preparation a first silicone fluid having a kinematic viscosity in the range of about 10,000 centistokes (cs) to about 15,000 cs, about 1% to about 80% by weight of the finished preparation a second silicone fluid having a kinematic viscosity in the range of about 25 cs to about 75 cs, about 1% to about 80% by weight of the finished preparation a third silicone fluid having a kinematic viscosity in the range of about 1 cs to about 10 cs, about 0.25% to about 80% by weight of the finished preparation an ascorbic acid ester, about 0.1% to about 1.0% by weight of the finished preparation hexylresorcinol, optionally about 1% to about 80% by weight of the finished preparation vinyl silicone crosspolymer, optionally about 0.25% to about 10% by weight of the finished preparation a fragrance-providing composition, and optionally about 0.1% to about 1.0% by weight of the finished preparation other skin lightening ingredients. Also provided are uses of the preparations.

Priority: US2007-868773 Applic. Date: 2007-10-08; US20090265382P Applic. Date: 2009-12-01; US20060852073P Applic. Date: 2006-10-16

Inventor: HANSON GERALD L [US]


Application No.: US20100124561A1  Published: 20/May/2010

Title: Anti-Aging Product

Applicant/Assignee:

Application No.: 12/273258   Filing Date: 18/Nov/2008

Abstract:The present invention is directed to an anti-aging product, a single use multi-chamber packaging and a method of using the anti-aging product for reducing and/or preventing age-related skin symptoms. More particularly, the present invention is directed to a single use multi-chamber packet that has at least two chambers or compartments each containing at least one portion of an anti-aging composition, wherein said portions can be combined prior to application to the skin for reducing and/or preventing age-related skin symptoms. In another embodiment, the present invention is directed to an anti-aging kit comprising at least two or more single use multi-chamber packets, each having at a different composition for reducing and/or preventing age-related skin symptoms.

Priority:

Inventor: STUDIN JOEL R [US]


Application No.: US20100124577A1  Published: 20/May/2010

Title: COMPOSITION FOR THE TREATMENT OF THE HAIR ROOTS

Applicant/Assignee: AURON INVESTMENTS LTD

Application No.: 12/325867   Filing Date: 01/Dec/2008

Abstract:The present invention is directed to a composition for the treatment of the hair roots in order to prevent or at least to reduce the loss of hairs, to restore the growth of the hairs and to prevent or at least to reduce the formation of white hairs. This composition contains an extract of at least one Chamomilla plant and/or of at least one Achillea plant.

Priority: GB20080021071 Applic. Date: 2008-11-18

Inventor: JAMEL YOUSEF ABDULLATIF [AT]; AHMED AL-DABOONI RAFIDA MOHAMMED [AE]; HAMED AL SARI KARAM MASHAAL [AE]


Application No.: US20100125048A1  Published: 20/May/2010

Title: COSMETIC COMPOSITIONS FOR SKIN-TIGHTENING AND METHOD OF SKIN-TIGHTENING USING THE SAME

Applicant/Assignee: STC NARA CO., LTD

Application No.: 12/522401   Filing Date: 11/Jan/2007

Abstract:The present invention relates to a skin-tightening cosmetic composition and a method of applying the same, and more specifically, to a cosmetic composition a method of applying the same that includes a hydrolyzed plant protein and glycoprotein. The cosmetic composition includes a hydrolyzed plant protein and glycoprotein in an optimal amount, thereby causing the occurrence of an immediate contraction effect and a long-lasting contracting effect, and achieving skin improvements such as skin moisturizing and induction of synthesizing collagen and elastine in use of the composition over a long period of time.

Priority: KR20070001883 Applic. Date: 2007-01-08; WO2007KR00199 Applic. Date: 2007-01-11

Inventor: LEE KYE-HO [KR]; CHUNG SUNG-HO [KR]; SONG JI-HOON [KR]; YOON JIN-SUNG [KR]; LEE JI-HYUN [KR]; JUNG MOON-JU [KR]; KIM JONG-HWAN [KR]


Application No.: US20100125255A1  Published: 20/May/2010

Title: Stye Care Kit and Method

Applicant/Assignee:

Application No.: 12/622424   Filing Date: 19/Nov/2009

Abstract:A stye treatment device for concurrent application of temperature and moisture to a stye. The device features a moisture component positioned in a central cavity formed in a sealing edge extending from the rear surface of an eyecup. A temperature component is positioned in the cavity rearward of the moisture component in a position to contact a stye when the device is biased by a strap to the face of the user. The device, when worn by the user, may impart either heat or cold temperature treatments and humidity or moisture treatment concurrently. Excessive pressure against the user's stye and eye is prevented by forming the moisture component of material adapted to collapse should the temperature component contact the face of the user under too much pressure which might otherwise cause pain.

Priority: US20080116168P Applic. Date: 2008-11-19

Inventor: PAULSON SUZANNE [US]


Application No.: US20100125256A1  Published: 20/May/2010

Title: GLOVES AND SOCKS FOR SKIN CARE

Applicant/Assignee: SKIN CARE KOREA CO., LTD

Application No.: 12/618943   Filing Date: 16/Nov/2009

Abstract:Provided are gloves and socks for skin care. The gloves for skin care include a first insertion part into which a hand is inserted and a second insertion part into which fingers are inserted. A first surface of a sheet forming the gloves is coated with cosmetic compositions, and forms an inner surface of the gloves that contacts the hand. A second surface, an opposite surface of the sheet is waterproofed, and forms an outer surface of the gloves that is exposed to the outside.

Priority: KR20080015257U Applic. Date: 2008-11-17

Inventor: KIM ILDONG [KR]


Application No.: US20100125295A1  Published: 20/May/2010

Title: Nostril dilator

Applicant/Assignee:

Application No.: 12/291987   Filing Date: 14/Nov/2008

Abstract:An internal nasal prosthesis of unitary construction. The prosthsis has three distinct segments, an arched medial segment and two lateral appendages on each end of the medial segment. Each appendage of this prosthesis is the mirror image of the other and is inclined at a compound angle, relative to said arched medial segment, so that each of said appendage is inclined, at an angle, into the plane of the page, of at least about 30 degrees, and at an angle, relative to the horizontal plane of the medial section, of about 90 degrees

and

Priority:

Inventor: WIEN ABRAHAM [US]


Application No.: US20100126281A1  Published: 27/May/2010

Title: REINFORCED PANEL

Applicant/Assignee:

Application No.: 12/451228   Filing Date: 24/Apr/2008

Abstract:A reinforced panel (1) comprising: a composite skin (2)

a plurality of stringers (3, 4) bonded to the skin

and one or more strain actuators (5), each positioned between an adjacent pair of stringers. A load is applied to the panel in the plane of the skin, and a local strain is applied to the skin by the strain actuators when the compressive load exceeds a predetermined threshold. This causes the skin to buckle and reduce interface stresses between the skin and the stringers.

Priority: GB20070009118 Applic. Date: 2007-05-14; WO2008GB50294 Applic. Date: 2008-04-24

Inventor: COSENTINO ENZO [GB]


Application No.: US20100126521A1  Published: 27/May/2010

Title: Personal Care Compositions Containing Skin Conditioning Agents

Applicant/Assignee:

Application No.: 12/338327   Filing Date: 18/Dec/2008

Abstract:Personal care compositions are provided that include an aqueous base composition and a volatile post foaming agent mixed with the base composition. The base composition comprises a lipophilic skin conditioning agent, a structuring agent, and a water soluble or water dispersible surface active agent.

Priority: US20070009152P Applic. Date: 2007-12-26

Inventor: KYTE III KENNETH EUGENE [US]


Application No.: US20100126727A1  Published: 27/May/2010

Title: IN SITU RECOVERY FROM A HYDROCARBON CONTAINING FORMATION

Applicant/Assignee: SHELL OIL COMPANY

Application No.: 12/329942   Filing Date: 08/Dec/2008

Abstract:An in situ process for treating a hydrocarbon containing formation is provided. The process may include providing heat from one or more heaters to at least a portion of the formation. The heat may be allowed to transfer from the one or more heaters to a part of the formation such that heat from the one or more heat sources pyrolyzes at least some hydrocarbons within the part. Hydrocarbons may be produced from the formation.

Priority: US2007-657442 Applic. Date: 2007-01-23; US2002-279288 Applic. Date: 2002-10-24; US20010334568P Applic. Date: 2001-10-24; US20010337136P Applic. Date: 2001-10-24; US20020374970P Applic. Date: 2002-04-24; US20020374995P Applic. Date: 2002-04-24

Inventor: VINEGAR HAROLD J [US]; SUMNU-DINDORUK MELLIHA DENIZ [US]; WELLINGTON SCOTT LEE [US]; MAHER KEVIN ALBERT [US]; KARANIKAS JOHN MICHAEL [US]; DE ROUFFIGNAC ERIC PIERRE [NL]; MESSIER MARGARET ANN [CA]; ROBERTS BRUCE EDMUNDS [CA]; CRANE STEVEN DEXTER [US]


Application No.: US20100129300A1  Published: 27/May/2010

Title: ORGANOSILICON COMPOUNDS, FATTY ACIDS AND OILS WITH HOMOGENOUS SILICON NANOPARTICLE DISPERSIONS

Applicant/Assignee: NANOSI ADVANCED TECHNOLOGIES, INC

Application No.: 12/620080   Filing Date: 17/Nov/2009

Abstract:The invention provides homogenous dispersions of luminescent silicon nanoparticles in organoslicoon compounds, fatty acids and oils. In methods of the invention, a fatty acid or oil and silicon nanoparticle homogenous dispersion is formed by mixing. The dispersion of nanoparticles in organosilicon compounds, fatty acid(s) or oil(s) can used as a delivery mechanism to homogenously incorporate the nanoparticles into a variety of cosmetic compounds and oils, such as foundation creams and other make-up products, sun tan lotions, sun tan oils, etc. Compounds of the invention with homogenous nanoparticle dispersions display homogeneous UV/blue absorption as well as down conversion to visible luminescence. The compounds can be tailored to exhibit white luminescence under UV illumination. Preferred skin care compounds provide a pleasing cosmetic effect in response to light. Preferred skin care compounds also provide uv protection.

Priority: US20080115772P Applic. Date: 2008-11-18

Inventor: NAYFEH MUNIR H [US]; MALKAWI HANAN I [JO]; AL-OLAYAN EBTESAM MOHAMMED SALANH [SA]; ALGHAMDI KHALID MOHAMMAD [SA]


Application No.: US20100129301A1  Published: 27/May/2010

Title: COSMETIC COMPOSITIONS

Applicant/Assignee:

Application No.: 12/624236   Filing Date: 23/Nov/2009

Abstract:A cosmetic composition comprises a) from about 0.1% to about 15% of an emulsifying crosslinked siloxane elastomer

b) from about 0.1% to about 10% of a noncrosslinked silicone emulsifier having a polyglycerin unit

c) from about 1% to about 50% of a solvent for the emulsifying crosslinked siloxane elastomer

d) from about 0.05% to about 10% of an amphiphilic active

and e) water.

Priority: US20080117264P Applic. Date: 2008-11-24

Inventor: TANAKA SHUHEI [JP]; YOSHIMI NAOHISA [JP]


Application No.: US20100129302A1  Published: 27/May/2010

Title: ANTIMICROBIAL COMPOSITION WITH LOW CYTOTOXICITY

Applicant/Assignee: OY GRANULA AB LTD

Application No.: 12/626072   Filing Date: 25/Nov/2009

Abstract:A composition includes at least one antimicrobial agent

a possible solvent system with either hydrophobic or hydrophilic nature, selected according to the target of usage

as well as possible surface active agent. The compound mixture is obtained by pulverizing wood or plant material and/or by extracting the possibly pulverized wood or plant material, so that the compound mixture contains at least two different polyphenolic compounds selected from the following group: lignans, stilbenes, juvabiones and flavonoids

the compound mixture further containing oligomers of the polyphenolic compounds, so that the compound mixture preferably has the following properties: the compound mixture has an antimicrobial effect in the composition

the cytotoxicity of the polyphenols contained in the compound mixture is at least 10 times lower with respect to BHT

the compound mixture does not irritate the skin in a so-called single patch test with contents of 0.1 wt %.

Priority: US20080117684P Applic. Date: 2008-11-25

Inventor: AHLNAES THOMAS [FI]


Application No.: US20100129303A1  Published: 27/May/2010

Title: SUNSCREEN AND PERSONAL CARE COMPOSITIONS COMPRISING A RANDOM TERPOLYMER

Applicant/Assignee:

Application No.: 12/575631   Filing Date: 08/Oct/2009

Abstract:Topically applicable, water-resistant cosmetic or dermatological compositions well suited for the UV-photoprotection of human skin and/or hair comprising an effective UV-photoprotecting amount of: (a) at least one UV screening agent from various classes and particularly effect mixtures thereof

and, (b) at least one random terpolymer

and, optionally, (c) other cosmetically acceptable ingredients. The various classes of UV-protecting compounds or UV sunscreens of special interest are selected from the groups b1 sparingly soluble micronized organic UV absorber, b2 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, b3 at least one oil soluble organic UV absorber, b4 at least one inorganic UV absorber and b5 at least one water soluble UV absorber further defined herein. The present invention also relates to personal care compositions comprising at least one random terpolymer and other cosmetically acceptable ingredients.

Priority: US20080196412P Applic. Date: 2008-10-17

Inventor: DUEVA-KOGANOV OLGA V [US]; JAYNES BINGHAM S [US]; LUPIA JOSEPH A [US]; TERMATEN ARJAN T [NL]; SLUIS MARCELLES VAN DER [NL]; SUURMEIJER MARLEEN [NL]; NORMINGTON DAVID [GB]; SCHNYDER MARCEL [CH]; GRUMELARD JULIE [FR]; SOHN MYRIAM [FR]


Application No.: US20100129304A1  Published: 27/May/2010

Title: METHOD FOR PREPARING A COMPOSITION COMPRISING A COMPOUND MIXTURE AND A CARRIER AGENT

Applicant/Assignee: OY GRANULA AB LTD

Application No.: 12/626063   Filing Date: 25/Nov/2009

Abstract:In a method for preparing a composition including a compound mixture and a carrier agent, the compound mixture is obtained by pulverizing the wood material and/or by extracting the wood material so that the compound mixture contains at least two different compounds, selected from a first specified group, at least one compound selected from a second specified group, the compound mixture is mixed with the carrier agent, the amount of the compound mixture is kept in a range of 0.1-5 wt % from the total weight of the composition, providing that the range is also such that the total cytotoxicity of compound mixture dissolved in ethanol, measured for a HaCat cell culture after 24 h incubation period, is lower than the cytotoxicity of 0.02-0.1 wt % butylated hydroxy toluene (BHT) dissolved in ethanol for a HaCat cell culture after 24 h incubation period.

Priority: US20080117702P Applic. Date: 2008-11-25

Inventor: AHLNAS THOMAS [FI]


Application No.: US20100129305A1  Published: 27/May/2010

Title: Compositions Containing Extracts From Radish

Applicant/Assignee:

Application No.: 12/615747   Filing Date: 10/Nov/2009

Abstract:A topical composition comprising an ingredient that is obtained by fermentation of Raphanus Sativus roots by the organism Leuconostoc or Lactobacillus.

Priority: US20080116880P Applic. Date: 2008-11-21

Inventor: LEE WILSON A [US]; KEUPP GEORGENA MOREIRA [US]; BRIEVA HERNANDO [US]; WARREN MATTHEW RONALD [US]


Application No.: US20100129324A1  Published: 27/May/2010

Title: BIOLOGICAL EFFECTS OF COMPOSITIONS COMPRISING ROSMARINIC ACID

Applicant/Assignee:

Application No.: 12/513631   Filing Date: 06/Nov/2007

Abstract:The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.

Priority: EP20060023060 Applic. Date: 2006-11-06; US20060869615P Applic. Date: 2006-12-12; WO2007EP09602 Applic. Date: 2007-11-06

Inventor: CRESPY VANESSA [CH]; CASTIEL ISABELLE [FR]; BEL-RHLID RACHID [CH]; PAGE NICOLAS [CH]; RAAB THOMAS [CH]


Application No.: US20100129332A1  Published: 27/May/2010

Title: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

Applicant/Assignee:

Application No.: 12/693968   Filing Date: 26/Jan/2010

Abstract:A pharmaceutical composition and method for inducing or accelerating a healing process of a skin wound are described. The pharmaceutical composition contains, as an active ingredient, a therapeutically effective amount of at least one agent for modulating PKC production and/or activation, and a pharmaceutically acceptable carrier. The method is effected by administering the composition to a wound.

Priority: US2009-404622 Applic. Date: 2009-03-16; US2003-644775 Applic. Date: 2003-08-21; US2002-169801 Applic. Date: 2002-07-09; WO2001IL00675 Applic. Date: 2001-07-23; US2002-214228 Applic. Date: 2002-08-08; US2000-629970 Applic. Date: 2000-07-31

Inventor: TENNENBAUM TAMAR [IL]; SAMPSON SANFORD [IL]; KUROKI TOSHIO [JP]; ALT ADDY [IL]; SHEN SHLOMZION [IL]


Application No.: US20100129426A1  Published: 27/May/2010

Title: PROTECTIVE AGENT AGAINST DAMAGE OF BIOLOGICAL TISSUE CAUSED BY NEAR-INFRARED RAY AND PRODUCT COMPRISING THE SAME

Applicant/Assignee:

Application No.: 12/452899   Filing Date: 29/Jul/2008

Abstract:The present invention is to provide a protective agent against damage of biological tissue caused by near-infrared rays which is capable of blocking the near-infrared rays from reaching not only skin but also deeper tissue than the skin tissue, preventing damage of such tissue caused by the near-infrared rays and preventing pathogenesis and development of various disease and acceleration of aging both of which are caused by the near-infrared rays, and a product using the protective agent. The protective agent against damage of biological tissue caused by near-infrared rays comprises a near-infrared ray penetration blocker that absorbs, reflects or scatters the near-infrared rays to prevent the damage of skin and deeper tissue than the skin in a living body caused by exposure with the near-infrared rays.

Priority: JP20070197592 Applic. Date: 2007-07-30; WO2008JP63558 Applic. Date: 2008-07-29

Inventor: TANAKA YOHEI [JP]; MATSUO KIYOSHI [JP]


Application No.: US20100129427A1  Published: 27/May/2010

Title: Hemostatic Wound Dressings

Applicant/Assignee: BIOLIFE, L.L.C

Application No.: 12/626478   Filing Date: 25/Nov/2009

Abstract:Hemostatic wound dressings for substantially arresting the flow of severe, life threatening bleeding from a wound by rapidly adhering to the wound site, absorbing and concentrating and thickening the blood at the dressing blood interface and accelerating the natural clot formation beneath the dressing and finally, forming a strong seal that will substantially prohibits further flow of blood out of the wound site. These hemostatic wound dressings are formed of unique combinations of hemostatic dressing aspects which achieve wound seal strengths that are significantly higher than the sum of seal strengths expected from the individual aspects alone. Some embodiments also achieve these synergistic seal strengths by combining one hemostatic dressing with a non-hemostatic device.

Priority: US20080200128P Applic. Date: 2008-11-25

Inventor: HEN JOHN [US]; KEENE TALMADGE KELLY [US]; TRAVI MARK [US]


Application No.: US20100130460A1  Published: 27/May/2010

Title: TOPICAL GLUCOCORTICOSTEROID FORMULATIONS

Applicant/Assignee: NYCOMED US INC

Application No.: 12/096753   Filing Date: 08/Dec/2006

Abstract:Disclosed are topical formulations comprising an androstane steroid, propylene glycol, and benzyl alcohol in an amount effective to dissolve the androstane steroid compound, wherein the amount of benzyl alcohol is not effective to act as a penetration enhancer. The formulations are useful for the treatment of inflammatory and/or pruritic manifestations of corticosteroid-responsive dermatoses.

Priority: US20050749333P Applic. Date: 2005-12-09; WO2006US47027 Applic. Date: 2006-12-08

Inventor: ALBANO BRIAN [US]; ANDERSON ROBERT J [US]; CHECK III JOSEPH A [US]; CROW WELDON [US]


Application No.: US20100130461A1  Published: 27/May/2010

Title: Pharmaceutical composition for topical application

Applicant/Assignee:

Application No.: 12/657663   Filing Date: 26/Jan/2010

Abstract:A topical composition for treatment of contact dermatitis comprising a corticosteroid, one or more drying agents, such as zinc oxide and talc, an alcohol solvent, a humectant and a viscosity agent, such as bentonite. The humectant may be glycerin, and the carrier is water.

Priority: US2007-904461 Applic. Date: 2007-09-27

Inventor: BURKENSTOCK SR BRUCE [US]


Application No.: US20100130462A1  Published: 27/May/2010

Title: LANOLIN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME

Applicant/Assignee:

Application No.: 12/596334   Filing Date: 18/Apr/2008

Abstract:A composition suitable for application to the skin comprising lanolin, an oil, an anti-oxidant, and a combination thereof. The composition is suitable for particular application to a human breast.

Priority: US20070913238P Applic. Date: 2007-04-20; US20070913490P Applic. Date: 2007-04-23; WO2008US60890 Applic. Date: 2008-04-18

Inventor: THOMAS SHERRY L [US]; MARSEGLIA LAURA [US]; HANSON STEPHEN F [US]; AMIRAN MOHSEN [US]


Application No.: US20100130502A1  Published: 27/May/2010

Title: Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders

Applicant/Assignee: GALDERMA LABORATORIES, INC

Application No.: 12/620982   Filing Date: 18/Nov/2009

Abstract:In methods, compounds, and topical formulations for treatment of inflammatory skin disorders incorporating compounds represented by the formulas below: wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy

each of R4 and R5 is independently hydrogen, alkyl, or alkoxy

and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy

wherein each of A1, A3, and A4 is independently hydrogen or alkyl

and A2 is independently hydrogen or hydroxy

and wherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy

and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith.

Priority: US2009-545638 Applic. Date: 2009-08-21; US2005-137911 Applic. Date: 2005-05-25; US2004-853585 Applic. Date: 2004-05-25; US20030473611P Applic. Date: 2003-05-27

Inventor: DEJOVIN JACK A [US]; DEJOVIN ISABELLE JEAN [US]


Application No.: US20100130605A1  Published: 27/May/2010

Title: Use of Derivatives of Sinapinic Acid and Compositions Comprising Such Derivatives

Applicant/Assignee: COGNIS IP MANAGEMENT GMBH

Application No.: 12/530037   Filing Date: 26/Feb/2008

Abstract:The present invention relates to substances which can be used as cosmetic ingredients, especially for skin whitening and as cosmetic agents against signs of ageing skin. The present invention also relates to the use of such substances for the manufacture of a medicament for the treatment of disorders related to the pigmentation of the skin. The invention furthermore relates to specific substances.

Priority: EP20070004523 Applic. Date: 2007-03-06; WO2008EP01492 Applic. Date: 2008-02-26

Inventor: MARKERT THOMAS [DE]; MOUSSOU PHILIPPE [FR]; DANOUX LOUIS [FR]; RATHJENS ANDREAS [FR]


Application No.: US20100130613A1  Published: 27/May/2010

Title: ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF CD1d OR IL-10

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/468528   Filing Date: 19/May/2009

Abstract:Adapalene or pharmaceutically acceptable salt thereof is administered to an individual in need of such treatment for modulating the expression of CD1d or IL-10 in an inflammatory acneic lesion.

Priority: WO2007FR52364 Applic. Date: 2007-11-19; US20060859968P Applic. Date: 2006-11-20

Inventor: DRENO BRIGITTE [FR]


Application No.: US20100130614A1  Published: 27/May/2010

Title: ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF IL-1ra

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/468641   Filing Date: 19/May/2009

Abstract:Adapalene or pharmaceutically acceptable salt thereof is administered to an individual in need of such treatment for modulating the expression of IL-1ra by the cells of acneic epidermis.

Priority: WO2007FR52367 Applic. Date: 2007-11-20; US20060859967P Applic. Date: 2006-11-20

Inventor: DRENO BRIGITTE [FR]


Application No.: US20100130618A1  Published: 27/May/2010

Title: TREATMENT OF HUMAN DISEASE CONDITIONS AND DISORDERS USING VITAMIN K ANALOGUES AND DERIVATIVES

Applicant/Assignee: VIRIDIS BIOPHARMA PVT. LTD

Application No.: 12/452803   Filing Date: 21/Jul/2008

Abstract:The present invention is related to the therapeutic uses of vitamin K, its analogues and derivatives in a diverse array of disease conditions. Vitamin K improves blood perfusion and ameliorates hypoxia in prevention and treatment of conditions such as chronic venous insufficiency manifestations, post thrombotic syndrome, skin conditions related to melanization, hyperpigmentation, Paresthesiae, oedema, varicose veins, VTE and cramps. The invention also provides pharmaceutical compositions comprising vitamin K, its analogues, derivatives or vitamin K-like compounds either alone or in combination with one or more therapeutically effective active agents for the diseases/conditions of venous, nerves and lymph, that are encompassed by this invention.

Priority: IN2007MU01419 Applic. Date: 2007-07-24; WO2008IN00465 Applic. Date: 2008-07-21

Inventor: VAIDYA ASHOK B [IN]; MEHTA DILIP S [IN]; DE SOUZA ANSELM [IN]; VAIDYA RAMA A [IN]


Application No.: US20100130955A1  Published: 27/May/2010

Title: REUSABLE ABSORBENT ARTICLE FOR AMBULATORY USERS

Applicant/Assignee:

Application No.: 12/625028   Filing Date: 24/Nov/2009

Abstract:The invention is a reusable, absorbent article, such as a diaper. The article comprises a main article assemblage and extensible hip panels attached to opposite sides of the posterior end of the assemblage. The assemblage further comprises: an impermeable exterior layer

a moisture transmitting, skin facing, layer

and, one or more layers of absorbent material secured between the exterior layer and the skin facing layer. The impermeable exterior layer is joined to the skin facing layer along the entire perimeter of the layer. A portion of the perimeter is joined with a groin contouring elastic member along each lateral edge of the central portion of the assemblage. The hip panels each further comprise a strip of woven material and a cut panel edge, together with a plurality of substantially parallel and evenly spaced strands of elastic thread, which are secured in place by corresponding stitching, and an edge stabilizing elastic member. The hip panels additionally comprise a corresponding snap facing attached to each hip panel. One or more snap fastener prongs are affixed to each of the snap facings

and, one or more snap fastener sockets corresponding to each snap fastener prong, are located on the assemblage along its lateral edges.

Priority: US20080117447P Applic. Date: 2008-11-24

Inventor: TICE RENEE J [US]


Application No.: US20100130988A1  Published: 27/May/2010

Title: EXFOLIATING SCRUBBER

Applicant/Assignee:

Application No.: 12/699599   Filing Date: 03/Feb/2010

Abstract:A scrubber mitt comprising a backing, a plurality of loops and a cavity. The backing may have an inner side and an outer side. The plurality of loops may be attached to the outer side. The cavity may be defined by the inner side. The cavity is adapted to fit around the hand of a person. There is also disclosed a process comprising disposing the scrubber mitt around a hand of a person and introducing a liquid cleanser into a reservoir defined by the backing.

Priority: US2006-466432 Applic. Date: 2006-08-22

Inventor: BOLTON JOHN [US]


Application No.: US20100131432A1  Published: 27/May/2010

Title: Methods and compositions of molecular profiling for disease diagnostics

Applicant/Assignee:

Application No.: 12/592065   Filing Date: 17/Nov/2009

Abstract:The present invention relates to compositions, kits, and methods for molecular profiling and cancer diagnostics, including but not limited to gene expression product markers, alternative exon usage markers, and DNA polymorphisms associated with cancer. In particular, the present invention provides molecular profiles associated with thyroid cancer, methods of determining molecular profiles, and methods of analyzing results to provide a diagnosis.

Priority: US20080199585P Applic. Date: 2008-11-17; US20090270812P Applic. Date: 2009-07-13

Inventor: KENNEDY GIULIA C [US]; ANDERSON BONNIE H [US]; CHUDOVA DARYA I [US]; WANG ERIC T [US]; WANG HUI [US]; PAGAN MORAIMA [US]; ROBBEE NUSRAT [US]; WILDE JONATHAN I [US]


Application No.: US20100132734A1  Published: 03/Jun/2010

Title: COSMETICS KIT AND METHOD OF USE

Applicant/Assignee: COLOUR GIRLS, LLC

Application No.: 12/464752   Filing Date: 12/May/2009

Abstract:The cosmetics kit includes a cosmetics box with a specific assortment of predetermined, prescribed cosmetics selected from a plurality of different prescribed color combinations predetermined to be skin-color coordinated with a corresponding plurality of different specific skin tones. The cosmetics box also includes a removable instructional guide overlay bearing informational labels with identifying information to identify cosmetics in the cosmetics box and instructions for use of the cosmetics. The cosmetics kit also includes accessory tools for applying the cosmetics, and a booklet of instructions keyed to the identifying information, instructions for use on the instructional guide overlay, and accessory tools.

Priority: US2005-064305 Applic. Date: 2005-02-23

Inventor: MILLS CASSANDRA [US]


Application No.: US20100135369A1  Published: 03/Jun/2010

Title: INTERACTION BETWEEN AN INPUT DEVICE AND A TERMINAL DEVICE

Applicant/Assignee: SIEMENS AKTIENGESELLSCHAFT

Application No.: 12/451424   Filing Date: 07/May/2008

Abstract:An input device interacts with a terminal device and/or controls the terminal device of a communication network. The terminal device serves to receive and to transmit a content data stream which represents a chat transmission. In addition, the terminal device functions to transmit messages created by the input device to a processing unit of the communication network. The input device has at least one sensor for determining a physical state of an operator of the input device. The input device is furthermore designed to transmit a value representing the physical state to the terminal and/or the processing unit.

Priority: EP20070009525 Applic. Date: 2007-05-11; WO2008EP55619 Applic. Date: 2008-05-07

Inventor: HAGL ERICH [AT]; HAGL PETER [AT]; MOSER MARKUS [AT]; PELZMANN MARTIN [AT]; ZIMMERMANN MATTHIAS [AT]


Application No.: US20100135920A1  Published: 03/Jun/2010

Title: METHOD TO TREAT PROPOLIS

Applicant/Assignee: BALLOT-FLURIN APICULTEURS

Application No.: 12/595149   Filing Date: 23/Apr/2008

Abstract:A method to treat propolis includes conducting at least one first extraction of propolis performed on a batch of raw propolis with a first pure solvent to obtain a first extract having first properties. A second extraction may be performed with a second different pure solvent on the filtration residues obtained after the first extraction, so as to collect and make usable the entirety of the components of propolis using organic solvents only

and finally the method may include a third extraction following after the second extraction, performed on the filtration residues obtained after this second extraction, using a third pure solvent different from the two others

the first solvent then being water, the second being alcohol and the third being oil. The method applies to the production of extracts of propolis for use in the manufacture of hygiene, care, cosmetic products, food products and food supplements.

Priority: FR20070054648 Applic. Date: 2007-04-24; WO2008FR50736 Applic. Date: 2008-04-23

Inventor: BALLOT-FLURIN CATHERINE [FR]


Application No.: US20100135926A1  Published: 03/Jun/2010

Title: ANTIMICROBIAL AND IMMUNOSTIMULATORY SYSTEM COMPRISING AN OXIDOREDUCTASE ENZYME

Applicant/Assignee:

Application No.: 12/444231   Filing Date: 05/Oct/2007

Abstract:The present invention relates to an antimicrobial and immunostimulatory system, applications thereof and a process for the production of the antimicrobial and immunostimulatory system. The present invention provides a storage-stable antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme, a substrate for the oxidoreductase enzyme and hydrogen peroxide in an aqueous solution wherein the substrate for the oxidoreductase enzyme is present up to 90% by weight and water is present up to 20% by weight based on the weight of the total composition

the system has a pH from approximately 4 to 8

and the system provides a two-stage hydrogen peroxide release.

Priority: GB20060019786 Applic. Date: 2006-10-06; WO2007IE00094 Applic. Date: 2007-10-05

Inventor: BARRETT JOHN REGINALD [IE]; BRENNAN JAMES JOSEPH [IE]; PATTON THOMAS PATRICK [IE]


Application No.: US20100135936A1  Published: 03/Jun/2010

Title: Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate

Applicant/Assignee:

Application No.: 12/386716   Filing Date: 22/Apr/2009

Abstract:This invention relates to a delivery system for hydrophobic benefit agents to keratinous substrates. The delivery system comprises amphiphilic block copolymers, and a hydrophobic benefit agent, which amphiphilic block copolymers comprise a siloxane segment and a cationic segment. The invention also relates to methods of delivering the hydrophobic benefit agents to the keratinous substrate. Furthermore, the delivery systems and methods of delivery are effective in retaining an hydrophobic benefit agents on the keratinous substrate after rinsing. More particularly, the delivery systems are especially suitable in personal cleansing, body wash or rinse off lotion compositions and comprise certain amphiphilic polymers which effectively deposit the hydrophobic benefit agents onto a keratinous substrate, such as skin or hair.

Priority: US20080125173P Applic. Date: 2008-04-23

Inventor: DUEVA-KOGANOV OLGA V [US]; KOROSKENYI BALINT [US]; ZHOU XIAN-ZHI [US]


Application No.: US20100135937A1  Published: 03/Jun/2010

Title: METAL OXIDE NANOCRYSTALS: PREPARATION AND USES

Applicant/Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

Application No.: 12/566135   Filing Date: 24/Sep/2009

Abstract:Nanocrystalline forms of metal oxides, including binary metal oxide, perovskite type metal oxides, and complex metal oxides, including doped metal oxides, are provided. Methods of preparation of the nanocrystals are also provided. The nanocrystals, including uncapped and uncoated metal oxide nanocrystals, can be dispersed in a liquid to provide dispersions that are stable and do not precipitate over a period of time ranging from hours to months. Methods of preparation of the dispersions, and methods of use of the dispersions in forming films, are likewise provided. The films can include an organic, inorganic, or mixed organic/inorganic matrix. The films can be substantially free of all organic materials. The films can be used as coatings, or can be used as dielectric layers in a variety of electronics applications, for example as a dielectric material for an ultracapacitor, which can include a mesoporous material. Or the films can be used as a high-K dielectric in organic field-effect transistors. In various embodiments, a layered gate dielectric can include spin-cast (e.g., 8 nm-diameter) high-K BaTiO3 nanocrystals and parylene-C for pentacene OFETs.

Priority: WO2008US03878 Applic. Date: 2008-03-25; US20070920004P Applic. Date: 2007-03-26; US20070908081P Applic. Date: 2007-03-26; US20090210481P Applic. Date: 2009-03-19

Inventor: O'BRIEN STEPHEN [US]; HUANG LIMIN [US]; CHEN ZHUOYING [GB]; KYMISSIS IOANNIS [US]; JIA ZHANG [US]


Application No.: US20100135942A1  Published: 03/Jun/2010

Title: Depigmenting keratin materials utilizing dithiolane compounds

Applicant/Assignee: L'OREAL

Application No.: 12/591714   Filing Date: 30/Nov/2009

Abstract:A cosmetic regime or regimen for depigmenting, lightening and/or bleaching keratin materials, especially the skin, entails topically applying thereon a cosmetic composition containing a dithiolane compound of formula (I): in which: Y is O, NR1 or S R1 is a hydrogen atom

a C1-C20 alkyl radical or an optionally substituted phenyl radical

R is a hydrogen atom

or a C1-C20 alkyl radical, or an optionally substituted phenyl radical, or a C1-C8 alkyl radical containing an optionally substituted phenyl substituent

n=0 or 1 or 2

and also the salts, chelates, solvates and optical isomers thereof.

Priority: FR20080058075 Applic. Date: 2008-11-28; US20080193507P Applic. Date: 2008-12-04

Inventor: MARAT XAVIER [FR]


Application No.: US20100135943A1  Published: 03/Jun/2010

Title: SKIN LIGHTENING COMPOSITIONS

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/698192   Filing Date: 02/Feb/2010

Abstract:A skin lightening composition is provided which comprises components (a) a flavanoid, (b) vitamin C and (c) vitamin E wherein at least component (b) is provided in a form suitable for systemic administration with the other components being provided

Priority: EP20040250394 Applic. Date: 2004-01-24; US2006-587136 Applic. Date: 2006-07-21

Inventor: CHARLES NEE NEWSHAM REBECCA LOUISE [GB]; YATES PAULA RACHEL [GB]


Application No.: US20100135980A1  Published: 03/Jun/2010

Title: Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy

Applicant/Assignee:

Application No.: 12/655783   Filing Date: 07/Jan/2010

Abstract:A method for the treatment and prophylaxis of diseases or conditions associated with aging which includes oxidative stress and cancer. Such diseases or conditions are associated with a decrease or increase presence of one or a combination of one or more Carbonic Anhydrase isozymes I TO VII in the tissue of a subject. These diseases include but are not limited to chronic neurodegenerative diseases such as Alzheimer's disease, parkinson's disease, multiple sclerosis, autism, lou gehrig's disease, huntington's disease, immune disorders which includes systemic lupus erythematosus, diabetes mellitus

musculo-skeletal disorders which includes osteoporosis,arthritis, osteomalacia. Cancer which includes the breast, lung, colon, prostate gland, ovary, esophagus, liver, rectum. The method comprises administering to the patient a pharmaceutically effective non toxic amount of one or a combination of one or more compounds that increases or decreases the level of one or more Cell Specific Carbonic Anhydrase Enzymes whose levels have been increased or decreased in the tissue of the subject. Such compound maybe the Cell Specific Carbonic Anhydrase Enzymes I to VII. A compound that when absorbed reacts or dissociates to form cell specific carbonic enzymes or one or more compounds that when administered promotes the increase or decrease level of one or more cell specific Carbonic anhydrase I,II,III,IV,V,VI,VII. As growth factors of stem cells as an alternative to stem cell therapy. These methods includes the administering of one or a combination of one or more of these compounds over an extended period of time ranging from 6 months until the patient dies.

Priority: US2007-801870 Applic. Date: 2007-05-12; US2004-858091 Applic. Date: 2004-06-01; US2002-077719 Applic. Date: 2002-02-15; US2000-688290 Applic. Date: 2000-10-16

Inventor: RODRIGUEZ VICTORIO C [US]


Application No.: US20100136064A1  Published: 03/Jun/2010

Title: NUTRACEUTICAL COMPOSITION

Applicant/Assignee:

Application No.: 12/626893   Filing Date: 28/Nov/2009

Abstract:A nutraceutical substance comprising Adansonia digitata (Baobab), Borojoa patinoi (Borojo), Cyclanthera Pedata (Caigua) and Aframomum melegueta (Grains of Paradise). In some embodiments, the whole fruit of these plants may be used. In other embodiments, roots bark, saps, roots or seeds from these plants may be used. The substance may be dried, powderized, and packaged for use directly, or processed into a pill or digestible capsule form. In other embodiments, the substance may be used as brew, water extract, alcohol extract, or pulp mixture. The substance is intended for ingestion by a human user, and may be useful to promote well-being, provide nutritional value, and aid in preventative health management. Cosmeceutical and hair care formulations employing these ingredients are also disclosed.

Priority: US20080119501P Applic. Date: 2008-12-03

Inventor: SHATKINA RUFINA [US]; GUREVICH SAM D [US]


Application No.: US20100136070A1  Published: 03/Jun/2010

Title: METHODS, DEVICES, AND COMPOSITIONS FOR DERMAL FILLING

Applicant/Assignee: JAKK GROUP, INC

Application No.: 12/630733   Filing Date: 03/Dec/2009

Abstract:Provided herein are methods, devices, and compositions for dermal filling. Also described herein are dermal filler cross-linked compositions and methods for making such compositions. Such compositions comprise, for example, a cross-linked composition of hyaluronic acid, derivatives of hyaluronic acid or mixtures thereof, alginic acid, derivatives of hyaluronic acid or mixtures thereof and calcium ions.

Priority: US20080119541P Applic. Date: 2008-12-03

Inventor: DOBAK JOHN DANIEL [US]; PRESTWICH GLENN DOWNES [US]


Application No.: US20100136093A1  Published: 03/Jun/2010

Title: Immunotherapeutic Method For Increasing Groundnut Tolerance In A Subject

Applicant/Assignee:

Application No.: 12/628077   Filing Date: 30/Nov/2009

Abstract:The present invention describes a new method for progressive desensitization of a subject to groundnut. More specifically, the invention relates to the immunotherapeutic method for increasing groundnut tolerance in an allergic subject using epicutaneous administration. The present invention is also relative to the use of a skin patch device for progressive desensitization of a subject to groundnut.

Priority: FR20070059503 Applic. Date: 2007-12-03; WO2008EP66737 Applic. Date: 2008-12-03; US20080084305P Applic. Date: 2008-07-29

Inventor: MONDOULET LUCIE [FR]; DUPONT CHRISTOPHE [FR]; BENHAMOU PIERRE-HENRI [FR]; DUPONT BERTRAND [FR]


Application No.: US20100136103A1  Published: 03/Jun/2010

Title: COSMETIC ANTI-AGEING SKIN CARE COMPOSITIONS

Applicant/Assignee: TUPPERWARE PRODUCTS S.A

Application No.: 12/599419   Filing Date: 08/May/2008

Abstract:The invention is directed to an anti ageing skin care composition, more in particular a cosmetic anti aging skin care composition. The anti ageing skin care composition of the invention comprise, in a physiologically acceptable medium, (i) at least one peptide from Laminin-1 that is able to promote synthesis of Laminin-5

(ii) at least one peptide capable of at least partially inhibiting neuronal exocytosis

and (iii) at least one tripeptide producing a rapid and strong stimulation of collagen synthesis. The compositions of the present invention are effective in reducing existing wrinkles and/or preventing the formation of new wrinkles.

Priority: EP20070107712 Applic. Date: 2007-05-08; WO2008NL50278 Applic. Date: 2008-05-08

Inventor: OTTE STEPHANUS CORNELIS MARIA [NL]; ESTRADA HEMANDEZ CLAUDIA AMALIA [MX]; WON ANNIS [AU]


Application No.: US20100136117A1  Published: 03/Jun/2010

Title: HYDROXYAPATITE TISSUE FILLER AND ITS PREPARATION AND USE

Applicant/Assignee:

Application No.: 12/444514   Filing Date: 04/Oct/2007

Abstract:The invention pertains to a biocompatible composition, suitable for use in soft or hard tissue augmentation, wherein the composition is an aqueous suspension containing a carrier fraction of ceramic particles of less than 15 [mu]m and an augmentation fraction of ceramic particles of at least 20 [mu]m. The ceramics typically comprise calcium phosphate. The composition is a may be used in soft tissue repair as well as hard bone replacement. It advantageously avoids the need for foreign body materials which are conventionally applied to stabilize augmentation suspensions.

Priority: EP20060121834 Applic. Date: 2006-10-05; US20060849485P Applic. Date: 2006-10-05; WO2007NL50479 Applic. Date: 2007-10-04

Inventor: DE GROOT KLAAS [NL]


Application No.: US20100136170A1  Published: 03/Jun/2010

Title: Procedure for Extruder Cooking of Animal Feed Without Using a Dryer

Applicant/Assignee:

Application No.: 12/085812   Filing Date: 24/Oct/2006

Abstract:Procedure for production of dry feeds for animals without using a drier by adding 25% of a digestible starchy or another extrudable powdery "glue" to a continuous extruder cooker, where it is cooked at high pressure and temperature until sufficient gelatinization and thermo-plastic condition is achieved. The glue product is then carried through a vacuum zone, in which the sudden pressure drop causes evaporation and temperature drop, so that the moisture content in the glue product drops. After the vacuum zone 75% of an unheated primary feed mixture is added to the glue product, and the two products are mixed. After the mixing zone the finished product is carried through a die and cut to pellets by a rotating knife.

Priority: DK20050001684 Applic. Date: 2005-11-30; WO2006DK05992 Applic. Date: 2006-10-24

Inventor: EDBERG DAN OUDAL [DK]


Application No.: US20100136294A1  Published: 03/Jun/2010

Title: FIBROUS STRUCTURES COMPRISING A LOTION AND METHODS FOR MAKING SAME

Applicant/Assignee:

Application No.: 12/624452   Filing Date: 24/Nov/2009

Abstract:Lotion-containing fibrous structures and more particularly lotion-containing multi-ply fibrous structures and methods for making such fibrous structures are provided.

Priority: US20080119492P Applic. Date: 2008-12-03

Inventor: MANIFOLD JOHN ALLEN [US]; SANDS KATHLEEN DIANE [US]; RASCH DAVID MARK [US]; NUGENT JEREMY HOWARD [US]; DONNER CHRISTOPHER GERALD [US]


Application No.: US20100137186A1  Published: 03/Jun/2010

Title: USE OF AN ACTIVE PRINCIPLE ORIGINATING FROM AMARANTH (AMARANTHUS) FOR PREPARING A COMPOSITION INTENDED TO ACTIVATE CELLULAR ENERGY AND TO PROTECT THE SKIN FROM OXIDATIVE DAMAGE

Applicant/Assignee: SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS S.A. (ISP VINCIENCE)

Application No.: 12/597867   Filing Date: 27/Oct/2009

Abstract:Methods of administering in a cosmetic composition or a pharmaceutical composition, an effective amount of a peptide active principle originating from amaranth of the species Amaranthus hypochondriacus. The active principle is intended to activate cellular energy and to protect the skin from oxidativ damage, and the active principle may be used alone or in association with at least one other active principles. The active principle may also be used in a cosmetic treatment for protecting the skin and the appendages from external aggressions and to combat cutaneous aging.

Priority: FR20070003062 Applic. Date: 2007-04-27; WO2008FR00576 Applic. Date: 2008-04-23

Inventor: DAL FARRA CLAUDE [FR]; DOMLOGE NOUHA [FR]; BOTTO JEAN-MARIE [FR]


Application No.: US20100137190A1  Published: 03/Jun/2010

Title: LIQUID COMPOSITION FOR EXTERNAL APPLICATION AND PREPARATION FOR EXTERNAL APPLICATION FOR TREATMENT OF SKIN ULCER

Applicant/Assignee: CELLGENTECH, INC

Application No.: 12/293622   Filing Date: 22/Mar/2007

Abstract:An object of the present invention is to provide a liquid composition for external application and a preparation for external application which are excellent in healing effect on skin ulcers including intractable skin ulcers such as bedsore (decubitus), diabetic skin ulcer and ischemic skin ulcer. The liquid composition for external application of the present invention as means for the resolution is characterized by comprising at least G-CSF (a granulocyte colony stimulating factor) as an active ingredient and 0.001% to 5% of alginic acid. The preparation for external application for treatment of a skin ulcer of the present invention is characterized by comprising the liquid composition for external application of the present invention as a medicinal ingredient.

Priority: JP20060079614 Applic. Date: 2006-03-22; WO2007JP55883 Applic. Date: 2007-03-22

Inventor: JIMI SHIRO [JP]; SUZUMIYA JUNJI [JP]


Application No.: US20100137198A1  Published: 03/Jun/2010

Title: PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION

Applicant/Assignee: FOAMIX LTD

Application No.: 12/705219   Filing Date: 12/Feb/2010

Abstract:A pharmaceutical or cosmetic carrier or composition for topical application characterized by rheological properties which render the carrier or composition semi-solid at rest and a liquid upon application of shear forces thereto. The composition or carrier are prepared by mixing 1-25 percent of a solidifying agent and 75-99 percent of a hydrophobic solvent, by weight, wherein at least one of them has therapeutic or cosmetic benefits, in the presence or absence of a biologically active substance.

Priority: US2005-294318 Applic. Date: 2005-12-05; US2003-392071 Applic. Date: 2003-03-19; US2000-653267 Applic. Date: 2000-08-31; US20000216162P Applic. Date: 2000-07-03

Inventor: EINI MEIR [IL]; TAMARKIN DOV [IL]


Application No.: US20100137349A1  Published: 03/Jun/2010

Title: ANTIMICROBIAL OXAZOLIDINONE, HYDANTOIN AND IMIDAZOLIDINONE COMPOSITIONS

Applicant/Assignee: NOVABAY PHARMACEUTICALS, INC

Application No.: 12/612572   Filing Date: 04/Nov/2009

Abstract:The present application relates to N-chlorinated oxazolidinone, hydantoin and imidazolidinone compounds of Formula I or pharmaceutically acceptable salts thereof, and associated compositions and methods of use as antimicrobial agents.

Priority: US20080112681P Applic. Date: 2008-11-07

Inventor: JAIN RAKESH K [US]; LOW EDDY [US]; FRANCAVILLA CHARLES [US]; SHIAU TIMOTHY P [US]; KIM BUM [US]; NAIR SATHEESH K [US]


Application No.: US20100137430A1  Published: 03/Jun/2010

Title: TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS

Applicant/Assignee:

Application No.: 12/632619   Filing Date: 07/Dec/2009

Abstract:This invention provides methods for treatment and inhibition of a male subject having an Androgen Decline in Aging Male (ADAM)-associated condition, for example sexual dysfunction, decreased sexual libido, erectile dysfunction, hypogonadism, sarcopenia, osteopenia, osteoporosis, an alteration in cognition and mood, depression, anemia, hair loss, obesity, muscle loss, dry eye, memory loss, benign prostate hyperplasia and/or prostate cancer, by administering to the subject a selective androgen receptor modulator (SARM) compound and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, pro-drug, polymorph, crystal, or any combination thereof.

Priority: US2004-849039 Applic. Date: 2004-05-20; US2002-270233 Applic. Date: 2002-10-15; US2001-935044 Applic. Date: 2001-08-23; US2001-935045 Applic. Date: 2001-08-23; US20010300083P Applic. Date: 2001-06-25

Inventor: DALTON JAMES T [US]; MILLER DUANE D [US]; YIN DONGHUA [US]; HE YALI [US]


Application No.: US20100137443A1  Published: 03/Jun/2010

Title: Ibuprofen for Topical Administration

Applicant/Assignee: BIOCHEMICS, INC

Application No.: 12/557470   Filing Date: 10/Sep/2009

Abstract:Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl)propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue. Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e.g., a pyrrolidone solvent or dimethylacetamide.

Priority: US20080095672P Applic. Date: 2008-09-10

Inventor: CARTER STEPHEN G [US]; ZHU ZHEN [US]; PATEL KANU [US]; KOZWICH DIANE L [US]


Application No.: US20100137560A1  Published: 03/Jun/2010

Title: Oligopeptides and their use in cosmetics

Applicant/Assignee:

Application No.: 11/665810   Filing Date: 10/Oct/2005

Abstract:The present invention relates to the cosmetic use of oligopeptides, cosmetic preparations which comprise such oligopeptides as well as certain oligopeptide derivatives themselves.

Priority: EP20040292475 Applic. Date: 2004-10-18; WO2005EP10893 Applic. Date: 2005-10-10

Inventor: MOUSSOU PHILIPPE [FR]; DANOUX LOUIS [FR]; PAULY GILLES [FR]; CONTET-AUDONNEAU JEAN-LUC [FR]


Application No.: US20100137775A1  Published: 03/Jun/2010

Title: DEVICE FOR DELIVERY OF REDUCED PRESSURE TO BODY SURFACES

Applicant/Assignee: SPIRACUR INC

Application No.: 12/626426   Filing Date: 25/Nov/2009

Abstract:Disclosed herein is a device which is intended to deliver and maintain reduced pressure to body surfaces for application of reduced pressure wound therapy (RPWT) also known as negative pressure wound therapy (NPWT). During application of this type of therapy, a substantially airtight seal is formed around a section of tissue to be treated. This seal is formed by a dressing which provides fluid communication from a section of tissue to a reduced pressure source. Disclosed herein is a dressing system which is configured to enhance usability and functionality of this dressing. First, the system may be configured to allow full rotation of the fluid communication conduit to the reduced pressure source along the axis substantially normal to the dressing. Second, the system may be configured to include a one-way valve to prevent backflow of any drainage fluids. Third, the system may be configured with transparent windows covered by opaque flaps to allow inspection through the dressing. Fourth, the system may be configured to include an indicator which visually makes clear whether reduced pressure is being applied or not. Fifth, the system is configured to minimize the profile of the dressing system.

Priority: US20080117921P Applic. Date: 2008-11-25; US20080117920P Applic. Date: 2008-11-25

Inventor: HU DEAN [US]; FONG KENTON [US]; PINTO MOSHE [US]; HUI PHILIP [US]; WU KENNETH [US]; MCGREEVY CRAIG [US]; ANDERSON EVAN [US]


Application No.: US20100137829A1  Published: 03/Jun/2010

Title: Injection Gateway

Applicant/Assignee:

Application No.: 12/525191   Filing Date: 01/Feb/2008

Abstract:The current invention relates to an injection gateway (1) comprising a base part (2) which during use is secured to the skin (3) of a patient, a cannula (7) which is connected to the base part and which is inserted into the body of the patient during use, a gate (13) through which fluid is injectable into the gateway via a needle based injection device, and a fluid passageway (12) where fluid injected through the gate is communicated to the cannula. The injection gateway further comprises a closing mechanism (5), said closing mechanism having a first position where a needle inserted into the gateway can be inserted into the cannula and a second position where a needle inserted into the gateway is prevented from coming into contact with the cannula. In this way, the gateway allows the use of typical injection needles without the risk of piercing the cannula or penetrating too deeply into the body of the user.

Priority: DK20070000179 Applic. Date: 2007-02-02; DK20070000185 Applic. Date: 2007-02-02; DK20070000191 Applic. Date: 2007-02-02; US20070899075P Applic. Date: 2007-02-02; US20070899062P Applic. Date: 2007-02-02; US20070899143P Applic. Date: 2007-02-02; WO2008EP51278 Applic. Date: 2008-02-01

Inventor: NIELSEN HENRIK BOEJE [DK]; NIELSEN JENS EGEBJERG [DK]; MATHIASEN ORLA [DK]; THEANDER JULIE GRUNDTVIG [DK]


Application No.: US20100137953A1  Published: 03/Jun/2010

Title: DEVICE FOR COOLING

Applicant/Assignee:

Application No.: 12/452992   Filing Date: 01/Aug/2008

Abstract:The invention relates to a cooling device, especially for cooling bodies or body parts of humans or animals, comprising at least one supporting material that contains superabsorber (SAP) which can absorb and re-dissipate moisture or liquid. The supporting material is wrapped in a covering fabric that has at least one moisture-permeable or air-permeable and steam-permeable zone. The invention is characterized in that at least one measuring instrument and/or sensor for measuring physical measuring values is provided on or in the device.

Priority: DE200710036496 Applic. Date: 2007-08-01; WO2008EP06360 Applic. Date: 2008-08-01

Inventor: STEIN GABRIELE [DE]


Application No.: US20100138980A1  Published: 10/Jun/2010

Title: Combination baseball cap sweat protector and front crown shaper

Applicant/Assignee:

Application No.: 12/592897   Filing Date: 04/Dec/2009

Abstract:The Combination Baseball Cap Sweat Protector and Crown Shaper has a first component for absorbing perspiration from the users skin and the second component holds the first component in place and helps to maintain the original front shape of the crown of the sports cap. The first component is bonded to the front side of the second component flexible Polymer material with moisture absorbing cool wicking fabric the same fabric used in sports clothes to help keep athletes cool, dry and feels good to the skin and is washable. The second component is a flexible Polymer plastic material that is centered within the interior front half of the front of the crown and extends around both sides of the sports cap inner rim and is attached with industrial Velcro so it can be removed when required.

Priority: US20080201017P Applic. Date: 2008-12-05

Inventor: DUDA MICHAEL EDWARD [US]; DUDA SHAWN MCFAUL [US]; DUDA MARCIA MCFAUL [US]


Application No.: US20100142755A1  Published: 10/Jun/2010

Title: Method, System, and Computer Program Product for Providing Cosmetic Application Instructions Using Arc Lines

Applicant/Assignee: PERFECT SHAPE COSMETICS, INC

Application No.: 12/626688   Filing Date: 27/Nov/2009

Abstract:Individuals want to look their best because when they look good, they feel good. It affects not only how they perceive themselves, but also how others perceive them. Unfortunately, many individuals don't look as good as they would like. And even more frustrating, they don't know how to produce their optimal facial look. Imagine a plain or average looking woman being able to transform herself into a very pretty woman. Imagine an already pretty woman being able to transform herself into a gorgeous woman. The Perfect Shape(TM) Makeover Process empowers individuals to achieve this magical transformation. Confidence, self-esteem, perception, and respect are enhanced in very positive ways. This is something individuals want on a universal, world-wide level. The Perfect Shape(TM) Makeover Process instructs the client how to use makeup to reshape each of these facial features to the ultimate of what they have to work with.

Priority: US20080118264P Applic. Date: 2008-11-26

Inventor: BRANDEWIE TED J [US]; SPRY JERRY D [US]; NICKELL BARRY [US]


Application No.: US20100143267A1  Published: 10/Jun/2010

Title: EXTRACTS OF TETRASELMIS SP.

Applicant/Assignee: SYMRISE GMBH & CO. KG

Application No.: 12/629441   Filing Date: 02/Dec/2009

Abstract:The present invention relates to extracts of Tetraselmis sp., preferably Tetraselmis suecica, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Tetraselmis sp., preferably Tetraselmis suecica.

Priority: US20080193537P Applic. Date: 2008-12-05

Inventor: PERTILE PAOLO [IT]; ZANELLA LORENZO [IT]; HERRMANN MARTINA [DE]; JOPPE HOLGER [DE]; GAEBLER SANDRA [DE]


Application No.: US20100143273A1  Published: 10/Jun/2010

Title: COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT

Applicant/Assignee:

Application No.: 12/516015   Filing Date: 20/Nov/2007

Abstract:The present application relates to a cosmetic composition comprising, in a physiologically acceptable medium, at least one aprotic hydrocarbon-based volatile solvent comprising no more than one branch, the volatility of said solvent being such that the amount evaporated in 30 minutes is between 4.1 mg/cm2 and 24 mg/cm2. This composition can be used as a product for caring for and/or making up keratin materials, in particular the skin, the lips and/or the integuments.

Priority: FR20060055058 Applic. Date: 2006-11-23; US20060872485P Applic. Date: 2006-12-04; WO2007EP62583 Applic. Date: 2007-11-20

Inventor: AUGUSTE FREDERIC [FR]; FOURON JEAN-YVES [FR]


Application No.: US20100143277A1  Published: 10/Jun/2010

Title: Skin Lightening Compositions with Acetylcholinesterase Inhibitors

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/332002   Filing Date: 10/Dec/2008

Abstract:Skin lightening additives and skin lightening compositions having an acetylcholinesterase inhibitor are described. The compositions are suitable for topical application and may comprise inhibitors like galanthamine, taspine or both.

Priority:

Inventor: MADISON STEPHEN ALAN [US]


Application No.: US20100143279A1  Published: 10/Jun/2010

Title: COSMETIC/DERMATOLOGICAL COMPOSITIONS COMPRISING A DERIVATIVE OF GLUCOSE AND OF VITAMIN F AND A SPECIFIC SURFACTANT

Applicant/Assignee: L'OREAL

Application No.: 12/704806   Filing Date: 12/Feb/2010

Abstract:Topically applicable cosmetic/dermatological compositions suited for improving the condition of human keratin fibers, notably human hair, especially for reducing or stopping loss and/or inducing and/or stimulating growth and/or density thereof, contain a thus effective amount of (a) at least one derivative of glucose and of vitamin F, solubilized in a topically applicable, physiologically acceptable medium therefor which includes (b) at least one nonionic surfactant having a hydrophilic/lipophilic balance (HLB) of greater than 10, (c) at least one C1-C4 alcohol and (d) water.

Priority: FR20050050363 Applic. Date: 2005-02-08; US2006-349249 Applic. Date: 2006-02-08; US20050672070P Applic. Date: 2005-04-18

Inventor: MEZURE PATRICIA [FR]; DUBIEF CLAUDE [FR]


Application No.: US20100143285A1  Published: 10/Jun/2010

Title: Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE

Application No.: 12/453968   Filing Date: 28/May/2009

Abstract:Topically applicable, dermatological/pharmaceutical compositions contain, formulated into a physiologically acceptable medium, benzoyl peroxide, at least one naphthoic acid compound and at least one compound of the polyurethane polymer type or derivatives thereof, wherein the benzoyl peroxide and the at least one naphthoic acid compound are dispersed therein.

Priority: FR20060055138 Applic. Date: 2006-11-28; WO2007FR52412 Applic. Date: 2007-11-28

Inventor: MALLARD CLAIRE [FR]; AT EMMANUELLE [FR]


Application No.: US20100143289A1  Published: 10/Jun/2010

Title: UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

Applicant/Assignee:

Application No.: 12/448458   Filing Date: 19/Dec/2007

Abstract:Compositions including topical formulations comprising secreted products obtained from the culture medium of human umbilical cord stem cells and particular combinations of components therefrom are provided for treatment of various dermatological conditions, such as adverse consequences of aging, wrinkling, altered pigmentation, altered viscoelasticity, and altered thickness, among others. Methods for using the compositions and topical formulations for treating adverse or undesirable dermatological conditions are also provided, as well as preventing the appearance of undesirable dermatological conditions.

Priority: US20060875558P Applic. Date: 2006-12-19; WO2007US25838 Applic. Date: 2007-12-19

Inventor: COHEN MICHAEL [US]; COHEN JACOB [US]


Application No.: US20100143413A1  Published: 10/Jun/2010

Title: APPARATUS AND METHOD FOR TREATING A NEUROMUSCULAR DEFECT

Applicant/Assignee: THE CLEVELAND CLINIC FOUNDATION

Application No.: 12/541221   Filing Date: 14/Aug/2009

Abstract:A method is provided for treating a neuromuscular defect in a subject. One step of the method includes locating a target nerve. After locating the target nerve, a treatment probe is provided. The treatment probe includes an elongated body member having a proximal end portion and a distal end portion. The distal end portion includes an energy delivery mechanism for stimulating or ablating the target nerve, a monitoring mechanism, and a fluid aspiration/delivery mechanism. Next, the target nerve is verified as an appropriate target for ablation by stimulating and then monitoring the target nerve via the energy delivery mechanism and the monitoring mechanism, respectively. After verifying the target nerve, a tumescent fluid is injected into the tissue surrounding the target nerve. An electric current is then delivered to the energy delivery mechanism to substantially ablate the target nerve.

Priority: US20080089015P Applic. Date: 2008-08-14

Inventor: PAPAY FRANCIS A [US]


Application No.: US20100143421A1  Published: 10/Jun/2010

Title: Delivery Device

Applicant/Assignee:

Application No.: 12/296978   Filing Date: 10/Apr/2007

Abstract:A process for the production of water-containing silicone rubber device comprising the steps of mixing an external phase comprising an organopolysiloxane polymer having at least two reactive groups per molecule, a water in oil emulsifier and where required one or more active ingredients and/or optional additives

with an internal phase comprising water and optionally one or more active ingredients to form an emulsion

and subsequently introducing a cure package comprising a cure package comprising a suitable catalyst, which will be determined by the cure reaction between the polymer and where required a cross-linker, and which contains more than two reactive groups, designed to react with the reactive groups in the polymer in the presence of said catalyst in order to cure the external phase of the composition, thereby entrapping the water within the body of said water-containing silicone rubber device. The resulting product is preferably used fragrance delivery in applications selected from aromatherapy anti stress ball, aromatherapy pillow, deodorising shoe sole solid deodorising device for houses, external prosthesis, facial mask for delivery of actives.

Priority: GB20060007438 Applic. Date: 2006-04-13; WO2007EP53456 Applic. Date: 2007-04-10

Inventor: VAN REETH ISABELLE [BE]; CAPRASSE VIRGINIE [BE]; THOMAS XAVIER [BE]; LECOMTE JEAN-PAUL [BE]; COUREL BENEDICTE [BE]; SCHIROSI ESTERNIA [BE]


Application No.: US20100143424A1  Published: 10/Jun/2010

Title: CASEIN NANOPARTICLE

Applicant/Assignee: FUJIFILM CORPORATION

Application No.: 12/630575   Filing Date: 03/Dec/2009

Abstract:It is an object of the present invention to provide: a positively charged nanoparticle which can be produced without using surfactants or synthetic polymers, the size of which can be controlled, which is stable at acidic condition, and which contains an active substance therein

and a method for producing the same. The present invention provides a casein particle, wherein zeta potential is positive.

Priority: JP20080310530 Applic. Date: 2008-12-05

Inventor: KANAZAWA KATSUHIKO [JP]


Application No.: US20100143426A1  Published: 10/Jun/2010

Title: COSMETIC DISPERSIONS UTILIZING A SILICONE-FREE HYDROCARBON COMPLEX

Applicant/Assignee: PRESPERSE, INC

Application No.: 12/634036   Filing Date: 09/Dec/2009

Abstract:Silicone-free compositions including hydrocarbons of widely different structures and origins combined with coated particles are provided which have both aesthetic and volatility properties similar to cyclopentasiloxane dispersions. The compositions are useful as full or partial replacement products for dispersions of cyclopentasiloxane, or "volatile silicones." The compositions are useful in UV-attenuating formulations including skin care products, color cosmetics, pharmaceutical products and especially sun care products such as sunblocks, sunscreens, tanning lotions, and the like.

Priority: US20080121317P Applic. Date: 2008-12-10

Inventor: LABA DENNIS [US]; SHAH PRITI [US]; YEDNAK-CARPENTER MARIE [US]


Application No.: US20100143445A1  Published: 10/Jun/2010

Title: Dermatological/cosmetic skin depigmenting compositions

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/588972   Filing Date: 04/Nov/2009

Abstract:Depigmenting compositions having improved effectiveness in the dermatological or cosmetic treatment of pigmentation contain, in a physiologically acceptable medium, at least one compound selected from among rucinol and salts thereof, and at least one retinoid

such compositions are also useful in the prevention and/or dermatological treatment of skin hyperpigmentation, and also for the cosmetic treatment of photoinduced or chronological aging of the skin or of the skin appendages.

Priority: FR20070054886 Applic. Date: 2007-05-04; WO2008FR50731 Applic. Date: 2008-04-22

Inventor: PELISSON ISABELLE [FR]; SUZIKI ITARU [FR]


Application No.: US20100143446A1  Published: 10/Jun/2010

Title: Novel skin moisturizing compositions

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/591715   Filing Date: 30/Nov/2009

Abstract:Novel skin moisturizing compositions are applied onto dry skin, particularly mild to moderately dry skin, are non-irritating and contain at least one natural moisturizing factor, butyrospermum parkii, at least one silicone, and Panthenol.

Priority: WO2008EP56722 Applic. Date: 2008-05-30; US20070924827P Applic. Date: 2007-06-01; US20080006290P Applic. Date: 2008-01-04

Inventor: RABOUILLE THIERRY [FR]


Application No.: US20100143449A1  Published: 10/Jun/2010

Title: ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS

Applicant/Assignee:

Application No.: 12/449912   Filing Date: 29/Feb/2008

Abstract:The present invention relates to pharmaceutical formulations comprising at least two compounds, one effecting opioid analgesia and one effecting cyclooxygenase 1 and 2 activity, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered in a physiologically acceptable topical excipient. The pharmaceutical formulations of the present invention are used to prevent or relieve acute pain and chronic peripheral neuropathy and/or neuropathic inflammation in a patient in need of such treatment.

Priority: EP20070090036 Applic. Date: 2007-03-02; WO2008EP52530 Applic. Date: 2008-02-29

Inventor: KOLESNIKOV YURI [EE]


Application No.: US20100143495A1  Published: 10/Jun/2010

Title: Antimicrobial body affecting products

Applicant/Assignee:

Application No.: 12/592693   Filing Date: 01/Dec/2009

Abstract:A method and apparatus for control the growth of microorganisms by enhancing the concentration metal ions therein. The method includes the step of to enhancing the effectiveness of an antimicrobial agent having a source of metal ions by adding a compound containing a hydantoin ring to the antimicrobial agent.

Priority: US20080201321P Applic. Date: 2008-12-08

Inventor: HILL JOHN [US]; KING JOSEPH A [US]


Application No.: US20100143677A1  Published: 10/Jun/2010

Title: WRINKLE-FREE NANOMECHANICAL FILM

Applicant/Assignee: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY

Application No.: 12/515155   Filing Date: 15/Nov/2007

Abstract:Methods to control and prevent polymer films from buckling are provided. Buckled morphologies are created by thermally cycling or mechanically compressing a substrate such as poly(dimethylsiloxane) (PDMS) coated with a polyelectrolyte multilayer film. By varying the dimensions of the surface topography relative to the buckling wavelength (e.g., pattern size is less than, equal to, and greater than the buckling wavelength) the orientation and the local morphology of the buckled films is controlled. Based on the information obtained, we demonstrate how to alleviate the unavoidable buckling by incorporating nanoparticles into the film. In addition, we studied the effect of the silica layer that results from oxygen plasma treatment and the critical temperature for permanent film buckling.

Priority: US20060859296P Applic. Date: 2006-11-15; WO2007US23986 Applic. Date: 2007-11-15

Inventor: LEE ILSOON [US]; HENDRICKS TROY R [US]


Application No.: US20100144643A1  Published: 10/Jun/2010

Title: Polymeric Biosufactants

Applicant/Assignee:

Application No.: 12/227825   Filing Date: 31/May/2007

Abstract:The present invention is directed to biosurfactants that can self-assemble or auto-aggregate into polymeric micellar structures and their use in topically-applied dermatologic products. The invention relates in particular to polymeric acylated biosurfactants (PABs) conforming to the formula Acyl-AA-Term where Acyl is an 8- to 22-membered carbon chain, branched or unbranched, saturated or unsaturated, AA is a consecutive sequence of four to nine amino acid residues, where at least one, preferably at least two of the amino acid residues is charged, and Term is an acid C-terminus or an amide C-terminus. PABs of the present invention have low critical micelle concentrations (predominantly less than about 100 ppm) in an aqueous environment of Minimal Essential Media (MEM) and can lower the surface tension in the aqueous MEM environment to less about 50 dynes/cm2. They also have the ability to increase metabolic soluble proteins.

Priority: US20060809825P Applic. Date: 2006-06-01; WO2007US12799 Applic. Date: 2007-05-31

Inventor: OWEN DONALD [US]; FAN LILI [US]


Application No.: US20100144746A1  Published: 10/Jun/2010

Title: METHOD FOR RESTRUCTURING A BIOLOGICAL TISSUE COMPRISING COLLAGEN FIBRILS AND RELATIVE USES

Applicant/Assignee:

Application No.: 12/632180   Filing Date: 07/Dec/2009

Abstract:A method for restructuring a biological tissue comprising collagen fibrils selected from a venous tissue, a cardiac valvular tissue, a cutaneous or subcutaneous tissue, a tissue of a muscular tendon, a tissue of a muscular fascia or a tissue of a muscular aponeurosis, comprising the following operational steps: a) bringing into contact a biological tissue comprising collagen fibrils with a cross-linking chemical composition able to induce cross-linking of collagen fibrils consequent to activation through electromagnetic radiation

b) activating said cross linking chemical composition through exposure to an electromagnetic radiation

c) cross-linking the collagen fibrils of said biological tissue in order to obtain a restructured biological tissue. The method according to the invention can be applied to recover a venous continence and both a venous and a cardiac valve diameter. The method reduces the visibility of cutaneous wrinkles, reinforces or repairs tendons, muscular fascia and aponeurosis as well as to heals surgical or traumatic cutaneous wounds or cutaneous ulcers.

Priority: IT2009MI01453 Applic. Date: 2009-08-07; US20080193557P Applic. Date: 2008-12-05

Inventor: FRULLINI ALESSANDRO [IT]


Application No.: US20100144753A1  Published: 10/Jun/2010

Title: CRYSTAL MODIFICATIONS OF TRANSMISSION DYES

Applicant/Assignee: CIBA CORPORATION

Application No.: 12/597930   Filing Date: 28/Apr/2008

Abstract:Disclosed is the use of an aqueous dispersion comprising (a) a micronized sparingly soluble organic benzophenone derivative of formula (1), selected from the crystal modifications (B) and (C), wherein the crystal modification (B) is characterized by a peak in the X-ray diffraction pattern at a d-spacing of about 7.70

and wherein the crystal modification (C) is characterized by a peak in the X-ray diffraction pattern at a d-spacing of about 7.06

and (b) a dispersing agent selected from anionic, non-ionic and amphoteric surfactants

for protecting the human skin from browning and skin aging. The new crystal modification (C) represents a thermodynamically stable compound of formula (1) at 25 DEG C. This modification is therefore suitable in dispersions comprising micro-fine particles.

Priority: EP20070107681 Applic. Date: 2007-05-08; WO2008EP55139 Applic. Date: 2008-04-28

Inventor: VOGT MARTIN [DE]; MUELLER STEFAN [DE]; GRUMELARD JULIE [FR]; DESHAYES CYRILLE [FR]; PAUL HOLGER [DE]; HAASE JUERG [CH]; EHLIS THOMAS [DE]


Application No.: US20100144813A1  Published: 10/Jun/2010

Title: NOVEL 4-HETEROARYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND PHARMACEUTICAL/COSMETIC APPLICATIONS THEREOF

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/631309   Filing Date: 04/Dec/2009

Abstract:Novel 4-heteroarylimidazole-2-thione tyrosinase inhibiting compounds corresponding to the following general formula (I): formulated into pharmaceutical or cosmetic compositions are useful for the treatment or prevention of pigmentary disorders, or for preventing and/or treating signs of skin aging, and/or for body or hair hygiene.

Priority: FR20070055473 Applic. Date: 2007-06-05; WO2008FR50995 Applic. Date: 2008-06-04

Inventor: BOITEAU JEAN GUY [FR]; BARBUIS CORINNE MILLOIS [FR]; BOUQUET KARINE [FR]


Application No.: US20100144814A1  Published: 10/Jun/2010

Title: NOVEL 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND PHARMACEUTICAL/COSMETIC APPLICATIONS THEREOF

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/631392   Filing Date: 04/Dec/2009

Abstract:Novel 4-phenylimidazole-2-thione tyrosinase inhibiting compounds corresponding to the following general formula (I): formulated into pharmaceutical or cosmetic compositions are useful for the treatment or prevention of pigmentary disorders, or for preventing and/or treating signs of skin aging, and/or for body or hair hygiene.

Priority: FR20070055470 Applic. Date: 2007-06-05; WO2008FR50994 Applic. Date: 2008-06-04

Inventor: BOITEAU JEAN GUY [FR]; BARBUIS CORINNE MILLOIS [FR]; TALANO SANDRINE [FR]


Application No.: US20100144861A1  Published: 10/Jun/2010

Title: Perfluorocarbon gel formulations

Applicant/Assignee:

Application No.: 12/590996   Filing Date: 17/Nov/2009

Abstract:A perfluorocarbon gel composition is disclosed with numerous uses including topical medical and cosmetic uses.

Priority: US2009-589202 Applic. Date: 2009-10-19; US20080200254P Applic. Date: 2008-11-25; US20090204785P Applic. Date: 2009-01-09; US20090205499P Applic. Date: 2009-01-21

Inventor: HUVARD GARY [US]; KIRAL RICHARD [US]; QUITARO MAXINE [US]; THOMPSON DEBORAH P [US]; GROSSMAN AHARON [US]; CLAUSON GARY [US]; SANDHU GURBHAGAT [US]


Application No.: US20100144871A1  Published: 10/Jun/2010

Title: Treating muscle wasting with selective androgen receptor modulators

Applicant/Assignee:

Application No.: 10/861923   Filing Date: 07/Jun/2004

Abstract:This invention provides: 1) a method of treating a subject suffering from a muscle wasting disorder

2) a method of preventing a muscle wasting disorder in a subject

3) a method of treating, preventing, suppressing, inhibiting or reducing muscle loss in a subject suffering from a muscle wasting disorder

4) a method of treating, preventing, inhibiting, reducing or suppressing muscle wasting in a subject suffering from a muscle wasting disorder

and/or 5) a method of treating, preventing, inhibiting, reducing or suppressing muscle protein catabolism in a subject suffering from a muscle wasting disorder, by administering to the subject a selective androgen receptor modulator (SARM) and/or an analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, impurity or crystal of said SARM compound, or any combination thereof.

Priority: US2002-310150 Applic. Date: 2002-12-05; US20010336185P Applic. Date: 2001-12-06

Inventor: STEINER MITCHELL S [US]; VEVERKA KAREN A [US]; DALTON JAMES T [US]; MILLER DUANE D [US]


Application No.: US20100144883A1  Published: 10/Jun/2010

Title: TOPICALLY APPLICABLE COMPOSITIONS FOR THE TREATMENT OF KERATINIZATION DISORDERS

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE

Application No.: 12/652417   Filing Date: 05/Jan/2010

Abstract:Topical compositions containing from 0.01% to 0.09% by weight of adapalene or salts thereof are useful for the treatment or prevention of keratinization disorders, particularly acne, and additionally contain at least one gelling agent selected from among carbomers, polysaccharides, cellulose and its derivatives, copolymers of acrylate and of alkyl acrylate, copolymers of acrylamide and of sodium acrylamido-2-methylpropanesulfonate, and xanthan gum.

Priority: WO2008EP58775 Applic. Date: 2008-07-07; US20070929652P Applic. Date: 2007-07-06

Inventor: DOUTREMEPUICH JEAN-DANIEL [FR]


Application No.: US20100144884A1  Published: 10/Jun/2010

Title: NOVEL 3-PHENYL ACRYLIC ACID COMPOUND ACTIVATORS OF TYPE PPAR RECEPTORS AND PHARMACEUTICAL/COSMETIC COMPOSITIONS COMPRISED THEREOF

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/632257   Filing Date: 07/Dec/2009

Abstract:Novel 3-phenyl acrylic acid compounds have the following general formula (I): and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, as well as in the field of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or into cosmetic compositions.

Priority: FR20070055478 Applic. Date: 2007-06-05; WO2008FR50997 Applic. Date: 2008-06-04

Inventor: BOITEAU JEAN-GUY [FR]; CLARY LAURENCE [FR]; PASCAL JEAN-CLAUDE [FR]; CHAMBON SANDRINE [FR]


Application No.: US20100144961A1  Published: 10/Jun/2010

Title: ROOM TEMPERATURE CURABLE SILICONE ELASTOMER COMPOSITION

Applicant/Assignee: FORM FORM FORM LTD

Application No.: 12/517057   Filing Date: 29/Nov/2007

Abstract:By preparing a one part silicone RTV composition with a high initial uncured plasticity, specifically a Williams plasticity of from 80 to 900 mm, formulations can be prepared that are easy and convenient for consumers to mould into a variety of shapes, which, once moulded, will hold their shape exactly during cure without slump or flow.

Priority: GB20060023972 Applic. Date: 2006-11-30; WO2007GB04580 Applic. Date: 2007-11-29

Inventor: DELEHANTY JANE MARY [GB]; MOSS IAN [GB]; WESTALL STEPHEN [GB]; DOWDEN THOMAS [GB]


Application No.: US20100145255A1  Published: 10/Jun/2010

Title: System And Method For Reducing The Appearance Of Fine Lines And Wrinkles And Improving the Skin Tone

Applicant/Assignee:

Application No.: 12/620647   Filing Date: 18/Nov/2009

Abstract:The present invention provides a system for rejuvenating the skin, reducing the appearance of fine lines and wrinkles, and improving the skin tone, which includes both a topical composition and a phototherapy device. Specifically, the topical composition contains one or more skin rejuvenating agents selected from the group consisting of creatine, adenosine phosphate, acetyl carnitine, acetyl hexapeptide, and combinations thereof in a pharmaceutically or cosmetically acceptable carrier. The phototherapy device contains one or more light emitting diodes (LEDs) for emitting electromagnetic radiation effective for energizing the skin cells and enhancing skin absorption of the skin rejuvenating agents. More particularly, the topical composition is capable of transmitting at least 80% of the electromagnetic radiation emitted by the phototherapy device to the skin.

Priority: US20080120499P Applic. Date: 2008-12-08

Inventor: POPESCU LAVINIA C [US]; HAWKINS GEOFFREY [US]; LOMBARDI JACK [US]; WOLF BARBARA ANNE [US]


Application No.: US20100145257A1  Published: 10/Jun/2010

Title: METHOD, APPARATUS, AND KIT FOR ONYCHOMYCOSIS TREATMENT

Applicant/Assignee: POWER PAPER, LTD

Application No.: 12/632277   Filing Date: 07/Dec/2009

Abstract:Methods, apparatus, and kits for onychomycosis treatment are presented. In one embodiment, a kit for treatment includes an anti-fungal agent, in a composition, and an electrically powered patch. Exemplary embodiments of the patch include a first electrode, a power source having a first and second terminal, a second electrode coupled to the second terminal of the power source, and a base member supporting the first electrode, the second electrode, and the power source. Embodiments include those where the first and second electrode and power source are printed on the base member. Anti-fungal agents may be unionized while the composition includes an ionizing agent. Home use may be practiced, as embodiments include those in which the voltage or current of the power source cannot be adjusted by a user. Exemplary methods include the selection of a nail or diseased area to which treatment is desired and administering the kit as described.

Priority: US2004-890297 Applic. Date: 2004-07-14; US20030486973P Applic. Date: 2003-07-14

Inventor: NITZAN ZVI [IL]; TAMARKIN DOV [IL]; MAVOR DANIELA [IL]; HAREL NURIT [IL]; EMANUEL NOAM [IL]


Application No.: US20100145886A1  Published: 10/Jun/2010

Title: Evaluation and Selection Process for Consumer Products

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/330231   Filing Date: 08/Dec/2008

Abstract:A product evaluation and selection process for consumer products is described. The process includes demonstrating the effectiveness of consumer product on consumer skin by comparing actual images of skin treated with product to images of skin that were artificially transformed. The process also includes the assignment of a symbol associated with a difference in product performance where the symbol may be used to aid consumers in selecting product.

Priority:

Inventor: VELTHUIZEN ROBERT PAUL [US]; JIANG ZHI-XING [US]; DESSIRIER JEAN-MARC [US]; COVELL EDWIN RALPH [US]


Application No.: US20100147322A1  Published: 17/Jun/2010

Title: Device for packaging and applying a substance

Applicant/Assignee: L'OREAL

Application No.: 12/656640   Filing Date: 05/Feb/2010

Abstract:The present invention provides a device for packaging and applying a substance, the device comprising: a receptacle for containing the substance, the receptacle comprising: a first part and a second part, the second part being turnable by the user relative to the first part

and an applicator

the second part defining at least one surface in contact with the substance inside the receptacle, the applicator and said surface being arranged in such a manner that turning said surface exerts pressure on the substance, causing the substance to move towards the applicator, the first part defining a backing surface, and said surface being capable of coming at least in part to face said backing surface at the end of turning the second part.

Priority: FR20040050727 Applic. Date: 2004-04-09; US2005-100374 Applic. Date: 2005-04-07; US20040566413P Applic. Date: 2004-04-30

Inventor: GUERET JEAN-LOUIS [FR]


Application No.: US20100147736A1  Published: 17/Jun/2010

Title: Container with Flattened Cap

Applicant/Assignee:

Application No.: 12/435918   Filing Date: 05/May/2009

Abstract:A biodegradable tube comprises a mom-rigid paper tubular body defining a lumen for containing a semi-solid composition

a paper tubular cap that slidably mates with the body

and wherein interior surfaces of the each of the body and the cap have a coating that is substantially impermeable to the semi-solid composition. In preferred embodiments the tube body and cap have tapered sealed ends, the coating comprises an adhesive, and the walls of the tube/cap comprise a rolled paper material upon which the coating has been applied. Contemplated semi-solid product materials include for example lip balm, facial cream, lotion, deodorant, sunscreen, caulk, grease sticks, mosquito repellant, and shoe polish.

Priority: US20080193689P Applic. Date: 2008-12-16

Inventor: WEST ELLERY [US]; WEST GAIL [US]


Application No.: US20100150850A1  Published: 17/Jun/2010

Title: DISPERSION, GEL AND EMULSIFICATION SYSTEM

Applicant/Assignee:

Application No.: 12/450097   Filing Date: 11/Mar/2008

Abstract:A dispersion which contains particles of a carboxylic acid polymer dispersed in an organic medium containing an emollient ester and/or a non-ionic surfactant. The dispersion can be used to form a gel composition by mixing with a water miscible emollient ester and optionally water. The dispersion and gel can be used to form an emulsification system. The dispersion, gel and emulsification system are suitable for use in forming end-use emulsions, preferably at low temperature and low shear, and in particular, emulsions having a high oil phase concentration. The emulsions can be used in a wide range of applications, including personal care, household and industrial.

Priority: GB20070004709 Applic. Date: 2007-03-12; WO2008AU00320 Applic. Date: 2008-03-11

Inventor: TAMOR MILDRED ESTRADA [SG]; DOWDELL DAVID PETER [AU]


Application No.: US20100150851A1  Published: 17/Jun/2010

Title: ANIONIC-CATIONIC COMPLEXES AS CONDITIONING AGENTS

Applicant/Assignee: ALZO INTERNATIONAL, INC

Application No.: 12/450865   Filing Date: 11/Apr/2008

Abstract:Novel compositions comprising anionic-cationic complexes as conditioning agents for use in products that improve the appearance and feel of skin and hair are well known. This invention describes the use of additional cationic surfactant in combination with an anionic-cationic complex made from a fatty alkyl dialkylamine and a "dicarboxylic acid", preferably a dimer acid. This combination provides exceptional conditioning for hair, improving both wet and dry combing. It also makes very stable oil-in-water emulsions, and adds a slippery feel and lubricity to shaving and skin cleaning products.

Priority: US20070925967P Applic. Date: 2007-04-24; WO2008US04669 Applic. Date: 2008-04-11

Inventor: ZOFCHAK ALBERT A [US]; CARSON JOHN [US]; SLAVASHEVICH PAUL [US]


Application No.: US20100150854A1  Published: 17/Jun/2010

Title: POLYETHYLENE GLYCOL ESTERS AND COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS

Applicant/Assignee: SYMRISE GMBH & CO., KG

Application No.: 12/596690   Filing Date: 09/Apr/2008

Abstract:The invention relates to polyethylene glycol esters and blends of the polyethylene glycol esters with polyethylene glycol ethers, together with in particular cosmetic and/or dermatological preparations containing them, methods for the production thereof and use thereof.

Priority: US20070907916P Applic. Date: 2007-04-23; WO2008EP54266 Applic. Date: 2008-04-09

Inventor: SCHMAUS GERHARD [DE]; LANGE SABINE [DE]; OHRMANN ROLF [DE]; ISSLEIB MARTINA [DE]


Application No.: US20100150869A1  Published: 17/Jun/2010

Title: USE OF TELLURIUM COMPOUNDS FOR TREATMENT OF BASAL CELL CARCINOMA AND/OR ACTINIC KERATOSIS

Applicant/Assignee: BIOMAS LTD

Application No.: 12/517222   Filing Date: 02/Jun/2009

Abstract:Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided.

Priority: US20050716923P Applic. Date: 2005-09-15; WO2006IL01080 Applic. Date: 2006-09-14

Inventor: SREDNI BENJAMIN [IL]; ALBECK MICHAEL [IL]


Application No.: US20100150972A1  Published: 17/Jun/2010

Title: Paper Tube Packaging with Open End And Coated Cap

Applicant/Assignee:

Application No.: 12/435852   Filing Date: 05/May/2009

Abstract:A biodegradable tube comprises a mom-rigid paper tubular body defining a lumen for containing a semi-solid composition

a paper tubular cap that slidably mates with the body

and wherein interior surfaces of the each of the body and the cap have a coating that is substantially impermeable to the semi-solid composition. In preferred embodiments the tube body and cap have tapered sealed ends, the coating comprises an adhesive, and the walls of the tube/cap comprise a rolled paper material upon which the coating has been applied. Contemplated semi-solid product materials include for example lip balm, facial cream, lotion, deodorant, sunscreen, caulk, grease sticks, mosquito repellant, and shoe polish.

Priority: US20080193689P Applic. Date: 2008-12-16

Inventor: WEST ELLERY [US]; WEST GAIL [US]


Application No.: US20100150975A1  Published: 17/Jun/2010

Title: Structured Composition Comprising an Encapsulated Active

Applicant/Assignee:

Application No.: 12/581941   Filing Date: 20/Oct/2009

Abstract:A structured liquid composition having a liquid matrix having water and a fibrous network structurant, the fibrous network structurant having a non-polymeric crystalline hydroxyl-functional materials

a bacterial cellulose network

and mixtures thereof

and an encapsulated active. The encapsulated active is suspended within the liquid matrix of the structured liquid composition such that the encapsulated actives do not undesirably sink, float, or collect in any discrete portion of the composition. Further, the structured liquid composition can be in the form of a raw material such as an encapsulated active slurry, in the form of an additive such as a laundry additive, and as a consumer end product. In one embodiment, the encapsulated active is a perfume microcapsule.

Priority: US20080106723P Applic. Date: 2008-10-20

Inventor: DIHORA JITEN ODHAVJI [US]; JAFFER SHAFFIQ AMIN [US]; RADOMYSELSKI ANNA VADIMOVNA [US]; VINSON PHILLIP KYLE [US]


Application No.: US20100150994A1  Published: 17/Jun/2010

Title: AMPHIPHILIC ENTITY NANOPARTICLES

Applicant/Assignee: ANTERIOS, INC

Application No.: 12/517154   Filing Date: 30/Nov/2007

Abstract:The present invention provides nanoparticle compositions comprising AE nanoparticles. The present invention provides AE nanoparticles comprising one or more amphiphilic entities and pharmaceutical compositions comprising AE nanoparticles. The present invention provides methods of manufacturing AE nanoparticles. The present invention provides methods of delivering a biologically active agent to a subject by administering AE nanoparticles containing a biologically active agent to a subject.

Priority: US20060872198P Applic. Date: 2006-12-01; WO2007US86018 Applic. Date: 2007-11-30

Inventor: KOTYLA TIMOTHY [US]


Application No.: US20100151008A1  Published: 17/Jun/2010

Title: Preparations and Methods for Textile and or Fiber Surface Finishing, Surface Finished Articles Prepared Thereby, and Uses Therefor

Applicant/Assignee: COGNIS IP MANAGEMENT GMBH

Application No.: 12/636247   Filing Date: 11/Dec/2009

Abstract:The invention relates to the use of liposomes, particularly liposomes based on soybean oil lecithins, for finishing textiles and fibers, a key aspect of the invention being that, besides a fiber-care effect, skin-friendly substances are transferred by liposome-finished fibers or textiles to the skin from those fibers or textiles.

Priority: DE20031039358 Applic. Date: 2003-08-27; US2004-925541 Applic. Date: 2004-08-25

Inventor: WACHTER ROLF [DE]; WEUTHEN MANFRED [DE]; STURM CLAUDIA [DE]; TWARDAWSKI ERIK [DE]


Application No.: US20100151032A1  Published: 17/Jun/2010

Title: Silver and Zinc Containing Body Care Agent

Applicant/Assignee: BIO-GATE AG

Application No.: 12/714251   Filing Date: 26/Feb/2010

Abstract:The invention relates to a body care agent containing metal particles which release zinc and silver ions in said body care agent by contacting body liquid or body humidity and whose metallic silver content at least equal or greater than 99 % (m/m).

Priority: DE20031040276 Applic. Date: 2003-08-29; US2006-569709 Applic. Date: 2006-10-02; WO2004EP09534 Applic. Date: 2004-08-26

Inventor: BECHERT THORSTEN [DE]; WAGENER MICHAEL [DE]; STEINRUECKE PETER [DE]


Application No.: US20100151218A1  Published: 17/Jun/2010

Title: INNERLINER WITH NYLON SKIN LAYER

Applicant/Assignee:

Application No.: 12/334188   Filing Date: 12/Dec/2008

Abstract:A multilayer film is provided that comprises a nylon skin layer, a buried high density polyethylene layer, and a sealant layer, for use, for example, to form a package for dry food products. The multilayer film has a thickness of less than about 2.0 mils, such as between 0.8-1.7 mils, a moisture vapor transmission rate of less than about 0.30 g/100 in2/day, and a tear strength in the machine direction of greater than 40 grams, for instance at least about 120 grams. The multilayer film may further include a buried nylon layer and exhibit a tear strength in the machine direction of greater 190 grams.

Priority:

Inventor: CURIE KEVIN J [US]; BLEMBERG ROBERT J [US]


Application No.: US20100151227A1  Published: 17/Jun/2010

Title: INTERIOR PANEL COMPONENT FOR USE WITH A VEHICLE AND METHOD FOR MAKING

Applicant/Assignee: INTERNATIONAL AUTOMATIVE COMPONENTS GROUP NORTH AMERICA, INC

Application No.: 12/336916   Filing Date: 17/Dec/2008

Abstract:The invention relates to an interior panel component and the method for making the component. The interior panel component for use with a vehicle includes a skin layer, and a resilient layer secured to the skin. The resilient layer is made from a polymeric MDI, a pure MDI, and a polyol. The polyol is less than 50 pphr of a soy-based polyol. The resilient layer is secured to a substrate to form the interior panel component.

Priority:

Inventor: DONATTI JOSEPH T [US]; WILLIAMS NELSON [US]


Application No.: US20100151229A1  Published: 17/Jun/2010

Title: Thin-layer lignocellulose composites and methods of making the same

Applicant/Assignee: JELD-WEN, INC

Application No.: 12/316321   Filing Date: 11/Dec/2008

Abstract:In one aspect, the present invention is a thin-layer lignocellulose composite having increased resistance to moisture. The thin-layer lignocellulosic composite includes a mixture of no more than about 95% by weight of a lignocellulosic fiber and at least about 5% by weight of an organic isocyanate resin. The mixture further includes short fibers and a release agent that does not interfere with subsequent processing of the thin-layer lignocellulosic composite. The mixture is pressed between two dies at an elevated temperature and pressure and for a sufficient time to form a thin-layer composite of predetermined thickness, and to allow the isocyanate resin to interact with the lignocellulosic fiber and short fibers such that the resultant thin-layer composite has a predetermined resistance to moisture.

Priority:

Inventor: CLARK RANDY JON [US]; KIEST KENNETH DALE [US]


Application No.: US20100152144A1  Published: 17/Jun/2010

Title: Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease

Applicant/Assignee:

Application No.: 12/660088   Filing Date: 19/Feb/2010

Abstract:A method for preventing or treating vascular hyperreactivity in which a chemical compound that is an estrogen beta receptor agonist is administered to a subject suffering from or at risk of vascular hyperreactivity. Preferably, the administration is topically to the skin.

Priority: US2003-690169 Applic. Date: 2003-10-21; US20020428811P Applic. Date: 2002-11-22

Inventor: HERMSMEYER R KENT [US]


Application No.: US20100152257A1  Published: 17/Jun/2010

Title: ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS

Applicant/Assignee: AMIRA PHARMACEUTICALS, INC

Application No.: 12/638702   Filing Date: 15/Dec/2009

Abstract:Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.

Priority: US20080122568P Applic. Date: 2008-12-15

Inventor: HUTCHINSON JOHN HOWARD [US]; SEIDERS THOMAS JON [US]; WANG BOWEI [US]; ARRUDA JEANNIE M [US]; ROPPE JEFFREY ROGER [US]; PARR TIMOTHY [US]


Application No.: US20100152683A1  Published: 17/Jun/2010

Title: Topical Dermal Delivery Device For Nitric Oxide Delivery

Applicant/Assignee:

Application No.: 12/593606   Filing Date: 27/Mar/2008

Abstract:A topical dermal delivery device, such as a patch, for topical delivery of nitric oxide (NO) to treatment sites of mammals is disclosed. The topical nitric oxide delivery device is provided for arrangement at a treatment site, and comprises a nitric oxide releasing fluid in use of said device, wherein said nitric oxide releasing fluid is at least partly liquid

a reservoir arranged to retain said nitric oxide releasing fluid

and a nitric oxide permeable layer adapted to adhere to said treatment site and adapted to provide an interfacial area for efficient transport of nitric oxide from said nitric oxide releasing fluid to said treatment site

wherein at least said nitric oxide permeable layer is geometrically flexible such that a loss of said interfacial area between said nitric oxide permeable layer and said treatment area is substantially avoided in use of said device, whereby said device is adapted to provide a desired, controllable and consistent delivery of said nitric oxide even under physical deformation of said device from said reservoir to said treatment site while avoiding transport of undesired species from said reservoir to said treatment site.

Priority: WO2007EP52923 Applic. Date: 2007-03-27; WO2008EP53692 Applic. Date: 2008-03-27

Inventor: LINDGREN LARS [SE]; MAARLIND LINDA [SE]; THORSEN RIKARD [SE]


Application No.: US20100152691A1  Published: 17/Jun/2010

Title: LIQUID SURFACTANT COMPOSITIONS THAT ADHERE TO SURFACES AND SOLIDIFY AND SWELL IN THE PRESENCE OF WATER AND ARTICLES USING THE SAME

Applicant/Assignee:

Application No.: 12/336262   Filing Date: 16/Dec/2008

Abstract:A liquid surfactant composition includes at least one anionic surfactant and at least one cationic surfactant. The combination of surfactants is formulated to provide a liquid composition that swells in the presence of water or body fluids, becomes a moldable solid in the presence of an excess of water, and adheres to surfaces. In addition, the liquid surfactant composition may be incorporated into or onto a substrate, such as an absorbent substrate, a fabric or cloth substrate, a tissue substrate, or a protective garment substrate.

Priority:

Inventor: SEIDLING JEFFERY RICHARD [US]; WENZEL SCOTT W [US]; KOENIG DAVID WILLIAM [US]


Application No.: US20100155431A1  Published: 24/Jun/2010

Title: DISPENSING DEVICE FOR VISCOUS MATERIALS

Applicant/Assignee:

Application No.: 12/641808   Filing Date: 18/Dec/2009

Abstract:A dispenser for viscous materials has a housing with a moveable wall that divides the interior volume of the housing into a distal product chamber and a proximal pressure chamber. An outlet from the product chamber is located adjacent to the distal end of the housing and an air inlet is provided to allow air to enter the pressure chamber. Displacement of the product occurs when accumulated excess air pressure in the pressure chamber acts on the back of the movable wall. The excess air pressure is built up by a bellows assembly arranged in fluid communication with the pressure chamber. On actuation, the bellows can be reduced in volume and subsequently recover by entry of air through the inlet. The direction of force application is preferably perpendicular to the housing axis and the location of the bellows is preferably distant from the product outlet.

Priority: EP20080172863 Applic. Date: 2008-12-23

Inventor: BARTOLUCCI STEFANO [GB]; HOEFTE PAULUS [BE]; LAMB JOHN DAVID [GB]; SCOTT PAUL ROBERT [BE]; VANDECAPPELLE PEDRO VINCENT [BE]


Application No.: US20100158818A1  Published: 24/Jun/2010

Title: ANTIMICROBIAL N-CHLORINATED COMPOSITIONS

Applicant/Assignee: NOVABAY PHARMACEUTICALS, INC

Application No.: 12/614347   Filing Date: 06/Nov/2009

Abstract:The present application relates to N-chlorinated cationic compounds of Formula I or a salt thereof, and associated compositions and methods of use as antimicrobial agents.

Priority: US20080112674P Applic. Date: 2008-11-07

Inventor: JAIN RAKESH K [US]; LOW EDDY [US]; FRANCAVILLA CHARLES [US]; SHIAU TIMOTHY P [US]; NAIR SATHEESH K [US]


Application No.: US20100158822A1  Published: 24/Jun/2010

Title: PEPTIDES THAT BIND TO SILICA-COATED PARTICLES

Applicant/Assignee: E .I. DU PONT DE NEMOURS AND COMPANY

Application No.: 12/632829   Filing Date: 08/Dec/2009

Abstract:Peptides having strong affinity for silica as well as surfaces comprising silica are described. The silica-binding peptides may be used to construct peptide based-reagents suitable for delivery of a silica-coated particulate benefit agent to a surface, such as body surface, for personal care and cosmetic applications. Peptide-based reagents formed by coupling at least one of the silica-binding peptides to at least one body surface-binding peptide, either directly or through a spacer, are described. The peptide-based reagents may be used in conjunction with at least one silica-coated colorant to color body surfaces.

Priority: US20080138631P Applic. Date: 2008-12-18

Inventor: FAHNESTOCK STEPHEN R [US]; FOSSER KARI A [US]; PARTHASARATHY ANJU [US]; WANG HONG [US]


Application No.: US20100158823A1  Published: 24/Jun/2010

Title: PEPTIDE LINKERS FOR EFFECTIVE MULTIVALENT PEPTIDE BINDING

Applicant/Assignee: E. I. DU PONT DE NEMOURS AND COMPANY

Application No.: 12/632831   Filing Date: 08/Dec/2009

Abstract:Short single chain peptides having affinity for a target surface often lack the binding durability required for certain commercial applications. One way to improve durability is to promote multivalent binding by linking together binding sequences using peptide linkers. However, the resulting single chain binding peptides often suffer from linker entropy. It has been discovered that the use of rigid peptide linkers when linking together multiple binding sequences enhances the binding affinity of the resulting single chain peptide.

Priority: US20080138633P Applic. Date: 2008-12-18

Inventor: CHENG QIONG [US]; FAHNESTOCK STEPHEN R [US]; HE HONGXIAN [US]; KOSTICHKA KRISTY N [US]; WANG HONG [US]


Application No.: US20100158825A1  Published: 24/Jun/2010

Title: COSMETIC AND PERSONAL CARE PRODUCTS CONTAINING SYNTHETIC MAGNESIUM ALUMINO-SILICATE CLAYS

Applicant/Assignee: CHEVRON U.S.A., INC

Application No.: 12/337892   Filing Date: 18/Dec/2008

Abstract:The invention provides for cosmetic and personal care compositions comprising a synthetic magnesium aluminosilicate clay. The synthetic magnesium aluminosilicate clay is formed at ambient pressure by a series of reaction steps and a pH change from acidic pH to basic pH. The characteristics of the magnesium aluminosilicate clay, including platelet size, degree of stacking, and porosity can be tuned depending on the cosmetic or personal care product desired. In addition, these cosmetic and personal care compositions optionally include one or more of the following components: odor controlling agents, skin protectants, diluents, lipophilic skin health benefit agents, sunscreens, humectants, emollients, slip compounds, and moisturizers.

Priority:

Inventor: MAESEN THEODORUS [US]; KUPERMAN ALEXANDER E [US]; UCKUNG IBRAHIM J [US]


Application No.: US20100158828A1  Published: 24/Jun/2010

Title: Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/342197   Filing Date: 23/Dec/2008

Abstract:Cosmetic compositions comprising cis-6-nonenol and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. Cis-6-nonenol is believed to have modulatory activity against at least one biochemical pathway implicated in skin aging.

Priority:

Inventor: PTCHELINTSEV DMITRI S [US]; HWANG CHENG SHINE [US]


Application No.: US20100158829A1  Published: 24/Jun/2010

Title: Method and Composition for Color Modulation

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/343817   Filing Date: 24/Dec/2008

Abstract:The invention is directed to a method and composition suitable for skin color modulation. Particularly, the action of D-dopachrome tautomerase on melanogenesis and/or the transfer of melanin from melanosomes in keratinocytes is reduced, thereby resulting in a change in skin color.

Priority:

Inventor: BAJOR JOHN STEVEN [US]; BOSKO CAROL ANNETTE [US]; CARDENAS JORGE LOUIE [US]; DRENNAN DIANA JEAN [US]; MARRERO DIANA [US]; ROCHA SHEILA ALVES [US]; MCGARVEY LEONARD SHORE [US]; MCGARVEY MARGARET [US]


Application No.: US20100158830A1  Published: 24/Jun/2010

Title: Multiphase Personal Care Composition With Enhanced Deposition

Applicant/Assignee:

Application No.: 12/510880   Filing Date: 28/Jul/2009

Abstract:A multiphase personal care composition that comprises a structured surfactant phase and an oil continuous benefit phase. The structured surfactant phase comprises from about 5% to about 30% of a mixture of lathering surfactants, a lamellar inducing agent and a cationic polymer. The oil continuous benefit phase comprises a hydrocarbon based benefit material and a low HLB emulsifier. The low HLB emulsifier comprises an unsaturated monoglyceryl ester having from about 14 to about 30 carbon atoms. The oil continuous benefit phase comprises a ratio of said hydrocarbon based benefit materials to said low HLB emulsifier comprising from about 30:1 to about 200:1.

Priority: US20080084146P Applic. Date: 2008-07-28

Inventor: WEI KARL SHIQING [US]; STELLA QING [US]


Application No.: US20100158834A1  Published: 24/Jun/2010

Title: COMPOSITION COMPRISING AT LEAST TWO DIFFERENT CYCLOALKYLMETHICONES AND USE THEREOF

Applicant/Assignee: MOMENTIVE PERFORMANCE MATERIALS INC

Application No.: 12/640235   Filing Date: 17/Dec/2009

Abstract:A cosmetic composition includes comprising a blend of cycloalkylmethicones comprising at least two different cycloalkylmethicones having general formula I: where R1 is a hydrocarbon radical containing about 2 to about 4 carbon atoms

R2, R3, R4, R5, and R6 are independently selected from the group consisting of a hydrocarbon radical containing about 1 to about 4 carbon atoms

a is a positive number between 0

b and c are independently selected from 0 to 5 wherein (a+b+c)!<=5

and wherein the rates of evaporation of the composition as measured in accordance with standard DIN 53249 test is from about 80% to about 99% by weight loss in about 200 to about 6000 minutes, more preferably in about 200 to about 1000 minutes, and even more preferably in about 200 to about 500 minutes.

Priority: US20080203082P Applic. Date: 2008-12-18

Inventor: FALK BENJAMIN [US]


Application No.: US20100158837A1  Published: 24/Jun/2010

Title: IRON OXIDE-BINDING PEPTIDES

Applicant/Assignee: E. I. DU PONT DE NEMOURS AND COMPANY

Application No.: 12/632827   Filing Date: 08/Dec/2009

Abstract:Peptides having strong affinity for iron oxide pigment particles have been identified. Peptide-based reagents comprising at least one of the present iron oxide-based pigment-binding peptides and at least one body surface-binding peptide are described. The peptide-based reagents may be used in conjunction with at least one iron oxide-based pigment to color body surfaces.

Priority: US20080138623P Applic. Date: 2008-12-18

Inventor: FAHNESTOCK STEPHEN R [US]; KOSTICHKA KRISTY N [US]; PARTHASARATHY ANJU [US]; WANG HONG [US]


Application No.: US20100158842A1  Published: 24/Jun/2010

Title: NATURAL SKIN WHITENER: 4-HYDROXY-OXINDOLE-3-ACETIC ACID

Applicant/Assignee: SPECTRUM DYNAMICS LLC

Application No.: 12/576570   Filing Date: 09/Oct/2009

Abstract:A cosmetic and dermatological composition comprises 2, 3-dihydro-4-hydroxy-2-oxo-1-H-indole-3-acetic acid (4-hydroxy-1-oxindole-3-acetic acid) as an active ingredient for use as a melanin inhibitor and as an anti-tyrosinase enzyme inhibitor. This composition is excellent as a skin whitening agent. Since it also has potent antioxidant and anti-irritant activities it is useful in a cosmetic composition for improving hyperpigmentation disorders of the skin.

Priority: US20080195697P Applic. Date: 2008-10-09

Inventor: WILLE JR JOHN JACOB [US]


Application No.: US20100158843A1  Published: 24/Jun/2010

Title: NOVEL 3-PHENYLPROPANOIC COMPOUND ACTIVATORS OF RECEPTORS OF PPAR TYPE AND PHARMACEUTICAL/COSMETIC COMPOSITIONS COMPRISED THEREOF

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/632159   Filing Date: 07/Dec/2009

Abstract:Novel 3-phenylpropanoic acid compounds have the general formula (I) below: and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.

Priority: FR20070055476 Applic. Date: 2007-06-05; WO2008FR50996 Applic. Date: 2008-06-04

Inventor: BOITEAU JEAN-GUY [FR]; CLARY LAURENCE [FR]; PASCAL JEAN-CLAUDE [FR]; PARNET VERONIQUE [FR]


Application No.: US20100158975A1  Published: 24/Jun/2010

Title: EXTRACELLULAR MATRIX COMPOSITIONS

Applicant/Assignee: HISTOGEN, INC

Application No.: 12/509171   Filing Date: 24/Jul/2009

Abstract:The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Priority: US2009-501312 Applic. Date: 2009-07-10; US2009-363488 Applic. Date: 2009-01-30; US20080024854P Applic. Date: 2008-01-30; US20080034361P Applic. Date: 2008-03-06; US20080050940P Applic. Date: 2008-05-06

Inventor: NAUGHTON GAIL K [US]; ZIEGLER FRANK [US]; BAUMGARTNER MARK [US]; NICKEY KYLE [US]


Application No.: US20100158993A1  Published: 24/Jun/2010

Title: Topical Gel Compositions

Applicant/Assignee: ISW GROUP, INC

Application No.: 12/643582   Filing Date: 21/Dec/2009

Abstract:Topical alcoholic gel compositions are disclosed that are useful for delivering therapeutic levels of an NSAID to target in and below the skin. The compositions comprise a topically active drug, an alcoholic solvent, a polymeric thickener, and optionally a keratolytic agent. In one embodiment, excellent viscosity for dermal application is attained without the need of a step for neutralizing the pH of the composition. Alcoholic and alcohol-free topical compositions comprising an NSAID prodrug are also disclosed. The compositions are particularly useful for the treatment of pseudofolliculitis barbae.

Priority: US2006-361384 Applic. Date: 2006-02-24

Inventor: SPANN-WADE MONIQUE [US]; WARD ANTHONY [US]


Application No.: US20100159006A1  Published: 24/Jun/2010

Title: IMPROVED ANTIMICROBIAL PEPTIDES

Applicant/Assignee: DERMAGEN AB

Application No.: 12/300959   Filing Date: 15/May/2007

Abstract:The invention relates to an antimicrobial peptide comprising a first set of amino acid residues having a length of from about 2 to about 36 amino acid residues or analogues thereof linked to the amino or carboxyterminal end a second set comprising from 3 to 8 hydrophobic amino acid residue or analogue thereof, wherein said peptide has an antimicrobial activity

Priority: SE20060001088 Applic. Date: 2006-05-16; US20060800644P Applic. Date: 2006-05-16; WO2007SE00477 Applic. Date: 2007-05-15

Inventor: SCHMIDTCHEN ARTUR [SE]; MALMSTEN MARTIN [SE]


Application No.: US20100159040A1  Published: 24/Jun/2010

Title: SYNERGISTIC ANTIOXIDANT COMBINATIONS OF HERB EXTRACTS AND METHODS RELATING THERETO

Applicant/Assignee: THE DIAL CORPORATION

Application No.: 12/342483   Filing Date: 23/Dec/2008

Abstract:The present invention comprises mixtures of herb extracts which exert synergistic antioxidant effect and comprise the herb licorice and at least one other herb selected from the group consisting of ginger, kudzu, sophora, and thyme. Skin care preparations incorporating such herb extract mixtures, and their methods of preparation and use, are also claimed.

Priority:

Inventor: GE HAIYAN [US]; SEITZ JR EARL P [US]; DOERING THOMAS [US]


Application No.: US20100159041A1  Published: 24/Jun/2010

Title: COMBINATIONS OF HERB EXTRACTS HAVING SYNERGISTIC ANTIOXIDANT EFFECT, AND METHODS RELATING THERETO

Applicant/Assignee: THE DIAL CORPORATION

Application No.: 12/342738   Filing Date: 23/Dec/2008

Abstract:The present invention comprises mixtures of herb extracts which exert synergistic antioxidant effect and comprise the herb sophora and at least one other herb selected from the group consisting of honeysuckle, kudzu, and licorice. Skin care preparations incorporating such herb extract mixtures, and their methods of preparation and use, are also claimed.

Priority:

Inventor: GE HAIYAN [US]; SEITZ JR EARL P [US]; DOERING THOMAS [US]


Application No.: US20100159082A1  Published: 24/Jun/2010

Title: NON-FRIED APPLE FOOD PRODUCTS AND PROCESSES FOR THEIR PREPARATION

Applicant/Assignee: HER MAJESTY THE QUEEN IN RIGHT OF THE PROVINCE OFNOVA SCOTIA, AS REPRESENTED BY THE NOVA SCOTIA

Application No.: 12/580715   Filing Date: 16/Oct/2009

Abstract:The present disclosure relates to value-added non-fried, crispy apple food products and a consumer-friendly process for manufacturing these products that does not use deep-frying in oil.

Priority: US20080106008P Applic. Date: 2008-10-16

Inventor: RUPASINGHE HANDUNKUTTI P V [CA]; JOSHI AJIT PAL KAUR [CA]; PITTS NANCY L [CA]


Application No.: US20100159613A1  Published: 24/Jun/2010

Title: Method for assaying the antioxidant capacity of a skin care product

Applicant/Assignee:

Application No.: 12/317500   Filing Date: 24/Dec/2008

Abstract:A method for assaying the antioxidant capacity of a skin care product, the method including preparing an emulsion base, dissolving a sample of a skin care product into the emulsion base to form a homogeneous emulsion mixture, adding a detection probe to the homogeneous emulsion mixture, adding reactive oxygen species generator and/or reactive nitrogen species generator to the homogeneous emulsion mixture, measuring the fluorescence intensity change of the detection probe in the presence of the sample over time, in the presence of the standard over time, and in the presence of a blank over time, and calculating the initial rate of oxidation of the detection probe to determine the antioxidant capacity of the sample of the skin care product.

Priority:

Inventor: OU BOXIN [US]; ZHANG LILIANG [US]; KONDO MIWAKO [US]; JI HONGPING [CN]; KOU YAN [CN]


Application No.: US20100160213A1  Published: 24/Jun/2010

Title: ANTIMICROBIAL AND ANTICANCER LIPOPEPTIDES

Applicant/Assignee: YEDA RESEARCH & DEVELOPMENT CO. LTD

Application No.: 12/685202   Filing Date: 11/Jan/2010

Abstract:The invention provides lipophilic conjugates comprising a peptide coupled to a fatty acid, the peptide comprising at least two positively charged amino acid residues, said peptide after conjugation to the fatty acid possessing antibacterial, antifungal, and/or anticancer activity higher than prior to conjugation. The lipophilic conjugates are suitable for treatment of infections caused by pathogenic organisms such as bacteria and fungi. The lipophilic conjugates are also suitable for sanitation, as disinfectants, or for food preservation.

Priority: US2006-560727 Applic. Date: 2006-10-10; WO2004IL00544 Applic. Date: 2004-06-18; US20030479465P Applic. Date: 2003-06-19

Inventor: SHAI YECHIEL [IL]; AVRAHAMI DORIT [IL]


Application No.: US20100160245A1  Published: 24/Jun/2010

Title: Quercetin-Containing Compositions

Applicant/Assignee: QUERCEGEN PHARMA LLC

Application No.: 12/639212   Filing Date: 16/Dec/2009

Abstract:This invention relates to a composition containing quercetin, vitamin B3, and vitamin C. Also disclosed is a method of using the composition for enhancing physical or mental performance or treating various diseases or disorders.

Priority: US2007-778234 Applic. Date: 2007-07-16; US20060807601P Applic. Date: 2006-07-17; US20060807694P Applic. Date: 2006-07-18; US20070900626P Applic. Date: 2007-02-08; US20070911747P Applic. Date: 2007-04-13; US20070913164P Applic. Date: 2007-04-20

Inventor: LINES THOMAS CHRISTIAN [US]


Application No.: US20100160368A1  Published: 24/Jun/2010

Title: Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy

Applicant/Assignee:

Application No.: 12/543434   Filing Date: 18/Aug/2009

Abstract:Pharmaceutical Formulations and Methods for the Topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namely, viral infections, such as Type I or Type II Herpes simplex infections and genital and perianal warts, actinic keratosis and superficial basal cell carcinoma, and to induce interferon biosynthesis to achieve an antiviral effect, with shorter durations of therapy, than currently approved for imiquimod by the Food & Drug Administration ("FDA").

Priority: US20080089887P Applic. Date: 2008-08-18; US20080090132P Applic. Date: 2008-08-19

Inventor: GREGORY JEFFERSON J [US]


Application No.: US20100160401A1  Published: 24/Jun/2010

Title: 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE

Application No.: 12/631450   Filing Date: 04/Dec/2009

Abstract:The tyrosinase inhibiting compounds of the following general formula formulated into pharmaceutical or cosmetic compositions, are useful for the treatment or prevention of pigmentary disorders, or for preventing and/or treating signs of skin aging, and/or for body or hair hygiene.

Priority: FR20070055468 Applic. Date: 2007-06-05; WO2008FR50993 Applic. Date: 2008-06-04

Inventor: BOITEAU JEAN-GUY [FR]; PELISSON ISABELLE [FR]; SUZUKI ITARU [FR]; MUSICKI BRANISLAV [FR]; BERTHIER MARIELLE [FR]


Application No.: US20100160439A1  Published: 24/Jun/2010

Title: DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/635866   Filing Date: 11/Dec/2009

Abstract:Dermatological compositions contain, formulated into a physiologically acceptable medium, at least one retinoid compound selected from among all-trans retinoic acid, isotretinoin, motretinide, and naphthoic acid compounds of formula (I), and salts and esters thereof: wherein R is a hydrogen atom, a hydroxyl radical, a branched or unbranched alkyl radical having from 1 to 4 carbon atoms, an alkoxy radical having from 1 to 10 carbon atoms, or a cycloaliphatic radical which is substituted or unsubstituted, and benzoyl peroxide, and also at least one anti-irritant compound selected from among 18[beta]-glycyrrhetinic acid, and its salts and derivatives thereof.

Priority: FR20070055658 Applic. Date: 2007-06-11; WO2008EP57310 Applic. Date: 2008-06-11; US20070929205P Applic. Date: 2007-06-18

Inventor: MALLARD CLAIRE [FR]


Application No.: US20100160457A1  Published: 24/Jun/2010

Title: Thickened Spreadable Warming Lubricant

Applicant/Assignee: ANSELL HEALTHCARE PRODUCTS LLC

Application No.: 12/716786   Filing Date: 03/Mar/2010

Abstract:A substantially anhydrous, thickened, spreadable, warming lubricant composition comprising a mixture of glycerin, polyhydric alcohol, a non-ionic surfactant, and a Carbomer thickener, the surfactant improving wetting and spreadability of the composition on skin and latex, and the thickener providing a creamy rich feel to the composition, such that the composition can be applied to skin or a condom and provide an optimal warming effect upon contact with ambient moisture during use and such that the composition can be added to a condom package and, over the course of a week, spread and coat nearly the entire internal and external surfaces of the condom.

Priority: US2005-064284 Applic. Date: 2005-02-23

Inventor: CHUAH BENG SIM [MY]; LUCAS DAVID M [MY]; YEUN TSUI SHIH [MY]; NARASIMHAN DAVE [US]


Application No.: US20100160747A1  Published: 24/Jun/2010

Title: SELECTION OF PREFERRED SAMPLING LOCATION ON HAND VIA MINIMIZATION OF SAMPLING ERROR, AND OPTICAL ALIGNMENT FOR REPEATABLY SAMPLING TISSUE

Applicant/Assignee:

Application No.: 12/636771   Filing Date: 13/Dec/2009

Abstract:The present invention relates to measurements of material properties by determination of the response of a sample to incident radiation, and more specifically to the measurement of analytes such as glucose or alcohol in human tissue. The invention is particularly useful in connection with noncontact optical sampling of skin. Some example embodiments of the invention provide for selection of preferred sampling locations responsive to optically-determined characteristics of the tissue. Some example embodiments of the invention provide for precise and repeatable alignment of the tissue based on optically-determined characteristics of the tissue.

Priority: US20080122158P Applic. Date: 2008-12-12; US20080122124P Applic. Date: 2008-12-12

Inventor: ROBINSON MARK RIES [US]; MAGEE ANDREA [US]; HAASS MICHAEL J [US]; ABBINK RUSSELL E [US]; RADIGAN WILLIAM [US]; GRAFE V GERALD [US]


Application No.: US20100160849A1  Published: 24/Jun/2010

Title: Methods for Identifying Areas of a Subject's Skin that Appear to Lack Volume

Applicant/Assignee:

Application No.: 12/600467   Filing Date: 08/Jun/2007

Abstract:The present embodiments relate to methods and systems for identifying areas of a subject's skin that lack sufficient volume. In some embodiments, this can be used to direct the administration of filler compositions or the application of techniques that increase the volume or firmness of the area. In some embodiments, the methods and systems provide for improved aesthetic benefit as well as suitability for instruction and training. In some embodiments, the methods are especially useful in the administration of dermal fillers to a subject.

Priority: US20070938425P Applic. Date: 2007-05-16; US20070938424P Applic. Date: 2007-05-16; WO2007US70806 Applic. Date: 2007-06-08

Inventor: BARBOUR JENNIFER [US]


Application No.: US20100160884A1  Published: 24/Jun/2010

Title: WOUND DRESSING

Applicant/Assignee:

Application No.: 12/719068   Filing Date: 08/Mar/2010

Abstract:A wound dressing includes an absorbent core defining opposed proximal and distal surfaces including a central portion and a border portion, and a liquid impervious, vapor permeable backing layer connected to the distal surface of the absorbent core. The backing layer defines a border portion extending beyond the periphery of the absorbent core. A skin adherent, perforated facing layer is secured to the proximal surface of the absorbent core. An adhesive layer is applied to at least a proximal segment of the border portion of the backing layer and has greater skin adherence properties than the facing layer.

Priority: US2003-725574 Applic. Date: 2003-12-03; US20020437146P Applic. Date: 2002-12-31; US20030482775P Applic. Date: 2003-06-27; US20030503546P Applic. Date: 2003-09-17; US20030518317P Applic. Date: 2003-11-10

Inventor: SIGURJONSSON GUDMUNDUR FERTRAM [IS]; ELEFSEN THORDUR M [IS]; GUDNASON PALMAR I [IS]


Application No.: US20100161029A1  Published: 24/Jun/2010

Title: Emulsifiers for Multiple Emulsions

Applicant/Assignee:

Application No.: 10/555477   Filing Date: 07/May/2004

Abstract:The present invention relates to a stable multiple water-in-oil-in-water emulsion comprising: A multiple water-in-oil-in-water emulsion composition comprising: (1) A discontinuous phase, wherein that discontinuous phase is an internal water-in-oil emulsion comprising a) a water discontinuous phase, b) an oil continuous phase, c) a polyisobutenyl succinic anhydride-derived emulsifier(s) and/or a polyisobutylene derived emulsifier(s) d) optionally a co-emulsifier and e) optionally thickeners for the discontinuous phase a)

and (2) A continuous phase, wherein that continuous phase is an external aqueous phase comprising: a) water b) an oil-in-water emulsifier and c) optionally thickeners for the external aqueous phase resulting in a stable water-in-oil-in-water multiple emulsion. The multiple emulsions are useful for personal care products.

Priority: US20030468439P Applic. Date: 2003-05-07; WO2004US14336 Applic. Date: 2004-05-07

Inventor: FILIPPINI BRIAN B [US]; HUANG NAI Z [US]; CAREY JEFFREY M [US]; MULLAY JOHN J [US]


Application No.: US20100162951A1  Published: 01/Jul/2010

Title: SYSTEM AND DEVICE FOR SELF-TANNING

Applicant/Assignee:

Application No.: 12/226554   Filing Date: 19/Apr/2007

Abstract:The present invention describes a system and device for self-tanning characterized by the fact that said device comprises a booth (2) whose two lateral walls (5) are fitted with a series of gratings (51) where, behind each grating (51), the presence of one or more lamps (52) is envisaged, which are intended to warm the area inside the booth and to radiate the skin of a person situated in the interior of the booth, means of movement (40) located externally to the rear wall (4) and intended to make a rod (41) run, with said rod being fitted with arms (42) whose free ends (43) are fitted with a spraying device (11) equipped with nozzles (12) designed to nebulize a tanning substance and a high pressure pump (14) connected to a compressor which is envisaged for sucking up the tanning solution from a recipient (15) and transferring it to a pipeline connected with the spraying device (11)

The device comprises a control panel (6) connected to a means of management envisaged for activating and governing the diverse functions of said device under the control of an operator or of a user who pushes a start button (7). The system comprises a series of operative phases which envisage, for a person who undergoes a self-tanning session: entering the booth after putting on a protective cap for their hair and half gloves that cover the palms of their hands

pressing start on the control panel

the lamps switching on for a preset time and switching off

a tanning solution being sprayed, followed by the lamps being switched on a second time to dry the tanning solution on the skin for a preset time

the lamps being switched off

the person leaving the booth.

Priority: IT2006MN00032 Applic. Date: 2006-04-21; WO2007IT00291 Applic. Date: 2007-04-19

Inventor: PINOTTI LUCIANO [IT]


Application No.: US20100163071A1  Published: 01/Jul/2010

Title: SILICONE AND SILOXANE-BASED IMPREGNATED COATING AND POLYMERIC MATERIALS FOR CONDITIONING

Applicant/Assignee: ROVCAL, INC

Application No.: 12/645696   Filing Date: 23/Dec/2009

Abstract:The present disclosure generally relates to a personal care device comprising an immiscible conditioning composition formed by combining a hydrophilic matrix, such as a polymeric material, and a hydrophobic conditioning agent. More particularly, the present disclosure relates to a personal care device comprising a hydrophilic matrix, such as a polymeric material, and a hydrophobic conditioning agent dispersed therein, such as a silicone or a siloxane-based agent suitable for transferring from the device surface, and more particularly the matrix surface, to hair or skin surfaces in contact therewith.

Priority: US20080141939P Applic. Date: 2008-12-31

Inventor: EVERETT JR DAVID W [US]; MURZYNSKI MACIEJ [US]; GONZALEZ GIOVANNI [US]; HARTHUN RICHARD A [US]


Application No.: US20100166677A1  Published: 01/Jul/2010

Title: Use of Tiliacora Triandra in Cosmetics and Compositions Thereof

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/345707   Filing Date: 30/Dec/2008

Abstract:The present disclosure relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents which increase expression levels genes, collagen replacement and retention, and cell proliferation of epidermis and dermis associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and aesthetic appearance of skin.

Priority:

Inventor: PTCHELINTSEV DMITRI S [US]


Application No.: US20100166681A1  Published: 01/Jul/2010

Title: Anhydrous Multiphase Gel System

Applicant/Assignee:

Application No.: 11/989968   Filing Date: 04/Aug/2006

Abstract:An anhydrous multiphase gel system consisting of an outer lipid matrix and an inner phase gelled by means of a polymer is described, which can be obtained by a) Melting the lipid phase with the formation of a liquid lipid phase, b) Mixing and homogenizing polymers or polymer blends capable of swelling with the formation of a polymer phase to be dispersed, c) Combining the polymer phase with the liquid lipid phase and homogenizing the phases, and d) Cold stirring the phase mixture until a solid gel-like mixed structure of the entire system is formed. The anhydrous multiphase gel system is particularly suitable for taking up difficultly soluble active substances in high concentration and for providing topical and transdermal applications. The described system is called an EDRS, "Entrapped Drug Reservoir System".

Priority: DE200510037844 Applic. Date: 2005-08-04; WO2006DE01410 Applic. Date: 2006-08-04

Inventor: FRANKE PATRICK [DE]


Application No.: US20100166682A1  Published: 01/Jul/2010

Title: CHELATED MINERAL WATER

Applicant/Assignee: GEOLOGIX, INC

Application No.: 12/596603   Filing Date: 19/Apr/2008

Abstract:A composition comprising mineral water and a chelating agent present in an amount sufficient to maintain all of the minerals in the water in solution. The mineral water is preferably obtained from Mount Clemens, Mich., US, and is preferably chelated with an ammonium and/or a sodium salt of an acid selected from the group consisting of ethylenediaminetetraacetic acid, nitrilotetraacetic acid, [beta]-alaninediacetic acid, ethylenediaminosuccinic acid, aminotrimethylenephosphoric acid, serinediaacetic acid, asparaginediacetic acid, methylgylcinediacetic acid and mixtures thereof. The resultant chelated mineral water may be combined with a cosmetically acceptable skin-conditioning agent and a cosmetically acceptable topical carrier, thereby resulting in a cosmetic composition that will confer beneficial effects on the skin, e.g., softening, hydrating and healing effects.

Priority: US20070912994P Applic. Date: 2007-04-20; WO2008US05092 Applic. Date: 2008-04-19

Inventor: MUSUMECI STEPHEN [US]


Application No.: US20100166685A1  Published: 01/Jul/2010

Title: NOVEL BLOCK POLYMERS, COMPOSITIONS COMPRISING THEM, AND TREATMENT METHODS

Applicant/Assignee: L'OREAL S.A

Application No.: 12/705239   Filing Date: 12/Feb/2010

Abstract:The present disclosure relates to novel block polymers comprising particular silicone monomers and monomers of formula: CH2-C(R1)-COOR2 wherein R1 is chosen from a hydrogen atom and a methyl group and R2 is chosen from C4 to C12 cycloalkyl groups. The present disclosure also relates to cosmetic or pharmaceutical compositions comprising these polymers, and also to a cosmetic treatment method using them.

Priority: FR20060054944 Applic. Date: 2006-11-16; US2007-984284 Applic. Date: 2007-11-15; US20060861427P Applic. Date: 2006-11-29

Inventor: FARCET CELINE [FR]


Application No.: US20100166689A1  Published: 01/Jul/2010

Title: Compositions and Methods for Treating Hyperpigmentation

Applicant/Assignee: REVANCE THERAPEUTICS, INC

Application No.: 12/647739   Filing Date: 28/Dec/2009

Abstract:This invention provides compositions and methods for reducing hyperpigmentation. In preferred embodiments, the compositions are topical compositions that contain kojic acid and a carrier molecule for enhancing the transdermal penetration of kojic acid. This invention also provides kits for treating hyperpigmentation.

Priority: US20080142094P Applic. Date: 2008-12-31

Inventor: WAUGH JACOB M [US]


Application No.: US20100166691A1  Published: 01/Jul/2010

Title: Polyamide-Polyether Block Copolymer

Applicant/Assignee:

Application No.: 12/721309   Filing Date: 10/Mar/2010

Abstract:Copolymers having linked internal polyether blocks and internal polyamide blocks have advantageous physical properties and solvent-gelling abilities. The copolymer may be prepared from a reaction mixture that contains 1,4-cyclohexane dicarboxylic acid (CHDA) and poly(alkyleneoxy)diamine (PAODA). Optionally, the reaction mixture contains no monofunctional compound reactive with either amine or carboxylic acid groups, however some of this monofunctional compound may be present. Dimer diamine and/or dimer acid may be present in the reaction mixture. A copolymer may also be prepared from a reaction mixture containing dimer acid and at least two diamine compound(s) including PAODA and short-chain aliphatic diamine having 2-6 carbons (SDA), wherein: a) the reaction mixture comprises x grams of PAODA and y grams of SDA, and x/(x+y) is 0.8-0.98

b) the reaction mixture weighs z grams, and x/z is at least 0.25

and c) the reaction mixture contains either no co-diacid, or comprises a small amount of co-diacid, wherein, if the reaction mixture comprises a small amount of co-diacid, then acid equivalents from co-diacid contribute less than 25% of the total acid equivalents present in the reaction mixture.

Priority: US2007-753447 Applic. Date: 2007-05-24; US2005-252441 Applic. Date: 2005-10-18; US2003-395050 Applic. Date: 2003-03-20

Inventor: PAVLIN MARK S [US]


Application No.: US20100166798A1  Published: 01/Jul/2010

Title: METHOD AND KIT FOR TREATMENT/PREVENTION OF HAIR LOSS

Applicant/Assignee: PACIFIC BIOSCIENCE LABORATORIES, INC

Application No.: 12/612313   Filing Date: 04/Nov/2009

Abstract:The method includes the steps of cleansing of the scalp sufficiently to remove material which would otherwise block antiviral medication from reaching hair follicles, heating the scalp to increase the absorption of the antiviral medication and applying the antiviral medication to the scalp in effective amount to suppress viral replication or viral activation present in the nerves leading to the scalp.

Priority: US2006-531488 Applic. Date: 2006-09-13

Inventor: AKRIDGE ROBERT E [US]


Application No.: US20100166814A1  Published: 01/Jul/2010

Title: Cosmetic Composition Containing At Least Two Osmolytes With A Moisturizing Or Antiaging Effect

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/644067   Filing Date: 22/Dec/2009

Abstract:The present invention relates to a cosmetic composition, which comprises a combination of at least two osmolytes chosen from the group comprising taurine or a derivative thereof, inositol, betaine and trehalose. This composition is intended for restoring, maintaining or reinforcing the moisturization of the skin and/or for protecting it against different types of stress and/or for preventing or retarding the appearance of the signs of aging of the skin, or for attenuating the effects thereof, or alternatively for promoting cell or tissue longevity.

Priority: FR20080059083 Applic. Date: 2008-12-24

Inventor: DUMAS MARC C M [FR]; KRZYCH VALERIE A S [FR]; PELLE DE QUERAL DELPHINE [FR]; HEUSELE CATHERINE [FR]


Application No.: US20100166824A1  Published: 01/Jul/2010

Title: EXTRACELLULAR MATRIX COMPOSITIONS

Applicant/Assignee: HISTOGEN, INC

Application No.: 12/501312   Filing Date: 10/Jul/2009

Abstract:The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Priority: US2009-363488 Applic. Date: 2009-01-30; US20080024854P Applic. Date: 2008-01-30; US20080034361P Applic. Date: 2008-03-06; US20080050940P Applic. Date: 2008-05-06

Inventor: NAUGHTON GAIL K [US]; ZIEGLER FRANK [US]; BAUMGARTNER MARK [US]; NICKEY KYLE [US]


Application No.: US20100166838A1  Published: 01/Jul/2010

Title: Methods And Compositions For Modulating Keratinocyte Function

Applicant/Assignee:

Application No.: 11/791388   Filing Date: 23/Nov/2005

Abstract:The disclosure is generally directed to methods and compositions for modulating keratinocyte function, more particularly, to compositions and methods for normalizing keratinocyte proliferation and differentiation, compositions and methods for modulating levels of phosphatidylglycerol (PG) in keratinocyes, and compositions and methods for treating skin conditions by modulating keratinocyte proliferation.

Priority: US20040635565P Applic. Date: 2004-11-23; WO2005US42748 Applic. Date: 2005-11-23

Inventor: BOLLAG WENDY BOLLINGER [US]; ZHONG XIAOFENG [US]; ZHENG XIANGJIAN [US]


Application No.: US20100166841A1  Published: 01/Jul/2010

Title: Prostaglandin Based Compositions and Method of Use Thereof

Applicant/Assignee:

Application No.: 12/465522   Filing Date: 13/May/2009

Abstract:The present disclosure sets forth particular prostaglandin based compounds that are relatively more stable in aqueous environments than other such compounds

and further that by complexing such a prostaglandin based compound of the disclosure with an agent, such as cyclodextrin, the prostaglandin based compound may be stabilized and provided in a cosmetic composition that can be used to enhance the appearance of hair.

Priority: US20080127686P Applic. Date: 2008-05-14

Inventor: ROTH PETER THOMAS [US]; BLAKE BRIDGET [US]


Application No.: US20100166844A1  Published: 01/Jul/2010

Title: POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD

Applicant/Assignee:

Application No.: 12/527641   Filing Date: 12/Feb/2008

Abstract:The present patent application relates to novel dispersions of particles of polymer stabilized at the surface in a nonaqueous medium, in which dispersions the polymer comprises mainly hydrophilic cationic monomers. Another subject-matter of the invention is a cosmetic or pharmaceutical composition comprising the said dispersion in a cosmetically or pharmaceutically acceptable medium. The invention also relates to a method for the cosmetic treatment of keratinous substances employing the said composition.

Priority: FR20070053336 Applic. Date: 2007-02-19; US20070904175P Applic. Date: 2007-03-01; WO2008FR50213 Applic. Date: 2008-02-12

Inventor: MOUGIN NATHALLE [FR]; JEGOU GWENAELLE [FR]


Application No.: US20100166852A1  Published: 01/Jul/2010

Title: Cream gels comprising at least one retinoid and benzoyl peroxide

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/457788   Filing Date: 22/Jun/2009

Abstract:The invention relates to a composition in the form of a cream gel comprising, in a physiologically acceptable medium, at least one dispersed retinoid and dispersed benzoyl peroxide, to its process of preparation and to its use in cosmetics and in dermatology.

Priority: FR20060055784 Applic. Date: 2006-12-21; WO2007FR52613 Applic. Date: 2007-12-21

Inventor: MALLARD CLAIRE [FR]; LOUIS FABIENNE [FR]; AT EMMANUELLE [FR]


Application No.: US20100166862A1  Published: 01/Jul/2010

Title: Local Complement Inhibition for Treatment of Complement-Mediated Disorders

Applicant/Assignee: POTENTIA PHARMACEUTICALS, INC

Application No.: 12/525799   Filing Date: 05/Feb/2008

Abstract:The present invention features the local administration of complement inhibitors for treatment of complement-mediated disorders. In certain embodiments the invention features inhibiting activation of one or more locally produced complement proteins. The invention provides sustained release formulations and devices comprising a complement inhibitor and methods of use thereof.

Priority: US20070899474P Applic. Date: 2007-02-05; WO2008US01483 Applic. Date: 2008-02-05

Inventor: FRANCOIS CEDRIC [US]; DESCHATELETS PASCAL [US]; OLSON PAUL [US]


Application No.: US20100166891A1  Published: 01/Jul/2010

Title: Composition comprising hemp oil for treating topical diseases, especially hand-foot syndrome

Applicant/Assignee: INTENDIS GMBH

Application No.: 12/640795   Filing Date: 17/Dec/2009

Abstract:The invention relates to a novel composition comprising hemp oil for treating topical diseases, in particular the hand-foot syndrome.

Priority: EP20080075967 Applic. Date: 2008-12-23; US20080140132P Applic. Date: 2008-12-23

Inventor: SCHMIDT TIMM [DE]


Application No.: US20100166897A1  Published: 01/Jul/2010

Title: COMBINATION OF MONOSACCHARIDES WITH ANTIOXIDANTS AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649368   Filing Date: 30/Dec/2009

Abstract:The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one antioxidant. The present invention also relates to the use of such a composition.

Priority: FR20080059154 Applic. Date: 2008-12-30; US20090144753P Applic. Date: 2009-01-15

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]; LUCET-LEVANNIER KARINE [FR]


Application No.: US20100167327A1  Published: 01/Jul/2010

Title: System for obfuscating identity

Applicant/Assignee: SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE

Application No.: 12/658391   Filing Date: 04/Feb/2010

Abstract:Compositions, apparatus, systems, kits, and methods for obfuscating the nucleic acid and/or protein content of an environment.

Priority: US2006-510754 Applic. Date: 2006-08-24; US2006-510756 Applic. Date: 2006-08-24; US2006-510753 Applic. Date: 2006-08-24

Inventor: HILLIS W DANIEL [US]; MYHRVOLD NATHAN P [US]; WILSON RICHA [US]


Application No.: US20100167987A1  Published: 30/Jul/2009

Title: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

Applicant/Assignee: BAR ILAN UNIVERSITY

Application No.: 12/404622   Filing Date: 16/Mar/2009

Abstract:A pharmaceutical composition and method for inducing or accelerating a healing process of a skin wound are described. The pharmaceutical composition contains, as an active ingredient, a therapeutically effective amount of at least one agent for modulating PKC production and/or activation, and a pharmaceutically acceptable carrier. The method is effected by administering the composition to a wound.

Priority: US2003-644775 Applic. Date: 2003-08-21; US2002-169801 Applic. Date: 2002-07-09; WO2001IL00675 Applic. Date: 2001-07-23; US2000-629970 Applic. Date: 2000-07-31; US20030486906P Applic. Date: 2003-07-15

Inventor: TENNENBAUM TAMAR [IL]; SAMPSON SANFORD [IL]; KUROKI TOSHIO [JP]; ALT ADDY [IL]; SHEN SHLOMZION [IL]


Application No.: US20100167997A1  Published: 01/Jul/2010

Title: METHOD FOR STIMULATION COLLAGEN SYNTHESIS AND/OR KGF EXPRESSION

Applicant/Assignee: ATYR PHARMA, INC

Application No.: 11/815307   Filing Date: 24/Jan/2006

Abstract:The present invention relates to a method for stimulating collagen synthesis and/or KGF expression, and more particularly, to a method for stimulating collagen synthesis and/or KGF expression using the AIMP1 or its fragment. The AIMP1 or its fragment can be effectively used for the stimulation of collagen synthesis and/or KGF expression in a subject in need thereof, the treatment of skin aging in the subject, the treatment of the flaccid and/or wrinkled skin in the subject, the promoting the smoothing and/or firming of the skin in the subject, the treatment of adverse cutaneous effects of menopause in the subject, and the treatment of adverse effects of menopause on the collagen.

Priority: WO2005KR00300 Applic. Date: 2005-02-01; WO2006KR00275 Applic. Date: 2006-01-24

Inventor: KIM SUNG-HOON [KR]


Application No.: US20100168041A1  Published: 01/Jul/2010

Title: COMBINATION OF MONOSACCHARIDES AND DESQUAMATING AGENTS, AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649372   Filing Date: 30/Dec/2009

Abstract:The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one desquamating agent. The present invention also relates to the use of such a composition, and to a device containing it.

Priority: FR20080059149 Applic. Date: 2008-12-30; US20090144755P Applic. Date: 2009-01-15

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]


Application No.: US20100168045A1  Published: 01/Jul/2010

Title: Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same

Applicant/Assignee: PIERRE FABRE DERMO-COSMETIQUE

Application No.: 12/086625   Filing Date: 14/Dec/2006

Abstract:The invention concerns novel polyunsaturated compounds of formula (I) wherein: R1 represents a R'1, -A-R'1 group, R'1 being selected from -COOH, -COOR3, -CONH2, -CONHR3, -CONR3, R4, -CHO, -CH2OH, -CH2OR5, and A represents a C2-C16 alkylene, alkenylene or alkynylene

R2 represents: an optionally substituted aryl group or an optionally substituted heteroaryl group

a sugar residue or, a fatty acid residue optionally branched and/or substituted preferably at the chain terminus and particularly by hydroxy, acetoxy radical or by an optionally protected amino radical

a -OC-(CH2)n CO-tocopheryl (alpha, beta or gamma or delta) group, with 2 $m(F) n $m(F) 10

a -R'2-O-R6 group, wherein R'2 is an optionally substituted arylene group or an optionally substituted heteroarylene group, and R6 represents a hydrogen atom, a straight or branched optionally substituted C1-C16 alkyl, a straight or branched optionally substituted C2-C16 alkenyl, or a straight or branched C2-C16 alkynyl group, an optionally substituted tocopheryl radical or the like, an amino acid residue, or a sugar residue. The invention also concerns the compositions, in particular cosmetic and/or dermatological compositions containing at least one compound of formula (I) as well as their use as whitening and/or depigmenting agent, and the cosmetic method using said compositions.

Priority: FR20050012661 Applic. Date: 2005-12-14; WO2006EP69731 Applic. Date: 2006-12-14

Inventor: BORDAT PASCAL [FR]; TARROUX ROGER [FR]; SAURAT JEAN-HILAIRE [CH]; SORG OLIVIER [CH]; BRAYER JEAN-LOUIS [FR]; FRISON NATACHA [FR]


Application No.: US20100168049A1  Published: 01/Jul/2010

Title: COMBINATION OF MONOSACCHARIDES AND ADENOSINE AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649367   Filing Date: 30/Dec/2009

Abstract:The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one additional compound chosen from adenosine, an analogue thereof and a mixture thereof.

Priority: FR20080059151 Applic. Date: 2008-12-30; US20090144756P Applic. Date: 2009-01-15

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]


Application No.: US20100168055A1  Published: 01/Jul/2010

Title: COMBINATION OF MONOSACCHARIDE WITH C-GLYCOSIDE DERIVATIVE AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649366   Filing Date: 30/Dec/2009

Abstract:Composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, at least one of mannose, and rhamnose and at least one additional compound chosen from C-glycosides and C-glycoside derivatives. Use of such a composition, and also a device containing it.

Priority: FR20080059150 Applic. Date: 2008-12-30; US20090144754P Applic. Date: 2009-01-15

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]


Application No.: US20100168126A1  Published: 01/Jul/2010

Title: Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine Carbomamides and Related Compounds

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/344868   Filing Date: 29/Dec/2008

Abstract:Cosmetic compositions comprising 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging.

Priority:

Inventor: PTCHELINTSEV DMITRI S [US]; HU HONG [US]; MENON GOPINATHAN K [US]; SCHMALENBERG KRISTINE [US]; LYGA JOHN W [US]


Application No.: US20100168127A1  Published: 01/Jul/2010

Title: Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine Carbomamides and Related Compounds

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/645622   Filing Date: 23/Dec/2009

Abstract:Cosmetic compositions comprising 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging.

Priority: US2008-344868 Applic. Date: 2008-12-29

Inventor: PTCHELINTSEV DMITRI S [US]; HU HONG [US]; MENON GOPINATHAN K [US]; SCHMALENBERG KRISTINE [US]; LYGA JOHN W [US]


Application No.: US20100168223A1  Published: 01/Jul/2010

Title: 7-Hydroxy Chromones As Potent Antioxidants

Applicant/Assignee: UNIGEN PHARMACEUTICALS, INC

Application No.: 12/721371   Filing Date: 10/Mar/2010

Abstract:The present invention describes the identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising administering an effective amount of a 7-hydroxychrome or a mixture of 7-hydroxychromones. The present invention includes methods that are effective in inhibiting free radical and oxidation caused damage through the simultaneous suppression of free radical generation and the suppression of the production of reactive oxygen species (ROS). The present invention also includes methods for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes. The method for preventing and treating ROS mediated diseases and conditions and diseases and conditions associated with other oxidative processes is comprised of administering to a host in need thereof an effective amount of a composition comprised of a 7-hydroxychrome or a mixture of 7-hydroxychromones and a pharmaceutically acceptable carrier. Included in this invention is an improved method to isolate and purify 7-hydroxychromones from plant sources.

Priority: US2005-085896 Applic. Date: 2005-03-21; US2002-138932 Applic. Date: 2002-05-03

Inventor: JIA QI [US]; FARROW THOMAS M [US]


Application No.: US20100170996A1  Published: 08/Jul/2010

Title: WELDABLE HIGH-STRENGTH ALUMINUM ALLOYS

Applicant/Assignee:

Application No.: 12/349668   Filing Date: 07/Jan/2009

Abstract:An aluminum alloy comprises aluminum, magnesium, scandium, and an enhancing system. The magnesium is from about 0.5 percent to about 10.0 percent by weight based on the aluminum alloy. The scandium is from about 0.05 percent to about 10.0 percent by weight based on the aluminum alloy. The enhancing system is from about 0.05 percent to about 1.5 percent by weight based on the aluminum alloy.

Priority:

Inventor: SANKARAN KRISHNAN K [US]; SLATTERY KEVIN T [US]


Application No.: US20100172847A1  Published: 08/Jul/2010

Title: ANTIMICROBIAL COMPOSITIONS CONTAINING LOW CONCENTRATIONS OF BOTANICALS

Applicant/Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

Application No.: 12/694119   Filing Date: 26/Jan/2010

Abstract:The present invention relates to a preservative or antimicrobial compositions with broad spectrum antimicrobial activity comprising low concentrations of essential oil (and/or one or more component thereof) and a botanical extract in synergistic combination with a fruit acid and alkanediol, and optionally a solvent. The compositions of the invention may be used in personal care products such as creams or soap products.

Priority: US2009-367851 Applic. Date: 2009-02-09; WO2008US72006 Applic. Date: 2008-08-01; US20070953654P Applic. Date: 2007-08-02

Inventor: MODAK SHANTA [US]; BAIJU NAYANA [US]; CARAOS LAUSERPINA [US]


Application No.: US20100172848A1  Published: 08/Jul/2010

Title: SKIN AND SURFACE DISINFECTANT COMPOSITIONS CONTAINING BOTANICALS

Applicant/Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

Application No.: 12/694141   Filing Date: 26/Jan/2010

Abstract:The present invention relates to a skin or surface disinfectant composition with broad spectrum antimicrobial activity comprising one or more essential oil (and/or one or more component thereof) and one or more fruit acid. The compositions of the invention may be used as non-toxic alternatives to conventional disinfectants or may be added to other antimicrobial agents to enhance their activity. The invention provides effective alternatives to harsher products which may be particularly useful in personal care and household products and where children and/or pet exposure may be a concern.

Priority: WO2008US72006 Applic. Date: 2008-08-01

Inventor: MODAK SHANTA [US]; BAIJU NAYANA [US]; CARAOS LAUSERPINA [US]


Application No.: US20100172851A1  Published: 08/Jul/2010

Title: Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites

Applicant/Assignee:

Application No.: 12/726522   Filing Date: 18/Mar/2010

Abstract:A composition and method for producing a beneficial effect on a subject's nerve associated with at least one of a cosmetic condition, a dermatological indication and a dental indication and another condition. The composition comprises a hydroxy-oligocarboxylic ester and is formulated for topical administration of the product to a subject to produce the beneficial effect. The method includes topically applying to the subject in a region where the beneficial effect is desired a hydroxy-oligocarboxylic ester in an amount effective to produce the beneficial effect.

Priority: US2006-548945 Applic. Date: 2006-10-12; US20050727419P Applic. Date: 2005-10-17; US20060759525P Applic. Date: 2006-01-17

Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]


Application No.: US20100172892A1  Published: 08/Jul/2010

Title: HYALURONIDASE AND METHOD OF USE THEREOF

Applicant/Assignee:

Application No.: 12/664667   Filing Date: 19/Jun/2008

Abstract:The present invention provides a tnaluronidase. The hyaluronidase can be produced by the strain Streptomyces aitinocidm 77, Exemplary characteristics of the hyaluronidase include specific C-terminal or other amino acid sequences, including full-length sequences, and improved physico-chemical and actix itj properties as compared to known h> al[upsilon]ronidase preparatkiiis. Described are also various uses of the hyaiur[upsilon]nidasc, including topical administration of the h> aiuronidasc to improve skin penetration of a co-administered active substance.

Priority: US20070945037P Applic. Date: 2007-06-19; WO2008IB02688 Applic. Date: 2008-06-19

Inventor: UVARKINA TAMARA P [RU]; KAHOJAN EUGENE G [RU]


Application No.: US20100172943A1  Published: 08/Jul/2010

Title: PEPTIDE NANOPARTICLES AND USES THEREFOR

Applicant/Assignee: ANTERIOS, INC

Application No.: 12/517149   Filing Date: 30/Nov/2007

Abstract:The present invention provides nanoparticle compositions including one or more peptides. The present invention achieves transdermal delivery of such peptides without the need for peptide modification, or for use of chemical or mechanical abrasion or disruption of skin.

Priority: US20060872206P Applic. Date: 2006-12-01; WO2007US86040 Applic. Date: 2007-11-30

Inventor: EDELSON JONATHAN [US]; KOTYLA TIMOTHY [US]


Application No.: US20100172944A1  Published: 08/Jul/2010

Title: COMBINATION OF MONOSACCHARIDES WITH SUNSCREENS AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649415   Filing Date: 30/Dec/2009

Abstract:The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one sunscreen. The present invention also relates to the use of such a composition.

Priority: FR20080059146 Applic. Date: 2008-12-30; US20090144757P Applic. Date: 2009-01-15

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]


Application No.: US20100172957A1  Published: 08/Jul/2010

Title: EFLUCIMIBE MEDICAMENTS FOR PREVENTING/TREATING A DISEASE DUE TO SEBACEOUS GLAND DYSFUNCTION IN HUMANS OR ANIMALS

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/688277   Filing Date: 15/Jan/2010

Abstract:Administration of at least one compound selected from (S)-2-dodecylsulfanyl-N-(4-hydroxy-2,3,5-trimethylphenyl)-2-phenylacetanilide (eflucimibe) of formula (I): or (R)-2-dodecylsulfanyl-N-(4-hydroxy-2,3,5-trimethylphenyl)-2-phenylacetanilide ((R) enantiomer), or pharmaceutically acceptable salt or pharmaceutically acceptable solvate thereof, is useful for preventing or treating disorders due to a sebaceous gland dysfunction in humans or animals, for example, acne and/or or any state or pathological condition related to an overproduction of sebum, e.g., seborrhoeic dermatitis, greasy skin or a greasy scalp.

Priority: FR20070056604 Applic. Date: 2007-07-19; WO2008FR51341 Applic. Date: 2008-07-17

Inventor: BIADATTI-PORTAL THIBAUD [FR]


Application No.: US20100172960A1  Published: 08/Jul/2010

Title: PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES

Applicant/Assignee:

Application No.: 12/663262   Filing Date: 04/Jun/2007

Abstract:The novel positively charged pro-drugs of NSAIAs in the general formulas (1, 2a, 2b, 2c, or 2d) "Structure 1, 2a, 2b, 2c, or 2d" were designed and synthesized. The compounds of the general formulas (1, 2a, 2b, 2c, or 2d) "Structure 1, 2a, 2b, 2c, or 2d" indicated above can be prepared from metal salts, organic base salts, or immobilized base salts of NSAIAs with suitable halide compounds. The positively charged amino groups in the pro-drugs in this invention largely increase the solubility of the drugs in water and will bond to the negative charge on the phosphate head group of membrane. Thus, the local concentration of the outside of the membrane or skin will be very high and will facilitate the passage of these pro-drugs from a region of high concentration to a region of low concentration. This bonding will disturb the membrane a little bit and may make some room for the lipophilic portion of the pro-drug. When the molecules of membrane move, the membrane may "crack" a little bit due to the bonding of the pro-drug. This will let the pro-drug insert into the membrane. At pH 7.4, only about 99% of the amino group is protonated. When the amino group is not protonated, the bonding between the amino group of the pro-drug and the phosphate head group of the membrane will disassociate, and the pro-drug will enter the membrane completely. When the amino group of the pro-drug flips to the other side of the membrane and thus becomes protonated, then the pro-drug is pulled into the cytosol, a semi-liquid concentrated aqueous solution or suspension. These pro-drugs can be used for treating and preventing diabetes (type I or/and type II), abnormal blood glucose and lipid levels, stroke, heart attack, and other heart and vascular diseases Alzheimer's diseases, Parkinson's diseases and other neurodegenerative diseases, psoriasis, discoid lupus erythematosus, systemic lupus erythematosus (SLE), autoimmune hepatitis, multiple sclerosis (MS), and other autoimmune diseases, amyotrophic lateral sclerosis (ALS), oculopharyngeal muscular dystrophy (OPMD), and other muscle disorders, inflamed hemorrhoids, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani, prostatitis, prostatocystitis, varicose veins, autoimmune liver inflammation, autoimmune kidney inflammation, vein inflammation and other inflammations, skin cancers, breast cancer, colon-rectum cancer, oral cancer, and other cancers, scars, abnormal vascular skin lesions, birthmarks, moles (nevi), skin tags, aging spots (liver spots), and other skin disorders. These pro-drugs can be administered transdermally without the help of skin penetration enhancers.

Priority: WO2007IB52090 Applic. Date: 2007-06-04

Inventor: YU CHONGXI [US]; XU LINA [CN]


Application No.: US20100172993A1  Published: 08/Jul/2010

Title: PARTICLES FOR DELIVERY OF ACTIVE INGREDIENTS, PROCESS OF MAKING AND COMPOSITIONS THEREOF

Applicant/Assignee:

Application No.: 12/377185   Filing Date: 10/Aug/2007

Abstract:The present invention discloses compositions having particles comprising, inorganic element

one or more active ingredient and optionally a release rate modulating agent, suitable for the delivery of active ingredients to human and animal tissues. The particles are nanoparticles or microparticles or mixtures thereof, made preferably by sol-gel method. The compositions are useful for application to the topical or mucosal surfaces preferably in the form of creams, gels, lotions, dry powders, spray, foam and other suitable forms.

Priority: IN2006MU01276 Applic. Date: 2006-08-11; IN2007MU00666 Applic. Date: 2007-04-03; WO2007IN00340 Applic. Date: 2007-08-10

Inventor: SINGH AMARJIT [IN]; SINGH SARABJIT [IN]; SINGH PARAMJIT [IN]; JAIN RAJESH [IN]


Application No.: US20100173003A1  Published: 08/Jul/2010

Title: COMPOSITION AND METHOD FOR ENCAPSULATING BENEFIT AGENTS

Applicant/Assignee: AMCOL INTERNATIONAL

Application No.: 12/601686   Filing Date: 27/May/2008

Abstract:A benefit agent encapsulated in a particulate-based encapsulant, and a method of manufacturing the encapsulated benefit agent, are disclosed.

Priority: US20070939988P Applic. Date: 2007-05-24; WO2008US64884 Applic. Date: 2008-05-27

Inventor: SENGUPTA ASHOKE K [US]; KOTLOSKI DAVE [US]; LOSACCO VINCENT J [US]; MCGREGOR DAVID [US]


Application No.: US20100173007A1  Published: 08/Jul/2010

Title: COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS IN MAMMALS

Applicant/Assignee:

Application No.: 12/725986   Filing Date: 17/Mar/2010

Abstract:A topical composition for treating skin diseases is provided. The composition comprises calendula, tea tree oil, eucalyptus oil, grape seed oil, and Aloe Vera. In some embodiment, the composition may also include beeswax, vegetable oil, vitamin E, rosemary oil, or shea butter or combinations thereof to further enhance its beneficial effects.

Priority: US2007-961333 Applic. Date: 2007-12-20

Inventor: DILEVA ROSE MARIE [US]


Application No.: US20100173008A1  Published: 08/Jul/2010

Title: METHOD OF TREATING OR ALLEVIATING THE SYMPTOMS OF ALESION IN MAMMAL

Applicant/Assignee:

Application No.: 12/727991   Filing Date: 19/Mar/2010

Abstract:Provided is a new use of Brown's gas, more particularly, to the use of Brown's gas for the treatment of diseases in mammals and a Brown's gas supply apparatus therefor. It is based on the assumption that the Brown's gas is a medium capable of directly supplying moisture (special form of water according to the third theory of Brown's gas) to many regions of the body via skin, etc. Various effects of the Brown's gas on the body have been demonstrated. In particular, provided is a new use of the Brown's gas for treatment or alleviation of the symptoms of a lesion in a lesional tissue, cell, or organ of a mammal. Provided is also a simple and inexpensive Brown's gas supply apparatus for supplying pure Brown's gas suitable to be applied to the human body.

Priority: KR20030083814 Applic. Date: 2003-11-24; US2004-580741 Applic. Date: 2004-11-24; WO2004KR03047 Applic. Date: 2004-11-24

Inventor: KANG SONG DOUG [KR]


Application No.: US20100173017A1  Published: 08/Jul/2010

Title: Method of manufacturing skin care cream containing baked shell powder

Applicant/Assignee: KABUSHIKI KAISHA ASADASYOKAI

Application No.: 12/656077   Filing Date: 15/Jan/2010

Abstract:In a method of manufacturing a skin care cream containing baked shell powder, highly calcium-containing shells such as dead shells or pearls is baked and crushed to fine powder to obtain baked shell powder. Then, the obtained baked shell powder is added to mix with a raw material for manufacturing cosmetic cream.

Priority: JP20050066248 Applic. Date: 2005-02-10; JP20050291659 Applic. Date: 2005-09-05; US2007-884023 Applic. Date: 2007-08-09; WO2006JP302391 Applic. Date: 2006-02-10

Inventor: SANADA KAZUNOBU [JP]


Application No.: US20100173021A1  Published: 08/Jul/2010

Title: Topical Product formulations containing strontium for reducing skin irritation

Applicant/Assignee: COSMEDERM TECHNOLOGIES, INC

Application No.: 12/654563   Filing Date: 23/Dec/2009

Abstract:Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.

Priority: US2007-979154 Applic. Date: 2007-10-31; US2001-992491 Applic. Date: 2001-11-21; US2001-871576 Applic. Date: 2001-05-31; US1998-149886 Applic. Date: 1998-09-08; US1996-666978 Applic. Date: 1996-06-20; US1994-362100 Applic. Date: 1994-12-21

Inventor: HAHN GARY S [US]; THUESON DAVID O [US]


Application No.: US20100173027A1  Published: 08/Jul/2010

Title: O/W EMULSION FOR HAND CARE

Applicant/Assignee: BEIERSDORF AG

Application No.: 12/303560   Filing Date: 24/May/2007

Abstract:An O/W emulsion which comprises one or more fatty alcohols, one or more glycerol esters of fatty acids and at least 15% by weight, based on the total weight of the emulsion, of at least one moisturizer. Also disclosed is a cosmetic composition which comprises the emulsion.

Priority: DE200610027138 Applic. Date: 2006-06-08; WO2007EP55032 Applic. Date: 2007-05-24

Inventor: KROEPKE RAINER [DE]; HAHN INGO [DE]; LEMM CHRISTEL [DE]


Application No.: US20100173853A1  Published: 08/Jul/2010

Title: COMBINATION OF MONOSACCHARIDES WITH ASCORBIC ACID AND USE THEREOF

Applicant/Assignee: L'OREAL

Application No.: 12/649370   Filing Date: 30/Dec/2009

Abstract:Composition containing a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one additional compound chosen from ascorbic acid, an analogue thereof and a mixture thereof. The present invention also relates to the use of such a composition for combating the signs of ageing, and also to a device containing the composition.

Priority: FR20080059152 Applic. Date: 2008-12-30; US20090145119P Applic. Date: 2009-01-16

Inventor: LABOUREAU JULIEN [FR]; SIMONNET JEAN-THIERRY [FR]; PORTES PASCAL [FR]


Application No.: US20100174164A1  Published: 08/Jul/2010

Title: TRANSCUTANEOUS ANALYTE SENSOR

Applicant/Assignee: DEXCOM, INC

Application No.: 12/728032   Filing Date: 19/Mar/2010

Abstract:The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Priority: US2005-077714 Applic. Date: 2005-03-10; US20040587787P Applic. Date: 2004-07-13; US20040587800P Applic. Date: 2004-07-13; US20040614683P Applic. Date: 2004-09-30; US20040614764P Applic. Date: 2004-09-30

Inventor: BRISTER MARK [US]; NEALE PAUL V [US]; BRAUKER JAMES [US]


Application No.: US20100175167A1  Published: 15/Jul/2010

Title: Foot moisturizing sock

Applicant/Assignee:

Application No.: 12/590423   Filing Date: 09/Nov/2009

Abstract:The present invention is a durable yet disposable plastic sock with an expandable opening designed to enclose foot care products allowing user to receive foot care treatments while granting mobility during the process.

Priority: US20090144142P Applic. Date: 2009-01-12

Inventor: RIETZSCH LINDSEY K [US]; RIETZSCH MANUEL MICHAEL [US]


Application No.: US20100175704A1  Published: 15/Jul/2010

Title: Device for applying a product

Applicant/Assignee: L'OREAL S.A

Application No.: 12/659393   Filing Date: 08/Mar/2010

Abstract:A device for applying a product may comprise a first portion and a second portion moveable with respect to the first portion so as to selectively place the device in one of a closed position and an open position. The first portion and the second portion may define a substantially closed reservoir when the device is in the closed position. The device may further comprise an application member. The application member may be at least partially compressible and configured such that, when the device is in the closed position, the application member is at least partially compressed inside the substantially closed reservoir and, when the device is moved from the closed position to the open position, the application member becomes substantially uncompressed.

The application member may be configured so that when the application member is uncompressed, the application member is capable of being loaded with substantially all of an amount of product that the device is capable of containing.

Priority: FR20010001373 Applic. Date: 2001-02-01; US2002-060234 Applic. Date: 2002-02-01

Inventor: GUERET JEAN-LOUIS H [FR]


Application No.: US20100178257A1  Published: 15/Jul/2010

Title: BLOCK POLYMER, COSMETIC COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS

Applicant/Assignee: L'OREAL

Application No.: 12/506511   Filing Date: 21/Jul/2009

Abstract:A block polymer containing, in a block with a Tg of less than 20 DEG C., at least one monomer of formula (I): The invention also relates to a cosmetic composition containing the block polymer in a cosmetically acceptable medium, and also to a cosmetic process for treating keratin materials using the composition, and most particularly to a process for making up the lips.

Priority: FR20080055069 Applic. Date: 2008-07-24; US20080095056P Applic. Date: 2008-09-08

Inventor: FARCET CELINE [FR]


Application No.: US20100178258A1  Published: 15/Jul/2010

Title: COMPOSITION AND METHOD FOR THE TREATEMENT OF SKIN IRRITATIONS

Applicant/Assignee: SIMPLURE, LLC

Application No.: 12/507601   Filing Date: 22/Jul/2009

Abstract:A composition is provided that is suitable for topical administration for the treatment of a skin irritation, the composition comprising acetylsalicylic acid and sodium bicarbonate. Also provided is a method for treating a skin irritation in an individual comprising topically administering to the affected area a therapeutically effective amount of a composition comprising acetylsalicylic acid and sodium bicarbonate. The composition is particularly useful for decreasing the temperature at the surface of a sunburn and for reducing pain and discomfort caused by a sunburn.

Priority: US2002-171253 Applic. Date: 2002-06-12

Inventor: FULLER PETER E [US]


Application No.: US20100178261A1  Published: 15/Jul/2010

Title: Cationic Cassia Derivatives and Applications Therefor

Applicant/Assignee:

Application No.: 12/732659   Filing Date: 26/Mar/2010

Abstract:This invention relates to cationically derivatized polycalactomannans obtained from cassia tora and cassia obtusifolia and to their use in personal care, household care, and institutional care compositions.

Priority: US2008-254437 Applic. Date: 2008-10-20; US2007-843920 Applic. Date: 2007-08-23; US2004-874296 Applic. Date: 2004-06-18; US20030479793P Applic. Date: 2003-06-19

Inventor: LEPILLEUR CAROLE A [US]


Application No.: US20100178286A1  Published: 15/Jul/2010

Title: METHODS AND COMPOSITIONS FOR REDUCING FACIAL LINES AND WRINKLES

Applicant/Assignee:

Application No.: 12/651932   Filing Date: 04/Jan/2010

Abstract:A dietary supplement composition comprising a therapeutically effective amount of at least one sirt 1 activating agent, a therapeutically effective amount of at least one Qi activating agent, and an therapeutically effective amount of at least one adaptogen is disclosed. An optional herbal treatment for stress-related deep wrinkles comprises chronic oral administration for at least two weeks of a beverage containing an effective amount of a valerian root extract sufficient to provide a desired reduction in the appearance of the deep wrinkles. A photoprotective agent may also be included. Also included are a microcirculation increasing agent. Also optional are an herbal toner and topical cellulite product.

Priority: WO2008US84730 Applic. Date: 2008-11-25; US2007-947465 Applic. Date: 2007-11-29; US20070962496P Applic. Date: 2007-07-27

Inventor: SMITH WALTER P [US]


Application No.: US20100178319A1  Published: 15/Jul/2010

Title: Topical Dermal Delivery Device For Nitric Oxide Delivery

Applicant/Assignee:

Application No.: 12/593605   Filing Date: 27/Mar/2007

Abstract:A topical dermal delivery device, such as a patch, for topical delivery of nitric oxide (NO) to treatment sites of mammals is disclosed. In an embodiment the patch has three layers

a backing with an activation window, a absorbent core as a reservoir and an NO permeable membrane with an adhesive layer towards the skin. The NO donor is applied into the device as a solution prior to application through the activation window. The window is closed after activation and the lid and backing is non-permeable for NO in order to increase the partial pressure of NO and thus the concentration of dissolved NO. The patch is fixated on the area to be treated with an adhesive layer that also assures sufficient contact throughout the treatment. The generated NO moves within the patch and can escape through the NO permeable membrane towards the area to be treated. Depending on therapy needed, the patch release curve differs and is chosen accordingly.

Priority: WO2007EP52923 Applic. Date: 2007-03-27

Inventor: LINDGREN LARS [SE]; MAARLIND LINDA [SE]; THORSEN RIKARD [SE]


Application No.: US20100178323A1  Published: 15/Jul/2010

Title: Dermal Delivery Device

Applicant/Assignee:

Application No.: 12/687489   Filing Date: 14/Jan/2010

Abstract:A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%.

Priority: WO2008US69618 Applic. Date: 2008-07-10; WO2008US69622 Applic. Date: 2008-07-10; US20070948757P Applic. Date: 2007-07-10; US20070948759P Applic. Date: 2007-07-10

Inventor: KYDONIEUS AGIS [US]; CONWAY ROBERT G [US]; ROSSI THOMAS M [US]


Application No.: US20100178391A1  Published: 15/Jul/2010

Title: FLEXIBLE PAD FOR PREPARING A BEVERAGE

Applicant/Assignee:

Application No.: 11/577078   Filing Date: 24/Oct/2005

Abstract:The present invention provides a flexible pad for preparing a beverage comprising: a filter bag defining a storage volume

the storage volume containing a water-soluble composition or a combination or mixture of water-soluble compositions for forming a beverage

wherein the storage volume further contains one or more absorbent elements.

Priority: GB20040023533 Applic. Date: 2004-10-22; WO2005GB04108 Applic. Date: 2005-10-24

Inventor: MACMAHON JOHN [GB]; NORTON MARK [GB]; BROWN PHIL [GB]; SUSAN RODETT [US]; TROUILLOT AUDREY [GB]; LAUDANO RAY [US]; FENNEL ADAM [GB]; PANESAR SATWINDER [GB]; ROWAN LEE [GB]; FERGUSON JAMES [GB]; HUDSON HEATHER [US]; GAONKAR ANILKUMAR [US]; ZELLER BARY [US]


Application No.: US20100179200A1  Published: 15/Jul/2010

Title: 2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID COMPOUNDS FOR PROMOTING DESQUAMATION OF THE SKIN

Applicant/Assignee: SOCIETE L'OREAL, S.A

Application No.: 12/683088   Filing Date: 06/Jan/2010

Abstract:2-oxothiazolidine-4-carboxylic acid compounds having the structural formula (I): are suited for promoting desquamation of the skin and/or stimulating epidermal renewal and/or combating aging of the skin.

Priority: FR20000014865 Applic. Date: 2000-11-17; US2007-806218 Applic. Date: 2007-05-30; US2003-440316 Applic. Date: 2003-05-19; WO2001FR03523 Applic. Date: 2001-11-12

Inventor: GALEY JEAN-BAPTISTE [FR]; BERNARD DOMINIQUE [FR]; SIMONETTI LUCIE [FR]


Application No.: US20100179209A1  Published: 15/Jul/2010

Title: Pactimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/688310   Filing Date: 15/Jan/2010

Abstract:Administration of at least one compound selected from N-(1-octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide (pactimibe) of formula (I): or pharmaceutically acceptable salt and pharmaceutically acceptable solvate thereof, is useful for preventing or treating a disorder due to a sebaceous gland dysfunction in humans or animals, for example acne and/or any state or pathological condition related to an overproduction of sebum, e.g., seborrhoeic dermatitis, greasy skin or a greasy scalp.

Priority: FR20070056602 Applic. Date: 2007-07-19; WO2008FR51345 Applic. Date: 2008-07-17

Inventor: BIADATTI-PORTAL THIBAUD [FR]


Application No.: US20100179219A1  Published: 15/Jul/2010

Title: Plane Tree Cream, Method for the Production Thereof and Use

Applicant/Assignee: WALA-HEILMITTEL GMBH

Application No.: 12/377206   Filing Date: 13/Aug/2007

Abstract:In order to prevent betulinic acid from crystallizing in a galenic preparation containing water, a plane tree cream in the form of a stable emulsion containing oil and water is proposed, which is characterized by a content of 2 to 10% by weight of a plane tree extract obtained from the bark of plane trees, 0.1 to 9.9% by weight of glycerol, 0.1 to 1.9% by weight of a gelatinizing agent and 5 to 15% by weight of a preservative. The plane tree extract used is obtained by extracting plane tree bark with a low alkanol. The plane tree cream is used for the topical treatment of the skin, including the mucous membranes.

Priority: DE200610038471 Applic. Date: 2006-08-17; WO2007EP07140 Applic. Date: 2007-08-13

Inventor: MEYER ULRICH [DE]


Application No.: US20100179226A1  Published: 15/Jul/2010

Title: Topical Dosage Form Comprising Tri-Substituted Glycerol Compounds

Applicant/Assignee: ALPHAPTOSE GMBH

Application No.: 12/520368   Filing Date: 09/Nov/2007

Abstract:The present invention relates to pharmaceutical dosage forms for topical administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The invention also relates to a corresponding method for preparing such dosage forms as well as to their use as medicaments for the treatment of cancer and immune diseases.

Priority: US20060875962P Applic. Date: 2006-12-20; WO2007EP62179 Applic. Date: 2007-11-09

Inventor: DIEDERICHS JULIA [DE]; RICHTER WOLFGANG [DE]; WEBER LUTZ [DE]


Application No.: US20100179403A1  Published: 15/Jul/2010

Title: METHOD AND KIT FOR SWEAT ACTIVITY MEASUREMENT

Applicant/Assignee: BIOGAUGE - NORDIC BIOIMPEDANCE RESEARCH AS

Application No.: 12/666050   Filing Date: 01/Jul/2008

Abstract:The invention relates to sweat activity measurement, e.g. for determining a physiological state of a subject, embodied by a method as well as a kit with an immittance measuring circuit and electrodes with contact electrolyte. Sweat activity is considered a transport phenomenon and can be defined as a flux, e.g. gram water per skin area per second. Prior art methods determining water absorbed per gram dry stratum corneum measures skin moisture and do not truly reflect sweat activity. A periodic signal with frequency of 60 Hz or lower is applied to reduce contribution from complex admittance of the skin, and skin conductance is measured as a degree of sweat activity. The contact electrolyte allows filling of sweat ducts with sweat from sweat glands, this may be characterized in that it does not substantially fill the sweat ducts when being positioned on the skin and/or in that it has a re-absorption time constant from the sweat ducts into the Epidermis of less than 15 min.

Priority: US20070947547P Applic. Date: 2007-07-02; WO2008EP58437 Applic. Date: 2008-07-01

Inventor: MARTINSEN ORJAN GROTTEM [NO]; GRIMNES SVERRE JORAN [NO]; FOSSE ERIK [NO]


Application No.: US20100179469A1  Published: 15/Jul/2010

Title: Organic Light Emitting Diode Phototherapy Lighting System

Applicant/Assignee: PLEXTRONICS, INC

Application No.: 12/652359   Filing Date: 05/Jan/2010

Abstract:A lighting system includes a plurality of organic light emitting diode (OLED) devices. By selecting the plurality of OLED devices, or by selectively controlling the plurality of OLED devices, the color characteristics of the lighting system can be tuned. The lifespan of the lighting system can be improved.

Priority: US20090142403P Applic. Date: 2009-01-05; US20090167352P Applic. Date: 2009-04-07

Inventor: HAMMOND TROY [US]; NAIK SUJIT [US]; PATTISON LISA [US]


Application No.: US20100180902A1  Published: 22/Jul/2010

Title: METHODS FOR DIAGNOSING SKIN LESIONS

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/726003   Filing Date: 17/Mar/2010

Abstract:Methods for diagnosing skin lesions are disclosed. Generally, the method include topically administering an IRM compound to a treatment area for a period of time and in an amount effective to cause a visible change in the appearance of a skin lesion including, in some cases, causing subclinical lesions to become visible. Suitable IRM compounds include agonists of one or more TLRs.

Priority: US2004-799997 Applic. Date: 2004-03-12; US20030454244P Applic. Date: 2003-03-13

Inventor: MILLER RICHARD L [US]; LEE JAMES H [US]; FOX TERRANCE L [US]


Application No.: US20100181223A1  Published: 22/Jul/2010

Title: Array Of Multi-Staged Cleaning Wipes

Applicant/Assignee:

Application No.: 12/717974   Filing Date: 05/Mar/2010

Abstract:An array of multi-stage configured cleansing wipe products may include first stage cleansing wipes and second stage cleansing wipes. The first stage cleansing wipes may have a first structure and a first composition selected in view of a first child developmental stage. The second stage cleansing wipes may have a second structure and a second composition selected in view of a second child developmental stage. The first structure and the first composition are different and potentially progressive from first stage to second stage. First stage product packaging may include at least one first stage-specific indicia and second stage product packaging may include at least one second stage-specific indicia. Stages of the array may be communicated and tailored based upon the foods eaten and the manner of eating (such as being fed or self-feeding) of the babies or children in each stage.

Priority: US2006-415709 Applic. Date: 2006-05-01

Inventor: WARREN ADAM MATTHEW [US]; ROSAR MARKUS [DE]; ALEGRE DE MIQUEL MARITA [DE]; KREUZER NATASCHA [DE]; WELLING JANE HOOPER [US]; BENJAMIN JOYCE MARIE [US]; NORMAN JOSHUA JAMES [US]; KING MELISSA MARIE [US]


Application No.: US20100183519A1  Published: 22/Jul/2010

Title: Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof

Applicant/Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION

Application No.: 12/663583   Filing Date: 06/Jun/2008

Abstract:This invention relates to therapeutic compositions comprising a surface active copolymer, such as poloxamer-188, in an amount effective to enhance microvascular blood flow and/or inflammation in injured skin or other tissue, and methods of using the therapeutic compositions of the invention to inhibit decreased blood flow associated with an injury, disease, or disorder.

Priority: US20070933902P Applic. Date: 2007-06-08; WO2008US66094 Applic. Date: 2008-06-06

Inventor: KATZ ADAM J [US]; RODEHEAVER GEORGE T [US]


Application No.: US20100183526A1  Published: 22/Jul/2010

Title: TIGER NUT MILK BASE CONCENTRATE AND METHOD FOR OBTAINING A COSMETIC PRODUCT FROM SAID BASE CONCENTRATE

Applicant/Assignee: HORCHATERIA DANIEL S.L

Application No.: 12/452804   Filing Date: 24/Jul/2008

Abstract:The present invention relates to a method for obtaining a cosmetic product from a tiger nut milk concentrate, characterized in that it comprises: a) mixing in a tank sugar-free tiger nut milk with cosmetic ingredients and thermal deionized distilled water

b) mixing in a second tank surfactants with molasses alcohol

c) mixing the products resulting from the previous steps in order to produce a base concentrate

d) applying ultrasounds to said base concentrate

and f) adding pharmaceutically acceptable excipients, as well as to the base concentrate, and to the cosmetic product resulting from said method.

Priority: ES20070002058 Applic. Date: 2007-07-24; WO2008ES00515 Applic. Date: 2008-07-24

Inventor: TORTAJADA FORNER DANIEL [ES]; NOVEJARQUE CONDE JOSE ANTONIO [ES]


Application No.: US20100183528A1  Published: 22/Jul/2010

Title: ACNE TREATMENT POWDER FOUNDATION

Applicant/Assignee: HARMONY LABORATORIES, INC

Application No.: 12/639851   Filing Date: 16/Dec/2009

Abstract:Dry powder foundation formulations that include a sustained-release salicylic acid composition, an effective, buffering amount of one or more salicylate ions, and one or more of zinc and titanium oxides, and pigments or colorants, are disclosed. The formulations provide both acne treatment and prevention, and sunblock protection. The formulation can also include other sunblocking or sunscreen agents to prevent photoaging and sunburn, such as avobenzone, and 3-benzophenone, and other cosmetically-acceptable active agents and excipients.

Priority: US20080138436P Applic. Date: 2008-12-17

Inventor: MALONEY JOHN D [US]; BARGER KATHERINE NATALIE [US]


Application No.: US20100183537A1  Published: 22/Jul/2010

Title: STABLE AND BIOAVAILABLE COMPOSITIONS OF ISOMERS OF CAROTENOIDS FOR SKIN AND HAIR

Applicant/Assignee: NESTEC S.A

Application No.: 12/376662   Filing Date: 07/Aug/2007

Abstract:Compositions that provide health benefits and methods regarding same are presented. In an embodiment, the present invention provides a primary composition comprising at least one carotenoid-containing material, enriched in Z isomers of the carotenoid compound. For example, the carotenoid-containing material contains by weight a greater percentage of an isomer selected from the group consisting of 5-Z, 9-Z and combinations thereof than of 13-Z isomer.

Priority: EP20060118579 Applic. Date: 2006-08-08; WO2007EP06972 Applic. Date: 2007-08-07

Inventor: BORTLIK KARLHEINZ [CH]; LAMBELET PIERRE [CH]; RICHELLE MYRIAM [CH]


Application No.: US20100183539A1  Published: 22/Jul/2010

Title: Personal Care Compositions of Sulfonated Estolides and Other Derivatives of Fatty Acids and Uses Thereof

Applicant/Assignee:

Application No.: 12/506930   Filing Date: 21/Jul/2009

Abstract:Formulations of personal care compositions and personal care concentrate compositions containing sulfo-estolides are described. Personal care compositions of the present technology include liquid hand soaps, bath and shower washes, shampoos, 2-in-1 or 3-in-1 shampoos, antidandruff shampoo, facial cleaners, among others.

Priority: WO2009US31608 Applic. Date: 2009-01-21

Inventor: BERNHARDT RANDAL J [US]; DADO GREGORY P [US]; SAJIC BRANKO [US]; SHAPIRO IRENE [US]


Application No.: US20100183688A1  Published: 22/Jul/2010

Title: Delivery System and Method of Manufacturing the Same

Applicant/Assignee: AMCOL INTERNATIONAL CORPORATION

Application No.: 12/373769   Filing Date: 23/Jul/2007

Abstract:A microparticle delivery system for an active compound which includes an active compound loaded onto polymeric microparticles, wherein the loaded microparticles are encased by a matrix material comprising about 68% to about 99%, by weight, of the microparticle delivery system. Compositions containing the microparticle delivery system, and methods of manufacturing the microparticle delivery system, also are disclosed.

Priority: US20060832880P Applic. Date: 2006-07-24; WO2007US16516 Applic. Date: 2007-07-23

Inventor: LIU LIMIN [US]; SPINDLER RALPH [US]; URBANEC STEPHEN J [US]; VAKILI-TAHAMI GHOLAM-REZA [US]; SENGUPTA ASHOKE K [US]; CURETON KEVIN [US]


Application No.: US20100183691A1  Published: 22/Jul/2010

Title: Use of Titanium metal fine-particles for increasing the effect of Germicidal medicines used for human skin dermatosis, skin infection and traumatism

Applicant/Assignee:

Application No.: 12/683478   Filing Date: 07/Jan/2010

Abstract:The use of Titanium metal fine-particles for increasing of effect of the germicidal medicines used for human skin, skin infection and traumatism, is provided. The application of the Titanium metal fine-particles layer being laid on or close to skin, in combination with a medicine, functions to restrain bacteria breeding and multiplying, accelerate skin and dermic-organism metabolism, and promoting capillary purification. By these functions, an environment which is harmful and fatal for bacteria breeding/multiplying will be developed on the human body skin and dermic-organism. These functions are demonstrated by the increased effects of the germicidal medicines which are used for human skin dermatosis, skin infection and traumatism.

Priority: CN20091045915 Applic. Date: 2009-01-22

Inventor: ZHU XIAOSONG [CA]


Application No.: US20100183692A1  Published: 22/Jul/2010

Title: COMPOSITIONS

Applicant/Assignee:

Application No.: 12/665490   Filing Date: 17/Jun/2008

Abstract:Provided are essentially preservative-free personal care product compositions that comprise a combination of fragrance compounds that stabilises the personal care product against microorganisms. The combination comprises certain benzaldehyde or benzaldehyde derivative compounds combined with certain fragrant acids. The composition is free of classical preservatives including parabens or their derivatives. Further provided are methods of forming such compositions and products and the use of the combination of fragrance compounds in such compositions and products.

Priority: GB20070012024 Applic. Date: 2007-06-22; WO2008CH00273 Applic. Date: 2008-06-17

Inventor: NATSCH ANDREAS [CH]


Application No.: US20100183723A1  Published: 22/Jul/2010

Title: Fetal Skin Cell Protein Compositions for the Treatment of Skin Conditions, Disorders or Diseases and Methods of Making and Using the Same

Applicant/Assignee: NEOCUTIS S.A

Application No.: 12/710437   Filing Date: 23/Feb/2010

Abstract:The present invention provides methods and compositions designed for treating a subject suffering from skin conditions, disorders or diseases. The compositions include fetal skin cell proteins obtained from fetal skin cells after induced cell lysis.

Priority: US2005-226558 Applic. Date: 2005-09-14; US20040610613P Applic. Date: 2004-09-15; US20050641067P Applic. Date: 2005-01-03

Inventor: LAURENT-APPLEGATE LEE [CH]; HOHLFELD PATRICK [CH]


Application No.: US20100183741A1  Published: 22/Jul/2010

Title: DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/635824   Filing Date: 11/Dec/2009

Abstract:Dermatological compositions contain, formulated into a physiologically acceptable medium, at least one retinoid compound selected from among all-trans retinoic acid, isotretinoin, motretinide, and naphthoic acid compounds of formula (I), and salts and esters thereof: wherein R is a hydrogen atom, a hydroxyl radical, a branched or unbranched alkyl radical having from 1 to 4 carbon atoms, an alkoxy radical having from 1 to 10 carbon atoms or a cycloaliphatic radical which is substituted or unsubstituted, and at least one anti-irritant compound and benzoyl peroxide.

Priority: FR20070055655 Applic. Date: 2007-06-11; WO2008EP57312 Applic. Date: 2008-06-11; US20070929204P Applic. Date: 2007-06-18

Inventor: MALLARD CLAIRE [FR]


Application No.: US20100184637A1  Published: 22/Jul/2010

Title: PHARMACEUTICAL AND/OR COSMETIC COMPOSITION CONTAINING AN ACTIVE ANTIOXYDANT PRINCIPLE AND CELL ENERGY ACTIVATOR

Applicant/Assignee: SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS S.A. (ISP VINCIENCE)

Application No.: 12/597862   Filing Date: 27/Oct/2009

Abstract:A cosmetic or pharmaceutical composition, and particularly dermatological composition, comprising, in a physiologically adapted medium, as active principle, polypeptides or peptides, and methods of administering a composition capable of increasing cell energy and to protect the skin from oxidative damage. Also, a cosmetic treatment procedure aimed at protecting the skin and the skin appendages from external aggressions and to combat skin aging.

Priority: FR20070003063 Applic. Date: 2007-04-27; WO2008FR00575 Applic. Date: 2008-04-23

Inventor: DAL FARRA CLAUDE [FR]; DOMLOGE NOUHA [FR]; BOTTO JEAN-MARIE [FR]


Application No.: US20100184689A1  Published: 22/Jul/2010

Title: Pharmaceutical Composition Containing Botulinum Neurotoxin

Applicant/Assignee: IPSEN DEVELOPMENTS LIMITED

Application No.: 12/748733   Filing Date: 29/Mar/2010

Abstract:A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of

(a) a much longer duration of action

(b) a much faster rate of onset of muscular paralysis

(c) a significantly greater intramuscular safety margin

(d) a selective action on inhibition of skeletal muscle contraction

(e) a selective action on inhibition of pain-related (nociceptive) nerve cell function: Wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1.

Priority: GB20040017367 Applic. Date: 2004-08-04; GB20040021288 Applic. Date: 2004-09-24; GB20040021290 Applic. Date: 2004-09-24; GB20040023952 Applic. Date: 2004-10-28; GB20040023953 Applic. Date: 2004-10-28; US2007-659448 Applic. Date: 2007-08-13; WO2005GB03036 Applic. Date: 2005-08-03

Inventor: PANJWANI NAVEED [GB]; WEBB PAUL [GB]; PICKETT ANDY [GB]


Application No.: US20100184733A1  Published: 22/Jul/2010

Title: SKIN TREATMENT COMPOSITION

Applicant/Assignee: EVONIK GOLDSCHMIDT GMBH

Application No.: 12/445365   Filing Date: 19/Mar/2010

Abstract:The invention discloses skin treatment compositions consisting essentially of a mixture of ceramides, cholesterol, free fatty acids-the mixture being able to mimic skin identical lamellar structures-and nonionic emulsifiers. These compositions are liquid and pumpable at room temperature which means that they can be incorporated easily into cosmetic formulations with no need for heating. Furthermore, the skin treatment compositions allow the stable inclusion of long-chain ceramides into oil-in-water emulsions as well as into water-in-oil emulsions. Inclusion of short chain ceramides that can act as dermatological regulators did not affect the lamellar lipid organization. The skin treatment compositions are claimed as well as their use in cosmetic and dermatological formulations.

Priority: WO2006EP09919 Applic. Date: 2006-10-13

Inventor: KOREVAAR CORNELIS GERRIT NIJS [NL]; FARWICK MIKE [DE]; MEYER JUERGEN [DE]; LERSCH PETER [DE]; REIDICK WILMA [DE]; WEITEMEYER CHRISTIAN [DE]


Application No.: US20100184786A1  Published: 22/Jul/2010

Title: Polar Quinazolines

Applicant/Assignee: WYETH LLC

Application No.: 12/622058   Filing Date: 19/Nov/2009

Abstract:Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): in which, R1, R2, R3, R4, R5, R6, R22, R23, R24, R25, R26, R27, R28, R29, W, W1, W2, Ra, Rb, Rc, Rd, Re, Rf, Rg, Rh, Ri, Rj, Rm, Rn, Ro, Rp, Rq, Rr, Rs, Rt, Ru, and n can be as defined anywhere herein. In general, these compounds can be used for treating or preventing one or more diseases, disorders, conditions or symptoms mediated by LXRs.

Priority: US20080116272P Applic. Date: 2008-11-19

Inventor: TRAVINS JEREMY MARK [US]; BERNOTAS RONALD CHARLES [US]; WROBEL JAY EDWARD [US]; KAUFMAN DAVID HARRY [US]; HU BAIHUA [US]; JETTER JAMES WINFIELD [US]; O'NEILL DAVID JOHN [US]; MANN CHARLES WILLIAM [US]


Application No.: US20100184817A1  Published: 22/Jul/2010

Title: METHODS OF TREATING NEUROPATHY

Applicant/Assignee: TARAXOS INC

Application No.: 12/749183   Filing Date: 29/Mar/2010

Abstract:Methods and compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and methods for administering the compositions to treat various neuropathies.

Priority: US2002-307509 Applic. Date: 2002-11-25

Inventor: WOLICKI RICHARD [US]


Application No.: US20100184847A1  Published: 22/Jul/2010

Title: COMPOSITIONS FOR SKIN PROTECTION AND IMPROVEMENT OF SKIN DISEASES CONTAINING THE DIBENZO-P-DIOXINE DERIVATIVES

Applicant/Assignee: LIVECHEM, INC

Application No.: 12/670062   Filing Date: 30/Jul/2008

Abstract:The present invention relates to compositions for skin protection and improvement that contain dibenzo-p-dioxine derivatives as effective components. Since the compositions for skin protection and improvement that contain the dibenzo-p-dioxine derivative according to the present invention have excellent functions such as moisturizing and/or wrinkle prevention which are useful in prevention and improvement of various skin diseases, they can be extensively used as cosmetic ingredients or pharmaceutical agents for prevention and improvement of skin diseases.

Priority: KR20070076852 Applic. Date: 2007-07-31; WO2008KR04450 Applic. Date: 2008-07-30

Inventor: SHIN HYEON-CHEOL [KR]; HWANG HYE-JEONG [KR]


Application No.: US20100184855A1  Published: 22/Jul/2010

Title: Hard Surface Cleaner Compositions of Sulfonated Estolides and Other Derivatives of Fatty Acids and Uses Thereof

Applicant/Assignee:

Application No.: 12/507786   Filing Date: 22/Jul/2009

Abstract:Sulfo-estolides and formulations of sulfo-estolides in and as hard surface cleaners, glass cleaners, toilet bowl cleaners, carpet cleaners, all purpose cleaners, floor cleaners, and others are described. Further details of cleaning performance, stability of diluted and concentrated forms and contemplated cleaning applications are provided.

Priority: WO2009US31608 Applic. Date: 2009-01-21

Inventor: BERNHARDT RANDAL J [US]; ALONSO LOURDES R [US]; DADO GREGORY P [US]; PYTEL JACQUELINE MAAS [US]


Application No.: US20100184867A1  Published: 22/Jul/2010

Title: USE OF ACTIVE AGENTS FOR STIMULATING THE EXPRESSION OF FN3K AND/OR FN3K RP FOR COMBATING AGEING OF THE SKIN

Applicant/Assignee: CHANEL PARFUMS BEAUTE

Application No.: 12/664124   Filing Date: 13/May/2008

Abstract:A cosmetic process for caring for human skin, which is intended for preventing and/or combating at least one sign of ageing of the skin or the 'orange peel' appearance of the skin, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing and/or combating at least one sign of ageing of the skin or the 'orange peel' appearance of the skin associated with cellulite is also disclosed.

Priority: US20070943101P Applic. Date: 2007-06-11; WO2008EP55861 Applic. Date: 2008-05-13

Inventor: LASSERRE CHRISTELLE [US]; FEDOROVA ELENA [US]; MAESTRO YANNICK [FR]


Application No.: US20100185064A1  Published: 22/Jul/2010

Title: SKIN ANALYSIS METHODS

Applicant/Assignee:

Application No.: 12/690749   Filing Date: 20/Jan/2010

Abstract:The present invention generally relates to a skin care device comprising an electromagnetic radiation source capable of directing incident electromagnetic radiation to a location on the skin of a user, a radiation detector for measuring various parameters of radiation re-emitted from the location and a skin condition analysis module coupled to the detector, the analysis module capable of generating a skin condition assessment in real-time, based partly on at least one of RGB analysis and diffused reflectance analysis of the radiation parameters. In accordance with the described embodiments of the present technique, the device provides a mirror or a reflecting surface for capturing an image of desired body part and gets product recommendations. The recommended products are brought up on to the screen of the mirror to facilitate the consumer to choose there from. The device may be further connected to a computer and a database to get desired results for the consumer.

Priority: US2008-970448 Applic. Date: 2008-01-07; US2009-350164 Applic. Date: 2009-01-07; US2009-612297 Applic. Date: 2009-11-04; US20090145756P Applic. Date: 2009-01-20; US20090150010P Applic. Date: 2009-02-05; US20090149025P Applic. Date: 2009-02-02; US20090149027P Applic. Date: 2009-02-02; US20090150053P Applic. Date: 2009-02-05; US20090150331P Applic. Date: 2009-02-06; US20090169316P Applic. Date: 2009-04-15; US20090235362P Applic. Date: 2009-08-20; US20090254214P Applic. Date: 2009-10-23; US20070883769P Applic. Date: 2007-01-05; US20070883764P Applic. Date: 2007-01-05; US20070883768P Applic. Date: 2007-01-05; US20080019440P Applic. Date: 2008-01-07; US20080061852P Applic. Date: 2008-06-16

Inventor: BANDIC JADRAN [RS]; MEHENDALE RAHUL [US]; MARINKOVICH SAVA [US]; KORUGA DJURO [RS]


Application No.: US20100186140A1  Published: 29/Jul/2010

Title: Multi-sport hand covers and uses of said covers

Applicant/Assignee:

Application No.: 12/322060   Filing Date: 29/Jan/2009

Abstract:According to the various features characteristics and embodiments of the present invention which will become apparent as the description thereof proceeds, the present invention provides partial hand covers and the use of said covers, intended to increase the overall performance in sports activities.

Priority:

Inventor: RAMIREZ JOHN CUEVAS [US]


Application No.: US20100189662A1  Published: 29/Jul/2010

Title: DMS (derma membrane structure) in Foam Creams

Applicant/Assignee: NEUBOURG SKIN CARE GMBH & CO. KG

Application No.: 12/664732   Filing Date: 19/Jun/2008

Abstract:The invention relates to a foam formulation comprising an emulsion, comprising an oil phase and a water phase, the oil phase comprising at least one membrane-forming substance forming a lamellar membrane in the foam formulation.

Priority: EP20070110571 Applic. Date: 2007-06-19; WO2008EP57791 Applic. Date: 2008-06-19

Inventor: NEUBOURG THOMAS [DE]


Application No.: US20100189669A1  Published: 29/Jul/2010

Title: Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives

Applicant/Assignee:

Application No.: 12/692826   Filing Date: 25/Jan/2010

Abstract:Personal care compositions containing an active selected from the group consisting of phlorogine, phlorgine BG, deoxyArbutin, sucrose dilaurate, bakuchiol, pyrenoine, millet, arlatone dioic acid, cinnamic acid, ferulic acid, achromaxyl, methyl nicotinamide, oil soluble licorice extract, folic acid, undecylenic acid, zinc undecylenate, L-tryptophan, thiamine HCl, hexylresorcinol, lipidami red vine, dragosine, methyl gentisate, inositol, symdiol 68, laminaine, their salts, their derivatives, their precursors, and/or combinations thereof. Methods for regulating the condition of mammalian keratinous tissue by topically applying the personal care compositions are also provided.

Priority: US20090148081P Applic. Date: 2009-01-29

Inventor: HAKOZAKI TOMOHIRO [US]


Application No.: US20100189675A1  Published: 29/Jul/2010

Title: COSMETIC USE OF AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AS DESQUAMATING AGENT

Applicant/Assignee: L'OREAL

Application No.: 12/666466   Filing Date: 24/Jun/2008

Abstract:The present invention relates to the cosmetic use of at least one imidopercarboxylic acid derivative in a cosmetic composition comprising a physiologically acceptable medium, as agent for promoting desquamation of the skin and/or the scalp and/or for stimulating epidermal renewal, the associated method of cosmetic treatment and a composition comprising the said imidopercarboxylic acid derivative and a desquamating agent and/or an anti-ageing agent.

Priority: FR20070056026 Applic. Date: 2007-06-26; US20070981552P Applic. Date: 2007-10-22; WO2008IB52507 Applic. Date: 2008-06-24

Inventor: PELLETIER PASCALE [FR]


Application No.: US20100189709A1  Published: 29/Jul/2010

Title: ELASTASE INHIBITOR

Applicant/Assignee: KAO CORPORATION

Application No.: 12/753453   Filing Date: 02/Apr/2010

Abstract:An elastase inhibitor containing, as an active ingredient, a protein hydrolysate (with soybean protein hydrolysate and almond protein hydrolysate being excluded). Pharmaceuticals and cosmetics containing such an elastase inhibitor which exhibit an inhibitory effect against the growth of body hair, and skin aging preventing effect by restoring elasticity and tonicity of the skin and reducing wrinkles.

Priority: US2007-627704 Applic. Date: 2007-01-26; US2004-855358 Applic. Date: 2004-05-28

Inventor: MORIWAKI SHIGERU [JP]; MORISAKI NAOKO [JP]; HALL CHRISTINE [US]


Application No.: US20100189761A1  Published: 29/Jul/2010

Title: Methods for Prevention and/or Treatment of Capsular Contracture

Applicant/Assignee: J&E SOLUTIONS, LLC

Application No.: 12/617502   Filing Date: 12/Nov/2009

Abstract:Methods for prevention or treatment of capsular contracture following surgical implants and other fibrosis related conditions comprising applying a topical composition comprising a pharmaceutically acceptable keratolytic, a pharmaceutically acceptable protein denaturant, a hydrating agent, and combinations thereof are disclosed.

Priority: US20090146778P Applic. Date: 2009-01-23; US20090183150P Applic. Date: 2009-06-02

Inventor: FRIEDMAN JEANNE V [US]; RASKIN ELSA M [US]


Application No.: US20100189795A1  Published: 29/Jul/2010

Title: CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS

Applicant/Assignee: NEOCUTIS S.A

Application No.: 12/688107   Filing Date: 15/Jan/2010

Abstract:The present invention provides compositions containing one or more calcium sequestration agents and methods for topical application of such compositions to the skin to treat skin pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation, pigmentation changes due to skin aging, or any other skin conditions related with normal such as skin of color or abnormal pigmentation such as hypo- or hyper-pigmentation in humans.

Priority: US20090145325P Applic. Date: 2009-01-16

Inventor: DREHER FRANK [US]


Application No.: US20100189821A1  Published: 29/Jul/2010

Title: COMPOSITION OF SKIN EXTERNAL APPLICATION CONTAINING GINSENG BERRY EXTRACTS

Applicant/Assignee:

Application No.: 12/602421   Filing Date: 30/May/2008

Abstract:Disclosed herein is a. skin external composition containing ginseng berry extract. More specifically, disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract having the specific components and compositions, among the above-ground parts of ginseng, and thus promotes the production of collagen in the skin, shows an MMP-I inhibitory effect and, at the same time, has skin-aging inhibitory and wrinkle-reducing effects, resulting from antioxidant effects and DNA damage-protecting effects. Also disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract, which has a skin whitening effect resulting from the effects of inhibiting melanin production and reducing pigmentation caused by UV radiation, the effects of relieving dry skin symptoms and atopic symptoms by inducing and maintaining the normal differentiation of skin keratinocytes, the effect of relieving acne and skin troubles by the regulation of sebum secretion and an anti-inflammatory effect, and makes complexion ruddy through the improvement of peripheral blood circulation to make the skin clean and clear. Also disclosed is a food composition for reducing and preventing obesity, which contains, as an active ingredient, ginseng berry extract, which increases the expression of a carnitine palmitoyl transterase-1 (CPT-I) gene, serves to transport fatty acids into mitochondria in fatty acid oxidation and promotes fat oxidation.

Priority: KR20070053097 Applic. Date: 2007-05-31; WO2008KR03069 Applic. Date: 2008-05-30

Inventor: PARK CHAN WOONG [KR]; YEOM MYEONG HOON [KR]; LEE JIN YOUNG [KR]; JEON HEE YOUNG [KR]; LEE SANG JUN [KR]; CHO NAM HOON [KR]; LEE DONG SUNG [KR]


Application No.: US20100190675A1  Published: 29/Jul/2010

Title: Personal Care Article For Sequentially Dispensing Compositions With Variable Concentrations Of Hydrophobic Benefit Materials

Applicant/Assignee:

Application No.: 12/478624   Filing Date: 04/Jun/2009

Abstract:The personal care article comprises a single chamber package and a personal care product. The package comprises a dispensing orifice, a first zone, a second zone and a third zone that are located proximal, medial and distal to the dispensing orifice. The personal care product comprises a first, a second and a third personal care composition with a first, second, and third concentration of hydrophobic benefit material. The first, second, and third personal care compositions are substantially within the first, second and third zones. The personal care product comprises a second concentration that is greater than the first and third concentration of hydrophobic benefit material. The personal care product is sequentially dispensed, such that, the first personal care composition is capable of being substantially dispensed prior to the second and third personal care compositions and the second is capable of being substantially dispensed prior to the third personal care composition.

Priority: US2009-361492 Applic. Date: 2009-01-28

Inventor: CETTI JONATHAN ROBERT [US]; PUTMAN CHRISTOPHER DEAN [US]; FARRIS RICHARD DUFFY [US]; WEI KARL SHIQING [US]; ABSHER SARAH NOELLE [US]


Application No.: US20100190721A1  Published: 29/Jul/2010

Title: PEPTIDE WHITENING AGENTS AND COSMETIC COMPOSITIONS COMPRISING THE SAME

Applicant/Assignee: CHANEL PARFUMS BEAUTE

Application No.: 12/668773   Filing Date: 16/Jun/2008

Abstract:The present invention relates to novel peptide compounds having the following formula [R1R2N-CH(Ra)-CO]a-(AA1)m-(AA2)b-X1-X2-X3-Y1-Y2-Y3-X4-(AA3)n-[NH-CH(Rb)-COOR3]c. It also pertains to cosmetic and dermatological compositions comprising one or more of these peptide compounds and to their uses in the cosmetic whitening of human skin and for the manufacture of a dermatological preparation intended to depigment human skin.

Priority: US20070929818P Applic. Date: 2007-07-13; WO2008EP57558 Applic. Date: 2008-06-16

Inventor: HONING STEFAN [DE]; SAINTIGNY GAELLE [FR]


Application No.: US20100190727A1  Published: 29/Jul/2010

Title: USE OF MONOSACCHARIDES AND COMPOSITION THEREFOR

Applicant/Assignee: L'OREAL

Application No.: 12/648485   Filing Date: 29/Dec/2009

Abstract:The present invention relates to the use, especially the cosmetic use, of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, for reducing or preventing the signs of ageing of the skin or its integuments. The present invention also relates to a cosmetic composition and a device containing it.

Priority: FR20080059147 Applic. Date: 2008-12-30; US20090144774P Applic. Date: 2009-01-15

Inventor: SIMONNET JEAN-THIERRY [FR]; LABOUREAU JULIEN [FR]; PORTES PASCAL [FR]; BOULLE CHRISTOPHE [FR]


Application No.: US20100190742A1  Published: 29/Jul/2010

Title: COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISING HYALURONIC ACID AND ADMINISTRATION THEREOF FOR REDUCING SIGNS OF AGING

Applicant/Assignee: L'OREAL

Application No.: 12/704978   Filing Date: 12/Feb/2010

Abstract:Cosmetic/pharmaceutical compositions contain, formulated into a physiologically acceptable medium, at least (i) hyaluronic acid and/or one of its derivatives and (ii) a C-glycoside compound, at least one of the constituents (i) and (ii) advantageously being in a form suitable for administration by injection, and administration thereof for filling depressions on the surface of the skin and for reducing signs of aging or for re-establishing the volume of the body or face.

Priority: FR20070057054 Applic. Date: 2007-08-13; WO2008FR51473 Applic. Date: 2008-08-07

Inventor: BRETON LIONEL [FR]; LECLAIRE JACQUES [FR]; GROLLIER JEAN-FRANCOIS [FR]


Application No.: US20100190824A1  Published: 29/Jul/2010

Title: Novel Substituted Piperidones as HSP Inducers

Applicant/Assignee:

Application No.: 12/452389   Filing Date: 24/Jun/2008

Abstract:The present invention relates to novel compounds of formula (I) or (II), their pharmaceutically acceptable salts and their hydrates, solvates, stereoisomers, conformers, tautomers, polymorphs and prodrugs and also pharmaceutically acceptable compositions containing them Wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification. The compounds of the present invention are HSP inducers and by virtue of this effect, useful for the treatment of various diseases accompanying pathological stress. The present invention also relates to a process for the preparation of the said novel compounds. The invention also relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.

Priority: IN2007KO00947 Applic. Date: 2007-06-29; WO2008IN00400 Applic. Date: 2008-06-24

Inventor: KUMAR PRABHAT [IN]; MOHANAN ANOOKH [IN]; ARGADE NAVNATH [IN]; HADOLE CHAKRADHAR [IN]; MANDHARE APPAJI [IN]; GUPTA RAMESH [IN]; DESHPANDE SHAILESH [IN]; JAMADARKHANA PRASHANT [IN]; JOSHI POONAM [IN]


Application No.: US20100190839A1  Published: 29/Jul/2010

Title: Telomere-Encoding Synthetic DNA Nanocircles, and Their Use for the Elongation of Telomere Repeats

Applicant/Assignee:

Application No.: 12/359448   Filing Date: 26/Jan/2009

Abstract:Telomere-encoding nucleic acid nanocircles, methods for their preparation, and methods for their use are disclosed. The nanocircles can be constructed containing multiple repeats of the complement of telomere repeat sequences. The telomere-encoding nanocircles are useful for extending telomeres both in vitro and in vivo, for treating macular degeneration, the effects of skin aging, liver degeneration, and cancer. The nanocircles are further useful for treating cell cultures to produce long-lived non-cancerous cell populations. This use has wide applicability in scientific research, tissue engineering, and transplantation.

Priority:

Inventor: KOOL ERIC T [US]


Application No.: US20100190847A1  Published: 29/Jul/2010

Title: ORAL COMPOSITION WITH AN ANTIAGEING EFFECT ON THE SKIN

Applicant/Assignee: CONOPCO INC., D/B/A UNILEVER

Application No.: 12/752468   Filing Date: 01/Apr/2010

Abstract:A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand

such as EPA or DHA (ii) an oestrogen receptor binding agent

such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen

such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin.

Priority: EP20060252019 Applic. Date: 2006-04-12; US2008-226158 Applic. Date: 2008-10-09; WO2007EP52918 Applic. Date: 2007-03-27

Inventor: CASEY JOHN [GB]; JENKINS GAIL [GB]; ROGERS JULIA SARAH [GB]


Application No.: US20100190873A1  Published: 29/Jul/2010

Title: Extract of the plant Ashwaganda (Withania Somnifera) consisting of the seeds of said plant dried and processed into a flour to be used as an ingredient to be incorporated in tablets and/or capsules for human consumption and/or to be available as a base for solvent extraction where said extaction(s) would be used for tablets and/or capsules for human consumption and/or human skin creams and/or lotions

Applicant/Assignee:

Application No.: 12/321731   Filing Date: 26/Jan/2009

Abstract:This patent presents a previously undescribed flour obtained from the seeds of Ashwaganda (Withania Somnifera) to be incorporated into tablets and/or capsules or act as a base for solvent extraction where said extractions will be incorporated into tablets and/or capsules and where said extractions may be incorporated into creams/and/or lotions for application to human skin.

Priority:

Inventor: BIBB ROBERT D [US]


Application No.: US20100191171A1  Published: 29/Jul/2010

Title: Iontophoresis device

Applicant/Assignee: LG HOUSEHOLD & HEALTH CARE LTD

Application No.: 12/310584   Filing Date: 29/Aug/2007

Abstract:The iontophoresis device according to the exemplary embodiment of the present invention may concentrate care skin to where liver spots and freckles exist, and may be compact, portable, and convenient. An iontophoresis device according to an exemplary embodiment of the present invention may include: a housing providing an inner space

a battery installed in the housing for supplying power

a control circuit for controlling a current output from the battery

a first contact portion electrically connected with the battery and contacting the skin

a second contact portion electrically connected with the battery and disposed to the housing

and an operation portion for turning the power on and off.

Priority: KR20060083057 Applic. Date: 2006-08-30; KR20060118999 Applic. Date: 2006-11-29; KR20070068180 Applic. Date: 2007-07-06; KR20070085302 Applic. Date: 2007-08-24; WO2007KR04158 Applic. Date: 2007-08-29

Inventor: PARK HYEON-WOO [KR]


Application No.: US20100191204A1  Published: 29/Jul/2010

Title: MULTI-LAYERED ADHESIVE APPLIANCE

Applicant/Assignee:

Application No.: 12/452227   Filing Date: 17/Jun/2008

Abstract:A body waste collecting device comprising an adhesive composite that fastens a collecting bag to the skin is disclosed. The adhesive composite is highly moisture resistant while still being water absorbing. The adhesive composite comprises at least three layers, a backing layer, a moisture absorbing layer and a thin layer of vapour permeable, low-absorbing adhesive layer.

Priority: DK20070000895 Applic. Date: 2007-06-19; DK20070000896 Applic. Date: 2007-06-21; DK20070001003 Applic. Date: 2007-07-06; DK20070001424 Applic. Date: 2007-10-03; DK20080000755 Applic. Date: 2008-06-02; WO2008DK50148 Applic. Date: 2008-06-17

Inventor: BACH ANDERS [DK]; STROEBECH ESBEN [DK]; LYKKE MADS [DK]; TOFTKAER ASTRID [DK]; BUUS KASSA [DK]; KONGEBO TOM [DK]


Application No.: US20100196292A1  Published: 05/Aug/2010

Title: Hydrophylic silicone elastomers in cosmetics

Applicant/Assignee: ALZO INTERNATIONAL, INC

Application No.: 12/657850   Filing Date: 28/Jan/2010

Abstract:The invention is directed to the use of a number of hydrophilic silicone elastomers in various cosmetic and personal care products where they serve various functions such as emulsifiers, film forming agents, viscosity stabilizers, conditioning agents and protective barrier forming agents. Emulsions and personal care products based upon same are also described.

Priority: US20090206106P Applic. Date: 2009-01-28

Inventor: CARSON JOHN C [US]; AWAD NAGI M [US]; ZOFCHAK ALBERT A [US]; MOSQUERA MICHAEL [US]


Application No.: US20100196298A1  Published: 05/Aug/2010

Title: Coloring Materials And Their Use In Compositions, In Particular Cosmetic Compositions

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/648716   Filing Date: 29/Dec/2009

Abstract:The invention relates to a coloring material comprising a colored product bound to a solid substrate in which said colored product is a colored derivative of geniposide and/or genipin and/or geniposidic acid and/or an extract of a plant comprising at least one of the abovementioned products and said solid substrate is based on silicate and includes at least one metal cation. It also relates to a process for preparing this coloring material. It also relates to the use of this coloring material in the preparation of a coloring composition, in particular of a cosmetic composition, and to a method for making up the skin or superficial body growths.

Priority: FR20080059168 Applic. Date: 2008-12-31

Inventor: ANDRE PATRICE [FR]; TRANCHANT JEAN-FRANCOIS [FR]; GARCIA MICHEL [FR]


Application No.: US20100196343A1  Published: 05/Aug/2010

Title: COMPOSITIONS, METHODS, DEVICES, AND SYSTEMS FOR SKIN CARE

Applicant/Assignee:

Application No.: 12/554872   Filing Date: 04/Sep/2009

Abstract:Accordingly, a need has arisen for improved compositions, methods, devices, and systems for skin care including, without limitation, topical compositions and phototherapy devices and methods. A skin care method may comprise, in some embodiments, contacting at least a portion of the skin of a subject with a homogeneous, stable, self-foaming composition, illuminating the at least a portion of the skin exclusively with light of a desired wavelength (e.g., from about 390 nm to about 430 nm, and contacting the at least a portion of the skin with an anti-oxidant serum composition.

Priority: US20080097513P Applic. Date: 2008-09-16

Inventor: O'NEIL MICHAEL P [US]; RUBIN JOEL [US]; STIMSON DRAKE [US]


Application No.: US20100196429A1  Published: 05/Aug/2010

Title: Oil-In-Water Emulsion Composition And Method For Producing The Same

Applicant/Assignee: SHISEIDO COMPANY LTD

Application No.: 12/670895   Filing Date: 22/Jul/2008

Abstract:The present invention provides: an oil-in-water emulsion composition, into which an oil-soluble drug is stably incorporated and which is excellent in feeling during use

and a method for producing the aforementioned composition, which does not require complicated operations. An oil-in-water emulsion composition comprising

(A) a polyoxyethylene phytosterol, (B) a glycerin fatty acid diester, (C) a polyoxyethylene-polyoxypropylene random copolymer dialkyl ether, (D) an oil-soluble drug, (E) oil, and (F) water

wherein a layered gel structure composed of the components (A) and (B) is present in an emulsion particle in the emulsion composition.

Priority: JP20070195719 Applic. Date: 2007-07-27; JP20080049393 Applic. Date: 2008-02-29; WO2008JP63106 Applic. Date: 2008-07-22

Inventor: OKA TAKASHI [JP]; MIYAHARA REIJI [JP]; TESHIGAWARA TAKASHI [JP]


Application No.: US20100196445A1  Published: 05/Aug/2010

Title: SYSTEMS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS

Applicant/Assignee:

Application No.: 12/617511   Filing Date: 12/Nov/2009

Abstract:The invention provides methods and devices for the delivery of therapeutic or biologically active agents to tissue, for example by facilitating the transport of said agents through the skin of a human or animal. Therapeutic agents include various botulinum neurotoxin (BoNT) and other biologically active agents, which can be delivered across the skin and into the dermis using multiple strategies including microneedle drug delivery, transport moieties, or penetration enhancers such as extracellular matrix-digestive enzymes.

Priority: US20080113975P Applic. Date: 2008-11-12

Inventor: DAVID NATHANIEL E [US]; MAHMOOD TAHIR A [US]; DICKERSON TOBIN [US]


Application No.: US20100196449A1  Published: 05/Aug/2010

Title: SYSTEM AND METHOD TO IMPROVE SENSORY FUNCTION

Applicant/Assignee: HANDEVELOP AB

Application No.: 12/678982   Filing Date: 11/Sep/2008

Abstract:A system and method to improve sensory functions in the hand or foot by dermal topical application of a local anaesthetic substance to adjacent skin areas, using a tailored application device or kit specially designed to fit the size and anatomical shape of the body part which is to be anaesthetised. The concept is to block sensory input from the anaesthetised skin area hereby inducing a functional reorganisation in sensory brain cortex resulting in enhanced sensory functions in body parts adjacent to the anaesthetised area with focus on the hand and sole of the foot.

Priority: SE20070002071 Applic. Date: 2007-09-18; WO2008SE00507 Applic. Date: 2008-09-11

Inventor: LUNDBORG GOERAN [SE]


Application No.: US20100196484A1  Published: 05/Aug/2010

Title: Use of expanded amorphous mineral particles for increasing the tenacity of a fragrance, scenting composition and method for treating body odours

Applicant/Assignee: L'OREAL

Application No.: 12/620236   Filing Date: 17/Nov/2009

Abstract:The subject-matter of the invention is a cosmetic method for scenting a human keratinous substance which consists in applying, to the said substance, a scenting composition comprising, in a cosmetically acceptable medium, at least 0.3% by weight of at least one scenting substance and at least particles of an expanded amorphous mineral material and in particular of an expanded amorphous mineral material resulting from at least one volcanic rock and more particularly expanded perlite particles. Another subject-matter of the present invention is a cosmetic method for treating human body odours, in particular axillary odours, which consists in applying, to the surface of the skin, an effective amount of the said composition. The invention relates to specific scenting compositions comprising, in a cosmetically acceptable medium: a) at least 0.3% by weight, with respect to the total weight of the composition, of a scenting substance

b) at least the said particles.

Priority: FR20080057790 Applic. Date: 2008-11-17; US20080116802P Applic. Date: 2008-11-21

Inventor: AUBRUN ODILE [FR]; CASSIER MATTHIEU [FR]


Application No.: US20100196517A1  Published: 05/Aug/2010

Title: TOPICAL DELIVERY OF A NITRIC OXIDE DONOR TO IMPROVE BODY AND SKIN APPEARANCE

Applicant/Assignee: STRATEGIC SCIENCE & TECHNOLOGIES, LLC

Application No.: 12/761034   Filing Date: 15/Apr/2010

Abstract:This invention generally relates to improvement of the body and skin appearance, for example enhancing the appearance of sagging, wrinkled, or cellulite-afflicted areas of the skin and body, through the local delivery of a nitric oxide donor, for example, using delivery vehicles such as lotions, creams, liquids, and/or transdermal patches. In some embodiments, a delivery vehicle containing a nitric oxide donor, for example, L-arginine (an important biological precursor) or its derivatives in a sufficient concentration to improve the appearance of a selected area of the body may be applied. In certain cases, one or more agents may also be included that aid in the transfer of the nitric oxide donor into the tissue, which may overcome the resistance to transfer into the skin. Non-limiting examples of suitable agents include agents able to create hostile biophysical environments, for instance, choline chloride, magnesium chloride, and/or sodium chloride.

Priority: US2007-590300 Applic. Date: 2007-06-21; WO2005US05726 Applic. Date: 2005-02-23; US20040546214P Applic. Date: 2004-02-23; US20040563566P Applic. Date: 2004-04-19

Inventor: FOSSEL ERIC THOR [US]


Application No.: US20100196521A1  Published: 05/Aug/2010

Title: Formulation for the treatment of hypoxia and related disorders

Applicant/Assignee:

Application No.: 12/700729   Filing Date: 05/Feb/2010

Abstract:A plant extract formulation is described comprising lemon oil, eucalyptus oil, basil oil, davana oil, rosewood oil, fennel oil and citronella oil. The formulation is used for the treatment of hypoxia and related disorders.

Priority: US20090150005P Applic. Date: 2009-02-05

Inventor: LIU YUK KWAN [HK]


Application No.: US20100196552A1  Published: 05/Aug/2010

Title: Method of preparing popped fruit

Applicant/Assignee:

Application No.: 12/583498   Filing Date: 20/Aug/2009

Abstract:A reduced-step method of producing puffed fruit pieces is provided. The invention is a two-part drying process, where the fruit is oven baked and then popped. The crispy fruit pieces can be flavored using flavorings. From the novel infusion-free and reduced step process the fruit pieces contain nutrients of their fresh fruit essence, making them a healthful and desirable snack. The method includes drying fruit pieces in a wind oven until a specified moisture-content of the fruit pieces are reached, then storing the fruit pieces in a refrigerated environment. The chilled fruit pieces are flavored, and then dehydrated in a low-pressure dehydration chamber until the fruit pieces change from a first state to a second state, and immediately packaged in a nitrogen-filled hermetically sealed package.

Priority: US2009-322707 Applic. Date: 2009-02-04

Inventor: GIANNINI BEAU [US]


Application No.: US20100196618A1  Published: 05/Aug/2010

Title: Actinic Radiation Curable Coating Compositions

Applicant/Assignee: CHEMQUE, INC

Application No.: 12/758156   Filing Date: 12/Apr/2010

Abstract:A method of preparing a cured coating or molded article prepared from a composition comprising an actinic-radiation curing polymer, wherein the composition is cured with actinic radiation at a temperature of at most 150 DEG C. to form the cured coating or molded article

wherein the cured coating or molded article has a thickness of at least about 0.5 mm and a hardness of about Shore A 90 to about Shore D 90

Priority: US2005-139508 Applic. Date: 2005-05-31

Inventor: BOTRIE ALEX [CA]; DENG YUAN [CA]; FOUCHER DANIEL [CA]; NGUYEN TUAN [CA]


Application No.: US20100197563A1  Published: 05/Aug/2010

Title: COMPOSITIONS AND METHODS FOR ALTERING ELASTOGENESIS

Applicant/Assignee:

Application No.: 12/526625   Filing Date: 07/Feb/2008

Abstract:Compositions and methods are provided for promoting elastin fiber formation (elastogenesis) in a cell, including methods that comprise contacting a cell that is capable of elastogenesis with (i) a mutated biglycan polypeptide that lacks chondroitin sulphate proteoglycan chains, (ii) a versican V3 isoform polypeptide that lacks most or all of the polypeptide regions encoded by one or more of exons 4, 5 or 6 or by exons 9-10 or 11-13, and/or with (iii) metastatin.

Priority: US20070901951P Applic. Date: 2007-02-16; WO2008US53341 Applic. Date: 2008-02-07

Inventor: WIGHT THOMAS N [US]; MERRILEES MERVYN [NZ]


Application No.: US20100197594A1  Published: 05/Aug/2010

Title: METHODS FOR USING SOY PEPTIDES TO INHIBIT H3 ACETYLATION, REDUCE EXPRESSION OF HMG-COA REDUCTASE AND INCREASE LDL RECEPTOR AND SP1 EXPRESSION IN A MAMMAL

Applicant/Assignee:

Application No.: 12/756126   Filing Date: 07/Apr/2010

Abstract:Controlled studies demonstrate that methods using soy related peptides inhibit H3 acetylation, reduce expression of HMG-CoA reductase and increase LDL receptor and Sp1 expression in mammals. The present disclosure is generally directed to using lunasin peptides and/or lunasin peptide derivatives to 1) inhibit H3 acetylation, 2) reduce expression of HMG-CoA reductase, 3) increase LDL receptor expression or 4) increase Sp1 expression in a mammal. In at least one exemplary embodiment of the present disclosure, an effective amount of lunasin peptides or lunasin peptide derivatives and one or more enzyme inhibitors is provided to a mammal to 1) inhibit H3 acetylation, 2) reduce expression of HMG-CoA reductase, 3) increase LDL receptor expression or 4) increase Sp1 expression in a mammal. Additionally, lunasin will protect against, prevent, or reduce: 1) the expression of Matrix metalloproteinase (MMP-1), 2) collagen breakdown, 3) photoaging and 4) the formation of skin wrinkles.

Priority: US2006-532528 Applic. Date: 2006-09-16; US2009-441384 Applic. Date: 2009-03-14; WO2007US78584 Applic. Date: 2007-09-15; US20060966529P Applic. Date: 2006-09-16; US20070007925P Applic. Date: 2007-07-17

Inventor: GALVEZ ALFREDO FLORES [US]


Application No.: US20100197649A1  Published: 05/Aug/2010

Title: Compositions and Methods for Diagnosing and Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus

Applicant/Assignee:

Application No.: 12/670457   Filing Date: 07/Aug/2008

Abstract:The present invention includes compositions and methods for diagnosing and treating CA-MRSA infections in patients. The methods are based on the finding that combining cefoxitin and a synthetic penicillin in a treatment regimen results in a synergistic effect of the two drugs, an effect that is related to PBP4 activity in CA-MRSA isolates. Also provided is a CA-MRSA-specific biomarker which can be used to detect the presence of a CA-MRSA infection in a patient.

Priority: US20070957314P Applic. Date: 2007-08-22; WO2008US72442 Applic. Date: 2008-08-07

Inventor: CHEUNG AMBROSE [US]; MEMMI GUIDO [US]


Application No.: US20100198134A1  Published: 05/Aug/2010

Title: HAIR REMOVAL APPARATUS FOR PERSONAL USE AND THE METHOD OF USING SAME

Applicant/Assignee:

Application No.: 12/355749   Filing Date: 16/Jan/2009

Abstract:Hair or partial hair removal system and hair growth deterrent that includes mechanical process for cutting, plucking or shaving hair follicles, along with pre and/or post skin treatment techniques. The skin treatment techniques can include the application of energy to the skin surface before, after and/or during the application of the mechanical process. Such techniques include the application of heat and/or energy from illumination sources and/or RF emitters. Further skin treatment techniques include the application of solutions before, after and/or during the mechanical process and/or the application of heat and/or energy. Overall, the system operates to treat an area of skin to facilitate the removal of all or a portion of hair, retard further growth, and recovery of skin surface.

Priority: US20080021723P Applic. Date: 2008-01-17; US20080045282P Applic. Date: 2008-04-16

Inventor: ECKHOUSE SHIMON [IL]; KUTSCHER TUVIA DROR [IL]


Application No.: US20100198176A1  Published: 05/Aug/2010

Title: ADHESIVE COMPONENT FOR OSTOMY DEVICES

Applicant/Assignee:

Application No.: 12/452508   Filing Date: 17/Jun/2008

Abstract:A component for sealing a body opening and for use in combination with a body waste collecting device, said component comprises a soft adhesive composition wherein the soft adhesive composition comprises a liquid impermeable, moisture permeable adhesive composition.

Priority: DK20070001003 Applic. Date: 2007-07-06; DK20080000561 Applic. Date: 2008-04-17; WO2008DK50144 Applic. Date: 2008-06-17

Inventor: STROEBECH EBEN [DK]; BACH ANDERS [DK]; LYKKE MADS [DK]; TOFTKAER ASTRID [DK]; BUUS HASSE [DK]; KONGEBO TORN [DK]


Application No.: US20100198682A1  Published: 05/Aug/2010

Title: SENSITIVE SKIN PRODUCT MARKETING ARTICLES

Applicant/Assignee:

Application No.: 12/365291   Filing Date: 04/Feb/2009

Abstract:Sensitive skin product marketing articles that are designed to communicate to consumers of sensitive skin products the relevance and/or characteristics of the sensitive skin product are provided.

Priority:

Inventor: FARAGE MIRANDA AREF [US]; DUVAL DEAN LARRY [US]


Application No.: US20100198683A1  Published: 05/Aug/2010

Title: METHOD AND SYSTEM FOR SIMULATED PRODUCT EVALUATION VIA PERSONALIZING ADVERTISEMENTS BASED ON PORTRAIT IMAGES

Applicant/Assignee:

Application No.: 12/626323   Filing Date: 25/Nov/2009

Abstract:Advertising method and system for creating a personalized advertisement, and for recommending a product being advertised. An uploaded facial photograph is received, the facial photograph including a plurality of facial features. At least one facial feature of the plurality of facial features is detected. Personal information may be extracted by analyzing the at least one detected facial feature. A product being advertised may be recommended, wherein the recommended product applies to a treatment related to the extracted personal information.

Priority: US20090206520P Applic. Date: 2009-02-02; US20090209828P Applic. Date: 2009-03-12

Inventor: AARABI PARHAM [CA]


Application No.: US20100202978A1  Published: 12/Aug/2010

Title: FOAMABLE BENZOYL PEROXIDE COMPOSITIONS FOR TOPICAL ADMINISTRATION

Applicant/Assignee:

Application No.: 12/546189   Filing Date: 24/Aug/2009

Abstract:Described herein are benzoyl peroxide compositions useful in the treatment of acne and other skin conditions, which exhibit enhanced stability, even under accelerated conditions. The compositions also exhibit reduced color formation, reduced irritation, and enhanced moisturizing properties. They can be formulated into a topical aerosol foam with inert, non-flammable propellants, such as hydrofluoroalkanes, and may be used in cosmetics or pharmaceuticals. Additionally, methods of formulating these compositions are described.

Priority: US20090152022P Applic. Date: 2009-02-12

Inventor: GURGE RONALD M [US]; TRUMBORE MARK W [US]


Application No.: US20100202989A1  Published: 12/Aug/2010

Title: METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS

Applicant/Assignee:

Application No.: 12/762497   Filing Date: 19/Apr/2010

Abstract:A method of reducing the appearance of skin conditions associated with loss of skin tightness, skin firmness, or dark circles under the eyes with topical compositions comprising compounds of any of the Formulae I or Ia as described herein, is disclosed.

Priority: US2004-910095 Applic. Date: 2004-08-02; US20030492591P Applic. Date: 2003-08-04; US20040542934P Applic. Date: 2004-02-09

Inventor: WANG BING [US]; BODUPALLI SEKHAR [US]; LI XIANGFENG [US]; MAHMOOD KHALID [US]; ZHANG WEI [US]; MILLER GUY [US]


Application No.: US20100203004A1  Published: 12/Aug/2010

Title: COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER

Applicant/Assignee: L'OREAL

Application No.: 12/676541   Filing Date: 28/Oct/2008

Abstract:The invention relates to a cosmetic composition comprising, in a physiologically acceptable medium, a skin-tensioning agent and an acrylic polymer containing a group of phosphorylcholine type. The invention also relates to a cosmetic skincare process, more particularly for facial skin, in particular wrinkled skin, comprising the application of the composition to the skin.

Priority: WO2008EP64612 Applic. Date: 2008-10-28; FR20070058725 Applic. Date: 2007-10-31

Inventor: SIMONNET JEAN-THIERRY [FR]; CASSIN GUILLAUME [FR]


Application No.: US20100203029A1  Published: 12/Aug/2010

Title: LYSYL OXIDASE-LIKE 1 (LOXL1) AND ELASTOGENESIS

Applicant/Assignee: MASSACHUSETTS EYE & EAR INFIRMARY

Application No.: 12/699701   Filing Date: 03/Feb/2010

Abstract:Described are methods of treating and preventing conditions associated with a loss of elastic fibers. Also provided herein are methods of screening for agents useful in treating such conditions, and animal models of conditions associated with a loss of elastic fibers.

Priority: US2007-809495 Applic. Date: 2007-06-01; US2005-041589 Applic. Date: 2005-01-24; US20040538962P Applic. Date: 2004-01-23

Inventor: LI TIANSEN [US]; LIU XIAOQING [US]


Application No.: US20100203077A1  Published: 12/Aug/2010

Title: Compositions And Methods For Treating Skin With Extract From Trametes

Applicant/Assignee:

Application No.: 12/306372   Filing Date: 21/Nov/2008

Abstract:Compositions for treating skin containing at least one extract from the genus Trametes and at least one viscosity enhancing synthetic polymer, and methods for whitening skin, treating skin for improvement, or treating skin disorders associated with pigmentation such as uneven pigmentation, skin mottling, or age spots or other dermatological disorders such as eczema, rosacea, hyperkeratinization, and so on.

Priority: US20070014837P Applic. Date: 2007-12-19; WO2008US84373 Applic. Date: 2008-11-21

Inventor: SCHNITTGER STEVEN F [US]; MAES DANIEL H [US]; SULLIVAN MICHAEL [US]


Application No.: US20100203094A1  Published: 12/Aug/2010

Title: COMBINATION OF A MICROORGANISM AND A PHYTOSPHINGOSINE DERIVATIVE, COMPOSITION, METHODS OF USE

Applicant/Assignee: L'OREAL

Application No.: 12/685697   Filing Date: 12/Jan/2010

Abstract:At least one phytosphingosine salicylate derivative and at least one lysate of at least one microorganism of the genus Bifidobacterium. Composition, combination. Use, including cosmetic use for reinforcing the repair and regeneration capacity of an epithelium, especially an epidermis, in particular an aged epidermis.

Priority: FR20090050143 Applic. Date: 2009-01-12; US20090146319P Applic. Date: 2009-01-22

Inventor: AMAR DAVID [FR]; BERNARD BRUNO [FR]; BERNARD DOMINIQUE [FR]; CASTIEL ISABELLE [FR]


Application No.: US20100203140A1  Published: 12/Aug/2010

Title: METHODS, COMPOSITIONS, AND KITS FOR ORGAN PROTECTION DURING SYSTEMIC ANTICANCER THERAPY

Applicant/Assignee:

Application No.: 12/683293   Filing Date: 06/Jan/2010

Abstract:Methods, compositions, and kits are presented for local tissue protection during systemic administration of anticancer therapeutic agents.

Priority: US2008-073424 Applic. Date: 2008-03-05; US2005-196921 Applic. Date: 2005-08-03; US2004-918199 Applic. Date: 2004-08-13; US2003-684203 Applic. Date: 2003-10-10; US2003-364383 Applic. Date: 2003-02-12; US20020355764P Applic. Date: 2002-02-12

Inventor: FORD JOHN P [US]


Application No.: US20100203154A1  Published: 12/Aug/2010

Title: Elasmobranch-Repelling Compounds, Methods of Use and Devices

Applicant/Assignee:

Application No.: 11/884190   Filing Date: 13/Feb/2006

Abstract:Elasmobranch-repelling compositions are prepared from elasmobranch carcasses. Extraction of these elasmobranch carcasses with polar solvent after a period of aerobic decay yields semiochemical repellents that induce a flight reaction in sharks when introduced into the sharks' oceanic proximity.

Priority: US20050652482P Applic. Date: 2005-02-12; US20050715239P Applic. Date: 2005-09-08; WO2006US05035 Applic. Date: 2006-02-13

Inventor: STROUD ERIC MATTHEW [US]


Application No.: US20100203158A1  Published: 12/Aug/2010

Title: ANTISEPTIC COMPOSITIONS AND USES THEREOF

Applicant/Assignee: RAMOT AT TEL AVIV UNIVERSITY LTD

Application No.: 12/703853   Filing Date: 11/Feb/2010

Abstract:Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are disclosed. Further disclosed are uses of the antiseptic compositions as disinfectants and in the treatment of wounds.

Priority: US20090151539P Applic. Date: 2009-02-11

Inventor: HADAR NOA [IL]; FREEMAN AMIHAY [IL]


Application No.: US20100203528A1  Published: 12/Aug/2010

Title: System for obfuscating identity

Applicant/Assignee: SEARETE LLC

Application No.: 12/658381   Filing Date: 04/Feb/2010

Abstract:Compositions, apparatus, systems, kits, and methods for obfuscating the nucleic acid and/or protein content of an environment.

Priority: US2006-510754 Applic. Date: 2006-08-24; US2006-510756 Applic. Date: 2006-08-24; US2006-510753 Applic. Date: 2006-08-24; US2007-724033 Applic. Date: 2007-03-13; US2007-724051 Applic. Date: 2007-03-13; US2007-724058 Applic. Date: 2007-03-13

Inventor: HILLIS W DANIEL [US]; MYHRVOLD NATHAN P [US]; WILSON RICHA [US]


Application No.: US20100203628A1  Published: 12/Aug/2010

Title: Novel modified galectin 9 proteins and use thereof

Applicant/Assignee:

Application No.: 11/547091   Filing Date: 29/Mar/2005

Abstract:It is suggested that recombinant galectin 9 (rGal 9), produced in host Escherichia coli, exhibits an immune system-mediated action and a direct action on tumor cells (i.e., activity of inducing the intercellular adhesion and apoptosis of the tumor cells), thereby potent in inducing the inhibition of cancer metastasis and reduction. Moreover, the rGal 9 exerts no efficacy on non-activated lymphocytes but can induce apoptosis in activated T cells, in particular, CD4-positive T cells causing an excessive immune response. The rGal 9 has a further potent apoptosis-inducing property on synovial cells participating in joint deformation in rheumatism, etc. In the rGal 9, however, a link domain linking two CRDs is highly susceptible to protease and, therefore, is very easily digestible with the enzyme, thereby losing the above activities. Thus, there is a need for a more stabilized molecule in view of further studies. Modification of the link domain linking two CRDs in galectin 9 provides a modified molecule having an elevated activity without any undesirable effects on the above activities.

Priority: JP20040094401 Applic. Date: 2004-03-29; JP20040287005 Applic. Date: 2004-09-30; JP20050043156 Applic. Date: 2005-02-18; WO2005JP06580 Applic. Date: 2005-03-29

Inventor: NISHI NOZOMU [JP]; HIRASHIMA MITSUOMI [JP]; YAMAUCHI AKIRA [JP]; ITO AIKO [JP]


Application No.: US20100204175A1  Published: 12/Aug/2010

Title: USE OF CONJUGATES OF HYALURONIC ACID IN THE LOCAL TREATMENT OF HYPERPROLIFERATIVE SKIN DISEASES

Applicant/Assignee: FIDIA FARMACEUTICI S.P.A

Application No.: 12/666286   Filing Date: 19/Jun/2008

Abstract:The use is described of a conjugate between hyaluronic acid or a derivative thereof and antitumoral drugs for the preparation of pharmaceutical compositions for the topical treatment of hyperproliferative skin diseases.

Priority: IT2007MI01267 Applic. Date: 2007-06-22; WO2008IB01706 Applic. Date: 2008-06-19

Inventor: RENIER DAVIDE [IT]; PANFILO SUSY [IT]


Application No.: US20100204317A1  Published: 12/Aug/2010

Title: METHODS OF TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS

Applicant/Assignee: QLT INC

Application No.: 12/513094   Filing Date: 02/Nov/2007

Abstract:This invention is directed to the use of TOFA in the treatment of acne and other dermatological disorders. This invention is also directed to pharmaceutical compositions comprising TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.

Priority: US20060856604P Applic. Date: 2006-11-03; WO2007US83535 Applic. Date: 2007-11-02

Inventor: HUNT DAVID W C [CA]; MORRIS JEROME ARTHUR [US]; JIANG HUIJUN [CA]; LEUNG DANNY [CA]; BOCH RONALD ERWIN [CA]


Application No.: US20100204323A1  Published: 12/Aug/2010

Title: ANTIMICROBIAL COMPOSITIONS COMPRISING ORGANIC ACID ESTERS AND METHODS FOR REDUCING VIRUS AND BACTERIAL POPULATIONS USING SUCH COMPOSITIONS

Applicant/Assignee: THE DIAL CORPORATION

Application No.: 12/764632   Filing Date: 21/Apr/2010

Abstract:Antimicrobial compositions comprising organic acid esters and methods for reducing virus and/or bacteria populations using such compositions are provided. In one embodiment, an antimicrobial composition comprises a virucidally effective amount of an organic acid ester, the organic acid ester having a pKa1 value in the range of from about 3 to about 4.5. The composition further comprises a disinfecting alcohol present in an amount of 0 wt. % to about 75 wt. % and a carrier. The antimicrobial composition has a pH of no greater than about 5 at 25 DEG C.

Priority: US2008-791257 Applic. Date: 2008-03-04; WO2005US43910 Applic. Date: 2005-12-05; US20040634464P Applic. Date: 2004-12-09

Inventor: THEILER RICHARD F [US]; SEITZ JR EARL P [US]; FULS JANICE L [US]


Application No.: US20100204632A1  Published: 12/Aug/2010

Title: PERMEABLE PRESSURE SENSITIVE ADHESIVE

Applicant/Assignee:

Application No.: 12/452513   Filing Date: 17/Jun/2008

Abstract:The present invention relates to a pressure sensitive, hot melt processable adhesive composition comprising a polar plasticising oil and a polar polyethylene copolymer, and a layered adhesive construct and a medical device comprising the adhesive composition according to the invention.

Priority: DK20070001003 Applic. Date: 2007-07-06; WO2008DK50146 Applic. Date: 2008-06-17

Inventor: LYKKE MADS [DK]; TOFTKAER ASTRID [DK]; BUUS HASSE [DK]; KONGEBO TOM [DK]


Application No.: US20100204665A1  Published: 12/Aug/2010

Title: COLLECTING DEVICE FOR BODY FLUIDS

Applicant/Assignee:

Application No.: 12/452510   Filing Date: 17/Jun/2008

Abstract:A body waste collecting device comprising a collecting pouch and an adhesive wafer for attachment to the body, said adhesive wafer comprising a backing layer and a first adhesive layer, said first adhesive layer comprising a liquid impermeable, moisture permeable adhesive composition wherein the adhesive wafer comprising an additional second adhesive for sealing around a body opening.

Priority: DK20070001003 Applic. Date: 2007-07-06; DK20080000589 Applic. Date: 2008-04-25; WO2008DK50149 Applic. Date: 2008-06-17

Inventor: STROEBECH ESBEN [DK]; BACH ANDERS [DK]; LYKKE MADS [DK]; TOFTKAER ASTRID [DK]; BUUS HASSE [DK]; KONGEBO TOM [DK]


Application No.: US20100206764A1  Published: 19/Aug/2010

Title: Dehydrated and Semi-Hydrated Personal Care Items

Applicant/Assignee:

Application No.: 12/372084   Filing Date: 17/Feb/2009

Abstract:A personal care item is disclosed. The personal care item includes at least one partially dehydrated personal care item formulated without at least one aqueous ingredient to thereby allow travelers to bring personal care items while complying with present security restrictions regarding the transport of liquids on transportation means and when said at least one partially dehydrated personal care item is combined with at least one aqueous ingredient, the personal care item is in a usable form.

Priority:

Inventor: KETCHUM RUSS [US]


Application No.: US20100207877A1  Published: 19/Aug/2010

Title: Image Generation System

Applicant/Assignee:

Application No.: 12/703954   Filing Date: 11/Feb/2010

Abstract:An image generation system for generating an image on a display screen. The image generation system includes an eye-tracking system capable of determining a user's eye orientation and outputting a signal indicative of same. The image generation system also includes a bio-feedback sensor capable of detecting activity of one or more physiological functions of the user and outputting a signal indicative of the level of activity. A processor is included and is adapted to receive and process the output signals from the eye-tracking system and bio-feedback sensor. The processor determines an image to be generated on the display screen indicative of the signals from the eye-tracking system and bio-feedback sensor.

Priority: NZ20070560457 Applic. Date: 2007-08-15; WO2008NZ00212 Applic. Date: 2008-08-15

Inventor: WOODARD WILLIAM BRYAN [NZ]


Application No.: US20100209361A1  Published: 19/Aug/2010

Title: HIGHLY CATIONIC COPOLYMERS BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS

Applicant/Assignee: BASF SE

Application No.: 12/669315   Filing Date: 01/Jul/2008

Abstract:The present invention relates to a copolymer with high cationic charge based on quaternized nitrogen-containing monomers, to cosmetic or pharmaceutical compositions which comprise at least one such copolymer, and to further uses of these copolymers.

Priority: EP20070112639 Applic. Date: 2007-07-17; WO2008EP58439 Applic. Date: 2008-07-01

Inventor: MEIER NICOLE [DE]; CASTRO IVETTE GARCIA [DE]; WOOD CLAUDIA [DE]; STAUB JESSICA [DE]


Application No.: US20100209364A1  Published: 19/Aug/2010

Title: Emulsified Composition

Applicant/Assignee: ROHTO PHARMACEUTICAL CO., LTD

Application No.: 12/669744   Filing Date: 17/Jul/2008

Abstract:An emulsified composition comprises (A) petrolatum, (B) lecithin, (C) glycerin, (D) water and (E) a water-soluble polymer, wherein the content of the petrolatum (A) is 10 to 30 wt % relative to 100 wt % of the emulsified composition, and an internal phase of the emulsified composition has an average particle diameter of not more than 800 nm as measured by a dynamic light scattering method based on the dynamic light scattering theory.

Priority: JP20070190216 Applic. Date: 2007-07-20; WO2008JP62912 Applic. Date: 2008-07-17

Inventor: ABE MASAMICHI [JP]; ISHIKAWA TAKASHI [JP]; KATANO TAKASHI [JP]; MARUKAWA JUNKO [JP]; KASUGA SHINYA [JP]


Application No.: US20100209370A1  Published: 19/Aug/2010

Title: Skin treatment composition

Applicant/Assignee:

Application No.: 12/461426   Filing Date: 11/Aug/2009

Abstract:A skin treatment composition of the present invention is an external composition for skin comprising an alkylene oxide derivative expressed by Formula (I): R1O-[(AO)m(EO)n]-R2 (I) wherein AO is an oxyalkylene group of C3 or C4

EO is an oxyethylene group

m and n are 1!<=m!<=70 and 1!<=n!<=70 respectively, wherein EO is 20-80% by weight with respect to a total of AO and EU

each of R1 and R2 is a hydrogen or a hydrocarbon group having C1-4. The alkylene oxide derivative (I) has a moisturizing effect, a rough skin improving effect, a stickiness improving effect, and a transdermal absorption promoting effect. When a refreshing agent is used together therewith in the composition of the present invention, the refreshing effect lasts for a long time and it is excellent in feeling of use without skin stimulation.

Priority: JP20010304029 Applic. Date: 2001-09-28; JP20020089259 Applic. Date: 2002-03-27; JP20020095092 Applic. Date: 2002-03-29; US2002-134441 Applic. Date: 2002-04-30

Inventor: OHMORI TAKASHI [JP]; OKAMOTO TOHRU [JP]; KAKOKI HIROYUKI [JP]; MIYAHARA REJI [JP]; NANBA TOMIYUKI [JP]; NAKANE TOSHIHIKO [JP]; HAMANO YOHEI [JP]; TAKEOKA ERIKO [JP]


Application No.: US20100209371A1  Published: 19/Aug/2010

Title: USE OF RESINS FOR STABILIZING COLORANTS

Applicant/Assignee: CHANEL PARFUMS BEAUTE

Application No.: 12/670748   Filing Date: 25/Jul/2008

Abstract:A process for preparing a cosmetic composition, characterized in that it includes: optionally a pretreatment of an organic ion-exchange resin, the absorption of at least one organic colorant onto the optionally pretreated resin in order to form a resinate, the optional grinding of the resulting resinate and the incorporation of the resinate into a cosmetically acceptable polar medium. It also relates to the composition obtained, to the resinate formed and also to the use of at least one organic ion-exchange resin for stabilizing at least one organic colorant in a cosmetically acceptable polar medium.

Priority: FR20070005476 Applic. Date: 2007-07-26; WO2008FR51404 Applic. Date: 2008-07-25

Inventor: CASADO-CHAUDANSON AUDREY MARJORIE [FR]; PASTOR AUDREY CELINE MARCELLE [FR]


Application No.: US20100209374A1  Published: 19/Aug/2010

Title: Multi-Phase Personal Care Composition Comprising a Stabilizing Perfume Composition

Applicant/Assignee:

Application No.: 12/708368   Filing Date: 18/Feb/2010

Abstract:A method of stabilizing a multiphase composition is described. The composition comprises a structured surfactant phase, a benefit phase and a perfume comprising perfume raw materials. The method comprises a step of selecting at least 70% of the perfume raw materials that have a ClogP of greater than 1.8.

Priority: US2006-591240 Applic. Date: 2006-11-01; US20050732312P Applic. Date: 2005-11-01

Inventor: WEI KARL SHIQING [US]; TAYLOR REBECCA ANN [US]; SMITH III EDWARD DEWEY [US]; DUBOIS ZERLINA GUDZAR [US]


Application No.: US20100209377A1  Published: 19/Aug/2010

Title: HAIR STYLING AND CONDITIONING PERSONAL CARE FILMS

Applicant/Assignee:

Application No.: 12/665254   Filing Date: 26/Jun/2008

Abstract:The present invention provides personal care compositions in film form having less than about 30 weight percent water-soluble chitosan derivative and greater than about 40 weight percent of a water soluble film forming agent.

Priority: US20070947141P Applic. Date: 2007-06-29; WO2008US68366 Applic. Date: 2008-06-26

Inventor: DROVETSKAYA TATIANA V [US]; YU WEI HONG [US]; DIANTONIO EDWARD F [US]; JORDAN SUSAN L [US]


Application No.: US20100209388A1  Published: 19/Aug/2010

Title: Nutraceutical composition and method of use for treatment / prevention of cancer

Applicant/Assignee:

Application No.: 12/657903   Filing Date: 30/Jan/2010

Abstract:The invention describes a nutraceutical composition and method for preventing/treating cancer comprised of A) quinones (2,3-dimethoxy-5-methyl-1,4-benzoquinone, thymoquinone, tocopherolquinone) B) compounds capable of maximizing oxidative mitochondrial function preferably riboflavin, FAD, FMN, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B1, lipoic acid, biotin, vitamin B6, vitamin B12, folate, B3, C and pantothenate C) lactic acid dehydrogenase inhibitors

2',3,4'5,7-pentahydroxyflavone, epigallocatechin gallate, quercetin, citric acid, rosemary, black walnut, clove, nutmeg, licorice root, coriander, cinnamon, ginger root, myrrh gum and green tea D) alkalizing agents: aloe vera, chlorella, wheat grass, apple cider vinegar, burdock root, kudzu root, alfalfa, barley grass, spirulina, parsley leaf, calcium, magnesium, potassium or bicarbonate salts E) potent tumoricidal herbs

gromwell root, wild yam, beth root, teasel root, balm of gilead bud, frankincense, bakuchi seed, dichroa root, kochia seed, kanta kari, sweet myrrh, galbanum, garcinia fruit, mace, white sage and tumoricial plant derived constituents: gambogic acid, shikonin, diosmin or boswellic acid F) an antiproliferative herb (speranskia or goldenseal) and G) a pharmaceutically acceptable carrier.

Priority: US2007-711833 Applic. Date: 2007-02-28; US2005-233279 Applic. Date: 2005-09-20; US2004-909590 Applic. Date: 2004-08-02; US20030491841P Applic. Date: 2003-08-02; US20040540525P Applic. Date: 2004-01-29

Inventor: MAZZIO ELIZABETH ANNE [US]; SOLIMAN KARAM F [US]


Application No.: US20100209407A1  Published: 19/Aug/2010

Title: MC-1R, MC-2R, AND/OR MU OPIOID RECEPTORS MODULATION

Applicant/Assignee: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S

Application No.: 12/663021   Filing Date: 06/Jun/2008

Abstract:The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the [mu] opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or restore normal pigmentation, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances.

Priority: FR20070055529 Applic. Date: 2007-06-06; WO2008EP57130 Applic. Date: 2008-06-06

Inventor: PAIN SABINE [FR]; DEZUTTER COLETTE [FR]; ANDRE VALERIE [FR]; REYMERMIER CORINNE [FR]; ORLY ISABELLE [FR]; PERRIER ERIC [FR]


Application No.: US20100209466A1  Published: 19/Aug/2010

Title: MEROCYANINE DERIVATIVES

Applicant/Assignee:

Application No.: 12/715839   Filing Date: 02/Mar/2010

Abstract:Disclosed is the use of merocyanine derivatives of formula Q is hydrogen

C1-C22alkyl

-OH

-OR7

-NR7R8

or -N-R9

R1 is hydrogen

C1-C22alkyl

-OR7, -SR7

-NR7R8

C1-C22alkyl

C2-C12 alkenyl

C2-C12alkinyl

C3-C12cycloalkyl

C3-C12cycloalkenyl

C7-C12aralkyl

C1-C12heteroalkyl, C2-C11heteroaralkyl

C6-C10aryl

or C1-C9heteroaryl

R4 is cyano

COR7, COOR7

CONR7R8

SO2(C6-C12)aryl

C2-C12alk-1-enyl

C3-C12cycloalk-1-enyl

C2-C12alk-1-inyl

C2-C12heteroalkyl

C3-C5heterocycloalkyl

C6-C10aryl

or C1-C9heteroaryl

R5 is -COR7

-COOR7

-OR7

-SR7, -NHR7, -NR7R8

C1-C22alkyl

C2-C12alkenyl

C2-C12alkinyl

C3-C12cycloalkyl

C3-C12cycloalkenyl

C7-C12aralkyl

C1-C12alkylphenyl

C1-C12alkoxy-C6-C10aryl

C1-C12heteroalkyl

C2-C11heteroaralkyl

C3-C12cycloheteroalkyl

C6-C10aryl

C1-C12alkoxy-C6-C10aryl

or C1-C9heteroaryl

R6 is hydrogen

C1-C22alkyl

C1-C22alkoxy

or COR7

R7 and R8 independently from each other are hydrogen

C1-C22alkyl

C2-C12alkenyl

C2-C12alkinyl

C3-C12cycloalkyl

C3-C12cycloalkenyl

-(CH2)tCOOH

C7-C12aralkyl

C1-C12heteroalkyl

C2-C11heteroaralkyl

C6-C10aryl

C1-C9heteroaryl

Si-R10R11R12

Si(OR10)(OR11)(OR12)

SiR10(OR11)(OR12)

SiR10R11(OR12)

-(CH2)u-O-(CH2)v-SiR10R11R12

or a radical X-Sil

t, u and v, independently from each other are a number from 1 to 5

R9 is a (C1-C6)alkylidene radical

R10, R11, R12 independently form each other are C1-C22alkyl

X is a linker

for protecting of human hair and skin against the damaging effect of UV radiation.

Priority: EP20040103018 Applic. Date: 2004-06-29; US2006-630489 Applic. Date: 2006-12-21; WO2005EP52850 Applic. Date: 2005-06-20

Inventor: WAGNER BARBARA [DE]; BIENEWALD FRANK [FR]; WOLLEB HEINZ [CH]; WALLQUIST OLOF [CH]; HERZOG BERND [DE]; EHLIS THOMAS [DE]; HAASE JUERG [CH]


Application No.: US20100209483A1  Published: 19/Aug/2010

Title: TRANSDERMAL DELIVERY OF MEPTAZINOL

Applicant/Assignee:

Application No.: 12/377287   Filing Date: 14/Aug/2007

Abstract:A delivery system for the delivery of a salt of meptazinol which increases the bioavailability of meptanizol by an effective amount to provide analgesic relief is disclosed. One embodiment of the delivery system is a transdermal device which increases the skin flux of meptazinol by an effective amount to provide analgesic relief. Also disclosed are methods of providing analgesic relief.

Priority: US2006-614165 Applic. Date: 2006-12-21; US20060822318P Applic. Date: 2006-08-14; US20060862114P Applic. Date: 2006-10-19; US20050753357P Applic. Date: 2005-12-21; WO2007US75902 Applic. Date: 2007-08-14

Inventor: FRANKLIN RICHARD [GB]


Application No.: US20100209488A1  Published: 19/Aug/2010

Title: PROTEIN KINASE MODULATING COMPOUNDS AND METHODS FOR MAKING AND USING THEM

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 12/602759   Filing Date: 15/Jul/2008

Abstract:The invention provides compositions, e.g., small molecules, that disrupt the activity of protein kinases, including constitutively activated protein kinases, such as kinases constitutively activated through mutations, and kinases in their native inactivated state, and methods for making and using them. In one aspect, compositions of the invention bind a protein kinase in its inactive conformation involving the conserved asparagine-phenylalanine-glycine residue motif, or "Asp-Phe-Gly" or "DFG" motif, of the activation loop in the allosteric binding site. The small molecule protein kinase inhibitors of the invention comprise or are derivatives or analogs of oxadiazoles, thiadiazoles, oxazoles, thiazoles, arylamides, quinolones, pyrazoles, pyrazolones, imides, pyrolles, imidazoles and/or triazoles.

Priority: US20070950104P Applic. Date: 2007-07-16; WO2008US70079 Applic. Date: 2008-07-15

Inventor: WRASIDLO WOLFGANG [US]; MURPHY ERIC [US]; CHERESH DAVID [US]


Application No.: US20100209544A1  Published: 19/Aug/2010

Title: BOTANICAL EXTRACTS FROM OIL PALM VEGETATION LIQUOR FOR COSMECEUTICAL APPLICATIONS

Applicant/Assignee:

Application No.: 12/595612   Filing Date: 14/Apr/2008

Abstract:A cosmeceutical composition comprising phenolic compounds, fruit acids and sugars. extracted from the vegetation liquor of the palm oil milling process has been suggested. This composition is rich in antioxidants, and significantly improves skin health, including preventing aging of the skin.

Priority: MY20070000568 Applic. Date: 2007-04-12; WO2008MY00030 Applic. Date: 2008-04-14

Inventor: SAMBANTHMURTHI RAVIGADEVI [MY]; TAN YEW AI [MY]; MANICKAM KALYANA SUNDRAM [MY]; WAHID MOHD BASRI BIN [MY]


Application No.: US20100209667A1  Published: 19/Aug/2010

Title: NONWOVEN STRETCH FABRIC

Applicant/Assignee: UNI-CHARM CORPORATION

Application No.: 12/593490   Filing Date: 24/Mar/2008

Abstract:A nonwoven fabric which, even when having a low basis weight, has a wide stretch range at time of use. It is inhibited from breaking or decreasing in strength upon stretching. It feels good to the touch and has excellent cushioning properties and high air permeability. The nonwoven stretch fabric has a longitudinal direction and a transverse direction perpendicular to the longitudinal direction. It has, arranged on each side, strip-form sparse regions extending in the longitudinal direction and strip-form dense regions extending likewise, the two kinds of regions being alternately and successively arranged in the transverse direction. The strip-form dense regions on one side and those on the other side are alternately arranged in the transverse direction. The nonwoven stretch fabric is constituted of a mixture of stretched fibers and stretchable fibers or is composed of stacked layers of these two kinds of fibers. The stretched fibers include stretched fibers which have been partly stretched in the area located between each of the strip-form dense regions on that one side and the adjacent one of the strip-form dense regions on the other side. The fibers constituting the partly stretched fibers have an average fiber diameter of 12-21 [mu]m.

Priority: JP20070094903 Applic. Date: 2007-03-30; WO2008JP55362 Applic. Date: 2008-03-24

Inventor: MITSUNO SATOSHI [JP]; GODA HIROKI [JP]


Application No.: US20100210499A1  Published: 19/Aug/2010

Title: SKIN AND HAND CLEANING COMPOSITIONS WITH HYDROPHILIC EMOLLIENTS

Applicant/Assignee: EVONIK STOCKHAUSEN GMBH

Application No.: 12/595531   Filing Date: 22/Apr/2008

Abstract:The invention relates to skin cleansers/hand cleaners, particularly coarse hand cleaners, containing at least 0.1 wt. % of at least one hydrophilic emollient having an HLB value of >=10. Said skin cleansers/ hand cleaners especially contain, relative to the entire composition of the cleanser/cleaner, a.) at least 0.1 wt. % of at least one hydrophilic emollient, preferably a polyol ester, b.) 2 to 40 wt. % of at least one surfactant selected from among the group comprising fatty alcohol ethoxylates, fatty alcohol ether sulfates, and salts of sulfated and/or sulfonated fatty acids, c.) 30 to 90 wt. % of water, d.) 0 to 30 wt. % of one or more cleaning promoters selected from among the group comprising polyols, polyether, polyphosphates, and phosphates, e.) 0 to 30 wt. % of one or more abrasive agents, f.) 0 to 1.0 wt. % of propoxylated fatty alcohols, g.) one or more optional viscosity-forming agents, h.) other optional cosmetic auxiliary agents, additives, and/or active substances, the total of components a.) to h.) amounting to 100 wt. %.

Priority: DE200710022693 Applic. Date: 2007-05-11; WO2008EP54834 Applic. Date: 2008-04-22

Inventor: ALLEF PETRA [DE]; KLOTZBACH VOLKER [DE]; VEEGER MARCEL [DE]


Application No.: US20100210530A1  Published: 19/Aug/2010

Title: EXTRACELLULAR MATRIX COMPOSITIONS

Applicant/Assignee: HISTOGEN, INC

Application No.: 12/632721   Filing Date: 07/Dec/2009

Abstract:The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Priority: US2009-509171 Applic. Date: 2009-07-24; US2009-501312 Applic. Date: 2009-07-10; US2009-363488 Applic. Date: 2009-01-30; US20080024854P Applic. Date: 2008-01-30; US20080034361P Applic. Date: 2008-03-06; US20080050940P Applic. Date: 2008-05-06

Inventor: NAUGHTON GAIL K [US]; ZIEGLER FRANK [US]; BAUMGARTNER MARK [US]; NICKEY KYLE [US]


Application No.: US20100210585A1  Published: 19/Aug/2010

Title: USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED FOR IMPROVING IN PARTICULAR THE PROTECTIVE FUNCTION OF THE SKIN, THE EYE AND THE MUCOUS

Applicant/Assignee: AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS A.R.D

Application No.: 12/670219   Filing Date: 04/Jul/2008

Abstract:The present invention relates to the use of hyaluronic acid for the preparation of compositions intended for improving the protective function of the skin, the eye and the mucous membranes, in particular of the upper and lower airways and the intestinal mucosa.

Priority: FR20070005349 Applic. Date: 2007-07-23; WO2008FR00959 Applic. Date: 2008-07-04

Inventor: BRESIN ANTHONY [FR]; PUCHELLE EDITH [FR]; ZAHM JEAN-MARIE [FR]; MILLIOT MAGALI [FR]


Application No.: US20100210727A1  Published: 19/Aug/2010

Title: HEPOXILIN ANALOG ENANTIOMERS

Applicant/Assignee: EVOLVA S.A

Application No.: 12/226457   Filing Date: 19/Apr/2007

Abstract:The present invention relates to enantiomeric forms of hepoxilin analogs of Formula I-VIII, pharmaceutical compositions thereof, a method for the separation of said enantiomeric forms of hepoxilin analogs comprising applying said hepoxilin to a chiral phase HPLC column and eluting said hepoxilin with an alkane and alcohol solvent mixture. Said enantiomeric forms of hepoxilin analogs of Formula I-VIII were found to be useful in controlling the biological effects of PPAR mediated transcriptional control for the treatment of diseases such as cancer, thromboxane-mediated diseases and for modulating intracellular calcium concentration.

Priority: US20060793008P Applic. Date: 2006-04-19; US20060794584P Applic. Date: 2006-04-25; US20060833477P Applic. Date: 2006-07-27; US20060844356P Applic. Date: 2006-09-14; WO2007CA00668 Applic. Date: 2007-04-19

Inventor: PACE-ASCIAK CECIL [CA]; SORENSEN ALEXANDRA SANTANA [CH]; MEYER JEAN-PHILIPPE [FR]; DEMIN PETER [RU]


Application No.: US20100210728A1  Published: 19/Aug/2010

Title: COMPOSITION FOR TREATING A DERMAL ANOMALY

Applicant/Assignee:

Application No.: 12/765361   Filing Date: 22/Apr/2010

Abstract:An improved composition for treatment of ulcer-type skin conditions. The composition is primarily characterized by a combination of nitroglycerin and arginine. Other embodiments comprise emollient cream, mineral oil, tumeric powder, folic acid, vitamin B12, and zinc citrate. The composition is particularly effective in improving blood flow in the underlying capillary bed about the wound, improving nerve growth about the wound, increasing circulation, and having a standardized and more predictable therapeutic characteristic.

Priority: US2004-992623 Applic. Date: 2004-11-17

Inventor: BERKSON LINDSEY [US]; BURTON KENNETH G [US]


Application No.: US20100210994A1  Published: 19/Aug/2010

Title: DELIVERY OF THERAPEUTICALLY/DERMATOLOGICALLY ACTIVE SPECIES INTO THE SKIN VIA ELECTROPORATION

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/541376   Filing Date: 14/Aug/2009

Abstract:A regime or regimen for treating a skin disease, disorder or condition afflicting a patient in need thereof includes forming at least one micropore to a predetermined depth through a surface of the afflicted skin of such patient

positioning at least a first electrode on the surface of the afflicted skin electrically coupled to the at least one micropore and a second electrode on the surface of the afflicted skin spaced apart from the first electrode

applying an electrical voltage from the first and second electrodes to produce a desired electroporation in the skin, and further including the step of delivering a biologically active species to the afflicted skin at the at least two micropores formed therein, wherein the biologically active species is therapeutically/dermatologically active against the skin disease, disorder or condition.

Priority: WO2008EP52081 Applic. Date: 2008-02-20; US20070902088P Applic. Date: 2007-02-20

Inventor: ZARIF LEILA [FR]


Application No.: US20100211055A1  Published: 19/Aug/2010

Title: METHOD FOR BODY TONING AND AN INTEGRATED DATA MANAGEMENT SYSTEM FOR THE SAME

Applicant/Assignee:

Application No.: 12/388501   Filing Date: 18/Feb/2009

Abstract:Tracking toning history of a subject and determining parameters of a current toning session is provided by recording and storing into the memory of a toning device, or a computer or some other processing device, parameters of each of the preceding tissue toning procedures, as well as segments of the subject body affected by such toning procedures. Next, the recorded data is analyzed and one or more protocols related to the current tissue toning session are then derived. Concurrently, with executing the protocol, recommendations on skin care options, new products adapted for skin care and complementary to the skin/tissue toning, and any other skin care news that may be relevant to the subject skin care are identified and provided.

Priority:

Inventor: ECKHOUSE SHIMON [IL]; FLYASH LION [IL]


Application No.: US20100215594A1  Published: 26/Aug/2010

Title: Tyrosinase Inhibitors

Applicant/Assignee: MERCK PATENT GMBH

Application No.: 12/673312   Filing Date: 17/Jul/2008

Abstract:The invention relates to compounds of the formula I where the substituents AA1, AA2, o and R have a meaning indicated in claim 1, and to the salts and solvates and mixtures thereof, to a process for the preparation thereof, preparations and the use thereof.

Priority: DE200710038097 Applic. Date: 2007-08-13; WO2008EP05830 Applic. Date: 2008-07-17

Inventor: HUBER SYLVIA [DE]; MUJICA-FERNAUD TERESA [DE]


Application No.: US20100215595A1  Published: 26/Aug/2010

Title: Personal Care Compositions Containing Silicone-Organic Gels From Polyalkyloxlene Crosslinked Silicone Elastomers

Applicant/Assignee:

Application No.: 12/680269   Filing Date: 26/Sep/2008

Abstract:Silicone organic gels and ge! paste compositions are disclosed containing a silicone organic elastomer in a carrier fluid. The silicone organic elastomer is a reaction product of a linear or branched organohydrogensiioxane, an [alpha], [omega]-unsaturated poly[upsilon]xyalkylene, and a hydrosilylation catalyst. The silicone organic elastomer is particularly useful to gel organic carrier fluids. The gels and gels pastes also provide enhanced compatibility with many personal and health care actives.

Priority: US20070975318P Applic. Date: 2007-09-26; WO2008US77791 Applic. Date: 2008-09-26

Inventor: KENNAN JOHN JOSEPH [US]; MESSNER KATHRYN ELIZABETH [US]; VAN REETH ISABELLE [CN]; GARAUD JEAN-LUC [FR]


Application No.: US20100215596A1  Published: 26/Aug/2010

Title: Aqueous Meta-Stable Oil-in-Water Emulsions

Applicant/Assignee: COGNIS IP MANAGEMENT GMBH

Application No.: 12/681727   Filing Date: 25/Sep/2008

Abstract:Disclosed are aqueous o/w emulsions with the ability to invert into w/o emulsions by introduction of mechanical energy, comprising (a) oil components, (b) w/o emulsifiers, (c) cationic surfactants, (d) actives, and (e) cationic-compatible stabilisers. The emulsions are useful for making cosmetic or pharmaceutical compositions, particularly sprayable sun care emulsions.

Priority: EP20070019441 Applic. Date: 2007-10-04; WO2008EP08122 Applic. Date: 2008-09-25

Inventor: AMELA CONESA CRISTINA [ES]; DOMINGO MARTA [ES]; BEUCHE MARC [FR]


Application No.: US20100215626A1  Published: 26/Aug/2010

Title: MRSA Decolonization Kit (MDK)

Applicant/Assignee:

Application No.: 12/392334   Filing Date: 25/Feb/2009

Abstract:The MRSA Decolonization Kit, or MDK, is a unique process available in a single kit to eliminate MRSA from individuals who have recently suffered an invasive infection from the potentially deadly bacteria and strengthen their body's ability to prevent recurrent infection. The kit provides patients with everything they need to remove MRSA from their skin flora and replace it with a far less dangerous bacteria, Staphylococcus Epidermidis. The kit has detailed instructions on using the bactericidal ointments and cleansers followed by the application of Sepiderm Lotion that contains viable, healthy Staphylococcus Epidermidis. It also includes detailed instructions on ridding the home environment of the dangerous bacteria as well as the vital component of personal hygiene to minimize repeat contamination with the bacteria.

Priority:

Inventor: MURPHY BRIAN PATRICK [US]


Application No.: US20100215634A1  Published: 26/Aug/2010

Title: VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS

Applicant/Assignee:

Application No.: 12/652798   Filing Date: 06/Jan/2010

Abstract:The present disclosure relates to compositions and methods for treating acne and other conditions. In particular, the compositions and methods are useful for the treatment of sebum associated conditions.

Priority: US20090208386P Applic. Date: 2009-02-24; US20090261453P Applic. Date: 2009-11-16

Inventor: TENNENBAUM TAMAR [IL]; BRAIMAN-WIKSMAN LIORA [IL]; MANDIL-LEVIN REVITAL [IL]


Application No.: US20100215657A1  Published: 26/Aug/2010

Title: Methods and Compositions Using Klotho-FGF Fusion Polypeptides

Applicant/Assignee: NOVARTIS AG

Application No.: 12/696693   Filing Date: 29/Jan/2010

Abstract:The present invention is directed to methods, kits and compositions for preventing or treating age-related conditions or metabolic disorders. The Klotho fusion polypeptides of the invention include at least a Klotho protein or an active fragment thereof. In one embodiment, the fusion polypeptide comprises a Klotho polypeptide, a FGF (such as FGF23) and (optionally) a modified Fc fragment. The Fc fragment can, for example, have decreased binding to Fc-gamma-receptor and increased serum half-life. The Klotho fusion proteins are useful in the treatment and prevention of a variety of age-related conditions and metabolic disorders. In another embodiment, the fusion polypeptide comprises a FGF (such as FGF23) and a modified Fc fragment.

Priority: US2009-360970 Applic. Date: 2009-01-28; US20080063015P Applic. Date: 2008-01-28

Inventor: GLASS DAVID [US]; HU SHOU-IH [US]


Application No.: US20100215700A1  Published: 26/Aug/2010

Title: Shear Gels and Compositions Comprising Shear Gels

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/392646   Filing Date: 25/Feb/2009

Abstract:The present invention is directed to shear gels and topical compositions comprising the same. The topical compositions can be substantially free of silicone elastomers and yield excellent sensory characteristics when applied.

Priority:

Inventor: MOADDEL TEANOOSH [US]; DOBKOWSKI BRIAN JOHN [US]; WIS GABRIELA MARIA [US]; PEHRATOVIC HASIBA [US]


Application No.: US20100215701A1  Published: 26/Aug/2010

Title: COSMETIC COMPOSITION COMPRISING A FINE POWDER

Applicant/Assignee: ARKEMA FRANCE

Application No.: 12/595672   Filing Date: 14/Apr/2008

Abstract:The present invention relates to cosmetic compositions used in the care and make-up field. This composition mainly comprising a continuous aqueous phase, a fatty phase and a fine and porous pulverulent copolyamide powder phase, is in the form of creamy, liquid or gelled compositions. This is in particular an emulsion, but it may also be a two-phase formulation or composition in which the fatty phase and aqueous phase are separate. The invention more particularly relates to cosmetic care and/or make-up compositions having a continuous aqueous phase in the case of an oil-in-water emulsion.

Priority: FR20070054431 Applic. Date: 2007-04-12; WO2008FR50662 Applic. Date: 2008-04-14

Inventor: LOYEN KARINE [FR]


Application No.: US20100215710A1  Published: 26/Aug/2010

Title: Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 11/886363   Filing Date: 10/Apr/2006

Abstract:Methods for increasing rate of healing of wounds in epithelial tissues by administration of beta-2 adrenergic receptor antagonists to target patients are provided. Methods for decreasing cell growth around implanted devices and methods for decreasing wound contraction by administration of beta-2 adrenergic receptor agonists are also provided. Pharmaceutical compositions and kits including beta-2 adrenergic receptor agonists and antagonists are described, as are devices coated with beta-2 adrenergic receptor agonists.

Priority: US20050669839P Applic. Date: 2005-04-08; WO2006US13415 Applic. Date: 2006-04-10

Inventor: ISSEROFF ROSLYN RIVKAH [US]; PULLAR CHRISTINE E [US]


Application No.: US20100215728A1  Published: 26/Aug/2010

Title: Skincare Methods

Applicant/Assignee: ASAN LABORATORIES COMPANY (CAYMAN), LIMITED

Application No.: 12/700843   Filing Date: 05/Feb/2010

Abstract:Disclosed are compositions and methods for skincare, e.g., reducing skin wrinkles and for treating skin disorders.

Priority: US2007-848272 Applic. Date: 2007-08-31; US2006-499936 Applic. Date: 2006-08-07; US2004-798119 Applic. Date: 2004-03-11; US2002-205738 Applic. Date: 2002-07-25; US2004-843025 Applic. Date: 2004-05-10; US2005-079370 Applic. Date: 2005-03-14; US2002-132999 Applic. Date: 2002-04-26

Inventor: CHUNG YIH-LIN [TW]; PUI NAM-MEW [TW]; CHANG WEI-WEI [US]


Application No.: US20100215755A1  Published: 26/Aug/2010

Title: Resveratrol Ferulate Compounds, Compositions Containing The Compounds, And Methods Of Using The Same

Applicant/Assignee:

Application No.: 12/775676   Filing Date: 07/May/2010

Abstract:The present invention relates to methods of using topical or cosmetic compositions containing resveratrol ferulates for skin lightening and anti-aging applications and method of synthesizing resveratrol ferulates.

Priority: US2008-204064 Applic. Date: 2008-09-04; US20070970943P Applic. Date: 2007-09-08; US20080029600P Applic. Date: 2008-02-19

Inventor: BRATESCU DANIELA [US]; MOHAMMADI FATERNEH [US]; ZECCUHINO JULIUS R [US]; DANESHYAR FRED [US]


Application No.: US20100215761A1  Published: 26/Aug/2010

Title: COMPOSITION FOR REGULATING LIPID METABOLISM

Applicant/Assignee: EXICHOL SA

Application No.: 12/738116   Filing Date: 16/Oct/2008

Abstract:This invention concerns a composition for regulating lipid metabolism and methods that may be used in the food industry as well as in the nutraceutical and therapeutic fields. In particular, the invention involves food additives or supplements, a composition containing these and the use thereof, in particular for revitalizing a subject's metabolism, in particular, that of human beings.

Priority: EP20070118598 Applic. Date: 2007-10-16; WO2008IB02815 Applic. Date: 2008-10-16

Inventor: BOURGEOIS-LUGAND MARIE FRANCOISE YVONNE [FR]; WAHLI WALTER [CH]; EL KOCHAIRI IIHEM [CH]; PRADERVAND SYLVAIN [CH]; PARISOT GILES DIDIER [CH]


Application No.: US20100215762A1  Published: 26/Aug/2010

Title: EDIBLE COMPOSITION FOR TREATING CUTANEOUS SIGNS OF AGEING

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/707706   Filing Date: 18/Feb/2010

Abstract:This invention relates to the provision of an edible composition for the treatment of cutaneous signs of ageing, in particular those associated with loss of skin elasticity, wrinkles and sagging. Thus the inventive composition provides skin benefits selected from the group consisting of enhancing collagen deposition in the skin, reducing the appearance of wrinkles and reducing sagging. Thus the invention provides an edible composition for treating aged skin, the composition comprising: (a) 2 to 1000, preferably 5 to 750, most preferably 10 to 500 mg anthocyanidin and derivatives thereof

and (b) 1 to 20, preferably 5 to 15, most preferably 2 to 10 mg lutein and derivatives thereof

wherein the weight ratio of anthocyanidin to lutein is at least 1:1, preferably at least 10:1 and more preferably at least 25:1, even more preferably at least 50:1, most preferably at least 100:1

wherein the composition excludes copper in the form of separately or in combination copper gluconate and copper oxide

and further excludes separately or in combination with the copper exclusion Nandina domestica or an extract thereof. The invention also relates to a cosmetic method for providing the aforesaid skin benefits using the inventive composition.

Priority: EP20090153407 Applic. Date: 2009-02-23

Inventor: CASEY JOHN [GB]; JENKINS GAIL [GB]; WAINWRIGHT LINDA JANE [GB]


Application No.: US20100215785A1  Published: 26/Aug/2010

Title: COMPOSITIONS AND METHODS FOR TREATING SIGNS OF SKIN AGING

Applicant/Assignee:

Application No.: 12/390102   Filing Date: 20/Feb/2009

Abstract:The invention relates to methods and compositions for treating skin aging, said compositions comprising at least one tropoelastin promoter and at least one tropoelastin crosslinker.

Priority:

Inventor: KIZOULIS MENAS G [US]; SOUTHALL MICHAEL [US]; TUCKER-SAMARAS SAMANTHA D [US]


Application No.: US20100215832A1  Published: 26/Aug/2010

Title: MEAT ANALOGUE WITH EXTERNAL TEXTURE

Applicant/Assignee: MARS INCORPORATED

Application No.: 12/663394   Filing Date: 13/Jun/2008

Abstract:A method of manufacturing an extruded meat analogue, said method including the step of holding the extrudate at ambient temperature and pressure conditions, thereby facilitating the formation of a 'skin' on the outer surface of the extrudate, and contraction of the cross-sectional area of the extrudate, thereby to cause said 'skin' to wrinkle in a manner which resembles the appearance of cooked muscle meat.

Priority: AU20070903168 Applic. Date: 2007-06-13; WO2008AU00853 Applic. Date: 2008-06-13

Inventor: REDMAN ANDREW JASON [AU]


Application No.: US20100216165A1  Published: 26/Aug/2010

Title: USE OF SOLUBLE FORMS OF THE DESMOGLEIN I PROTEIN FOR THE PURPOSES OF SCREENING FOR ANTI-AGEING ACTIVE AGENTS

Applicant/Assignee: L'OREAL

Application No.: 12/687601   Filing Date: 14/Jan/2010

Abstract:The invention relates to the use of one or more complexed or noncomplexed, soluble peptide form(s) of Desmoglein I, as a marker for evaluating the effectiveness of active agents and/or of treatments, in particular anti-ageing active agents and/or treatments, with regard to an epidermis.

Priority: FR20090050159 Applic. Date: 2009-01-13; US20090202078P Applic. Date: 2009-01-27

Inventor: DONOVAN MARK [FR]; SIMONETTI LUCIE [FR]; BERNARD DOMINIQUE [FR]


Application No.: US20100216707A1  Published: 26/Aug/2010

Title: COSMETIC USE OF APOLIPOPROTEIN D TYPE PROTEINS

Applicant/Assignee: L'OREAL

Application No.: 12/602246   Filing Date: 20/Jun/2008

Abstract:The subject of the present invention is the use, in particular the cosmetic and/or therapeutic use, of the apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, of a nucleic sequence encoding such a polypeptide or of an agent modulating the activity or of the expression of such a polypeptide, in particular for stimulating terminal epithelial differentiation. The invention also relates to the use of the protein apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, or of a nucleic sequence encoding such a polypeptide as a marker for evaluating the state of the epidermis.

Priority: FR20070055976 Applic. Date: 2007-06-22; US20070952262P Applic. Date: 2007-07-27; WO2008IB52440 Applic. Date: 2008-06-20

Inventor: BERNARD DOMINIQUE [FR]; CASTIEL ISABELLE [FR]; SIMONETTI LUCIE [FR]


Application No.: US20100216753A1  Published: 26/Aug/2010

Title: CONTROLLED RELEASE OF DRUGS INTO/THROUGH THE SKIN

Applicant/Assignee: GALDERMA S.A

Application No.: 12/714739   Filing Date: 01/Mar/2010

Abstract:The slow and sustained, controlled release of a drug into and through the skin includes topically applying onto the skin of an individual in need of such treatment, a composition containing at least one solubilized drug, at least one film-forming silicone, and at least one volatile solvent.

Priority: US2007-000187 Applic. Date: 2007-12-10; WO2006EP05831 Applic. Date: 2006-05-22; US20050689282P Applic. Date: 2005-06-10

Inventor: ANDRES PHILIPPE [FR]; MALLARD CLAIRE [FR]


Application No.: US20100216880A1  Published: 26/Aug/2010

Title: TRANSDERMAL COMPOSITIONS FOR ANTICHOLINERGIC AGENTS

Applicant/Assignee:

Application No.: 12/614216   Filing Date: 06/Nov/2009

Abstract:The present invention relates generally to compositions or formulations for transdermal or transmucosal administration of anticholinergic agents such as oxybutynin. The invention utilizes a novel delivery vehicle and is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. A method is disclosed for treating a subject for urinary incontinence with these formulations while reducing the incidences of peak concentrations of drug and undesirable side effects associated with oral anticholinergics.

Priority: WO2000EP07533 Applic. Date: 2000-08-03; US2004-798111 Applic. Date: 2004-03-10; US20030510613P Applic. Date: 2003-10-10; US20030453604P Applic. Date: 2003-03-11

Inventor: CARRARA DARIO NORBERTO R [CH]; GRENIER ARNAUD [FR]


Application No.: US20100216888A1  Published: 26/Aug/2010

Title: LIQUID COMPOSITIONS CONTAINING SOLUBILIZED BENZOYL PEROXIDE, MEANS FOR APPLYING SAME AND METHODS OF TREATMENT USING SAME

Applicant/Assignee:

Application No.: 12/773322   Filing Date: 04/May/2010

Abstract:Liquid medicaments incorporate about 1.0-3.0% active benzoyl peroxide (BP) by weight in substantially fully solubilized form, while being substantially free of acetone and other harsh, dermatologically undesirable solvents. The novel compositions are produced by (a) creating an emulsion or slurry of BP in an emollient, topically acceptable ester, and (b) dissolving the emulsion or slurry in absolute alcohol. The medicaments may be used in the treatment of BP-responsive skin conditions in mammals, e.g., acne vulgaris or rosacea. The novel medicaments may be dispensed directly to the affected skin area through the use of an applicator device comprising a fluid reservoir associated with a foam applicator tip, or via a spray dispenser, atomizer or pump spray.

Priority: US2007-820949 Applic. Date: 2007-06-21

Inventor: BLACKMAN STEVEN T [US]


Application No.: US20100216892A1  Published: 26/Aug/2010

Title: Use of synergistically active 1,2-alkanediol mixtures as skin moisture-regulating compositions

Applicant/Assignee: SYMRISE GMBH & CO. KG

Application No.: 11/721113   Filing Date: 21/Dec/2005

Abstract:Synergistically active mixtures of straight-chain 1,2-alkanediols having 5 to 10 C atoms and their use as skin moisture-regulating compositions are described. Binary and ternary mixtures of 1,2-pentanediol, 1,2-hexanediol and 1,2-octanediol have proved to be particularly active here. Cosmetic or pharmaceutical formulations and ready-to-use cosmetic or pharmaceutical products comprising particularly synergistically active mixtures of the 1,2-alkanediols mentioned and the use of these formulations and products are furthermore described.

Priority: US20040639910P Applic. Date: 2004-12-29; WO2005EP57057 Applic. Date: 2005-12-21

Inventor: SCHMAUS GERHARD [DE]; PILLAI RAVIKUMAR [US]


Application No.: US20100217316A1  Published: 26/Aug/2010

Title: Suture treatment method and kit therefor

Applicant/Assignee:

Application No.: 12/380222   Filing Date: 25/Feb/2009

Abstract:A suture method and kit enables health care providers and patients to select colored sutures from a wide variety of colors. The colored sutures enable the patient to adorn a skin wound site so as to more effectively treat the wound with patient input and cooperation. The suturing method involves the steps of assessing a suture site or skin wound

selecting a suturing technique based on the assessed suture site or skin wound

providing a visual depiction of exemplary suture layout schema to the patient, which exemplary suture layout schema are reflective of the selected suturing technique

providing a patient with a selection of suture colors

inviting the patient to select at least one suture color from the suture color palette

selecting at least one suture color from the selection of suture colors

and suturing a suture site with a colored suture as selected by the patent.

Priority:

Inventor: FEDINEC JAMES J [US]


Application No.: US20100217357A1  Published: 26/Aug/2010

Title: Methods and Apparatus for Personal Care

Applicant/Assignee:

Application No.: 12/708464   Filing Date: 18/Feb/2010

Abstract:Methods, apparatus and systems for personal care, such as treatment of a skin or hair treatment surface, are disclosed. In some embodiments, a base device is configured to thermally modify (heat or cool) an applicator on a hand piece that can then be used to cleanse, treat and/or otherwise rejuvenate the treatment surface. The applicator can be formulated with a smooth or abrasive material that can absorb, be coated with or otherwise take up a variety of materials, such as liquids, lotions, gels or creams, which are suitable for application to the treatment surface. The base device may thermally modify the material that is then coupled to the applicator and applied to the treatment surface during treatment. Application of the applicator at the desired temperature to the treatment surface may, for example, stimulate deeper blood circulation, clear pores, diminishes or removes deep and fine wrinkles, accelerate acne clearing, treat blemished skin, decrease edema and erythema of the skin, and/or reduce puritis of various etiologies. The hand piece may comprise one or more secondary treatment elements, such as LEDs for photoactivation, electrodes for delivery of micro-currents or vibrating elements for rubbing or abraiding, in order to achieve additional activation of the treatment surface and/or of the thermally modified material coupled to the applicator, which may enhance or improve treatment.

Priority: US2008-263159 Applic. Date: 2008-10-31; US20090207998P Applic. Date: 2009-02-19

Inventor: DA SILVA LUIZ B [US]; CHANG T DEBUENE [US]; KOCHEMASOV IGOR G [RU]


Application No.: US20100221195A1  Published: 02/Sep/2010

Title: SUBSTANTIALLY NON-AQUEOUS FOAMABLE PETROLATUM BASED PHARMACEUTICAL AND COSMETIC COMPOSITIONS AND THEIR USES

Applicant/Assignee: FOAMIX LTD

Application No.: 12/778591   Filing Date: 12/May/2010

Abstract:The present invention relates to stable substantially non-aqueous, non-alcoholic, non-silicone, foamable carrier compositions comprising petrolatum or mixtures thereof, at least one foam agent, at least one propellant, and with and without the addition of an active agent. The formulations may contain a solvent substantially miscible therein. The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject in need thereof, comprising administering the above-mentioned compositions to an afflicted target site of said mammalian subject.

Priority: US2008-025547 Applic. Date: 2008-02-04; US2007-940290 Applic. Date: 2007-11-14; US20070899176P Applic. Date: 2007-02-02; US20070915859P Applic. Date: 2007-05-03; US20060858747P Applic. Date: 2006-11-14

Inventor: TAMARKIN DOV [IL]; FRIEDMAN DORON [IL]; ZIV ENBAL [IL]; EINI MEIR [IL]; BERMAN TAL [IL]; DANZIGER JORGE [IL]; KEYNAN RITA [IL]; SCHUZ DAVID [IL]


Application No.: US20100221197A1  Published: 02/Sep/2010

Title: ANTIMICROBIAL AGENT AND EXTERNAL PREPARATION FOR SKIN CONTAINING THE SAME

Applicant/Assignee: TAIYO CORPORATION

Application No.: 12/676857   Filing Date: 22/Aug/2008

Abstract:A novel antimicrobial agent which has a high degree of safety, an excellent compounding property and strong antimicrobial activity is provided. The antimicrobial agent is characterized by containing ricinoleic acid monoglyceride or diglycerine ricinoleic acid monoester as an active ingredient. The antimicrobial agent of the present invention is suitable as a compounding component of an antimicrobial object selected from a food product, a food packaging material, tableware, a perfume cosmetic, a cosmetic, an external preparation for skin, a skin washing agent, a disinfectant, a lotion for external use, an agent for hair, a wiping sterilization agent, a pharmaceutical, a quasi drug and a hygiene material for the oral cavity.

Priority: JP20070305710 Applic. Date: 2007-11-27; WO2008JP64990 Applic. Date: 2008-08-22

Inventor: TANAKA YASUO [JP]; KANATANI SHUJI [JP]


Application No.: US20100221200A1  Published: 02/Sep/2010

Title: COMPOSITIONS AND METHODS FOR SKIN CARE

Applicant/Assignee: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION

Application No.: 12/669246   Filing Date: 17/Jul/2008

Abstract:The present disclosure contemplates compositions and methods for skin care. In some embodiments, the compositions may comprise delta opioid receptor agonists. The skin care composition may comprise peptide delta opioid receptor agonists, non-peptide delta opioid receptor agonists, or combinations thereof. In further embodiments, the peptide delta opioid receptor agonists may be chosen from enkephalins and/or deltorphins. In yet other embodiments, the delta opioid receptor agonists may be conjugated to another molecule. For example, the delta opioid receptor agonist may be conjugated to a lipid in order to facilitate entry across the stratum corneum. Further disclosed herein is the cosmetic use of at least one combination as described above, in a composition suitable for topical application to the skin, as an agent for smoothing out wrinkles and fine lines, such as expression wrinkles.

Priority: US20070950224P Applic. Date: 2007-07-17; WO2008US70313 Applic. Date: 2008-07-17

Inventor: DURING MATTHEW J [US]


Application No.: US20100221201A1  Published: 02/Sep/2010

Title: Organosiloxanes Containing Ester Derivatives Of Ascorbic Acid

Applicant/Assignee:

Application No.: 12/680407   Filing Date: 16/Sep/2008

Abstract:Organosiloxanes containing ester derivatives of ascorbic acid are disclosed having the formula (RiSiO)11Ro-Ii)Si-X-A wherein R is an alkyl group containing 1 to 6 carbon atoms, n is I to 3 inclusive, X is a divalent organic linking group, A is an ester derivative of ascorbic acid. A method of making an organosiloxane containing ester derivatives of ascorbic acid and the products prepared according to the method arc also taught. The compounds and compositions of the present disclosure are useful to affect tissue lightening when applied topically to keratinaceous tissue.

Priority: US20070975863P Applic. Date: 2007-09-28; WO2008US76494 Applic. Date: 2008-09-16

Inventor: FERRITTO MICHAEL SALVATORE [US]; JOFFRE ERIC JUDE [US]; MCIVOR MARGO L [US]; STARCH MICHAEL STEPHEN [US]


Application No.: US20100221245A1  Published: 02/Sep/2010

Title: TOPICAL SKIN CARE COMPOSITION

Applicant/Assignee:

Application No.: 12/395251   Filing Date: 27/Feb/2009

Abstract:The present invention is directed to a topical skin care composition. The composition has the unique ability to treat acne without drying out the user's skin. In particular, the composition includes a base, an antibacterial agent, at least one anti-inflammatory agent, and at least one antioxidant. The antibacterial agent may be benzoyl peroxide.

Priority:

Inventor: KUNIN AUDREY [US]


Application No.: US20100221294A1  Published: 02/Sep/2010

Title: Use of Non-Straight Fiber Dispersed in a Composition and Compositions Thereof

Applicant/Assignee: AVONE PRODUCTS ,INC

Application No.: 12/089616   Filing Date: 14/Dec/2006

Abstract:Compositions and methods for enhancing, lengthening, volumizing, or concealment of keratinous surfaces or tissue. The compositions comprise non-straight fibers useful for formulating cosmetics, personal care products, and pharmaceutical compositions which are comfortable, durable, and overcome smudging, smearing, flaking, and detachment from keratinous surfaces, thereby resulting in an aesthetically pleasing appearance.

Priority: US20050754936P Applic. Date: 2005-12-29; WO2006US47764 Applic. Date: 2006-12-14

Inventor: KUREK JOHN S [US]; ZHENG TAO [US]; GLYNN JR JOHN R [US]; PAHLICK HAROLD E [US]


Application No.: US20100221295A1  Published: 02/Sep/2010

Title: COSMETIC USE OF WHEY PROTEIN MICELLES

Applicant/Assignee:

Application No.: 12/294447   Filing Date: 26/Mar/2007

Abstract:The present invention relates to use of whey protein micelles as a cosmetic agent or abrasive agents, and in particular to the use of such micelles in cosmetic compositions as well as to a method for obtaining such compositions.

Priority: EP20060006299 Applic. Date: 2006-03-27; WO2007EP52889 Applic. Date: 2007-03-26

Inventor: BOVETTO LIONEL JEAN RENE [CH]; SCHMITT CHRISTOPHE JOSEPH ETIENNE [CH]


Application No.: US20100221299A1  Published: 02/Sep/2010

Title: THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF

Applicant/Assignee:

Application No.: 12/778246   Filing Date: 12/May/2010

Abstract:The present invention relates to a composition and uses thereof for treatment of damaged tissue comprising at least one essential amino acid in L form and at least one essential lipid

wherein the composition is administered to a mammal suffering from severe tissue damage. The invention further relates to a composition and uses thereof comprising the mixture of one or more free L-amino acids in which the molar ratio of the free L-amino acids corresponds to the molar ratio of amino components in a mammalian tissue protein

and at least one essential lipid.

Priority: US2005-212530 Applic. Date: 2005-08-26; US2000-639859 Applic. Date: 2000-08-16; US19990149338P Applic. Date: 1999-08-17

Inventor: GIRSH LEONARD S [US]


Application No.: US20100221319A1  Published: 02/Sep/2010

Title: Compositions and Methods for Improved Skin Care

Applicant/Assignee:

Application No.: 12/780320   Filing Date: 14/May/2010

Abstract:Compositions and methods for administering collagen to a human subject have been developed. The collagen-containing lipid vesicles of the invention provide a delivery system for human collagen which eliminates problems associated with chemical and physical instability of the collagen as well as immune responses to non-human collagen.

Priority: US2006-542554 Applic. Date: 2006-10-03; US20050723043P Applic. Date: 2005-10-03; US20060833045P Applic. Date: 2006-07-25

Inventor: PINSKY MARK A [US]


Application No.: US20100221364A1  Published: 02/Sep/2010

Title: COMPOSITIONS AND METHODS OF INDUCING HAIR GROWTH UTILIZING COTINUS COGGYGRIA

Applicant/Assignee:

Application No.: 12/718101   Filing Date: 05/Mar/2010

Abstract:This application relates to compositions and methods for inducing hair growth and improving hair quality utilizing extracts of Cotinus coggygria in an amount effective to induce hair growth when applied topically to an area of the skin on which hair growth is desired.

Priority: US2007-952399 Applic. Date: 2007-12-07; US20060869770P Applic. Date: 2006-12-13

Inventor: BRUNING ELIZABETH [US]; STONE VIOLETTA IOTSOVA [US]; ZHAO RENBIN [US]


Application No.: US20100221372A1  Published: 02/Sep/2010

Title: WOLFBERRIES AND SKIN INFLAMMATION

Applicant/Assignee:

Application No.: 12/677488   Filing Date: 12/Sep/2008

Abstract:The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation.

Priority: EP20070116190 Applic. Date: 2007-09-12; WO2008EP62132 Applic. Date: 2008-09-12

Inventor: VIDAL KARINE [FR]; BLUM-SPERISEN STEPHANIE [CH]; PHILIPPE DAVID [FR]; BALLEVRE OLIVIER [CN]; BUCHELI PETER [CH]; WANG JUNKUAN [CH]


Application No.: US20100221684A1  Published: 02/Sep/2010

Title: IMPLANT FOR SUBCUTANEOUS OR INTRADERMAL INJECTION

Applicant/Assignee: AVENTIS PHARMACEUTICALS

Application No.: 12/776909   Filing Date: 10/May/2010

Abstract:The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years.

Priority: FR19970007334 Applic. Date: 1997-06-13; US2004-809349 Applic. Date: 2004-03-26; US1999-242103 Applic. Date: 1999-02-08; WO1998FR01241 Applic. Date: 1998-06-12

Inventor: ASIUS JEROME [FR]; FESSI HATEM [FR]; GOUCHET FRANCK [FR]; LAGLENNE BENEDICTE [FR]; LAUGIER-LAGLENNE ELISABETH [FR]


Application No.: US20100221698A1  Published: 02/Sep/2010

Title: In-Vitro Deposition Evaluation Method for Identifying Personal Care Compositions Which Provide Improved Deposition of Benefit Agents

Applicant/Assignee:

Application No.: 12/511034   Filing Date: 28/Jul/2009

Abstract:The present invention relates to an in-vitro deposition evaluation method and an system for evaluating deposition of personal care compositions. The method comprises the steps of providing a microplate and at least one body that is capable of movement within the plurality of wells of the microplate. The method comprises the steps of providing a sample that comprises a personal care composition and depositing sufficient volume of sample to submerge a body within the wells of the microplate. The method comprises the steps of providing a skin mimic and contacting the skin mimic and the microplate such that the skin mimic is exposed to the sample and the body. The method comprises the steps of causing at least one body to move wherein a portion of the sample is transferred to the skin mimic and quantifying the amount of the sample that is transferred to the skin mimic.

Priority: US20080084125P Applic. Date: 2008-07-28

Inventor: WEI KARL SHIQING [US]; STELLA QING [US]


Application No.: US20100221830A1  Published: 02/Sep/2010

Title: Device and Method for Ambient Storage of Fresh/Frozen Tissue Sections Via Desiccation

Applicant/Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA

Application No.: 12/576168   Filing Date: 08/Oct/2009

Abstract:The present invention discloses a method for storing and preserving previously sectioned, snap-frozen, and desiccated biological tissue samples at ambient conditions. Also disclosed are devices and systems for ambient storage of biological tissue sections, and methods for forming said devices.

Priority: US20080103750P Applic. Date: 2008-10-08

Inventor: SADLER THEODORE R [US]


Application No.: US20100222309A1  Published: 02/Sep/2010

Title: SKIN PROPERTY-IMPROVING THERAPEUTIC AGENT COMPRISING A MORPHINAN DERIVATIVE OR ANY OF ITS PHARMACOLOGICALLY PERMISSIBLE ACID ADDITION SALTS AS AN ACTIVE INGREDIENT

Applicant/Assignee: TORAY INDUSTRIES, INC

Application No.: 12/680908   Filing Date: 03/Oct/2008

Abstract:A skin property-improving therapeutic agent includes a compound having a specific morphinan skeleton typified by a compound 1 represented by the following formula (II) or any of its pharmacologically permissible acid addition salts as an active ingredient:

Priority: JP20070262015 Applic. Date: 2007-10-05; WO2008JP68092 Applic. Date: 2008-10-03

Inventor: ONA SHINJI [JP]; TAKESHITA KOICHIRO [JP]; ANDO NAOKI [JP]; YAMASHITA MASAHIRO [JP]


Application No.: US20100222403A1  Published: 02/Sep/2010

Title: Micogel Topical Formulations

Applicant/Assignee: BARRIER THERAPEUTICS, INC

Application No.: 11/993381   Filing Date: 27/Jun/2006

Abstract:The present invention encompasses anhydrous micogel formulations containing miconazole and methods of use for the treatment of topical disorders including acne.

Priority: US20050693924P Applic. Date: 2005-06-27; WO2006US25194 Applic. Date: 2006-06-27

Inventor: BORGERS MARCEL [BE]; VROOME VALERIE [BE]; CAUWENBERGH GEERT [US]


Application No.: US20100222659A1  Published: 02/Sep/2010

Title: Analyte Monitoring Device and Methods of Use

Applicant/Assignee: ABBOTT DIABETES CARE INC

Application No.: 12/779947   Filing Date: 13/May/2010

Abstract:An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

Priority: US2007-690826 Applic. Date: 2007-03-24; US2003-420057 Applic. Date: 2003-04-18; US2000-667199 Applic. Date: 2000-09-21; US1998-070677 Applic. Date: 1998-04-30

Inventor: SAY JAMES [US]; TOMASCO MICHAEL F [US]; HELLER ADAM [US]; GAL YORAM [IL]; ARIA BEHRAD [US]; HELLER EPHRAIM [US]; PLANTE PHILLIP JOHN [US]; VREEKE MARK S [US]; FRIEDMAN KEITH A [US]; COLMAN FREDRIC C [US]


Application No.: US20100222731A1  Published: 02/Sep/2010

Title: ADHESIVE BANDAGE WITH BARRIER TEAR AWAY TABS

Applicant/Assignee:

Application No.: 12/663881   Filing Date: 04/Jul/2008

Abstract:The adhesive bandage consists of a support with one surface having pressure sensitive adhesive and a wound covering pad placed centrally on it, which are covered by two protective detachable tear away tabs. The tear away tab consists of a single layer over the adhesive surface of the support and becomes two layered over the pad region. The two layers are fused at the zone of fusion near the margin of the pad, but are otherwise free from each other. The layer close to the pad, called inner barrier layer, completely covers the pad area. The outer layer, also called grasping layer, partially covers the barrier layer and the pad, and is folded upon itself to give sufficient length. When the outer layer is grasped to pull apart the releasable tear away tabs the inner barrier layer prevents contact of the finger to the pad. As one pulls apart the tear away tabs the barrier layers unfold and prevent contact of the fingers with the wound and wound exudates, preventing cross contamination. The bandage is enclosed in an envelope with the free ends of uneven dimension to have free part of the surface of both leaves, which are easy to grasp and separate.

Priority: IN2007MU01385 Applic. Date: 2007-07-18; WO2008IN00429 Applic. Date: 2008-07-04

Inventor: GAJIWALA KALPESH JAYANTKUMAR [IN]


Application No.: US20100222853A1  Published: 02/Sep/2010

Title: METHODS AND DEVICES FOR NON-ABLATIVE LASER TREATMENT OF DERMATOLOGIC CONDITIONS

Applicant/Assignee: CUTERA, INC

Application No.: 12/725159   Filing Date: 16/Mar/2010

Abstract:The invention comprises a system and method for non-ablative laser treatment of dermatologic conditions. A laser energy is transmitted to an underlying target element in the skin. The target element is heated to a temperature of at least forty degrees Celsius. In some embodiments, a pulsed, near infrared, high peak power laser energy is used. The systems and methods of the present invention may be used to treat acne, smooth wrinkles, remove hair, treat leg veins, treat facial veins, improve skin texture, decrease pore sizes, reduce rosacea, reduce "blush/diffuse redness, reduce striae, reduce scarring, or the like.

Priority: US2004-782534 Applic. Date: 2004-02-19; US20030448968P Applic. Date: 2003-02-21

Inventor: LEVERNIER MICHAEL [US]; SPOONER GREG [US]; GOLLNICK DAVID A [US]; MACFARLAND DEAN A [US]


Application No.: US20100224204A1  Published: 09/Sep/2010

Title: METHOD OF SHAVING USING SALICYLIC ACID DERIVATIVES

Applicant/Assignee: L'OREAL

Application No.: 12/575176   Filing Date: 07/Oct/2009

Abstract:Provided is a method of shaving, using a composition comprising, in a cosmetically acceptable medium, at least one salicylic acid derivative of formula R represents a saturated aliphatic chain containing 3 to 11 carbon atoms

an unsaturated aliphatic chain containing 3 to 17 carbon atoms bearing one or more conjugated or nonconjugated double bonds

an aromatic nucleus linked to the carbonyl radical directly or by means of saturated or unsaturated aliphatic chains containing 2 to 7 carbon atoms

said R groups may be substituted

R' represents a hydroxyl group or an ester function of formula (II) below: R1 represents a saturated or unsaturated aliphatic chain containing 1 to 18 carbon atoms, and/or salt thereof. Also provided is using the above derivative, in a shaving composition, to facilitate shaving and/or to decrease or eliminate ingrown hairs.

Priority: FR20080056811 Applic. Date: 2008-10-08; US20080105946P Applic. Date: 2008-10-16

Inventor: AUBERT LIONEL [FR]


Application No.: US20100224209A1  Published: 09/Sep/2010

Title: APPARATUS AND METHODS FOR MODIFYING KERATINOUS SURFACES

Applicant/Assignee:

Application No.: 12/688657   Filing Date: 15/Jan/2010

Abstract:An apparatus for modifying a keratinous surface that has an applicator which includes a motor and an applicator opening which is in fluid communication with a first modification composition. The applicator also includes a sensor and a CPU. The sensor reads the properties of a small portion of the keratinous surface, the readings are transmitted to the CPU, the CPU analyzes the sensor reading of the keratinous surface. The CPU sends a signal to the applicator to treat or not to treat the analyzed surface, and if the CPU sends a signal to the applicator to treat the surface, the motor is activated to move the stylus to the keratinous surface to apply a portion of the first modification composition to the same portion of the keratinous surface that was read by the sensor.

Priority: US20090145344P Applic. Date: 2009-01-16; US20090145350P Applic. Date: 2009-01-16; US20090145358P Applic. Date: 2009-01-16; US20090145365P Applic. Date: 2009-01-16; US20090145371P Applic. Date: 2009-01-16; US20090145378P Applic. Date: 2009-01-16

Inventor: RABE THOMAS ELLIOT [US]; WILSON DAVID EDWARD [US]


Application No.: US20100224210A1  Published: 09/Sep/2010

Title: APPARATUS AND METHODS FOR MODIFYING KERATINOUS SURFACES

Applicant/Assignee:

Application No.: 12/688751   Filing Date: 15/Jan/2010

Abstract:An apparatus for modifying a keratinous surface that has a rotatable applicator that is in fluid communication with a first modification composition. The apparatus also has a sensor and a CPU. The sensor is positioned forward of the applicator head such that as the head rolls across the keratinous surface the sensor reads the portion of the keratinous surface in front of the rolling head. The sensor readings are transmitted to the CPU, the CPU analyzes the sensor readings of the keratinous surface, and the CPU sends a signal to the applicator head to treat or not to treat the analyzed surface. When the CPU sends a signal to the applicator to treat the surface, a small portion of the first modification composition is applied to the head such that when the head rolls over the keratinous surface the first modification composition contacts the area of the keratinous surface that needs treatment.

Priority: US20090145344P Applic. Date: 2009-01-16; US20090145350P Applic. Date: 2009-01-16; US20090145358P Applic. Date: 2009-01-16; US20090145365P Applic. Date: 2009-01-16; US20090145371P Applic. Date: 2009-01-16; US20090145378P Applic. Date: 2009-01-16

Inventor: RABE THOMAS ELLIOT [US]; WILSON DAVID EDWARD [US]


Application No.: US20100224211A1  Published: 09/Sep/2010

Title: APPARATUS AND METHODS FOR MODIFYING KERATINOUS SURFACES

Applicant/Assignee:

Application No.: 12/688774   Filing Date: 15/Jan/2010

Abstract:An apparatus for modifying a keratinous surface that has an applicator that with a motor, and at least one protrusion The applicator further has a ribbon with a first and second side, the first side being adjacent the protrusion and a first modification composition on the second side of the ribbon. Further there is a sensor and a CPU. The sensor reads the properties of a small portion of the keratinous surface, the readings are transmitted to the CPU. If the CPU sends a signal to the applicator to treat the surface, the motor is activated to move the applicator to the keratinous surface such that the ribbon contacts the keratinous surface near the protrusion to apply a portion of the first modification composition to the keratinous surface that was read by the sensor.

Priority: US20090145344P Applic. Date: 2009-01-16; US20090145350P Applic. Date: 2009-01-16; US20090145358P Applic. Date: 2009-01-16; US20090145365P Applic. Date: 2009-01-16; US20090145371P Applic. Date: 2009-01-16; US20090145378P Applic. Date: 2009-01-16

Inventor: RABE THOMAS ELLIOT [US]; WILSON DAVID EDWARD [US]


Application No.: US20100226864A1  Published: 09/Sep/2010

Title: ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES

Applicant/Assignee: SYMRISE GMBH & CO. KG

Application No.: 12/696200   Filing Date: 29/Jan/2010

Abstract:The present invention relates to alkyl-substituted tetrahydropyrans, mixtures containing these alkyl-substituted tetrahydropyrans, their respective use and corresponding flavored products.

Priority: US20090158162P Applic. Date: 2009-03-06

Inventor: OERTLING HEIKO [DE]; BROCKE CONSTANZE [DE]; LOGES HUBERT [DE]; MACHINEK ARNOLD [DE]


Application No.: US20100226867A1  Published: 09/Sep/2010

Title: NON-IRRITATING COMPOSITIONS

Applicant/Assignee:

Application No.: 12/781523   Filing Date: 17/May/2010

Abstract:The present invention provides a base composition that allows for the formulation of non-irritating cosmetic and/or dermatological compositions. The base composition includes one or more of electrolyte, buffer, mild preservative, lubricant, or any combinations thereof. It is preferred that one or more of the above components are eye-safe and/or eye-compatible. The present invention also provides photoprotective cosmetic and/or dermatological compositions that include the base composition and one or more sunscreen active components and are non-irritating to mammalian eyes.

Priority: US2006-334071 Applic. Date: 2006-01-18; US20050692106P Applic. Date: 2005-06-20

Inventor: DUEVA-KOGANOV OLGA V [US]; SANOGUEIRA JAMES P [US]


Application No.: US20100226868A1  Published: 09/Sep/2010

Title: AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS

Applicant/Assignee:

Application No.: 12/711589   Filing Date: 24/Feb/2010

Abstract:Novel ampholytic ter-polymers comprising at least an ethylenically unsaturated cationic monomer, a monomer containing a carboxylic acid or sulfonic acid group and diallyamine or derivative are claimed. Further, the ter-polymers may be used in personal care or personal washing compositions optionally in the presence of conditioning agents such as silicone, fatty amines, fatty amine oxides and fatty quaternaries and/or various benefit agents. The ter-polymer compositions are especially useful in the treatment of keratin-containing substrates. Keratin substrates include, but are not limited to, animal and human hair, skin and nails.

Priority: US20090209293P Applic. Date: 2009-03-05; US20100300658P Applic. Date: 2010-02-02

Inventor: GAMEZ-GARCIA MANUEL [US]; ZHOU XIAN-ZHI [US]


Application No.: US20100226870A1  Published: 09/Sep/2010

Title: USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION

Applicant/Assignee: AVICENA GROUP, INC

Application No.: 12/561804   Filing Date: 17/Sep/2009

Abstract:The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates as energy generating systems and antioxidants for preservation of skin against adverse aging effects and damage secondary to insults such as harmful sun radiations, stress and fatigue. The creatine compounds which can be used in the present method include (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase

(2) molecules that mimic the biological activity of creatine (3) molecules that modulate the creatine kinase system.

Priority: US2005-090391 Applic. Date: 2005-03-24; US2001-852966 Applic. Date: 2001-05-10; US1999-344427 Applic. Date: 1999-06-25

Inventor: KADDURAH-DAOUK RIMA [US]


Application No.: US20100226871A1  Published: 09/Sep/2010

Title: HIGH INTENSITY FRAGRANCES

Applicant/Assignee: TAKASAGO INTERNATIONAL CORPORATION

Application No.: 12/716392   Filing Date: 03/Mar/2010

Abstract:The present invention relates to a high intensity fragrance composition for use in a cosmetic, toiletry, personal care, personal cleansing product or adsorbent article, which comprises by weight: a) 75% to 100% of at least 2 fragrance ingredients where each fragrance ingredients must contain only atoms of carbon, hydrogen, oxygen and nitrogen, comprise an ester functional group, an alcohol functional group or an aldehyde functional group, have boiling points between 100 DEG C. and 300 DEG C. at a pressure of 760 mm of mercury, have molecular weights within the range of 70 atomic mass units to 175 atomic mass units, and have ClogP values between 0.00 and 4.00

b) 0 to 25% of an essential oil

and c) 0 to 25% of a fragrance ingredient other than the fragrance ingredients in category a), wherein the sum of a), b) and c) equals 100%.

Priority: EP20090305204 Applic. Date: 2009-03-04; EP20090169071 Applic. Date: 2009-08-31

Inventor: FRASER STUART [GB]; GINDRE DOMINIQUE [FR]; WARR JONATHAN [FR]


Application No.: US20100226943A1  Published: 09/Sep/2010

Title: SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL

Applicant/Assignee: UNIVERSITY OF FLORIDA

Application No.: 12/550870   Filing Date: 31/Aug/2009

Abstract:Disclosed herein is an article that includes a first plurality of spaced features. The spaced features are arranged in a plurality of groupings

the groupings of features include repeat units

the spaced features within a grouping are spaced apart at an average distance of about 1 nanometer to about 500 micrometers

each feature having a surface that is substantially parallel to a surface on a neighboring feature

each feature being separated from its neighboring feature

the groupings of features being arranged with respect to one another so as to define a tortuous pathway. The plurality of spaced features provide the article with an engineered roughness index of about 5 to about 20.

Priority: US2006-567103 Applic. Date: 2006-12-05; US2005-202532 Applic. Date: 2005-08-12; US2004-780424 Applic. Date: 2004-02-17

Inventor: BRENNAN ANTHONY B [US]; LONG CHRISTOPHER JAMES [US]; BAGAN JOSEPH W [US]; SCHUMACHER JAMES FREDERICK [US]; SPIECKER MARK M [US]


Application No.: US20100226949A1  Published: 09/Sep/2010

Title: INSECT REPELLENT AND ATTRACTANTS

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 12/398164   Filing Date: 04/Mar/2009

Abstract:The disclosure provides compounds useful as insect repellents and compositions comprising such repellents. The disclosure further provides insect traps.

Priority:

Inventor: RAY ANANDASANKAR [US]; TURNER STEPHANIE LYNN [US]


Application No.: US20100226963A1  Published: 09/Sep/2010

Title: BI-FUNCTIONAL CO-POLYMER USE FOR OPTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS

Applicant/Assignee: EYEON PARTICLE SCIENCES LLC

Application No.: 12/708329   Filing Date: 18/Feb/2010

Abstract:The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.

Priority: US20090153416P Applic. Date: 2009-02-18

Inventor: COOPER EUGENE R [US]; KLEINMAN DAVID M [US]; LOXLEY ANDREW [US]; MITCHNICK MARK [US]


Application No.: US20100227002A1  Published: 09/Sep/2010

Title: ANTIOXIDANT COMPOSITIONS COMPRISING EXTRACTS OF MYRTLE AND ROSEMARY

Applicant/Assignee: NURAGING BIOTECH S.R.L

Application No.: 12/376363   Filing Date: 24/Jul/2007

Abstract:The invention relates to a composition based on extracts of myrtle and rosemary which has been found to synergistically increase the protection of cells against pathophysiological conditions characterised and partly caused by overproduction of free radicals and to counteract the oxidative stress caused by excessive production of said free radicals, as well as for preventing and/or treating related pathologies, including apoptosis.

Priority: IT2006RM00427 Applic. Date: 2006-08-04; WO2007EP57605 Applic. Date: 2007-07-24

Inventor: CARTA ANGELICO [IT]


Application No.: US20100227004A1  Published: 09/Sep/2010

Title: OXIDATION METHOD AND COMPOSITIONS THEREFOR

Applicant/Assignee: ALCIDE CORPORATION

Application No.: 12/726155   Filing Date: 17/Mar/2010

Abstract:The present invention generally relates to an improved two-part oxidizing system, as well as oxidizing compositions and methods for making and using the same, and in a particular embodiment to a two-part oxidizing system that, when mixed, yields an oxidizing composition. The two-part oxidizing system includes a metal chlorite first part, and an acid second part where the acid is sodium acid sulfate or a derivative thereof.

Priority: US2005-209116 Applic. Date: 2005-08-22

Inventor: WARF JR C CAYCE [US]; KOTROLA NAHED M [US]


Application No.: US20100227010A1  Published: 09/Sep/2010

Title: PESTICIDAL COMPOSITIONS AND METHODS OF USE THEREOF

Applicant/Assignee: ECOBLEND, LLC

Application No.: 12/698489   Filing Date: 02/Feb/2010

Abstract:A pest-combating composition including sodium lauryl sulfate and one or more of C6-12 fatty acids, preferably lauric and/or capric and/or caprylic acid, soy methyl ester, and 2-undecanone, and methods of combating pests utilizing same, are disclosed. The compositions can include a carrier oil such as silicon oil, soy methyl ester, or a vegetable oil, and can be in the form of an emulsion. The composition may be constituted as a spray composition, an aerosol, a lotion, a paste, or another compositional form. Pests that may be usefully combated with such composition include flying insects, including flies, mosquitoes, and wasps, ants, including arthropods such as fire ants, ticks, fleas, cockroaches, silver fish, thrips, gnats, aphids, Japanese beetles, and agricultural and horticultural arthropods and insects including beetles (potato and bean), flea beetles, fleahoppers, squash bugs, slugs, leaf hoppers, harlequin bugs, milk weed bugs, spiders, mites, lice, rodents, and deer.

Priority: US20090149114P Applic. Date: 2009-02-02

Inventor: JONES ALLEN [US]


Application No.: US20100227011A1  Published: 09/Sep/2010

Title: REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL-CARE COMPOSITIONS COMPRISING A TURMERONE COMPOUND

Applicant/Assignee:

Application No.: 12/709769   Filing Date: 22/Feb/2010

Abstract:Personal-care compositions for improving keratinous tissue conditions, particularly skin lightening, comprising a turmerone compound, a safe and effective amount of at least one additional skin and/or hair care active, and a dermatologically acceptable carrier are provided. Suitable additional skin and/or hair care actives are a sugar amine, a vitamin B3 compound, a retinoid, a peptide, a hexamidine, a sunscreen, a water-soluble vitamin, an oil-soluble vitamin, an additional skin lightener, and combinations thereof. Methods for regulating the condition of mammalian keratinous tissue and for lighening skin by topically applying the personal-care compositions are also provided.

Priority: US20090154941P Applic. Date: 2009-02-24

Inventor: KUHLMAN DENNIS EUGENE [US]; MISHRA RAJESH KANT [US]


Application No.: US20100227826A1  Published: 09/Sep/2010

Title: Stable Flavonoid Solutions

Applicant/Assignee:

Application No.: 12/086248   Filing Date: 06/Dec/2006

Abstract:A stable flavonoid solution comprising (i) at least one flavonoid or flavonoid derivative selected from the group consisting of luteolin, myricetin, baicalin, baicalein, silymarin and kushenol, (ii) a mixture of alkyl glycols of two to seven carbon atoms, (iii) a polyol ether and (iv) an antioxidant.

Priority: US20050742902P Applic. Date: 2005-12-07; WO2006US46626 Applic. Date: 2006-12-06

Inventor: MERCIER MICHEL F [US]


Application No.: US20100227830A1  Published: 09/Sep/2010

Title: USE OF ESCIN

Applicant/Assignee: MARINOMED BIOTECHNOLOGIE GMBH

Application No.: 12/376419   Filing Date: 03/Aug/2007

Abstract:The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.

Priority: EP20060450109 Applic. Date: 2006-08-04; WO2007EP06870 Applic. Date: 2007-08-03

Inventor: GRASSAUER ANDREAS [AT]; PRIESCHL EVA [AT]


Application No.: US20100227867A1  Published: 09/Sep/2010

Title: Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders

Applicant/Assignee: GALDERMA LABORATORIES INC

Application No.: 12/545638   Filing Date: 21/Aug/2009

Abstract:In methods, compounds, and topical formulations for treatment of inflammatory skin disorders incorporating compounds represented by the formulas below: wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy

each of R4 and R5 is independently hydrogen, alkyl, or alkoxy

and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy

wherein each of A1, A3, and A4 is independently hydrogen or alkyl

and A2 is independently hydrogen or hydroxy

and wherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy

and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith.

Priority: US2005-137911 Applic. Date: 2005-05-25; US2004-853585 Applic. Date: 2004-05-25; US20040574142P Applic. Date: 2004-05-25; US20030473611P Applic. Date: 2003-05-27

Inventor: DEJOVIN JACK A [US]; DEJOVIN ISABELLE JEAN [US]; ROSSI THOMAS M [US]


Application No.: US20100227899A1  Published: 09/Sep/2010

Title: Process for the treatment of bacterial infections using 2-phenyl-1,2-benzisoselenazol-3(2H)-one 1-oxide

Applicant/Assignee:

Application No.: 12/381120   Filing Date: 09/Mar/2009

Abstract:The subject invention demonstrates a novel antibacterial activity for 2-phenyl-1,2-benzisoselenazol-3(2H)-one 1-oxide, commonly referred to as ebselen se-oxide, and is directed to the treatment of bacterial infections by administration of an effective amount of said compound. Bacterial infections include those infections which are either systemic or superficial in nature. The treatment is intended for a variety of animals, such as premature neonates to adult humans. Administration of ebselen se-oxide to treat superficial bacterial infections may be performed by a topical application, such as via an ointment, a spray, a cream, a mouth wash, an eye drop solution, an ear drop solution, a soap, a gel, or a lotion. In addition, an antibacterial capsule can be administered orally or intravaginally. Administration of ebselen se-oxide to treat systemic bacterial infections may be performed by an intravenous route, a rectal route, an intranasal route, an oral route, an intramuscular route, or by inhalation. Administration of said compound may also be achieved via aerosol, which can be generated by a nebulizer. Ebselen se-oxide may be administered alone, or with a carrier such as dimethylsulfoxide (DMSO), an alcohol, or other suitable carrier. The effective daily amount of ebselen se-oxide is from about 1 [mu]g/kg to 10 mg/kg of body weight.

Priority:

Inventor: BILLACK BLASE CHRISTOPHER [US]; BILLACK ANETA MARTA [US]


Application No.: US20100227920A1  Published: 09/Sep/2010

Title: Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 12/587010   Filing Date: 29/Sep/2009

Abstract:The present invention provides methods and compositions for reducing pigmentation.

Priority: US20080100989P Applic. Date: 2008-09-29

Inventor: GANESAN ANAND [US]; WHITE MICHAEL A [US]; FARMER PATRICK J [US]


Application No.: US20100228107A1  Published: 09/Sep/2010

Title: Method for Assessing Adhesion of Soils or Exudates to the Skin

Applicant/Assignee:

Application No.: 12/781290   Filing Date: 17/May/2010

Abstract:Method of assessing the adhesion of soils or exudates to the skin. The method may allow for an assessment of the amount of artificial bowel movement remaining on the skin following treatment with a lotion.

Priority: US2007-807289 Applic. Date: 2007-05-25; US20060812782P Applic. Date: 2006-06-12

Inventor: MARSH RANDALL GLENN [US]; MILLER KRISTIN HOFMANN [US]; DANNENBERG ANDREA [US]


Application No.: US20100228180A1  Published: 09/Sep/2010

Title: Power Source Electrode Treatment Device

Applicant/Assignee: POWER PAPER LTD

Application No.: 12/223178   Filing Date: 25/Jan/2007

Abstract:The present invention provides a powered treatment device comprising at least one power source for supplying electrical energy to the device, and wherein at least one component of the power source is also configured as a power source treatment device electrode to facilitate electrical contact with a body region. In an embodiment wherein one component of the power source is configured as a power source treatment device electrode, the powered treatment device may further comprise at least one non-power source device electrode of opposite polarity from the power source treatment device electrode, wherein the at least one non-power source device electrode is electrically coupled to the at least one power source to facilitate electrical contact with a body area.

Priority: US20060762137P Applic. Date: 2006-01-26; WO2007IL00093 Applic. Date: 2007-01-25

Inventor: JAYES DALIA [IL]; MOSHKOVICH MORDECHAY [IL]; NITZAN ZVI [IL]


Application No.: US20100228181A1  Published: 09/Sep/2010

Title: USE OF GREEN LIGHT TO ACTIVATE L-AMINO ACID OXIDASE

Applicant/Assignee: L'OREAL

Application No.: 12/668689   Filing Date: 16/Jul/2008

Abstract:The present invention relates more specifically to the use of a source of green light for activating L-amino acid oxidase in the presence of at least one substrate of this enzyme in order to stimulate the energy metabolism of the cells of the skin, to stimulate their replacement and thus to improve the appearance of the skin and hair, in particular to prevent and/or treat cutaneous signs of ageing of the skin and hair. The invention also relates to a composition comprising at least one substrate of the enzyme and at least one substrate capable of emitting green light, to a kit comprising a green light device and the composition comprising at least one substrate of the said enzyme and to a cosmetic method employing the compositions or kits according to the invention.

Priority: FR20070056506 Applic. Date: 2007-07-16; US20070982455P Applic. Date: 2007-10-25; WO2008FR51333 Applic. Date: 2008-07-16

Inventor: LABOUREAU JULIEN [FR]; NGUYEN QUANG LAN [FR]


Application No.: US20100228689A1  Published: 09/Sep/2010

Title: Eyeglasses, eyecups, and methods of use and doing business

Applicant/Assignee:

Application No.: 12/660850   Filing Date: 04/Mar/2010

Abstract:Described herein are various embodiments of eyewear provided for advantageous use in sports, work, and casual activity. According to one embodiment, methods of retailing eyecup assemblies include a replenishment program for transmitting replacement eyecup assemblies to a purchaser at a regular interval. According to another embodiment, a method of retailing eyecup assemblies includes providing a retailer with eyecup assemblies differing from one another and providing the retailer with an eyeglasses frame. According to an embodiment, a method of retailing eyecup assemblies includes providing a retailer with eyecup assemblies differing from one another and without providing an eyeglasses frame. According to another embodiment, a kit having eyecup assemblies includes eyecup assemblies differing from one another and an eyeglasses frame. According to an embodiment, a kit having eyecup assemblies includes eyecup assemblies differing from one another without providing an eyeglasses frame.

Priority: US20090157432P Applic. Date: 2009-03-04

Inventor: HALL ROBERT [US]


Application No.: US20100229282A1  Published: 16/Sep/2010

Title: Powder-Free Anti-Blocking Coated Glove

Applicant/Assignee: ANSELL LIMITED

Application No.: 12/720155   Filing Date: 09/Mar/2010

Abstract:Provided herein are powder-free elastomeric articles exhibiting therapeutic properties, and anti-blocking properties. Also provided herein are methods for the manufacture of such articles that are substantially free from interfering materials, as well as packaging means for maintaining therapeutic efficacy.

Priority: US20090159266P Applic. Date: 2009-03-11

Inventor: ENG AIK HWEE [MY]; LAI HEE MENG [MY]; LIM KUANG LENG [MY]; TING KOON MEOW [MY]; LUCAS DAVID M [MY]; NARASIMHAN DAVE [US]


Application No.: US20100229356A1  Published: 16/Sep/2010

Title: JEWELRY CLASP ANCHORING DEVICE

Applicant/Assignee:

Application No.: 12/709539   Filing Date: 22/Feb/2010

Abstract:An anchoring device includes a base attachable to skin or clothing of a user and a loop to which a clasp or other element of a necklace or other loosely encircling item can be fixed, thereby preventing rotation of the encircling item about the user's neck, ankle, wrist, waist, or other body portion. The base can be moisture resistant, and can include hook attachment to clothing or adhesive attachment to clothing or skin. The base can blend in appearance with skin or clothes. The loop can blend in appearance with the clasp. Or the base and/or loop can be translucent or transparent. The device can include a plurality of loops. A removable, adhesive-protecting backing can be included, and a plurality of anchors can be provided on a common backing sheet. The loop can be flexible, foldable, and/or can include a clasping mechanism. The base and/or adhesive can be hypo-allergenic.

Priority: US20090159953P Applic. Date: 2009-03-13

Inventor: LAROCQUE COLLEEN P [US]


Application No.: US20100229884A1  Published: 16/Sep/2010

Title: System For Cleaning And Massaging A Foot

Applicant/Assignee:

Application No.: 12/401671   Filing Date: 11/Mar/2009

Abstract:A system for treating a foot. One system comprises an external container comprising tracks

and an inner appliance comprising foot treating elements. In operation, the foot is placed within the inner appliance and in contact with the foot treating elements, which are associated with the tracks such that moving the foot within the inner appliance back and forth in the external container activates the foot treating elements to apply a foot treatment. In embodiments, the foot treating elements comprise wheels operatively associated with the tracks, brushes, massaging elements, manicure elements and so forth. One system further comprises a double layered pellets' sock arranged to enhance massaging. One system further comprises a lotion sock comprising inbound pores connected to ducts connected to lotion bags with therapeutic lotion, excreted by motion of the foot treating elements.

Priority:

Inventor: ALONY NIR [IL]


Application No.: US20100233104A1  Published: 16/Sep/2010

Title: Amino-Acid Functional Siloxanes, Methods Of Preparation and Applications

Applicant/Assignee:

Application No.: 12/303784   Filing Date: 16/May/2007

Abstract:A method of preparing an amino acid functional siloxane by reacting an amino acid derivative selected from the group of an N-acyl amino acid and an N-aroyl amino acid with an amino functional siloxane optionally in the presence of a solvent. The invention extends to personal care products containing the resulting amino acid functional siloxanes.

Priority: GB20060011217 Applic. Date: 2006-06-08; WO2007GB50268 Applic. Date: 2007-05-16

Inventor: DRAKE ROBERT [GB]; POSTIAUX STEPHANIE [BE]


Application No.: US20100233106A1  Published: 16/Sep/2010

Title: SMALL-MOLECULE MODULATORS OF MELANIN EXPRESSION

Applicant/Assignee: UNIVERSITY OF ROCHESTER

Application No.: 12/593673   Filing Date: 28/Mar/2008

Abstract:The present invention relates to small molecule modulators of melanin expression and methods of making the small molecules. Also disclosed are methods of increasing pigmentation in a cell which involve providing compounds of the present invention and contacting a cell with the compounds under conditions effective to induce melanin expression in the cell, thereby increasing pigmentation. The present invention also relates to compositions containing compounds of the present invention and a carrier.

Priority: US20070909264P Applic. Date: 2007-03-30; WO2008US58716 Applic. Date: 2008-03-28

Inventor: MILLER BENJAMIN L [US]; MCNAUGHTON BRIAN R [US]; GAREISS PETER [US]; SCOTT GLYNIS [US]


Application No.: US20100233107A1  Published: 16/Sep/2010

Title: MEDICATED TONING LOTION

Applicant/Assignee:

Application No.: 12/652924   Filing Date: 06/Jan/2010

Abstract:A skin lotion includes, as a principal ingredient, a crosspolymer compound with as much as 50% adsorbed Salicylic Acid which can be gradually released to the skin after application. The lotion can also include, surfactants, humectants, preservatives, moisturizers, sunblocks, antibacterials and retinol precursors. A hydrophobically modified polymer contributes a smooth feel to the lotion.

Priority: US20090160130P Applic. Date: 2009-03-13

Inventor: CHANG JENNIFER [US]; ROCHA ADAYA [US]


Application No.: US20100233109A1  Published: 16/Sep/2010

Title: METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS

Applicant/Assignee: VICEPT THERAPEUTICS, INC

Application No.: 12/788746   Filing Date: 27/May/2010

Abstract:The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using [alpha]1-adrenergic receptor ([alpha]1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.

Priority: US2004-763807 Applic. Date: 2004-01-22

Inventor: SHANLER STUART D [US]; ONDO ANDREW [US]


Application No.: US20100233111A1  Published: 16/Sep/2010

Title: GASTROPOD BIOLOGICAL FLUID, METHOD OF MAKING AND REFINING AND USE

Applicant/Assignee:

Application No.: 12/643751   Filing Date: 21/Dec/2009

Abstract:The present technology generally relates to skin care compositions, cosmeceuticals or formulations and methods of making or using the same. More specifically, the presently described technology generally relates to methods of making and using compositions, cosmeceuticals or formulations including a unique composition collected and refine from a gastropod, namely Helix Aspersa Müller, among others.

Priority: WO2008US68047 Applic. Date: 2008-06-24; US20080123313P Applic. Date: 2008-04-06

Inventor: WANG WILLIAM [US]; YI JUN [CN]; KE SHENG [CN]; HALMELA MARIA [FI]


Application No.: US20100233128A1  Published: 16/Sep/2010

Title: Natural Skin Products Containing Dairy and Processes

Applicant/Assignee: MCI MEDIA CAPITAL INC

Application No.: 12/722754   Filing Date: 12/Mar/2010

Abstract:A skincare product containing one or more dairy products, and one or more ingredients such as a natural oil, an herb, a fruit, a vegetable, a grain, honey, sea salt, egg yolk and mixtures thereof, for application to human skin in order to improve the well-being of said skin. The skincare product is applied to the skin in order to cleanse, beautify, promote attractiveness, and/or alter the feel or appearance of the skin. Furthermore, the skincare product is applied to the skin by rubbing, pouring, sprinkling, and/or spraying the skincare product onto the skin.

Priority: CA20092658328 Applic. Date: 2009-03-13; CA20092660253 Applic. Date: 2009-03-27; US20090160009P Applic. Date: 2009-03-13

Inventor: PANASENKO OKSANA [CA]


Application No.: US20100233134A1  Published: 16/Sep/2010

Title: Use of Adipose-Tissue Cell Fractions for Post-Irradiation Tissue Regeneration

Applicant/Assignee: INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE

Application No.: 12/308445   Filing Date: 12/Jun/2007

Abstract:The present invention concerns the use of cells derived from the cellular fraction of the vascular stroma of the extramedullary adipose tissue to promote the regeneration of tissue following lesions caused by irradiation. More specifically, the use according to the invention aims to prepare a drug for promoting regeneration of the skin, and in particular to repair the cutaneous wounds caused by irradiation.

Priority: FR20060005190 Applic. Date: 2006-06-12; WO2007EP55782 Applic. Date: 2007-06-12

Inventor: TAMARAT RADIA [FR]; BENDERITTER MARC [FR]


Application No.: US20100233219A1  Published: 16/Sep/2010

Title: INORGANIC NANOPARTICLE COMPROMISING AN ACTIVE SUBSTANCE IMMOBILIZED ON THE SURFACE AND A POLYMER

Applicant/Assignee: FUJIFILM CORPORATION

Application No.: 12/293392   Filing Date: 30/Mar/2007

Abstract:An object of the present invention is to provide highly safe nanoparticles which can be used simultaneously for imaging, hyperthermia and DDS and have high drug incorporation ratio. The present invention provides a nanoparticle which comprises an inorganic nanoparticle of 1 to 500 nm in average particle size having an active substance immobilized on the surface and a polymer.

Priority: JP20060093480 Applic. Date: 2006-03-30; WO2007JP57719 Applic. Date: 2007-03-30

Inventor: AIMI MAKIKO [JP]; NEMORI RYOICHI [JP]; KOJIMA MASAYOSHI [JP]


Application No.: US20100233223A1  Published: 16/Sep/2010

Title: Powder-Free Antimicrobial Coated Glove

Applicant/Assignee: ANSELL LIMITED

Application No.: 12/720146   Filing Date: 09/Mar/2010

Abstract:Provided herein are powder-free elastomeric articles exhibiting good antimicrobial and anti-blocking properties. Also provided herein are methods for the manufacture of such articles substantially free from antimicrobial interfering materials, as well as packaging means for maintaining antimicrobial efficacy.

Priority: US20090159252P Applic. Date: 2009-03-11

Inventor: ENG AIK HWEE [MY]; LAI HEE MENG [MY]; LIM KUANG LENG [MY]; TING KOON MEOW [MY]; LUCAS DAVID M [MY]


Application No.: US20100233270A1  Published: 16/Sep/2010

Title: Delivery of Oligonucleotide-Functionalized Nanoparticles

Applicant/Assignee: NORTHWESTERN UNIVERSITY

Application No.: 12/724395   Filing Date: 15/Mar/2010

Abstract:The present invention relates to compositions and methods for delivering an oligonucleotide-functionalized nanoparticle.

Priority: US2010-684836 Applic. Date: 2010-01-08; US20090187759P Applic. Date: 2009-06-17; US20090143293P Applic. Date: 2009-01-08; US20090169384P Applic. Date: 2009-04-15

Inventor: MIRKIN CHAD A [US]; PALLER AMY S [US]; GILJOHANN DAVID A [US]


Application No.: US20100234304A1  Published: 16/Sep/2010

Title: BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING

Applicant/Assignee: UNIVERSITY OF LEEDS

Application No.: 12/729046   Filing Date: 22/Mar/2010

Abstract:There is described a material comprising tapes, ribbons, fibrils or fibres characterized in that each of the ribbons, fibrils or fibres have an antiparallel arrangement of peptides in a [beta]-sheet tape-like substructure.

Priority: GB20020016286 Applic. Date: 2002-07-15; US2005-521628 Applic. Date: 2005-09-08; WO2003GB03016 Applic. Date: 2003-07-15

Inventor: BODEN NEVILLE [GB]; AGGELI AMALIA [GB]; INGHAM EILEEN [GB]; KIRKHAM JENNIFER [GB]


Application No.: US20100234344A1  Published: 16/Sep/2010

Title: 8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS

Applicant/Assignee: JERINI AG

Application No.: 12/532703   Filing Date: 22/Mar/2008

Abstract:The present invention is related to compound of the formula (I): or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having from 1 to 3 heteroatoms, each independently selected from N or O and the other substituents are defined as in the claims.

Priority: EP20070006089 Applic. Date: 2007-03-23; WO2008EP02316 Applic. Date: 2008-03-22

Inventor: GIBSON CHRISTOPH [DE]; TRADLER THOMAS [DE]; SCHINATBAUM KARSTEN [DE]; PFEIFER JOCHEN [DE]; LOCARDI ELSA [DE]; SCHARN DIRK [DE]; PASCHKE MATHIAS [DE]; REIMER ULF [DE]; RICHTER UWE [DE]; HUMMEL GERD [DE]; REINEKE ULRICH [DE]


Application No.: US20100234401A1  Published: 16/Sep/2010

Title: 6,9-Disubstituted Purine Derivatives and Their Use For Treating Skin

Applicant/Assignee:

Application No.: 12/786027   Filing Date: 24/May/2010

Abstract:The present invention provides methods and compositions for countering the adverse effects of aging on mammalian cells in vitro and in vivo, especially human skin cells and human skin, and treatment of hyperproliferative and related skin diseases in mammals by administering compositions containing 6,9-disubstituted purine derivatives.

Priority: US2007-774652 Applic. Date: 2007-07-09; US20060806871P Applic. Date: 2006-07-10

Inventor: SZUCOVA LUCIE [CZ]; ZATLOUKAL MAREK [CZ]; SPICHAL LUKAS [CZ]; FROHLICH LUDEK [CZ]; DOLEZAL KAREL [CZ]; STRNAD MIROSLAV [CZ]; MASSINO FRANK J [US]


Application No.: US20100234460A1  Published: 16/Sep/2010

Title: Compositions Comprising A C2-C14 Carboxylic Acid And A Surfactant For Treating Hoof Diseases

Applicant/Assignee: DELAVAL HOLDINGS AB

Application No.: 12/440409   Filing Date: 10/Sep/2007

Abstract:Germicidal compositions containing at least one carboxylic acid combined with at least one nonionic or anionic surfactant, and methods of using the compositions for treatment or prevention of infectious hoof diseases are disclosed. The germicidal compositions remain active in the presence of manure, which eliminates the need to pre-clean the hooves before use. The compositions have particular utility for treating or preventing papillomatous digital dermatitis, interdigital phlegmon, interdigital dermatitis, laminitis, white line disease, heel erosion and other hoof diseases.

Priority: US20060843113P Applic. Date: 2006-09-08; US20070888243P Applic. Date: 2007-02-05; WO2007US77995 Applic. Date: 2007-09-10

Inventor: FORET CHRIS [US]; SKENDER ALEX [US]; HEMLING THOMAS C [US]; AHMED FAHIM U [US]; TRAISTARU CAMELIA N [US]


Application No.: US20100234466A1  Published: 16/Sep/2010

Title: Compositions and Methods for Reducing Body Fat

Applicant/Assignee:

Application No.: 12/652968   Filing Date: 06/Jan/2010

Abstract:The present invention relates to compositions, such as bimatoprost, latanoprost and travoprost, and methods to reduce fat in the body of an individual, for example, by topical administration, injection, and/or implantation of such compositions.

Priority: US2007-712839 Applic. Date: 2007-03-01; US20060785360P Applic. Date: 2006-03-23; US20060844337P Applic. Date: 2006-09-13

Inventor: GROSSKREUTZ CYNTHIA L [US]; PASQUALE LOUIS R [US]


Application No.: US20100234737A1  Published: 16/Sep/2010

Title: METHOD FOR ASSESSING SKIN IRRITATION USING INFRARED LIGHT

Applicant/Assignee:

Application No.: 12/402541   Filing Date: 12/Mar/2009

Abstract:A method for determining skin irritation is provided. The method uses a source of infrared light to determine the skin temperature of an area of skin.

Priority:

Inventor: FARAGE MIRANDA AREF [US]


Application No.: US20100234755A1  Published: 16/Sep/2010

Title: Electrode holder for use on hairy animals such as horses, camels, and the like

Applicant/Assignee:

Application No.: 12/381353   Filing Date: 11/Mar/2009

Abstract:An electrode holder comprising a pair of electrodes connected by a flexible, insulating rod which controls the position of the electrodes with respect to each other and the topographic surfaces of the body or body part of the animal.

Priority:

Inventor: LATMAN NEAL S [US]; BATSON JR JOSEPH E [US]; NICHOLSON ALAN [US]; GARZA LADISLADO [US]; FLOYD MIKE [US]


Application No.: US20100234772A1  Published: 16/Sep/2010

Title: Method of Treating Capsular Contracture

Applicant/Assignee:

Application No.: 12/722944   Filing Date: 12/Mar/2010

Abstract:A method of treating and ameliorating capsular contracture having the steps of providing ultrasound at our near the site of a breast implant, providing specific massage and/or physical manipulation the implant site, and providing a compression bandage at the implant site.

Priority: US20090159478P Applic. Date: 2009-03-12

Inventor: WEYANT TIM [US]


Application No.: US20100234828A1  Published: 16/Sep/2010

Title: Methods and Compositions for Facilitating Arterial Access

Applicant/Assignee:

Application No.: 12/712636   Filing Date: 25/Feb/2010

Abstract:Provided are methods and compositions for locally increasing arterial diameter and providing local anesthesia in a subject. The methods include applying to a skin site of the subject a topical composition that includes a vasodilation agent and an anesthetic agent in a manner sufficient for locally increasing arterial diameter and providing local anesthesia in the subject. In some embodiments, the method includes inserting a cannula into an artery at the skin site of the subject. Also provided are topical compositions that find use in performing the subject methods.

Priority: US20090159358P Applic. Date: 2009-03-11

Inventor: BOYLE ANDREW [US]; MAJURE DAVID [US]


Application No.: US20100239358A1  Published: 23/Sep/2010

Title: BRUSH HEAD FOR USE ON A CONTAINER FOR DISPENSING A COMPOSITION

Applicant/Assignee:

Application No.: 12/727737   Filing Date: 19/Mar/2010

Abstract:A brush for providing a composition to a surface comprising: a base

a plurality of bristles, said plurality of bristles having a distal end and a proximal end, wherein said distal end is functionally attached to the base

wherein the distal end has a greater bristle density than the proximal end wherein said plurality of bristles forms at least one flow path from said distal end towards said proximal end.

Priority: US20090162252P Applic. Date: 2009-03-20

Inventor: STURGIS THOMAS ARTHUR [US]; ALWATTARI ALI ABDELAZIZ [US]; GROH DAVID MATTHEW [US]; JOHNSON THERESA LOUISE [US]; POPIEL EDWARD JOHN [US]


Application No.: US20100239510A1  Published: 23/Sep/2010

Title: SKIN-CARE COMPOSITION COMPRISING DILL EXTRACT

Applicant/Assignee:

Application No.: 12/691471   Filing Date: 21/Jan/2010

Abstract:A skin-care composition may comprise a dill extract, a safe and effective amount of a peptide, a safe and effective amount of a hydrating skin active, and a dermatologically acceptable carrier. The skin-care composition may further comprise a safe and effective amount of an acute skin-care active. Further, a method of producing a chronic skin-firming benefit and, optionally, an acute skin-tightening sensation, said method comprising the step of topically applying to the skin of a mammal in need of such treatment, a safe and effective amount of the skin-care composition.

Priority: US20090146543P Applic. Date: 2009-01-22

Inventor: HA ROBERT BAO KIM [US]; OSBORNE ROSEMARIE [US]; SZCZEPANIAK RICHARD JOHN [US]


Application No.: US20100239512A1  Published: 23/Sep/2010

Title: ADSORPTION AND RELEASE OF NITRIC OXIDE IN METAL ORGANIC FRAMEWORKS

Applicant/Assignee:

Application No.: 12/377429   Filing Date: 16/Aug/2007

Abstract:Disclosed are metal organic frameworks that adsorb nitric oxide, NO-loaded metal organic frameworks, methods of preparing the NO-loaded metal organic frameworks, methods of releasing the nitric oxide into a solution or into air, and uses of the metal organic frameworks.

Priority: GB20060016350 Applic. Date: 2006-08-17; WO2007GB03129 Applic. Date: 2007-08-16

Inventor: MORRIS RUSSELL EDWARD [GB]; WHEATLEY PAUL STEWART [GB]


Application No.: US20100239514A1  Published: 23/Sep/2010

Title: COMPOSITIONS AND METHODS FOR USE ON ARTIFICIALLY COLORED HAIR

Applicant/Assignee: L:OREAL

Application No.: 12/679588   Filing Date: 16/Oct/2008

Abstract:The present invention provides a cosmetic composition comprising at least one saccharide-siloxane copolymer, a cosmetically-acceptable medium, and optionally, at least one auxiliary agent chosen from a nonionic agent and a cationic agent, wherein the pH of the composition is up to about 5.8. The present invention also provides for a method of using said composition for enhancing color protection of artificially colored hair while providing color vibrancy, excellent conditioning, natural feel and brilliant shine.

Priority: US20070981274P Applic. Date: 2007-10-19; WO2008US80141 Applic. Date: 2008-10-16

Inventor: PREM PADMAJA [US]; SULEIMAN AZIZA [US]; HUYNH MARIE [US]; CERVANTES FREDERIC [US]


Application No.: US20100239565A1  Published: 23/Sep/2010

Title: METHODS OF TREATMENT OF SKIN ULCERS

Applicant/Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

Application No.: 12/599601   Filing Date: 09/May/2008

Abstract:Methods for treating and/or preventing skin ulcers are provided featuring administration of pharmaceutical compositions comprising inhibitors of activity or expression Of Lp-PLA2 protein to patients subject to or at risk of developing skin ulcers.

Priority: US20070928759P Applic. Date: 2007-05-11; WO2008US63239 Applic. Date: 2008-05-09

Inventor: WILENSKY ROBERT [US]; HAMAMDZIC DAMIR [US]; PROFKA HARRILLA [US]


Application No.: US20100239624A1  Published: 23/Sep/2010

Title: CLEANSING LOTION WITH MOISTURISING, PROTECTING AND ODOR CONTROLLING AGENTS AND CLOTH COMPRISING SAID LOTION

Applicant/Assignee: COLOPLAST A/S

Application No.: 12/794844   Filing Date: 07/Jun/2010

Abstract:The invention relates to a soothing lotion, which cleanses, moisturizes and protects the skin and controls odor from feces and urine on skin. The invention also relates to a cloth comprising said lotion.

Priority: US2005-272018 Applic. Date: 2005-11-14

Inventor: MYHRA MEDEA [US]


Application No.: US20100239633A1  Published: 23/Sep/2010

Title: IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS

Applicant/Assignee: UNIVERSITY OF MARYLAND BALTIMORE

Application No.: 12/602609   Filing Date: 30/May/2008

Abstract:IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacements compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases.

Priority: US20070941644P Applic. Date: 2007-06-01; US20070015127P Applic. Date: 2007-12-19; US20070015547P Applic. Date: 2007-12-20; WO2008US65428 Applic. Date: 2008-05-30

Inventor: STROME SCOTT E [US]; SCHULZE DAN H [US]; BLOCK DAVID S [US]


Application No.: US20100239655A1  Published: 23/Sep/2010

Title: TAURINE-BASED COMPOSITIONS AND THERAPEUTIC METHODS

Applicant/Assignee:

Application No.: 12/749844   Filing Date: 30/Mar/2010

Abstract:Taurine and derivatives thereof may be used in conjunction with agents that activate or up-regulate the Taurine Transporter so as to enhance hydration of the skin and repair the skin bather, prevent apoptosis and oxidative damage in the skin, and heal or prevent photo-induced skin damage. The presence of biogenic taurine or taurine derivatives in tissues and/or body fluids can be used as a biomarker for tissue trauma. Detection and/or quantification of such biogenic taurine or derivatives form the basis for an assay for determining the presence and/or extent of tissue damage.

Priority: US2005-296112 Applic. Date: 2005-12-07; US2008-108610 Applic. Date: 2008-04-24; US20040634626P Applic. Date: 2004-12-09; US20070913546P Applic. Date: 2007-04-24

Inventor: LEVIS GEORGIA [US]


Application No.: US20100239677A1  Published: 23/Sep/2010

Title: NONAEROSOL/AEROSOL DISPENSING OF SUNSCREEN SPRAYS COMPRISING SILICA MICROPARTICLES

Applicant/Assignee: L'OREAL

Application No.: 12/792835   Filing Date: 03/Jun/2010

Abstract:Nonaerosol/atomizer pumps or aerosol dispensers comprise (A) a reservoir confining at least one vaporizable sunscreen composition suited for UV-photoprotecting the skin and/or hair against the damaging effects of UV radiation, the at least one vaporizable sunscreen composition comprising (1) a UV-photoprotecting amount of at least one UV-sunscreen and (2) an SPF-enhancing amount of generally spherical silica microparticles, formulated into (3) a topically applicable, cosmetically acceptable carrier therefor, and (B) at least one agent for pressurizing the at least one vaporizable sunscreen composition into a spray of fine sunscreen particles.

Priority: FR20020014599 Applic. Date: 2002-11-21; US2003-717523 Applic. Date: 2003-11-21; US20030449574P Applic. Date: 2003-02-26

Inventor: JOSSO MARTIN [FR]


Application No.: US20100239687A1  Published: 23/Sep/2010

Title: USES OF RARE EARTH ELEMENTS FOR SLIMMING

Applicant/Assignee: TAEWUNG ELS, INC

Application No.: 12/599812   Filing Date: 09/May/2008

Abstract:Disclosed is a use of rare earth element selected from the group consisting of lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), lutetium (Lu), scandium (Sc) and yttrium (Y), and a mixture thereof, or a salt or an oxide, for promoting lipidolysis, anti-cellulite, enhancing skin firmness, or for slimming.

Priority: KR20070046248 Applic. Date: 2007-05-11; WO2008KR02635 Applic. Date: 2008-05-09

Inventor: KIM SANG KOOK [KR]; JUNG HYUK [KR]


Application No.: US20100239697A1  Published: 23/Sep/2010

Title: ABELMOSCHUS MANIHOT MEDICUS FLOWER PERFUMED PRODUCT

Applicant/Assignee: BEIJING DONGSHENG AGRICULTURAL TECHNOLOGY DEVOPMENT (GROUP) CO., LTD

Application No.: 12/739405   Filing Date: 22/Apr/2010

Abstract:The Abelmoschus manihot Medicus flower perfumed product, which is made by immersing the Abelmoschus manihot Medicus flower containing volatile substance in Abelmoschus manihot Medicus oil, vegetable oil with more than 60% unsaturated fatty acid or cosmetic base oil grade mineral oil. The product using the edible oil and fat as the carrier can be used as food materials and that using mineral oil as the carrier can be used as the raw materials of medicine, skin care and hair care products.

Priority: WO2007CN70932 Applic. Date: 2007-10-22

Inventor: WANG ZHIYUAN [CN]; WANG SHAOZHANG [CN]


Application No.: US20100240280A1  Published: 23/Sep/2010

Title: Article of Clothing with Wicking Portion

Applicant/Assignee:

Application No.: 12/795226   Filing Date: 07/Jun/2010

Abstract:Articles of clothing that incorporate fabrics or chemicals having wicking, antibacterial/antifungal and low coefficients of friction either overall or in specific areas of the apparel that will minimize the development of irritation, bacterial and fungal infections of the skin. The invention also includes methods for producing this wicking, antibacterial/antifungal and low coefficient of friction apparel.

Priority: US2004-515580 Applic. Date: 2004-11-23; WO2003US16885 Applic. Date: 2003-05-27; US20020382964P Applic. Date: 2002-05-24

Inventor: MICHEL JOYCE [US]


Application No.: US20100240592A1  Published: 23/Sep/2010

Title: TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIMICROBIAL ACTIVITY

Applicant/Assignee: POLYPHOR LTD UNIVERSITAET ZUERICH

Application No.: 12/161065   Filing Date: 15/Jan/2007

Abstract:Template-fixed [beta]-hairpin peptidomimetics of the general formula (I) wherein Z is a template-fixed chain of 12 [alpha]-amino acid residues which, depending on their positions in the chain (counted starting from the N-terminal amino acid) are Gly, or Pro, or of certain types which, as the remaining Symbols in the above formula, are defined in the description and the claims, and salts thereof, have the property to selectively inhibit the growth of or to kill microorganisms such as Pseudomonas aeruginosa. They can be used as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials, or as medicaments to treat or prevent infections. These [beta]-hairpin peptidomimetics can be manufactured by processes which are based on a mixed solid- and Solution phase synthetic strategy.

Priority: WO2006CH00036 Applic. Date: 2006-01-16; WO2007CH00017 Applic. Date: 2007-01-15

Inventor: DEMARCO STEVEN J [CH]; VRIJBLOED WIM [CH]; DIAS RICARDO [CH]; ROBINSON JOHN ANTHONY [CH]; SRINIVAS NITYAKALYANA [CH]; GOMBERT FRANK [DE]; OBRECHT DANIEL [CH]


Application No.: US20100240628A1  Published: 23/Sep/2010

Title: SKIN TREATMENTS

Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER

Application No.: 12/792852   Filing Date: 03/Jun/2010

Abstract:Compositions comprising an LXR activator and retinoic acid and/or a metabolic precursor thereto are useful in reducing the effects of chronoageing and/or photoageing of the skin.

Priority: GB20030011815 Applic. Date: 2003-05-22; US2005-557944 Applic. Date: 2005-11-21; WO2004EP04942 Applic. Date: 2004-05-06

Inventor: JENKINS GAIL [GB]; MAYES ANDREW EASSON [GB]


Application No.: US20100240658A1  Published: 23/Sep/2010

Title: Oxadiazole Derivatives

Applicant/Assignee: MERCK SERONO SA

Application No.: 12/675235   Filing Date: 01/Oct/2008

Abstract:The invention relates to compounds of formula I: wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.

Priority: EP20070117921 Applic. Date: 2007-10-04; US20070998254P Applic. Date: 2007-10-09; WO2008EP63180 Applic. Date: 2008-10-01

Inventor: QUATTROPANI ANNA [CH]; MONTAGNE CYRIL [FR]; SAUER WOLFGANG [CH]; CROSIGNANI STEFANO [FR]; BOMBRUN AGNES [CH]; MUZERELLE MATHILDE [FR]; DORBAIS JEROME [FR]; MARIN DELPHINE [FR]; GONZALEZ JEROME [FR]; GERBER PATRICK [CH]


Application No.: US20100240724A1  Published: 23/Sep/2010

Title: Edible Film

Applicant/Assignee: C.L. PHARM

Application No.: 12/680720   Filing Date: 25/Sep/2008

Abstract:The present invention relates to an edible film composition comprising a waxy starch hydrolysate, a modified starch and a water-soluble polymer, and an edible film comprising the same. The present edible film may not only have an excellent film forming property, solubility and feeling in the oral cavity, but also be easily prepared at low cost, and thus be usefully used as an oral cleanser or a bad breath remover for oral cleansing, and a soluble formulation on tongue for uptake of drug in the oral cavity.

Priority: KR20070099559 Applic. Date: 2007-10-03; KR20080093403 Applic. Date: 2008-09-23; WO2008KR05698 Applic. Date: 2008-09-25

Inventor: CHANG SEOK HOON [KR]; JUNG KYOUNG TAE [KR]


Application No.: US20100240746A1  Published: 23/Sep/2010

Title: STEREOISOMERS OF TRICYCLODECAN-9-YL-XANTHOGENATE

Applicant/Assignee: LUMAVITA AG

Application No.: 12/666282   Filing Date: 03/Jul/2008

Abstract:Provided herein are optically active stereoisomers of tricylclodecan-9-yl xanthogenate, processes of preparation, and pharmaceutical compositions thereof. Also provided are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disease caused by a virus.

Priority: US20070958370P Applic. Date: 2007-07-03; WO2008EP05460 Applic. Date: 2008-07-03

Inventor: TOMIOKA MIYUKI [CH]; HASEGAWA KO [JP]


Application No.: US20100240754A1  Published: 23/Sep/2010

Title: UNSATURATED FATTY AMINO ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY

Applicant/Assignee: PIERRE FABRE DEMO-COSMETIQUE

Application No.: 12/523231   Filing Date: 16/Jan/2008

Abstract:The present invention relates to drugs consisting of unsaturated fatty amino-acid derivatives of the general formula (I), and to their pharmaceutically acceptable acid addition salts, in which: X is oxygen or NH, Rn are independently hydrogen or a (C1-C6)alkyl optionally substituted by halogen

R1 is hydrogen, fluorine, chlorine or bromine, or a CF3 or CHF2 or a (C1-C6)alkyl, (C1-C6)alkenyl or (C1-C6)alkynyl, optionally substituted by one or more halogen atoms

R is hydrogen or a (C1-C6)alkyl or (C3-C6)cycloalkyl optionally substituted by one or more halogen atoms

Ra and Rb are independently hydrogen (C1-C6)alkyl or (C1-C6)acyl, and Ra and Rb a hydrocarbonated cycle containing 4 to 6 carbon atoms

and n is an integer between 2 and 14.

Priority: FR20070000291 Applic. Date: 2007-01-16; FR20070053864 Applic. Date: 2007-03-15; WO2008EP50471 Applic. Date: 2008-01-16

Inventor: TARROUX ROGER [FR]; CHARVERON MARIE [FR]; DAUNES-MARION SYLVIE [FR]; FRISON NATACHA [FR]; FOLLEAS BENOIT [FR]; BRAYER JEAN-LOUIS [FR]


Application No.: US20100240755A1  Published: 23/Sep/2010

Title: THERAPEUTIC AND COSMETIC COMPOSITIONS FOR TREATMENT OF SKIN

Applicant/Assignee:

Application No.: 12/408341   Filing Date: 20/Mar/2009

Abstract:The present invention is directed to a skin cream containing L-glutathione and methyl sulfone in combination with perfluorodecalin and various vitamins such as Vitamin D and C. The cream can be used to treat cancerous and precancerous diseases found in or on the skin.

Priority:

Inventor: PEREZ THOMAS [US]


Application No.: US20100240759A1  Published: 23/Sep/2010

Title: USE OF AN AGENT THAT CONTAINS CORBAMIDE AND/OR AT LEAST A DERIVATIVE THEREOF AS A CLEANING AGENT

Applicant/Assignee:

Application No.: 12/608157   Filing Date: 29/Oct/2009

Abstract:The invention relates to the use of an agent that contains 5 to 99.9% in weight of carbamide and/or at least a derivative thereof, as a cleaning agent for closed systems, in particular as a dishwasher detergent, as a laundry detergent for washing machines, as an agent for cleaning, sanitizing and/or disinfecting for equipment in the food processing industry and for medical equipment, the use as a hand dishwashing detergent or sanitary cleaner or as a hand cleaner. In addition, the invention relates to a method for reducing or avoiding enzymes in cleaning agents for closed systems, in hand dishwashing detergents or in sanitary cleaning agents as well as an enzyme-free dishwashing detergent or enzyme-free sanitary cleaning agent that contain 5 to 99.9% in weight of carbamides or derivates thereof. Finally, the invention relates to the use of percarbamide as a bleaching agent in particular in dishwashing detergents and in sanitary toilet cleaning agents.

Priority: EP20090003835 Applic. Date: 2009-03-17; EP20090007638 Applic. Date: 2009-06-09

Inventor: HAAKE MANFRED [DE]; BECKER KLAUS [DE]


Application No.: US20100240774A1  Published: 23/Sep/2010

Title: USE OF HYDROPHOBIN POLYPEPTIDES AS PENETRATION ENHANCERS

Applicant/Assignee: BASF SE

Application No.: 12/721973   Filing Date: 11/Mar/2010

Abstract:The present invention relates to the use of hydrophobin polypeptides as penetration intensifiers.

Priority: EP20070116363 Applic. Date: 2007-09-13; EP20070121650 Applic. Date: 2007-11-27; WO2008EP60870 Applic. Date: 2008-08-20

Inventor: SUBKOWSKI THOMAS [DE]; KAROS MARVIN [DE]; BARG HEIKO [DE]; BOLLSCHWEILER CLAUS [DE]


Application No.: US20100240977A1  Published: 23/Sep/2010

Title: METHOD FOR MEASURING THE RESPONSE OF A TISSUE TO AN ELECTROMAGNETIC FIELD

Applicant/Assignee:

Application No.: 12/602909   Filing Date: 20/Jun/2007

Abstract:The present invention relates to a method for measuring the response of the tissue of a human or animal body to an electromagnetic field, comprising the steps of i) treatment of a skin area of said body with a topical composition comprising one or more reversible mnAChR-antagonists, ii) applying to the treated skin area a measuring device and iii) measuring by means of said measuring device at least one parameter depending on a response to said electromagnetic field

to a method for measuring in vivo the glucose content in blood and to topical compositions useful in said methods

Priority: WO2007CH00305 Applic. Date: 2007-06-20

Inventor: CADUFF ANDREAS [CH]


Application No.: US20100241056A1  Published: 23/Sep/2010

Title: FACE MASK

Applicant/Assignee:

Application No.: 12/095528   Filing Date: 29/Nov/2006

Abstract:A face mask for cleansing of facial skin. The face mask 100 comprises two or more electrodes 22, 23 to which an electric cleansing signal generated by a cleansing signal generator of the face mask is conveyable, the electrodes provided in the face mask 100 being arranged as electrode pairs 24 which comprise a positive electrode 22 and a negative electrode 23 such that all electrode pairs 24 reside in the face mask 100 substantially in the facial area. The face mask is characterized in that the outer edge of the face mask 100 has an edge portion 101 provided with gripping means 120 for fitting the face mask onto the skin of a user of the face mask.

Priority: FI20050005630 Applic. Date: 2005-11-30; WO2006FI50527 Applic. Date: 2006-11-29

Inventor: LEHTOLUOTO EEVA LIISA [FI]


Application No.: US20100241181A1  Published: 23/Sep/2010

Title: EXTERNAL DEFIBRILLATOR

Applicant/Assignee:

Application No.: 12/724269   Filing Date: 15/Mar/2010

Abstract:A variety of arrangements and methods relating to a defibrillator are described. In one aspect of the invention, a defibrillator includes two paddles that each include a defibrillator electrode covered in a protective housing. The two paddles are sealed together using a releasable seal to form a paddle module such that the housings of the paddles form the exterior of the paddle module. An electrical system including at least a battery and a capacitor is electrically coupled with the paddles. The battery is arranged to charge the capacitor. The capacitor is arranged to apply a voltage at the defibrillator electrodes, which generates an electrical shock for arresting a cardiac arrhythmia.

Priority: US20090161014P Applic. Date: 2009-03-17

Inventor: SAVAGE WALTER T [US]; SAVAGE SHELLEY J [US]; MACLAY WALTER N [US]; MORRISON DOUGLAS C [US]; GERATY THOMAS K [US]; BRINKERHOFF MARK D [US]; BOEDER RONALD S [US]; TON TONY M [US]; GREGER JEFFREY S [US]


Application No.: US20100242198A1  Published: 30/Sep/2010

Title: Cleansing and Personal Care Article

Applicant/Assignee:

Application No.: 12/599273   Filing Date: 07/May/2008

Abstract:A single- or multiple-use cleansing or personal care article comprising (i) a flexible, three-dimensional, water-absorbent substrate material comprising a cavity for accepting an electronic device within a waterproof housing, wherein the water-absorbent substrate is comprised of a web of substantially water-insoluble fibers and (ii) an electronic device within a waterproof housing comprised of one or more of a light-emitting device, a sound-emitting device, or an electromechanical vibrating device or a waterproof metered dispenser and either or both of (iii) a pourable soap impregnated into the water-absorbent material in an amount sufficient to produce foam in water having a di- or trivalent cationic salts present at a concentration of at least about 120 mg/L and/or (iv)

a solid anhydrous composition having a melting point of from about 450 C to about 550 C said anhydrous composition comprising a haircare or skincare active ingredient.

Priority: US20070924271P Applic. Date: 2007-05-07; WO2008US05811 Applic. Date: 2008-05-07

Inventor: POPOVSKY MICHAEL [US]


Application No.: US20100246619A1  Published: 07/Jul/2005

Title: Eye safe dermatological phototherapy

Applicant/Assignee: INOLASE 2002 LTD

Application No.: 11/005253   Filing Date: 06/Dec/2004

Abstract:A method and apparatus are disclosed for improving bodily safety during exposure to an intense pulsed light source by diverging the light, such as with a diffuser. At a first position of the distal end of the light source the energy density of exit light from the distal end is substantially equal to the energy density of the light required for desired applications, such as effecting an aesthetic improvement without appearance of purpura or scarring, and at a second position of the distal end the radiance of the light emitted therefrom is significantly less than the radiance of the intense pulsed light. Eye safety is further enhanced by attaching at least one element of adjustable opacity to the handpiece of the light source, so that subcutaneously backscattered light may be absorbed by the at least one element.

Priority: IL20020150094 Applic. Date: 2002-06-06; IL20020151694 Applic. Date: 2002-09-11; WO2002IL00635 Applic. Date: 2002-08-02; WO2003IL00277 Applic. Date: 2003-04-03; IL20010147009 Applic. Date: 2001-12-10; IL20040160510 Applic. Date: 2004-02-22; US2004-498382 Applic. Date: 2004-06-10; US2003-614672 Applic. Date: 2003-07-07

Inventor: SLATKINE MICHAEL [IL]


Application No.: US20100247454A1  Published: 30/Sep/2010

Title: COMPOSITIONS FOR ELASTOGENESIS AND CONNECTIVE TISSUE TREATMENT

Applicant/Assignee:

Application No.: 12/686330   Filing Date: 12/Jan/2010

Abstract:The present invention describes therapeutic compositions comprising one or more minerals, including trivalent iron, divalent manganese and salts thereof, suitable in facilitating synthesis and deposition of connective tissue matrix, particularly rich of elastin and collagen, and mitogenic potential in human dermal fibroblasts. It also describes the phenomenon in which stimulation of elastogenesis by arterial SMC associates with a net decrease in proliferation of these cell types. The present invention also describes methods of treatment of human skin fibroblasts and arterial smooth muscle cells. The therapeutic compositions of the present invention comprise one or more of trivalent iron or divalent manganese or salts thereof and may be combined with an elastic tissue digest.

Priority: US2005-062377 Applic. Date: 2005-02-22; US20040546682P Applic. Date: 2004-02-20; US20040622104P Applic. Date: 2004-10-26

Inventor: MITTS THOMAS [US]; JIMENEZ FELIPE [US]; HINEK ALEKSANDER [CA]; BUNDA SEVERA [CA]


Application No.: US20100247459A1  Published: 30/Sep/2010

Title: HAIR STYLING AND CONDITIONING PERSONAL CARE FILMS

Applicant/Assignee:

Application No.: 12/665261   Filing Date: 26/Jun/2008

Abstract:The present invention provides personal care compositions in film form having greater than about 30 weight percent water-soluble chitosan derivative.

Priority: US20070947128P Applic. Date: 2007-06-29; WO2008US68369 Applic. Date: 2008-06-26

Inventor: DROVETSKAYA TATIANA V [US]; YU WEI HONG [US]; DIANTONIO EDWARD F [US]; JORDAN SUSAN L [US]


Application No.: US20100247460A1  Published: 30/Sep/2010

Title: Silicone Organic Elastomer Gels From Organopolysiloxane Resins

Applicant/Assignee:

Application No.: 12/680212   Filing Date: 22/Sep/2008

Abstract:Gel compositions are disclosed comprising a silicone elastomer from the reaction of an SiH containing organopolysiloxane resin and an organic compound having at least two aliphatic unsaturated groups in its molecule.

Priority: US20070975365P Applic. Date: 2007-09-26; WO2008US77167 Applic. Date: 2008-09-22

Inventor: LIN SHAOW BURN [US]; STARK-KASLEY LORI ANN [US]


Application No.: US20100247463A1  Published: 30/Sep/2010

Title: N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE

Applicant/Assignee:

Application No.: 12/816514   Filing Date: 16/Jun/2010

Abstract:The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine. Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.

Priority: US2009-428906 Applic. Date: 2009-04-23; US2008-194203 Applic. Date: 2008-08-19; US2007-621287 Applic. Date: 2007-01-09; US20060757614P Applic. Date: 2006-01-10

Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]


Application No.: US20100247464A1  Published: 30/Sep/2010

Title: COSMETIC COMPOSITION HAVING ANTI-RADICAL PROPERTIES AND CORRESPONDING APPLICATION METHOD

Applicant/Assignee:

Application No.: 12/452458   Filing Date: 03/Jul/2008

Abstract:The invention provides a cosmetic composition for topical use having anti-radical properties and including at least one plant extract of natural origin in a cosmetically acceptable medium, the composition being characterized in that said at least one plant extract of natural origin is insoluble.

Priority: FR20070004925 Applic. Date: 2007-07-06; WO2008FR00949 Applic. Date: 2008-07-03

Inventor: MASSON STEPHANE JACQUES JOSEPH [FR]; SIMONNET ANNE MARIE CATHERINE [FR]; DE LA SAYETTE ANNE MARIE GUILLEMETTE [FR]; BRUNET CHRISTINE ANNE-MARIA RAYMONDE [FR]


Application No.: US20100247466A1  Published: 30/Sep/2010

Title: COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER

Applicant/Assignee: L'OREAL

Application No.: 12/796005   Filing Date: 08/Jun/2010

Abstract:The present invention relates to a care, and/or treatment, and/or make-up cosmetic composition for keratin materials, comprising, in a physiologically acceptable medium, an efficient amount of at least one linear, branched or cyclic polymer, or dendrimer, comprising: a -POL- polymeric backbone comprising at least two repeating patterns, and at least two binding groups (A), attached on the polymeric backbone and adapted to create H links with one or more partner binding groups, of an identical or different chemical nature, each coupling of two binding groups involving at least three H links.

Priority: FR20010007476 Applic. Date: 2001-06-07; US2003-479716 Applic. Date: 2003-12-05; WO2002FR01966 Applic. Date: 2002-06-07

Inventor: MOUGIN NATHALIE [FR]; LIVOREIL AUDE [FR]; MONDET JEAN [FR]


Application No.: US20100247468A1  Published: 30/Sep/2010

Title: Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/585634   Filing Date: 21/Sep/2009

Abstract:Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

Priority: FR20030007487 Applic. Date: 2003-06-20; US2005-311449 Applic. Date: 2005-12-20; WO2004EP07200 Applic. Date: 2004-06-16; US20030489672P Applic. Date: 2003-07-24

Inventor: CLARY LAURENCE [FR]; THOREAU ETIENNE [FR]; RIVIER MICHEL [FR]; AUBERT JEROME [FR]; CHANTALAT LAURENT [FR]; VOEGEL JOHANNES [FR]


Application No.: US20100247544A1  Published: 30/Sep/2010

Title: Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms

Applicant/Assignee:

Application No.: 12/690081   Filing Date: 19/Jan/2010

Abstract:Compositions are provided for promoting healing of tissue of a vertebrate organism. The compositions can be for internal administration of a therapeutically effective amount of pharmacologically active, protease inhibiting, aqueous media soluble polysulfonated materials in salt form and associated with a secondary material to reduce one or more of inflammation, bacterial proliferation, proteolytic activity, and cancerous cell growth. The compositions may additionally or alternatively be cross-linked so as to alter the solubility of these pharmacologically active salts or slow dissolution by providing biodegradable cross-linkers. Compositions for healing the tissue of a multicellular organism are provided that can include a polysulfonated material in a liquid mixture, as solid particles or constructs that may or may not biodegrade or deliver a pharmacologically relevant value. Some of the compositions are also provided for inclusion into a device for preventing infection, reducing inflammation, and preserving the activity of a protein or protein drug.

Priority: US2008-162990 Applic. Date: 2008-07-31; WO2007US02780 Applic. Date: 2007-01-31; US20060764033P Applic. Date: 2006-01-31

Inventor: VACHON DAVID JOHN [US]


Application No.: US20100247563A1  Published: 30/Sep/2010

Title: TOPICAL SKIN CARE FORMULATIONS

Applicant/Assignee: MARY KAY INC

Application No.: 12/605170   Filing Date: 23/Oct/2009

Abstract:Disclosed is a topical skin care composition comprising: (a) a combination of the following extracts: Malpighia punicifolia (acerola) extract

Argania spinosa (argan) extract

Myrciaria dubia (camu camu) extract

Punica granatum (pomegrannate) extract

Pinus sylvestris extract

Terminalia ferdinandiana (kakadu plum) extract

Linum usitatissimum (linseed) extract

Ribes nigrum (black current) extract

Secale cereale (rye) extract

algae extract

and yeast extract

and (b) a dermatologically acceptable vehicle.

Priority: US20090166139P Applic. Date: 2009-04-02; US20090164802P Applic. Date: 2009-03-30

Inventor: HINES MICHELLE [US]; FLORENCE TIFFANY [US]


Application No.: US20100247564A1  Published: 30/Sep/2010

Title: METHODS AND COMPOSITIONS FOR THE USE OF SARGASSUM FUSIFORME FOR THE INHIBITION OF HIV-1 INFECTION

Applicant/Assignee:

Application No.: 12/601072   Filing Date: 23/May/2008

Abstract:The methods, kits, articles, and compositions of the invention feature a natural product (e.g., Sargassum fusiforme), an extract thereof, and fatty acid components of the extract (e.g., palmitic acid) for the treatment of a viral infection, e.g., HIV or herpes. The natural products used in the methods and compositions of the invention include brown algae, specifically algae of the Sargassum fusiforme species. The Sargassum fusiforme algae, extracts thereof, specific components of the extract, and related compounds of the invention may be used to treat or prevent HIV and herpes infections.

Priority: US20070931619P Applic. Date: 2007-05-24; WO2008US06601 Applic. Date: 2008-05-23

Inventor: LEE DAVID YUE-WEI [US]; CANKI MARIO [US]


Application No.: US20100247587A1  Published: 30/Sep/2010

Title: PIGMENTATION-REGULATING COMPOUNDS

Applicant/Assignee: LIPOTEC, S.A

Application No.: 12/440707   Filing Date: 11/Apr/2008

Abstract:The present invention relates to compounds of general formula (I): wherein X is selected from the group consisting of O or S and R is a linear or branched, saturated or unsaturated aliphatic group with from 2 to 23 carbon atoms (C2 to C23), or a cyclic group, and which can contain substituents selected from the group consisting of hydroxy, alkoxy, amino, carboxyl, cyano, nitro, alkylsulfonyl or halogen atoms, a method of obtaining them, cosmetic or pharmaceutical compositions containing them and the use thereof for treating, caring for and/or cleaning skin, hair and/or nails, preferably those conditions, disorders or pathologies of the skin, hair and/or nails which require regulating melanogenesis.

Priority: ES20070001663 Applic. Date: 2007-06-15; US20080037085P Applic. Date: 2008-03-17; WO2008ES00230 Applic. Date: 2008-04-11

Inventor: CEBRIAN PUCHE JUAN [ES]; MESSEGUER PEYPOCH ANGEL [ES]; FERRER MONTIEL ANTONIO [ES]; ALMINANA DOMENECH NURIA [ES]; CARRENO SERRAIMA CRISTINA [ES]


Application No.: US20100247613A1  Published: 30/Sep/2010

Title: Dressing Modified to Receive Medicine

Applicant/Assignee: WEBTEC CONVERTING, LLC

Application No.: 12/415605   Filing Date: 31/Mar/2009

Abstract:A laminated dressing defining an area adapted to receive and hold medicine. In one embodiment of the invention, the dressing comprises a contact layer and a backing layer, both fabricated from absorbent materials. The contact layer has an inboard surface and an opposing outboard surface defined. The outboard surface of the contact layer is adapted to be applied to a patient's skin surrounding a wound. The contact layer further defines a die-cut through-opening substantially in the center of the contact layer. Adhering to the inboard surface of the contact layer is the backing layer, which likewise has an inboard surface and an opposing outboard surface defined. Medicine is received in the area defined by the through-opening in the contact layer and the inboard surface of the backing layer. A polymer film covers the outboard surface of the backing layer to prevent the escape of medicine from the dressing through the backing layer. A removable release film covers the adhesive-covered outboard surface of the contact layer, the reception area and the medicine until the dressing is ready to be used.

Priority:

Inventor: HOLMES RANDEL B [US]


Application No.: US20100247630A1  Published: 30/Sep/2010

Title: Skin Treatment Compositions Containing Copper-Pigment Complexes

Applicant/Assignee:

Application No.: 12/813791   Filing Date: 11/Jun/2010

Abstract:A therapeutic method is described in which copper is delivered into the skin as a complex with sodium chlorophyllin. Sodium copper chlorophyllin is encapsulated in suitable lecithin-type liposomes, containing a high concentration of linoleic acid and having diameters in the range 150-350 nanometers. The method provides therapeutic benefits in the treatment of environmentally-induce premature skin aging, excessively oily skin, acne and acne-related skin disorders, acne-rosacea, and also stimulates the natural tanning response of skin to sunlight and other ultraviolet-containing radiation.

Priority: US2005-320280 Applic. Date: 2005-12-28

Inventor: DOROGI PETER LADISLAUS [US]; VASILY DAVID BRUCE [US]; MCCOOK JOHN PATRICK [US]


Application No.: US20100247670A1  Published: 30/Sep/2010

Title: Red Grape Dry Composition and Health Tea

Applicant/Assignee:

Application No.: 12/383714   Filing Date: 26/Mar/2009

Abstract:Disclosed is a dry composition prepared from red grape by natural fermentation that is, once brewed, steeped within hot water, tasteful to ingest as herb tea, and that complementary contains antioxidants, Catechin, Resveratrol, Tannin, Quercetin bearing anti-inflammatory and blood glucose lowering capacities

as well as a human skin rejuvenating natural product derived there from.

Priority:

Inventor: SHOUTOV DMITRIY [US]


Application No.: US20100247689A1  Published: 30/Sep/2010

Title: Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue

Applicant/Assignee: MERZ PHARMA GMBH & CO. KGAA

Application No.: 12/802250   Filing Date: 02/Jun/2010

Abstract:The invention relates to a novel agent containing fat (oil), which contains onion extract, in addition to the production and use thereof for caring, preventing or treating damaged skin tissue, such as after operations, biopsies, wounds, burns and other accidents, and especially scarred tissue, stretch marks, degenerative skin conditions and others. The agent is characterised in that the base thereof is based on oil, which can be used to produce, for example, cream, lotion, fluid, massage, or balm based products which contain fail (oil). Surprisingly, the onion extract, which contains water, alcohol or water-alcohol, can be integrated into a base containing oil without the effectiveness thereof being reduced or a phase separation being produced. The effectiveness thereof could be proved when the medical application thereof was monitored.

Priority: DE20011032003 Applic. Date: 2001-07-03; US2003-481773 Applic. Date: 2003-12-22; WO2002EP07216 Applic. Date: 2002-07-01

Inventor: PASPALEEVA-KUEHN VALENTINA [DE]; BEUTLER ROLF D [DE]; SCHATSCHNEIDER SIMONE [DE]; HEBERER MARTINA [DE]


Application No.: US20100247693A1  Published: 30/Sep/2010

Title: COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA

Applicant/Assignee:

Application No.: 12/410336   Filing Date: 24/Mar/2009

Abstract:The present invention features novel cosmetic skin care compositions for improving the appearance of rosacea-affected skin.

Priority:

Inventor: MARINI JAN L [US]


Application No.: US20100247886A1  Published: 30/Sep/2010

Title: BIAXIALLY ORIENTED METALLIZED POLYLACTIC ACID FILM WITH HIGH METAL ADHESION AND HIGH BARRIER PROPERTIES

Applicant/Assignee: TORAY PLASTICS (AMERICA), INC TORAY INDUSTRIES, INC

Application No.: 12/731925   Filing Date: 25/Mar/2010

Abstract:Metallized multi-layer biaxially oriented polylactic acid base polymer (BOPLA) films that exhibits improved barrier properties and metal adhesion. The films include a core layer including crystalline polylactic acid base polymer, a first skin layer consisting essentially of amorphous polylactic acid base polymer, and a metal layer on the first skin layer. The films may include a second skin layer consisting essentially of amorphous polylactic acid base polymer.

Priority: US20090164177P Applic. Date: 2009-03-27

Inventor: LEE MARK S [US]; PAULINO CLAUDIO M [US]; MIZUMURA TAKESHI [US]; CHANG KEUNSUK P [US]; YOKOTA NAO [US]; MASUDA JUN ICHI [JP]


Application No.: US20100247914A1  Published: 30/Sep/2010

Title: Porous Silica-Based Particles Having Smooth Surface, Method for Production Thereof and Cosmetic Comprising Such Particles

Applicant/Assignee: JGC CATALYSTS AND CHEMICALS LTD

Application No.: 12/746007   Filing Date: 03/Jun/2010

Abstract:Disclosed are porous silica-based particles having high surface smoothness, a method for producing the porous silica-based particles, and a cosmetic comprising the porous silica-based particles. The porous silica-based particles have an average particle diameter of 0.5 to 30 [mu]m and have a surface smoothness of a level to such an extent that, when the entire surface of the particle is observed from a photograph thereof taken by a scanning electron microscope (SEM) with a magnifying power of 10,000, a foreign matter attached to the surface thereof can be hardly seen.

Priority: JP20070317754 Applic. Date: 2007-12-07; WO2007JP73980 Applic. Date: 2007-12-12

Inventor: ENOMOTO NAOYUKI [JP]; MIYOSHI YASUTAKA [JP]; KAWASHIMA TSUNEO [JP]; MIYAZAKI TAKUMI [JP]


Application No.: US20100249041A1  Published: 30/Sep/2010

Title: COMPOSITIONS COMPRISING ORNITHINE KETOGLUTARATE (OKG)

Applicant/Assignee:

Application No.: 12/676774   Filing Date: 02/Sep/2008

Abstract:Suggested are new compositions comprising Ornithine Ketoglutarate (OKG) and a cosmetically acceptable carrier the latter selected from the group consisting of aliphatic alcohols or polyols having 2 to 15 carbon atoms or oil bodies.

Priority: EP20070017538 Applic. Date: 2007-09-07; WO2008EP07143 Applic. Date: 2008-09-02

Inventor: PERTILE PAOLO [IT]


Application No.: US20100249042A1  Published: 30/Sep/2010

Title: COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS

Applicant/Assignee: PROCYTE CORPORATION

Application No.: 12/697048   Filing Date: 29/Jan/2010

Abstract:The fullness and length of eyelashes and eyebrows can be enhanced by topical application of a composition comprising at least one peptide copper complex to an area of skin at the base of the eyelashes and eyebrows. Disclosed are compositions and methods for such treatment.

Priority: US20090148260P Applic. Date: 2009-01-29

Inventor: PATT LEONARD M [US]


Application No.: US20100249043A1  Published: 30/Sep/2010

Title: COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH

Applicant/Assignee: LA CANADA VENTRURES, INC

Application No.: 12/413436   Filing Date: 27/Mar/2009

Abstract:The present invention relates to a composition for promoting hair growth and a method of use thereof. The composition comprises: (a) 0.15 to 4.5 wt %, preferably 0.15 to 0.75 wt % of panthenyl ethyl ether, (b) 0.15 to 4.5 wt %, preferably 0.15 to 0.75 wt % of inositol, (c) 0.015 to 0.9 wt %, preferably 0.015 to 0.15 wt % of milk protein, (d) 0.03 to 1.8 wt %, preferably 0.03 to 0.3 wt % of one or more sulfur-rich amino acids on the basis of the total weight of the said composition. The composition and method are capable of making hair much longer and thicker in relatively shorter time without any serious side effects.

Priority: US20090163460P Applic. Date: 2009-03-25

Inventor: LIN SUAN [US]


Application No.: US20100249060A1  Published: 30/Sep/2010

Title: Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes

Applicant/Assignee:

Application No.: 12/660181   Filing Date: 22/Feb/2010

Abstract:A new topical formulation is provided, with a high chemical stability, of for example a low dose clobetasol propionate, suitable for the topical treatment of skin and mucous membrane conditions associated with disorders including psoriasis, eczema, and other forms of dermatitis and also topical use associated with the mouth, such as lichen planus. The formulation includes an aqueous vehicle of based on propylene glycol as a solvent and moisture-retaining agent, and macrogol-glycerol hydroxystearate as a non-ionic emulsifier, being capable of holding surprisingly low concentrations of clobetasol. The vehicle holds concentrations about 0.005% to about 0.05% by weight of 17-clobetasol propionate, more preferably about 0.02 to 0.025%, even more preferably 0.025% by weight of 17-clobetasol propionate. The formulation has a good chemical stability, resulting in a long durability.

Priority: US20090208369P Applic. Date: 2009-02-23

Inventor: SMITH JAN G [SE]


Application No.: US20100249080A1  Published: 30/Sep/2010

Title: PERSONAL CARE COMPOSITION

Applicant/Assignee:

Application No.: 12/745975   Filing Date: 11/Nov/2008

Abstract:A personal care composition comprising a eutectic mixture, the eutectic mixture comprising a CB receptor activating agent, in which the CB receptor is preferably palmitoylethanolamide. A method of mitigating scalp itch.

Priority: EP20070122472 Applic. Date: 2007-12-06; WO2008EP65287 Applic. Date: 2008-11-11

Inventor: BURRY JASON SHAUN [GB]; EVANS RICHARD LIVESEY [GB]; HALL CAROLINE ALEXANDRA [GB]; KHOSHDEL EZAT [GB]; MACKAY COLINA [GB]


Application No.: US20100249106A1  Published: 30/Sep/2010

Title: Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds

Applicant/Assignee: SOLVAY PHARMACEUTICALS B.V

Application No.: 12/796097   Filing Date: 08/Jun/2010

Abstract:Thiopheneprymidinone compounds useful in therapy, especially for use in the treatment and/or prevention of a steroid hormone dependent disorder, preferably a steroid hormone dependent disease or disorder requiring the inhibition of a 17[beta]-hydroxysteroid dehydrogenase (17[beta]-HSD) such as 17[beta]-HSD type 1, type 2 or type 3 enzyme.

Priority: US2004-861922 Applic. Date: 2004-06-07; US20030477017P Applic. Date: 2003-06-10

Inventor: WAEHAELAE KRISTIINA [FI]; LILIENKAMPF ANNAMARIA [FI]; ALHO SARI [FI]; HUHTINEN KAISA [FI]; JOHANSSON NINA [FI]; KOSKIMIES PASI [FI]; VIHKO KIMMO [FI]


Application No.: US20100249222A1  Published: 30/Sep/2010

Title: METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS

Applicant/Assignee: MARY KAY INC

Application No.: 12/796820   Filing Date: 09/Jun/2010

Abstract:A method for treating skin, reducing oxidative damage to a skin cell, reducing lipoxygenase (LO) activity in a skin cell, reducing cyclooxygenase (COX) activity in a skin cell, reducing tumor necrosis factor alpha (TNF-[alpha]) in a skin cell, or reduction matrix metalloproteinase enzyme activity in a skin cell comprising contacting skin or a skin cell with an aromatic skin-active ingredient.

Priority: US2008-105957 Applic. Date: 2008-04-18; US20080025631P Applic. Date: 2008-02-01

Inventor: WALKE BOB [US]; GOMEZ CRISTI [US]; FLORENCE TIFFANY C [US]; HINES MICHELLE D [US]


Application No.: US20100249232A1  Published: 30/Sep/2010

Title: MOSQUITO REPELLENT

Applicant/Assignee: BIO & HNT, INC

Application No.: 12/600346   Filing Date: 31/May/2007

Abstract:The present invention relates to a mosquito repellent comprises at least one or more selected from the group consisting of neric acid and derivatives thereof in an effective amount to repel mosquito.

Priority: KR20070048299 Applic. Date: 2007-05-17; WO2007KR02659 Applic. Date: 2007-05-31

Inventor: KWOEN HYOUK II [KR]; PARK KYE CHUNG [KR]; OH HYUN WOO [KR]


Application No.: US20100249244A1  Published: 30/Sep/2010

Title: METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS

Applicant/Assignee:

Application No.: 12/751728   Filing Date: 31/Mar/2010

Abstract:The presently claimed and disclosed inventive concept(s) contemplates compositions comprising compounds, in particular dihydroeugenol (DHE) and/or isoeugenol (IE) and/or ethyl vanillin (EV) or salts, esters, ethers, or derivatives thereof, and methods for topically or systemically delivering them for treatment against inflammation-related and other dermatological conditions such as described herein. These DHE and/or IE and/or EV or salts, esters, ethers or derivatives thereof also are delivered to a measurable extent transepidermally or transdermally. In one of its method aspects, this presently claimed and disclosed inventive concept(s) is directed to a method for treating a patient with a dermatological disease or condition by topically administering to said patient a pharmaceutical or cosmetic composition comprising a pharmaceutically or cosmetically acceptable topical carrier and an effective dermatological disease, disorder or condition-treating amount of a formulation of DHE and/or IE and/or EV, or salts, esters, ethers, or derivatives thereof. In particular, the presently claimed and disclosed inventive concept(s) is directed to a method of using a composition comprising one or more of DHE and/or IE and/or EV or salts, esters, ethers, or derivatives for treating dermatologic diseases, disorders or conditions, aging effects related to decreasing production of collagen, elastin, or hyaluronic acid, or to hyperpigmentation. The formulations may further contain cinnamaldehyde.

Priority: WO2008US79534 Applic. Date: 2008-10-10

Inventor: FULLER BRYAN B [US]


Application No.: US20100249247A1  Published: 30/Sep/2010

Title: ANTIMICROBIAL COMPOSITIONS

Applicant/Assignee:

Application No.: 12/414843   Filing Date: 31/Mar/2009

Abstract:An antimicrobial composition for use as a disinfectant or a preservative. The disinfectant may be used in disinfecting and cleaning surfaces. The preservative is particularly useful in personal care and cosmetic products, and pharmaceuticals. The composition includes a base component and an alkyl mono propylene glycol ether, an alkyl mono glycerol ether, or a combination of these ethers. The base component may be water, alcohol, lotion, cream, shampoo, soap, cosmetic color agent, hair conditioner, lip balm, and face, eye or lip make up, ointment.

Priority:

Inventor: ANDREWS JEFFREY FALLIN [US]; COOK WILLIAM GERARD [US]


Application No.: US20100249373A1  Published: 30/Sep/2010

Title: SCREENING METHODS

Applicant/Assignee:

Application No.: 12/743519   Filing Date: 11/Nov/2008

Abstract:A method of identifying a compound that modulates NCKX-mediated calcium ion exchange across a cell membrane, the method comprising the steps of providing an adherent cell, the cell membrane of which comprises a NCKX polypeptide or a functionally equivalent variant thereof, exposing the cell in suspension to a fluorescent calcium-sensitive dye, thereby causing intracellular uptake of the dye, settling the cell onto a solid support without allowing the cell to adhere to the solid support, exposing the cell to a test compound, exposing the cell to calcium and potassium ions, and measuring fluorescence from the intracellular calcium-sensitive dye after exposure of the cell to the test compound and the calcium and potassium ions, thereby to determine the rate and/or amount of calcium ion exchange across the cell membrane in the presence of the test compound.

Priority: EP20070121613 Applic. Date: 2007-11-27; WO2008EP65330 Applic. Date: 2008-11-11

Inventor: OGBORNE RICHARD MARTIN [GB]; SCHNETKAMP PAUL PETRUS MARIUS [CA]


Application No.: US20100249726A1  Published: 30/Sep/2010

Title: TROCARLESS INTRAVENOUS CANNULA WITH A MULTIFILAMENT TIP

Applicant/Assignee: KING SAUD UNIVERSITY

Application No.: 12/410926   Filing Date: 25/Mar/2009

Abstract:A trocarless intravenous cannula with a multifilament tip is described. The trocarless intravenous cannula has a tapered, distal multifilament tip that is comprised of a plurality of individual filaments. In one aspect, the distal part of the cannula is fenestrated. The tip and the distal part of the cannula may both be covered in a dry, water-soluble coating.

Priority:

Inventor: AL-RASHEED ABDULLAH K [SA]


Application No.: US20100249731A1  Published: 30/Sep/2010

Title: METHOD FOR MEASURING SKIN ERYTHEMA

Applicant/Assignee:

Application No.: 12/411642   Filing Date: 26/Mar/2009

Abstract:A method for measuring skin erythema and determining the efficacy of skin care treatment products utilizing digital images.

Priority:

Inventor: STAMATAS GEORGIOS [FR]


Application No.: US20100251647A1  Published: 07/Oct/2010

Title: RAINSCREEN ATTACHMENT SYSTEM

Applicant/Assignee:

Application No.: 12/749851   Filing Date: 30/Mar/2010

Abstract:A wall mounted panel system wherein panels are permitted three directions of expansion and contraction since each of panel is affixed to the wall at a single point. For example, the system includes a first and second panel adjacent to one another. An upper bracket and a lower bracket are affixed to the back of each panel, wherein the upper brackets are affixed to the wall and wherein the lower bracket of the first panel is movably engaged with the upper bracket of the second panel. The panels do not communicate with any sealing members, thereby allowing for air to flow freely behind the panels for providing a means of removing moisture from behind the panels. A brace member in communication with the interior surface of each panel has an upper end affixed to the upper bracket and a lower end affixed to the lower bracket.

Priority: US20090167457P Applic. Date: 2009-04-07

Inventor: ENNS DOUGLAS BRENT [US]


Application No.: US20100254581A1  Published: 07/Oct/2010

Title: DEVICE, METHOD, AND APPARATUS FOR BIOLOGICAL TESTING WITH A MOBILE DEVICE

Applicant/Assignee: REVEAL SCIENCES, LLC

Application No.: 12/755688   Filing Date: 07/Apr/2010

Abstract:Compositions, methods, and systems for the imaging and analysis of skin, hair and associated health conditions are described herein. The system includes a method and apparatus for analyzing skin and hair samples by taking a sample, identifying desired components of the sample, obtaining an image electronically using a mobile consumer device, storing and transmitting the image, analyzing the image using an analysis software on a remote server, and optionally sending the results of the analysis back to the consumer device.

Priority: US20090167493P Applic. Date: 2009-04-07

Inventor: NEESER JASON [US]; RASOULIAN MICHAEL [US]; BORICH DAMON V [US]; HANES ROBERT EUGENE [US]; HARLAN THOMAS A [US]


Application No.: US20100254919A1  Published: 07/Oct/2010

Title: Topical Turmeric Skin Care Products

Applicant/Assignee: JOAI'S PRODUCTS LLC

Application No.: 12/815958   Filing Date: 15/Jun/2010

Abstract:A topical skin care product is provided that contains therapeutic concentrations of turmeric and other constituents which is colorless upon application to the skin. The product can be used for cosmetic, protective, and healing purposes without staining skin or clothing yellow.

Priority: US2008-148242 Applic. Date: 2008-04-17; US2006-509212 Applic. Date: 2006-08-24; US20050713560P Applic. Date: 2005-09-01

Inventor: BOMMARITO ALEXANDER A [US]


Application No.: US20100254920A1  Published: 07/Oct/2010

Title: Aqueous photoprotective compositions comprising hydrophilic metal oxide nanopigments and vinylpyrrolidone homopolymers

Applicant/Assignee: L'OREAL

Application No.: 11/653392   Filing Date: 16/Jan/2007

Abstract:Stable, reduced whitening photoprotective compositions contain: a) at least one aqueous phase, b) at least hydrophilic metal oxide nanoparticles, and c) at least one vinylpyrrolidone homopolymer, formulated into d) a topically applicable, physiologically acceptable medium therefor.

Priority: FR20040007828 Applic. Date: 2004-07-13; WO2005EP07368 Applic. Date: 2005-06-20; US20040600781P Applic. Date: 2004-08-12

Inventor: L ALLORET FLORENCE [FR]; SIMONNET JEAN-THIERRY [FR]


Application No.: US20100254928A1  Published: 07/Oct/2010

Title: NOVEL COMPOSITION CONTAINING OZONIZED SURFACTANT

Applicant/Assignee:

Application No.: 12/734790   Filing Date: 26/Nov/2008

Abstract:To provide an antiseptics, a detergent, an antimicrobial, a deodorizer against nitrogenous odor, an insecticide, a repellent and a bactericide, containing an ozonized surfactant obtained by adding ozone to a surfactant having at least one olefin-based double bond in a hydrophobic group moiety. These are highly safe to the human body and have features and performance that ordinary surfactants do not have.

Priority: JP20070305826 Applic. Date: 2007-11-27; JP20070305834 Applic. Date: 2007-11-27; WO2008JP71386 Applic. Date: 2008-11-26

Inventor: YAMAZAKI KAZUTOSHI [JP]; TANAKA AKINORI [JP]


Application No.: US20100254961A1  Published: 07/Oct/2010

Title: WATER-SOLUBLE ELECTROSPUN SHEET

Applicant/Assignee: TAIYOKAGAKU CO., LTD

Application No.: 12/676030   Filing Date: 04/Sep/2008

Abstract:A water-soluble electrospun sheet, containing a water-soluble base material made of at least one material selected from a group consisting of: high-molecular proteins and decomposition products thereof

cellulose-based polymers

plant-based polymers and decomposition products thereof

vinyl-based polymers

acrylic-based polymers

and water-soluble polysaccharides

is provided. In addition to the water-soluble base material, the sheet may further contain at least one functional component selected from among: emulsifying components

stabilizing components

antimicrobial components

humectant components

skin-whitening components

anti-ultraviolet components

astringent components

keratin-softening components

anti-inflammatory components

and coloring components.

Priority: JP20070230518 Applic. Date: 2007-09-05; JP20070331778 Applic. Date: 2007-12-25; WO2008JP65987 Applic. Date: 2008-09-04

Inventor: NISHIO TOSHIHIKO [JP]; SUGINO HIDETOSHI [JP]; OKUBO TSUTOMU [JP]; ISHIGAKI SHOICHI [JP]


Application No.: US20100255025A1  Published: 07/Oct/2010

Title: COMPOSITIONS OF MARINE BOTANICALS TO PROVIDE NUTRITION TO AGING AND ENVIRONMENTALLY DAMAGED SKIN

Applicant/Assignee: MARY KAY INC

Application No.: 12/817870   Filing Date: 17/Jun/2010

Abstract:The present invention relates to methods and compositions comprising marine botanicals for treating aged, mature, nutritionally-compromised, or environmentally-damaged skin. These methods and compositions provide improvements in the skin's visual appearance, physiological functions, clinical properties, and biophysical properties.

Priority: US2007-937960 Applic. Date: 2007-11-09; US2005-300641 Applic. Date: 2005-12-14; US2004-751684 Applic. Date: 2004-01-05; US20030527568P Applic. Date: 2003-12-05

Inventor: MAJMUDAR GOPA [US]


Application No.: US20100255044A1  Published: 07/Oct/2010

Title: METHOD OF DEPOSITING PARTICULATE BENEFIT AGENTS ON KERATIN-CONTAINING SUBSTRATES

Applicant/Assignee:

Application No.: 12/722143   Filing Date: 11/Mar/2010

Abstract:This invention relates to the deposition of particulate benefit agents onto keratin-containing substrates such that the deposited particulates are resistant to removal by exposure to surfactants or cleansing agents. The deposition is accomplished by sequentially treating the substrate with a cationic composition followed by treatment with an anionic particulate benefit agent.

Priority: US20090164676P Applic. Date: 2009-03-30

Inventor: DALY SUSAN [US]; JACHOWICZ JANUSZ [US]; BIANCHINI ROBERT [US]; COLACO ALLWYN [US]


Application No.: US20100255045A1  Published: 07/Oct/2010

Title: COMPOSITION FOR PHOTODYNAMIC SKIN TREATMENT

Applicant/Assignee:

Application No.: 12/744399   Filing Date: 27/Nov/2008

Abstract:The invention relates to a composition for photodynamic therapy. The composition of the invention, in the form of a gel or a cross-linked hydrogel, includes a chlorophyll photosensitising substance or a derivative thereof, in particular chlorophyllin optionally associated with an additional ingredient such as an alpha- or beta-hydroxy acid, a depigmentation or lightening agent, and/or an antioxidant. The invention can be used in the treatment of skin aging signs and in skin regeneration.

Priority: FR20070008284 Applic. Date: 2007-11-27; WO2008FR01650 Applic. Date: 2008-11-27

Inventor: EYMARD DU VERNET MICHELE [FR]


Application No.: US20100255069A1  Published: 07/Oct/2010

Title: COMPOSITIONS AND METHODS FOR TREATING ANGIOGENESIS-RELATED DISEASES, WOUNDS AND COSMETIC USE OF COMPONENTS OF ANGELICA SINENSIS, AND METHODS OF PREPARATION THEREOF

Applicant/Assignee: SUNNY BIODISCOVERY, INC

Application No.: 12/758863   Filing Date: 13/Apr/2010

Abstract:Compositions and methods for treating angiogenesis-related diseases and for skin care in mammals is disclosed that includes, as an active pharmaceutical agent, an effective amount of purified extract from Angelica sinensis, or a fraction or a lyophilizate thereof, or one or more active component contained in said extract.

Priority: US2004-948590 Applic. Date: 2004-09-24

Inventor: ZHAO HUI [US]; BOJANOWSKI KRZYSZTOF [US]; ARIA FARIBA [US]; MORTEZAEI REZA [US]


Application No.: US20100255070A1  Published: 07/Oct/2010

Title: COMPOSITIONS AND METHODS FOR PREVENTING, MINIMIZING AND HEALING SKIN IRRITATION AND TRAUMA

Applicant/Assignee: PRELIEF INC

Application No.: 12/600031   Filing Date: 22/May/2008

Abstract:A composition for preventing, mitigating, and alleviating irritation and skin trauma is described. The composition contains calcium glycerophosphate and at least one skin compatible, film-forming component. The composition may be applied to the skin prior to application of an adhesive tape to reduce damage to the skin which is inflicted upon removal of the tape by forming a film on the skin. Upon removal of the adhesive tape from the skin, the film, rather than skin cells, is removed with the tape. The calcium glycerophosphate component of the composition also penetrates the skin and serves to alleviate any damage which may be inflicted on the skin. The composition may also be applied to the skin to prevent subsequent irritation, such as irritation inflicted by contact with poison ivy, clothing, jewelry, insect bites, a prosthetic, etc. A medical dressing which contains the composition is also included. Finally, methods for preventing and mitigating skin irritation and trauma using the inventive composition are described.

Priority: US20070939473P Applic. Date: 2007-05-22; WO2008US64516 Applic. Date: 2008-05-22

Inventor: KLIGERMAN ALAN E [US]


Application No.: US20100255076A1  Published: 07/Oct/2010

Title: COMPOSITION AND METHOD FOR DERMAL REGENERATION

Applicant/Assignee: ULTRACEUTICALS R & D PTY LTD

Application No.: 12/681391   Filing Date: 03/Oct/2008

Abstract:The present invention relates to glucommannan oligosaccharides and polysaccharides that possess one or more properties selected from skin regeneration, wound healing and skin augmentation. More particularly, the invention relates to the use of glucomannan oligosaccharides and polysaccharides for one or more of skin regeneration, wound healing and skin augmentation agents in a mammal. The invention also relates to a pharmaceutical formulation for treating skin of a subject comprising an active component comprising glucomannan in a suitable diluent, excipient or physical form such as dermal scaffold or sponge, the active component being capable of promoting an accumulation of fibroblasts in the skin and stimulating production of collagen in the skin.

Priority: AU20070905441 Applic. Date: 2007-10-04; WO2008AU01474 Applic. Date: 2008-10-03

Inventor: HEBER GEOFFREY [AU]; STAMFORD NICHOLAS PATRICK JOHN [AU]


Application No.: US20100255079A1  Published: 07/Oct/2010

Title: Systems and methods for skin rejuvenation

Applicant/Assignee: SESVALIA USA, LLC

Application No.: 12/798416   Filing Date: 02/Apr/2010

Abstract:Systems and methods for skin rejuvenation are disclosed herein. In an embodiment, a skin rejuvenation system includes a unit dose of a booster product that includes active ingredients of ferulic acid and phloretin

a unit dose of at least one exfoliating product that includes active ingredients of ferulic acid and phloretin in combination with fruit acids or alpha hydroxyacids

and a unit dose of a nano-additive product for enhancing penetration of the active ingredients. A method for skin rejuvenation includes applying topically, to a skin surface to be treated, a booster product including active ingredients of ferulic acid and phloretin

applying topically, to the skin surface, at least one exfoliating product including active ingredients of ferulic acid and phloretin in combination with one of fruit acids or alpha hydroxyacids

and applying topically, to the skin surface, a nano-additive product for enhancing penetration of the active ingredients.

Priority: US20090166192P Applic. Date: 2009-04-02; US20090166165P Applic. Date: 2009-04-02

Inventor: SANMIGUEL GABRIEL SERRANO [US]; NUNEZ JUAN MANUEL SERRANO [ES]; ZAMORA JOAQUIN MELENDEZ [ES]


Application No.: US20100255097A1  Published: 07/Oct/2010

Title: POLYSACCHARIDE DERIVATIVES OF LIPOIC ACID, AND THEIR PREPARATION AND USE AS SKIN COSMETICS AND MEDICAL DEVICES

Applicant/Assignee: SIGEA S.R.L

Application No.: 12/808885   Filing Date: 11/Dec/2008

Abstract:Disclosed are polysaccharides containing residues of glucosamine or galactosamine in the repetitive unit, characterised by the presence of esters on the hydroxyls or amides on the amine functions, with lipoic acid or with mixtures of lipoic acid and formic acid.

Priority: IT2007MI02416 Applic. Date: 2007-12-21; WO2008EP10534 Applic. Date: 2008-12-11

Inventor: PICOTTI FABRIZIO [IT]; BOSCO MARCO [IT]; STUCCHI LUCA [IT]; FABBIAN MATTEO [IT]


Application No.: US20100255109A1  Published: 07/Oct/2010

Title: STABILIZED ANTIOXIDANT PARTICLES, COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME

Applicant/Assignee: BIOGENICS, INC

Application No.: 12/671211   Filing Date: 04/Aug/2008

Abstract:The present invention provides stabilized antioxidant particles, each of which includes a core consisting of an antioxidant and a first coating layer formed on the surface of the core, wherein the first coating layer is formed by polymerizing at least one [alpha]-lipoic acid or its derivative, a composition including the same, and a method for preparing the same.

Priority: KR20070078692 Applic. Date: 2007-08-06; KR20070109312 Applic. Date: 2007-10-30; WO2008KR04508 Applic. Date: 2008-08-04

Inventor: KIM CHUL HWAN [KR]; SHIN CHAN JAE [KR]; SEO SO YEON [KR]; KWON JUNG AE [KR]


Application No.: US20100255126A1  Published: 07/Oct/2010

Title: MEDICAMENT FOR TREATMENT OF CANCER AND OTHER DISEASES

Applicant/Assignee: SWING AEROBICS LICENSING, INC

Application No.: 12/818723   Filing Date: 18/Jun/2010

Abstract:A medicament for the treatment of cancer and other diseases, including cardiovascular diseases, by increasing cellular oxygenation is described wherein a composition of organically grown, chemically unprocessed and unrefined oils is used that provides a ratio of parent omega-6 to parent omega-3 that is greater than 1:1 and preferably within a range from about 1.1:1 to about 5:1. Most preferably, the ratio is about 2.6:1. The medicament may be administered via capsule or liquid form and preferably on a periodic basis, such as daily. In further embodiments, the medicament may be applied in topical ointment form.

Priority: US2004-010792 Applic. Date: 2004-12-13

Inventor: PESKIN BRIAN [US]


Application No.: US20100255131A1  Published: 07/Oct/2010

Title: STABLE HYDROPHOBIC TOPICAL HERBAL FORMULATION

Applicant/Assignee: VEDIC ELEMENTS PRIVATE LIMITED

Application No.: 12/745858   Filing Date: 03/Dec/2008

Abstract:Disclosed herein is stable topical herbal composition, useful for the treatment of specific skin conditions, such as, including, but not limited to, psoriasis, eczema, dermatitis, inflammation, pigmentation, extreme dry skin and other skin conditions requiring therapeutic intervention, wherein the said topical herbal composition comprises, oil extract of Wrightia tinctoria in combination with hydrophobic excipients and other functional excipients, such as emulsifying agent, preservatives, humectant and anti oxidant.

Priority: IN2007CH02873 Applic. Date: 2007-12-03; WO2008IN00808 Applic. Date: 2008-12-03

Inventor: KANAUJIA PARIJAT [IN]; BALAKRISHNAN RAJAN [IN]; RAJAN JAYASHREE [IN]; KATAGERI SHIVARAJ BASAVARAJ [IN]


Application No.: US20100255176A1  Published: 07/Oct/2010

Title: BAKED POTATO PRODUCTS AND PROCESS FOR PREPARING SAME

Applicant/Assignee: NONPAREIL CORPORATION

Application No.: 12/598960   Filing Date: 06/May/2008

Abstract:The invention relates to baked potatoes and, particularly, to convenient forms of baked potatoes having an optimally-baked flavor and texture which can be simply prepared for serving in any size portion with a minimum of effort. In one preferred form, the product will be in the form of baked potato pieces with the skin attached, preferably having a moisture content of from about 70 to about 75% and flavor and texture profiles characteristic of optimally baked potatoes. A process and an apparatus for preparing the potatoes and a packaged form are also provided. The process calls for freezing a baked potato and subdividing the potato into discrete pieces of a size of from about 0.5 to about 1.5 inches, preferably by means comprising at least one roller pair comprising a plurality of rotatably mounted blades with cutting edges angularly offset (FIG. 7) or diagonally-opposed, spaced cutting blades (FIG. 7).

Priority: US2008-115839 Applic. Date: 2008-05-06; US20070916328P Applic. Date: 2007-05-07; US20080030257P Applic. Date: 2008-02-21; WO2008US62768 Applic. Date: 2008-05-06

Inventor: KERR JOHN C [US]; WOODLAND SYLVESTER L [US]; BOGDANOWICZ ROMAN J [US]; PAJAREE LYNN T [US]


Application No.: US20100256032A1  Published: 07/Oct/2010

Title: SOY SKIN CARE

Applicant/Assignee:

Application No.: 12/419397   Filing Date: 07/Apr/2009

Abstract:Skin care preparation materials comprising substantial amounts of food grade soy flour in soap bars in separate soap bars suitable for detoxification and makeup removal, exfoliation and moisturization. The food grade soy flours are of differing types and fat content as well as particle size and lecithin content suitable for each of the skin care purposes. A seriatim regimen of skin care with the soap bars is used for maximum skin care effect.

Priority:

Inventor: GOLDENBERG MICHAEL [US]


Application No.: US20100256067A1  Published: 07/Oct/2010

Title: LIQUID EDIBLE COMPOSITION COMPRISING ISOFLAVONES

Applicant/Assignee:

Application No.: 12/738190   Filing Date: 08/Oct/2008

Abstract:A liquid edible product comprising isoflavones, water, and which further comprises [beta]-lactoglobulin.

Priority: EP20070118805 Applic. Date: 2007-10-18; WO2008EP63464 Applic. Date: 2008-10-08

Inventor: BRUGGEMAN YVONNE EVELIEN [NL]; GUEZEY DEMET [NL]; STRAATJES NICOLETTE PETRONELLA M [NL]


Application No.: US20100256102A1  Published: 07/Oct/2010

Title: C-19 STEROIDS FOR COSMETIC AND FURTHER USES

Applicant/Assignee: ERLACOS GMBH

Application No.: 12/734621   Filing Date: 12/Nov/2008

Abstract:The present invention relates to novel uses of C-19 steroid compounds, in particular C-19 steroids having an androsten-17-(OR4)-3-one structure for cosmetic and further uses, wherein R4 is hydrogen or an unsubstituted or substituted alkyl, aryl, acyl or any group leading to hydroxyl upon biological metabolization or chemical deprotection. The present invention particularly relates to selected C-19 steroids displaying properties of high binding affinity to androgen receptor to block dihydrotestosterone from binding, while at the same time providing anabolic effects, which is useful for certain applications, particularly for influencing or controlling problems of the skin and its skin-associated body structures like cellulite, wrinkles, adipose fat tissues, hair follikles or hair growth

for influencing or controlling gland function and activity such as the sebaceous gland and other glands affecting the skin and/or perspiration. The present invention also describes a composition comprising a combination of such a compound and dimethyl isosorbide.

Priority: EP20070022015 Applic. Date: 2007-11-13; US20070002882P Applic. Date: 2007-11-13; WO2008EP09540 Applic. Date: 2008-11-12

Inventor: WINDISCH MARTIN [DE]


Application No.: US20100256129A1  Published: 07/Oct/2010

Title: SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF

Applicant/Assignee:

Application No.: 12/734993   Filing Date: 12/Dec/2008

Abstract:Provided herein are compounds of formulae I to II that bind to androgen receptors and/or modulate activity of androgen receptors

and to methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions.

Priority: US20070008731P Applic. Date: 2007-12-21; WO2008US13657 Applic. Date: 2008-12-12

Inventor: ZHI LIN [US]


Application No.: US20100256465A1  Published: 07/Oct/2010

Title: DEVICES AND TECHNIQUES ASSOCIATED WITH DIAGNOSTICS, THERAPIES, AND OTHER APPLICATIONS, INCLUDING SKIN-ASSOCIATED APPLICATIONS

Applicant/Assignee: SEVENTH SENSE BIOSYSTEMS, INC

Application No.: 12/716229   Filing Date: 02/Mar/2010

Abstract:The present invention generally relates to devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications, for example, devices for delivering and/or withdrawing fluid from subjects, e.g., through the skin. In some embodiments, the device includes a system for accessing an extractable medium from and/or through the skin of the subject at an access site, and a pressure regulator supported by a support structure, able to create a pressure differential across the skin at least a portion of the access site. The device may also include, in some cases, a sensor supported by the support structure for determining at least one condition of the extractable medium from the subject, and optionally a signal generator supported by the support structure for generating a signal relating to the condition of the medium determined by the sensor.

Priority: US20090156632P Applic. Date: 2009-03-02; US20090163710P Applic. Date: 2009-03-26; US20090269436P Applic. Date: 2009-06-24; US20090257731P Applic. Date: 2009-11-03; US20100294543P Applic. Date: 2010-01-13

Inventor: BERNSTEIN HOWARD [US]; CHICKERING III DONALD E [US]; LEVINSON DOUGLAS A [US]; WALT DAVID R [US]; DAVIS SHAWN [US]; HAGHGOOIE RAMIN [US]; LANGER ROBERT S [US]; BLICHARZ TIMOTHY M [US]


Application No.: US20100256617A1  Published: 07/Oct/2010

Title: Skin Resurfacing at 1930 NM

Applicant/Assignee:

Application No.: 12/754374   Filing Date: 05/Apr/2010

Abstract:Non-ablative skin resurfacing can include generating electromagnetic radiation having a wavelength of about 1920 nm to about 1950 nm and a fluence of about 3 J/cm2 to about 6 J/cm2. The electromagnetic radiation is delivered to a target region of skin to cause thermal injury to the epidermis in the target region sufficient to elicit a healing response that produces a substantially improved skin condition without detachment of the epidermis (e.g., within 3 days of treatment).

Priority: US20090166582P Applic. Date: 2009-04-03

Inventor: DOMANKEVITZ YACOV [US]; JONES CHRISTOPHER J [US]; HSIA JAMES C [US]


Application No.: US20100258243A1  Published: 14/Oct/2010

Title: METHOD OF MANUFACTURING LAMINATED BAMBOO SLIVER LUMBER

Applicant/Assignee:

Application No.: 12/739014   Filing Date: 24/Jan/2008

Abstract:A method of manufacturing laminated bamboo sliver lumber, comprising steps of: selecting and using the bamboo outer slivers obtained from a bamboo and having an air dry density no less than about 0.95 g/cm3 and removing siliceous and wax layers thereon to obtain bamboo slivers having a width of about 1-4 mm. Drying the bamboo slivers to a moisture content of about 6-15%, machining the dried bamboo slivers to a thickness of about 0.5-3.5 mm and a width of about 5-22 mm, then dehumidifying the bamboo slivers to a moisture content of about 3-10%. Applying a glue to the bamboo slivers in which a ratio of the glue to an absolute dry weight of the bamboo slivers may be about 3-16%. A arranging the glued bamboo slivers with their width direction consistent with the vertical direction, then pressing the arranged bamboo slivers and curing the glue under a side pressure of about 3-15 MPa and a top pressure of about 1-6 MPa.

Priority: CN20071156195 Applic. Date: 2007-10-30; WO2008CN70176 Applic. Date: 2008-01-24

Inventor: LIN HAI [CN]; XU XUFENG [CN]; JIN JIUHONG [CN]; LIU HONGZHENG [CN]


Application No.: US20100260687A1  Published: 14/Oct/2010

Title: PERSONAL CARE COMPOSITIONS INCLUDING POLYURETHANE DISPERSIONS

Applicant/Assignee:

Application No.: 12/679735   Filing Date: 23/Sep/2008

Abstract:Personal care compositions comprising a high solid aqueous polyurethane dispersion, substantially free of organic solvent and tertiary amines, are described.

Priority: US20070974646P Applic. Date: 2007-09-24; WO2008US77341 Applic. Date: 2008-09-23

Inventor: YU WEI H [US]; JORDAN SUSAN L [US]; LI WING K [US]; BHATTACHARJEE DEBKUMAR [US]


Application No.: US20100260694A1  Published: 14/Oct/2010

Title: Methionine Sulfoxide Peptide, Compositions And Methods Of Use

Applicant/Assignee:

Application No.: 12/758366   Filing Date: 12/Apr/2010

Abstract:Use of a peptide containing an oxidized methionine residue to ameliorate the effects of oxidative stress in human skin. A short polypeptide containing an oxidized methionine at its C-terminus is shown to inhibit the production of Sunburn Cells in living skin models and to upregulate methionine sulfoxide reductase. Cosmetically acceptable compositions and methods of using the polypeptide are disclosed. The oxidized peptide may repair oxidized alpha 1-antitrypsin, which, in turn, inhibits breakdown of connective tissue by elastase. This effect may have wide ranging ramifications, including, for example, repair of sun damaged skin and treatment of emphysema.

Priority: US20090168808P Applic. Date: 2009-04-13

Inventor: PELLE EDWARD [US]; MAES DANIEL H [US]


Application No.: US20100260695A1  Published: 14/Oct/2010

Title: COMBINATION OF PLANT EXTRACTS TO IMPROVE SKIN TONE

Applicant/Assignee: MARY KAY INC

Application No.: 12/633592   Filing Date: 08/Dec/2009

Abstract:Disclosed is a method of reducing the appearance of uneven skin tone comprising topically applying to skin having an uneven skin tone a composition comprising a combination of the following extracts: Lactobacillus ferment extract

Helianthus annus (sunflower) seed extract

Terminalia ferdinandiana (kakadu plum) fruit extract

and Ferula foetida root extract

and dermatologically acceptable vehicle, wherein topical application of the composition reduces the appearance of uneven skin tone.

Priority: US20090168104P Applic. Date: 2009-04-09

Inventor: BURKE-COLVIN DAWN [US]; GAN DAVID [US]; HINES MICHELLE [US]


Application No.: US20100260698A1  Published: 14/Oct/2010

Title: Anhydrous Antiperspirant Compositions with Improved Active Substance Release

Applicant/Assignee:

Application No.: 12/823484   Filing Date: 25/Jun/2010

Abstract:Antiperspirant compositions for personal body care, ready-made as a stick, soft solid, cream, gel, suspension, solution or impregnated on a substrate, containing at least one antiperspirant active substance, at least one oil, liquid under normal conditions, as a carrier, 0-3 wt. % by weight of free water, based on weight of the composition, and at least one organosiloxane oxyalkylene copolymer.

Priority: DE200710063352 Applic. Date: 2007-12-28; WO2008IB03974 Applic. Date: 2008-12-22

Inventor: GALANTE CHERYL [US]; BANOWSKI BERNHARD [DE]; BUSE NADINE [DE]


Application No.: US20100260703A1  Published: 14/Oct/2010

Title: INJECTABLE BIODEGRADABLE POLYMER COMPOSITIONS FOR SOFT TISSUE REPAIR AND AUGMENTATION

Applicant/Assignee:

Application No.: 12/678492   Filing Date: 05/Oct/2008

Abstract:Methods for soft tissue repair and/or augmentation using injectable, biodegradable polymers are described herein. In one embodiment, the polymer compositions are liquid or pastes at room temperature. In a preferred embodiment, the polymer composition contains liquid or pasty hydroxy fatty acid-based copolyesters, polyester-anhydrides, or combinations thereof. The viscosity of the polymers increases upon contact with bodily fluid to form a solid or semisolid implant suitable for soft tissue repair and/or augmentation. In another embodiment, the polymer composition contains particles of a polymer stereocomplex. One or more active agents may be incorporated into the polymer compositions. Suitable classes of active agents include local anesthetics, anti-inflammatory agents, antibiotics, analgesics, growth factors and agents that induce and/or enhance growth of tissue within the filled cavity or control the growth of a certain type of tissue, and combinations thereof. The polymer compositions may also contain one or more additives or excipients that modify the physical and/or mechanical properties of the polymer. The polymer compositions are typically administered by injection. The injectable polymers can be used for a variety of soft tissue repair and augmentation procedures.

Priority: US20070977991P Applic. Date: 2007-10-05; WO2008IL01320 Applic. Date: 2008-10-05

Inventor: YANKELSON LIOR [IL]; DOMB ABRAHAM J [IL]


Application No.: US20100260733A1  Published: 14/Oct/2010

Title: NOVEL ANTI AGING AGENTS AND METHODS TO IDENTIFY THEM

Applicant/Assignee:

Application No.: 12/758384   Filing Date: 12/Apr/2010

Abstract:The present invention discloses novel mechanisms in the aging process and describes novel methods for high-throughput screening to identify, detect, and purify agents to be used for improving mitochondrial function, maintaining the cell cycle-arrested state in senescent and post mitotic cells, and thus preventing or treating age-related diseases or disorders associated with accelerated mitochondrial function loss, telomere dysfunction, and/or deterioration of the growth-arrested state. The present invention also discloses a number of compounds or compositions identified from this method. The present invention further provides the use of low doses of rapamycin or its analogs as a mimic of caloric restriction in preventing age-related diseases or disorders.

Priority: US20090168311P Applic. Date: 2009-04-10; US20090168335P Applic. Date: 2009-04-10

Inventor: QI HAIYAN [US]


Application No.: US20100260823A1  Published: 14/Oct/2010

Title: PREPARATION WITH MARINE COLLAGEN FOR PROTEASE INHIBITION

Applicant/Assignee: LOHMANN & RAUSCHER GMBH & CO KG

Application No.: 12/377407   Filing Date: 28/Jul/2007

Abstract:The invention relates to pharmaceutical preparations made from marine collagens for inhibiting matrix metalloproteases and the use of a marine collagen for production of a pharmaceutical preparation for inhibiting matrix metalloproteases.

Priority: DE200610038252 Applic. Date: 2006-08-16; WO2007EP06694 Applic. Date: 2007-07-28

Inventor: ALUPEI CORNELIU IULIAN [DE]; RUTH PETER [DE]; WILHELMS TIM AXEL [DE]; ROHRER CHRISTIAN [AT]


Application No.: US20100260863A1  Published: 14/Oct/2010

Title: Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same

Applicant/Assignee:

Application No.: 12/747890   Filing Date: 11/Dec/2008

Abstract:This invention relates to a composition for the topical or internal treatment of animal tissues to buffer and normalize the pH of the cellular environment while also effecting specific cellular membrane ion channels as a method to affect inflammation, proteases, reactive oxygen species and free radicals.

Priority: US20070007228P Applic. Date: 2007-12-11; WO2008US86477 Applic. Date: 2008-12-11

Inventor: MONROE STEPHEN H [US]


Application No.: US20100261629A1  Published: 14/Oct/2010

Title: Benefit agent containing delivery particles

Applicant/Assignee: APPLETON PAPERS INC

Application No.: 12/384685   Filing Date: 08/Apr/2009

Abstract:The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the aforementioned particles and compositions. When employed in compositions, for example, compositions for cleaning, fabric care, or coating onto various substrates, textiles or surfaces, such particles increase the efficiency of benefit agent delivery, thereby allowing reduced amounts of benefit agents to be employed. In addition to allowing the amount of benefit agent to be reduced, such particles allow a broad range of benefit agents to be employed.

Priority:

Inventor: SMETS JOHAN [BE]; SANDS PEGGY DOROTHY [US]; GUINEBRETIERE SANDRA JACQUELINE [US]; PINTENS AN [BE]; DIHORA JITEN ODHAVJI [US]


Application No.: US20100261685A1  Published: 14/Oct/2010

Title: PERSONAL CARE COMPOSITION

Applicant/Assignee:

Application No.: 12/745970   Filing Date: 04/Nov/2008

Abstract:A personal care composition comprising a eutectic mixture, the eutectic mixture comprising a tertiary system, in which menthol may form part of the eutectic mixture or in the eutectic mixture comprises an antidandruff agent such as ketoconazole.

Priority: EP20070122469 Applic. Date: 2007-12-06; EP20070122470 Applic. Date: 2007-12-06; EP20070122471 Applic. Date: 2007-12-06; GB20080017566 Applic. Date: 2008-09-25; WO2008EP64926 Applic. Date: 2008-11-04

Inventor: BURRY JASON SHAUN [GB]; EVANS RICHARD LIVESEY [GB]; HALL CAROLINE ALEXANDRA [GB]; KHOSHDEL EZAT [GB]; MACKAY COLINA [GB]


Application No.: US20100261691A1  Published: 14/Oct/2010

Title: AMORPHOUS FORM OF AN ANTI-INFLAMMATORY COMPOUND

Applicant/Assignee: FERRER INTERNATIONAL, S.A NICOX SA

Application No.: 12/739131   Filing Date: 23/Oct/2008

Abstract:The invention relates to the technical field of anti-inflammatory compounds, specifically those of a steroid nature, in particular to a new amorphous form of a nitrooxy derivative of a corticosteroid, its pharmaceutical formulations and its use in the treatment or prevention of diseases or symptoms of the skin or mucous membranes.

Priority: ES20070002796 Applic. Date: 2007-10-25; WO2008EP64387 Applic. Date: 2008-10-23

Inventor: ANGLADA LUIS [ES]; ALBET CARLOS [ES]; GUGLIETTA ANTONIO [ES]


Application No.: US20100261754A1  Published: 14/Oct/2010

Title: NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/599624   Filing Date: 24/Apr/2008

Abstract:The invention relates to compounds corresponding to general formula (I) below: to the compositions containing same, to methods for the preparation thereof and to the use thereof in pharmaceutical compositions for use in human or veterinary medicine, or else in cosmetic compositions.

Priority: FR20070055019 Applic. Date: 2007-05-11; WO2008FR50747 Applic. Date: 2008-04-24

Inventor: BIADATTI-PORTAL THIBAUD [FR]


Application No.: US20100261769A1  Published: 14/Oct/2010

Title: Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/747272   Filing Date: 14/Nov/2008

Abstract:Cosmetic compositions comprising non-natural, non-proteogenic amino acids and methods of using such compositions to impart antiaging benefits to the skin are disclosed. The non-natural, non-proteogenic amino acids are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging, and in particular, are enhancers of LOXL-1.

Priority: US20070014846P Applic. Date: 2007-12-19; WO2008US83490 Applic. Date: 2008-11-14

Inventor: PTCHELINTSEV DMITRI S [US]; DRYER LAURENCE [US]; LUO XIAOCHUN [US]


Application No.: US20100261772A1  Published: 14/Oct/2010

Title: Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

Applicant/Assignee:

Application No.: 12/785788   Filing Date: 24/May/2010

Abstract:The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.

Priority: US2007-915436 Applic. Date: 2007-11-26; WO2006US20185 Applic. Date: 2006-05-24; US20050684433P Applic. Date: 2005-05-25

Inventor: FANG JING [US]; HEYER DENNIS [US]; KATAMREDDY SUBBA REDDY [US]; BATCHELOR KENNETH WILLIAM [US]; CALDWELL RICHARD DANA [US]


Application No.: US20100261984A1  Published: 14/Oct/2010

Title: Physiology sensing apparatus with navigation capability

Applicant/Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE

Application No.: 11/487497   Filing Date: 17/Jul/2006

Abstract:A physiology sensing apparatus with navigation capability is disclosed, which integrates therein a GPS module, a magnetic sensor, an inertial sensing module, and a bio sensing module so as to acquire signals relating to a user's coordinate position, physical condition, body movement, and so on, and then the acquired signals can be purified by filter devices so as to reduce the interference of noise, thereafter, processes the filtered signal by a signal processor and an alarming device so as to simultaneously obtain the information of user's location, physical condition, and whether the user is in danger or having an accident.

Priority: TW20050145783 Applic. Date: 2005-12-22

Inventor: TSAI MING-JYE [TW]; CHEN YUNG-YU [TW]; WANG SHI-HAO [TW]


Application No.: US20100262068A1  Published: 14/Oct/2010

Title: Method for creating an autologous radiofrequency capsule for containing filling solutions

Applicant/Assignee: PROMOITALIA GROUP S.P.A

Application No.: 12/461108   Filing Date: 31/Jul/2009

Abstract:A method for creating an autologous radiofrequency capsule for containing filling solutions, whose particularity is that it comprises the combined use of bipolar radiofrequencies and of filling or bio-revitalizing solutions based on hyaluronic acid or similar products.

Priority: IT2009NA00017 Applic. Date: 2009-04-10

Inventor: TRANFAGLIA EGIDIO [IT]; MATANO VALERIO [IT]


Application No.: US20100262090A1  Published: 14/Oct/2010

Title: WOUND CARE ARTICLE FOR EXTRACTION AND CONTROL OF WOUND FLUIDS

Applicant/Assignee:

Application No.: 12/443989   Filing Date: 28/Sep/2007

Abstract:The subject of the invention is a wound care article for extraction and control of wound fluids, comprising at least one first fluid-absorbing structure (1

10

36), which is surrounded by a liquid-permeable, first enclosure (2), and a liquid-permeable, second enclosure (3) comprising two enclosing surfaces (13.1, 13.2). The wound care article is thus characterized in that the first enclosure (2) is covered or supported on at least one of its flat sides (4.1, 4.2) by at least one fluid-absorbing material layer (6.1, 6.2

6.3), which is arranged (FIG. 1a) between the first enclosure (2) and one of the enclosing surfaces (13.1, 13.2) of the second enclosure (3).

Priority: DE200610047041 Applic. Date: 2006-10-02; WO2007EP60304 Applic. Date: 2007-09-28

Inventor: RIESINGER BIRGIT [DE]


Application No.: US20100262097A1  Published: 14/Oct/2010

Title: Delivery Device

Applicant/Assignee: SCA HYGIENE PRODUCTS AB

Application No.: 12/513104   Filing Date: 30/Apr/2009

Abstract:A delivery device for a sanitary article includes an encapsulating material with a first layer and a second layer, enclosing an additive in a space formed by these layers of encapsulating material. The delivery device also includes a third layer, positioned above the second layer of encapsulating material. The third layer extends beyond and thereby covers substantially all of the edges of the second layer of encapsulating material. The third layer may also extend into and throughout the space formed between the first and second layers of encapsulating material that enclose the additive. The third layer thereby protects the user of a product comprising the delivery device from contact with the edges of the second layer of encapsulating material and also provides a means for attaching the delivery device to an article to keep it in place during transport storage and use. The invention also relates to sanitary articles, such as hygiene tissues and absorbent articles, containing the delivery device.

Priority: WO2006SE01243 Applic. Date: 2006-11-02

Inventor: HILDEBERG JENNY [SE]; OLSSON ANNA KLINTE [SE]; HUSMARK ULRIKA [SE]; DAHL DENNIS [SE]


Application No.: US20100262118A1  Published: 14/Oct/2010

Title: Methods for Identifying Areas of a Subject's Skin that Appear to Lack Volume

Applicant/Assignee:

Application No.: 12/600468   Filing Date: 08/Jun/2007

Abstract:The present embodiments relate to methods and systems for identifying areas of a subject's skin that lack sufficient volume. In some embodiments, this can be used to direct the administration of filler compositions or the application of techniques that increase the volume or firmness of the area. In some embodiments, the methods and systems provide for improved aesthetic benefit as well as suitability for instruction and training. In some embodiments, the methods are especially useful in the administration of dermal fillers to a subject.

Priority: US20070938424P Applic. Date: 2007-05-16; US20070938425P Applic. Date: 2007-05-16; WO2007US70811 Applic. Date: 2007-06-08

Inventor: BARBOUR JENNIFER [US]; FISHER MARTIN D [US]


Application No.: US20100262367A1  Published: 14/Oct/2010

Title: MISSING CHILD REPORTING, TRACKING AND RECOVERY METHOD AND SYSTEM

Applicant/Assignee:

Application No.: 12/751123   Filing Date: 31/Mar/2010

Abstract:A method and system for marshaling resources needed to search for a missing child, declaring a missing child incident, coordinating a search for the missing child, tracking the progress of the search, locating the missing child, and recovering the missing child.

Priority: US20090211487P Applic. Date: 2009-03-31

Inventor: RIGGINS SCOTT A [US]; SHARP DAVID P [US]


Application No.: US20100263102A1  Published: 21/Oct/2010

Title: GARMENT PROTECTOR

Applicant/Assignee:

Application No.: 12/426146   Filing Date: 17/Apr/2009

Abstract:A garment protector is configured to absorb moisture and to thereby preserve a garment of a user. The garment protector can have a pad attached to the garment. The pad can absorb moisture and reduce or prevent moisture from staining the garment. The garment protector can have multiple layers to perform these functions. The garment protector can have one or more application channels. The application channel can span a seam and the associated cross-stitching of a garment so as not to add bulk at the seam that a pad would if over the seam.

Priority:

Inventor: TRESPALACIOS GABRIELLA [US]


Application No.: US20100263599A1  Published: 21/Oct/2010

Title: HIGH-THROUGHPUT, WHOLE-ANIMAL SCREENING SYSTEM

Applicant/Assignee:

Application No.: 12/670882   Filing Date: 11/Aug/2008

Abstract:Distinctive components that enable high-throughput, whole-animal screening are described. These components can be used individually or in various combinations. A staging chip strains off the excess fluid that the input animals are immersed in, increasing their density (number of animals in a given volume) and rapidly bringing them close to other fluidic components. A microfluidic sorter is adapted to isolate and immobilize a single, physiologically active animal in a selected geometry. A multiplexed micro-chamber chip receives single animals and the microchamber chip includes individually addressable screening chambers for imaging, incubation and exposure of individual animals to selected chemical compounds. An imaging structure generates sub-cellular, high-resolution images of the physiologically active animals. A well-plate interface chip is used to deliver elements from a compound library to a single output of the chip.

Priority: US20070954903P Applic. Date: 2007-08-09; WO2008US72768 Applic. Date: 2008-08-11

Inventor: YANIK MEHMET F [US]; ROHDE CHRISTOPHER [US]; ANGEL MATTHEW M [US]; GILLELAND CODY [US]


Application No.: US20100266512A1  Published: 21/Oct/2010

Title: CROSSLINKED HYALURONIC ACID IN EMULSION

Applicant/Assignee: EVONIK GOLDSCHMIDT GMBH

Application No.: 12/809809   Filing Date: 10/Dec/2008

Abstract:The present invention relates to methods of producing crosslinked hyaluronic acid microbeads, as well as the produced microbeads, said method comprising the steps of: (a) providing an aqueous alkaline solution comprising hyaluronic acid, or a salt thereof

(b) forming microdroplets having a desired size from the mixed solution of step (a) in an organic or oil phase to form a water in organic or water in oil (VWO) emulsion, wherein the amount of oil phase used is of from 20 to less than 50% by weight based on the sum of oil phase and water

(c) adding a solution comprising a crosslinking agent to the emulsion, whereby the reaction of hyaluronic acid with the crosslinking agent takes place to provide crosslinked hyaluronic acid microbeads

and (d) optionally working up the dispersion of crosslinked hyaluronic acid microbeads obtained in step (c).

Priority: EP20070150176 Applic. Date: 2007-12-19; US20070015261P Applic. Date: 2007-12-20; WO2008EP67172 Applic. Date: 2008-12-10

Inventor: WENK HANS HENNING [DE]; FARWICK MIKE [DE]; NATTLAND SANDRA [DE]; MACZKIEWITZ URSULA [DE]; MOELHOLM MALLE BIRGITTE [DK]


Application No.: US20100266516A1  Published: 21/Oct/2010

Title: PERSONAL CARE COMPOSITION

Applicant/Assignee: INNOSPEC LIMITED

Application No.: 12/742834   Filing Date: 17/Nov/2008

Abstract:An aqueous shear-thinning personal care composition comprises: (a) at least 3 wt % of a sulfonate compound of general formula (I): where R1 represents a C8-22 alkyl group alkyl group

R2 represents a C1-4 alkyl group

each of R3, R4 and R5 independently represents a hydrogen atom or a C1-4 alkyl group

and M+ represents a sodium or potassium cation

(b) at least 3 wt % of an amphoteric or zwitterionic surfactant

(c) at least 10 wt % of water

and (d) at least 0.5 wt % of an additional component in the form of particles or droplets suspended in the composition. The composition is stable in an aqueous environment and can be formulated with a wide range of additional components.

Priority: GB20070022550 Applic. Date: 2007-11-16; WO2008GB51071 Applic. Date: 2008-11-17

Inventor: COTRELL PHILIP [US]


Application No.: US20100266518A1  Published: 21/Oct/2010

Title: Process for the preparation of odourless polyether alcohols using DMC catalysts and their use in cosmetic and/or dermatological preparations

Applicant/Assignee: EVONIK GOLDSCHMIDT GMBH

Application No.: 12/759787   Filing Date: 14/Apr/2010

Abstract:Cosmetic and/or dermatological preparations prepared using polyether alcohols, characterized in that, for the preparation of the polyether alcohol, a) a DMC catalyst is used and b) the polyether alcohols obtained in this way are not further treated.

Priority: DE200910002371 Applic. Date: 2009-04-15

Inventor: SPRINGER OLIVER [DE]; THUM OLIVER [DE]; SCHUBERT FRANK [DE]


Application No.: US20100266523A1  Published: 21/Oct/2010

Title: COMPOSITIONS CONTAINING FLAVANOID POLYPHENOL DERIVATIVES, AND APPLICATIONS THEREOF IN CONTROLLING DISEASES AND AGEING OF LIVING ORGANISMS

Applicant/Assignee:

Application No.: 12/734678   Filing Date: 17/Nov/2008

Abstract:The invention relates to compositions of polyphenol derivatives, characterised in that said polyphenols contain monomers, oligomers or polymers of units of the formula (I), wherein said units are characterised by the simultaneous presence of a phloroglucinol-type core (core A) and of a catechol-type core (core B) bonded together by a segment of 3 carbons such as C, said derivatives being over-activated in terms of nucleophilic power by the alkylation of at least one phenol function of each constituent monomer unit, and stabilised by the esterification of all the others with mixtures of fatty acids in proportions representing those of vegetable oils mainly consisting of AGI. These compositions can particularly be used in cosmetics, nutrition and therapy.

Priority: FR20070008021 Applic. Date: 2007-11-15; WO2008IB54814 Applic. Date: 2008-11-17

Inventor: VERCAUTEREN JOSEPH [FR]


Application No.: US20100266549A1  Published: 21/Oct/2010

Title: NOVEL PROBIOTICS FOR PET FOOD APPLICATIONS

Applicant/Assignee: NESTEC S.A

Application No.: 12/823659   Filing Date: 25/Jun/2010

Abstract:The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions containing the same.

Priority: EP20000201867 Applic. Date: 2000-05-25; EP20010201503 Applic. Date: 2001-04-25; US2007-701916 Applic. Date: 2007-02-02; US2003-296070 Applic. Date: 2003-04-18; WO2001EP06039 Applic. Date: 2001-05-22

Inventor: ZINK RALF [CH]; RENIERO ROBERTO [FR]; ROCHAT FLORENCE [CH]; CAVADINI CHRISTOPH [CH]; DER WEID THIERRY [CH]; SCHIFFRIN EDUARDO [CH]; BENYACOUB JALIL [CH]; ROUSSEAU VIRGINIE [FR]; PEREZ PABLO [AR]


Application No.: US20100266647A1  Published: 21/Oct/2010

Title: Optical Blurring Pigment Composition Suitable for Use in Cosmetics

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/744061   Filing Date: 14/Nov/2008

Abstract:Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed. The compositions are capable of forming an effective film on the biological surface such as skin to blurring fine lines and wrinkles while retaining a natural look of the skin as a consequence of synergy between the fractal particles, the macroscopic particles, titanium dioxide and color pigments. Also disclosed methods for their use.

Priority: US20070016971P Applic. Date: 2007-12-27; WO2008US83508 Applic. Date: 2008-11-14

Inventor: DINGLEY AJAY G [US]; FAIR MICHAEL J [US]; GLYNN JR JOHN R [US]; SANDSTROM GIOVANA A [US]


Application No.: US20100266649A1  Published: 21/Oct/2010

Title: Gel Technology Suitable for Use in Cosmetic Compositions

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/747469   Filing Date: 19/Nov/2008

Abstract:A gel system comprising a fractal network of nanoparticles and macroscopic particles is disclosed. The gel system is capable of forming an "optical gel" effective to blurrfine lines and wrinkles as a consequence of the size domain differences between the fractal particles and the macroscopic particles. Cosmetic compositions comprising such gels and methods for their use are also disclosed.

Priority: US20070016967P Applic. Date: 2007-12-27; WO2008US84017 Applic. Date: 2008-11-19

Inventor: MAITRA PRITHWIRAJ [US]; BROWN STEVEN E [US]; GLYNN JR JOHN R [US]; ROTHOUSE JASON [US]; BRAHMS JOHN C [US]; FAIR MICHAEL J [US]


Application No.: US20100266650A1  Published: 21/Oct/2010

Title: METHOD OF COSMETIC CARE STIMULATING MITOCHONDRIAL ACONITASE

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/751710   Filing Date: 31/Mar/2010

Abstract:The invention relates to the use of a plant extract as a cosmetic agent. This extract is obtained from a plant belonging to the genus Citrus, or from hybrids derived from the crossing of plant species, at least one of which belongs to the genus Citrus, as a cosmetic active agent. The invention makes it possible to prevent or retard the appearance of the signs of ageing of the skin or to attenuate the effects thereof and/or to improve or restore the radiance of the skin complexion.

Priority: FR20090052072 Applic. Date: 2009-03-31

Inventor: NIZARD CARINE [FR]; MOREAU MARIELLE [FR]; ARCHAMBAULT JEAN-CHRISTOPHE [FR]


Application No.: US20100267302A1  Published: 21/Oct/2010

Title: SILICONE GEL ADHESIVE CONSTRUCTION

Applicant/Assignee: 3M INNOVATIVE PROPERTIES COMPANY

Application No.: 12/761118   Filing Date: 15/Apr/2010

Abstract:A silicone gel adhesive construction comprises (a) a porous backing, (b) an acrylic copolymer pressure sensitive adhesive layer on at least a portion of one side of the porous backing, and (c) a cured silicone gel adhesive on the pressure sensitive adhesive layer.

Priority: US20090170447P Applic. Date: 2009-04-17

Inventor: KANTNER STEVEN S [US]; LEWIS TERRY W [US]; BROWN MARY L [US]


Application No.: US20100267523A1  Published: 21/Oct/2010

Title: UNIVERSAL MULTIDIRECTIONAL EXERCISER FOR EXERCISING HAND, WRIST AND FOREARM IN MULTIPLE PLANES OF MOTION WITH ADJUSTABLE RESISTANCE

Applicant/Assignee:

Application No.: 12/425909   Filing Date: 17/Apr/2009

Abstract:The present invention provides a multidirectional exerciser for hand, wrist and forearm comprising a handle having an axial opening through which a bolt extends. A spring means is around one end of the bolt disposed against an adjustment ring. A resistance knob is mounted on the adjustment ring. A pressure plate is mounted at the opposite end of the handle between the handle and the head of the bolt. At least one clutch disc is disposed against the pressure plate. A knob is mounted around the pressure plate and clutch disc, mounted for relative rotational movement with respect to the handle. The wrists and hands are exercised by holding the handle in one hand and the knob/grip member in the other hand, and repetitively twisting the handle and knob/grip member in opposite directions. A detachable grip member is mounted over said knob and the detachable grip member further comprises a gyro ring and a squeeze grip strengthener.

Priority:

Inventor: WILKINSON WILLIAM T [US]; FERNANDEZ JUAN [US]


Application No.: US20100267603A1  Published: 21/Oct/2010

Title: Detergent Compositions for Cleaning and Fabric Care

Applicant/Assignee:

Application No.: 12/827249   Filing Date: 30/Jun/2010

Abstract:Detergent compositions comprising selected deposition polymers for improved deposition of fabric care benefit agents, such as organosilicones, polyolefin dispersions, polymer latexes, microencapsulated fabric care actives, onto fabrics through the laundering operation.

Priority: US2007-818473 Applic. Date: 2007-06-14; US20060815241P Applic. Date: 2006-06-20

Inventor: PANANDIKER RAJAN KESHAV [US]; SIVIK MARK ROBERT [US]; MCCHAIN ROBERT JOE [US]; BUESCHER SUSAN EILEEN [US]; ROTHGEB TIMOTHY MICHAEL [US]; SHEETS CONNIE LYNN [US]; KINDEL PAUL FRANCIS [US]


Application No.: US20100267633A1  Published: 21/Oct/2010

Title: N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators

Applicant/Assignee:

Application No.: 11/992446   Filing Date: 22/Sep/2006

Abstract:The invention relates to substituted N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamid derivatives which modulate androgen receptors to treat conditions such as: osteoporosis, peridontal disease, bone fracture, frailty, and sarcopenia.

Priority: US20050720587P Applic. Date: 2005-09-26; WO2006US37273 Applic. Date: 2006-09-22

Inventor: HANNEY BARBARA [US]; KIM YUNTAE [US]; MITCHELL HELEN J [US]; MUSSELMAN JEFFREY D [US]; PERKINS JAMES J [US]


Application No.: US20100267642A1  Published: 21/Oct/2010

Title: USE OF COMPLEX FORMS OF CALMODULIN-LIKE SKIN PROTEIN CLSP

Applicant/Assignee: L'OREAL

Application No.: 12/686672   Filing Date: 13/Jan/2010

Abstract:The present invention relates to the use of a complex form of calmodulin-like skin protein (CLSP), of polypeptides derived from this protein or of analogues thereof, as a marker for evaluating a state of an epithelium. The invention also relates to the use of these complex forms for the purposes of screening for biological or chemical compounds capable of modulating a biological activity of said complex forms and/or for preparing and/or improving a pluristratified cell model.

Priority: FR20090050162 Applic. Date: 2009-01-13; US20090202077P Applic. Date: 2009-01-27

Inventor: DONOVAN MARK [FR]; BERNARD DOMINIQUE [FR]


Application No.: US20100267662A1  Published: 21/Oct/2010

Title: AVENANTHRAMIDE-CONTAINING COMPOSITIONS

Applicant/Assignee: CEAPRO, INC

Application No.: 12/741695   Filing Date: 06/Nov/2008

Abstract:Methods and compositions for treating or preventing a skin condition, an inflammation, an irritation or an allergy associated with an ectoparasitic infection or infestation on an animal. The methods involve applying to the skin of the animal a pharmaceutical composition that contains a therapeutically effective amount of one or more than one avenanthramide, an optional ecto and/or endo-parasiticidal agent, and a pharmaceutically acceptable diluent or carrier

Priority: US20070986476P Applic. Date: 2007-11-08; WO2008CA02008 Applic. Date: 2008-11-06

Inventor: FIELDER DAVID A [CA]; REDMOND MARK J [CA]; COTTRELL IAN W [US]


Application No.: US20100267667A1  Published: 21/Oct/2010

Title: TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF

Applicant/Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

Application No.: 12/602956   Filing Date: 04/Jun/2008

Abstract:The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.

Priority: US20070924875P Applic. Date: 2007-06-04; US20080006924P Applic. Date: 2008-02-06; US20070929525P Applic. Date: 2007-07-02; US20070929524P Applic. Date: 2007-07-02; WO2008IL00756 Applic. Date: 2008-06-04

Inventor: GAZIT AVIV [IL]; SLAVIN SHIMON [IL]; PRIEL ESTHER [IL]; YITZCHAK SARA [IL]


Application No.: US20100267680A1  Published: 21/Oct/2010

Title: USE OF AT LEAST ONE OXIME DERIVATIVE OF CHOLEST-4-EN-3-ONE AS ANTIOXIDANTS

Applicant/Assignee:

Application No.: 12/670459   Filing Date: 24/Jul/2008

Abstract:The invention relates to the use of at least one oxime derivative of cholest-4-en-3-one as antioxidants in the cosmetics and food fields, and as antioxidant preservatives that can be used, in particular, in cosmetic, food and pharmaceutical products.

Priority: FR20070005426 Applic. Date: 2007-07-25; WO2008FR01101 Applic. Date: 2008-07-24

Inventor: PRUSS REBECCA [FR]; DROUOT CYRILLE [FR]


Application No.: US20100267792A1  Published: 21/Oct/2010

Title: Topical Compositions Containing Desthiobiotin and its Derivatives and a Method of Treating Skin

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/747364   Filing Date: 19/Nov/2008

Abstract:Topical compositions and methods of use to treat symptoms of reduced skin elasticity are provided comprising desthiobiotin and certain desthiobiotin analogues. These compounds are effective in stimulating LOXL-1 activity and can thus increase elastin remodeling and improve appearance of fine lines, wrinkles, skin sagging and other symptoms of reduced elastin function.

Priority: US20070015703P Applic. Date: 2007-12-21; WO2008US84005 Applic. Date: 2008-11-19

Inventor: PTCHELINTSEV DMITRI S [US]; LUO XIAOCHUN [US]; CHEN SIMING W [US]


Application No.: US20100267837A1  Published: 21/Oct/2010

Title: USE OF AT LEAST ONE OXIME DERIVATIVE OF 3,5-SECO-4-NOR-CHOLESTANE AS ANTIOXIDANTS

Applicant/Assignee: TROPHOS

Application No.: 12/670482   Filing Date: 24/Jul/2008

Abstract:The invention relates to the use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants in the cosmetics and food fields, and as antioxidant preservatives that can be used, in particular, in cosmetic, food and pharmaceutical products.

Priority: FR20070005428 Applic. Date: 2007-07-25; WO2008FR01102 Applic. Date: 2008-07-24

Inventor: PRUSS REBECCA [FR]; DROUOT CYRILLE [FR]


Application No.: US20100267839A1  Published: 21/Oct/2010

Title: Diarylalkanes as potent inhibitors of binuclear enzymes

Applicant/Assignee: UNIGEN PHARMACEUTICALS, INC

Application No.: 12/814190   Filing Date: 11/Jun/2010

Abstract:The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds-diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.

Priority: US2008-027090 Applic. Date: 2008-02-06; US2005-139200 Applic. Date: 2005-05-27; US20040575599P Applic. Date: 2004-05-28

Inventor: JIA QI [US]; ZHAO JI-FU [US]


Application No.: US20100267842A1  Published: 21/Oct/2010

Title: Emulsions of Perfluorocarbons

Applicant/Assignee:

Application No.: 12/761379   Filing Date: 15/Apr/2010

Abstract:The subject application provides for an emulsion comprising an amount of a perfluorocarbon liquid dispersed as particles within, a continuous liquid phase, wherein the dispersed particles have a monomodal particle size distribution and uses thereof. The subject application also provides for a method of manufacturing a perfluorocarbon emulsion, a process for preparing a pharmaceutical product containing a PFC emulsion and a process for validating a batch of an emulsion for pharmaceutical use.

Priority: US20090281191P Applic. Date: 2009-11-13; US20090279359P Applic. Date: 2009-10-19; US20090214992P Applic. Date: 2009-04-29; US20090212689P Applic. Date: 2009-04-15

Inventor: KIRAL RICHARD [US]; THOMPSON DEBORAH P [US]; CLAUSON GARY L [US]


Application No.: US20100268012A1  Published: 21/Oct/2010

Title: Radioprotective materials, methods of transport and utilization thereof, nanoscale-microscale supramagnetic and supraconducting particles, spherical flow dynamics and sonoluminesence

Applicant/Assignee:

Application No.: 11/655342   Filing Date: 19/Jan/2007

Abstract:A spherical sonoluminesence chamber is treated with a positively charged transducer at one end and a negatively charged transducer at the other end, and a charge is applied to a medium of helium or other gas or liquid, with the anions, cat ions, or oxides of our selected particles dispersed therein. With the application of sufficient energy, a supraconducting entity is thus achieved via cooper-pair bonding, with techniques for enhancing the entity's paraconducting and supraconducting properties. Applications for using these novel entities in a variety of arenas are disclosed.

Priority:

Inventor: PLUMMER PATRICK ALLEN [US]; ZAKALA MARINA LISA [US]; PLUMMER MACK CARTER [US]


Application No.: US20100269858A1  Published: 28/Oct/2010

Title: COMPOSITIONS AND KITS FOR THE REMOVAL OF IRRITATING COMPOUNDS FROM BODILY SURFACES

Applicant/Assignee: NEUROGESX, INC

Application No.: 12/830997   Filing Date: 06/Jul/2010

Abstract:The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.

Priority: US2003-655911 Applic. Date: 2003-09-05; US20020408751P Applic. Date: 2002-09-05; US20020410616P Applic. Date: 2002-09-13

Inventor: ANGEL ARTURO J [US]; LITLE LARRY W [US]; BLEY KEITH R [US]; WILCOX ALLAN L [US]; JAMIESON GENE CURTIS [US]; MUHAMMAD NAWEED [US]


Application No.: US20100271470A1  Published: 28/Oct/2010

Title: METHOD AND APARRATUS FOR CHARACTERIZING A PERSON'S SKIN IMPERFECTIONS

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/762853   Filing Date: 19/Apr/2010

Abstract:A method of characterizing a person's skin imperfections uses a digital color image-taking device to take at least one digital image of an area of skin including at least one imperfection to be characterized. An apparatus for characterizing the imperfections of the skin and a method for measuring the effectiveness of a treatment for skin imperfections use an active cosmetic, dermatological or pharmaceutical agent and further measure the effectiveness of a staining method aiming to attenuate or mask skin imperfections.

Priority: FR20090052660 Applic. Date: 2009-04-23

Inventor: STEPHAN SANDRINE [FR]; PELLE DE QUERAL DELPHINE [FR]


Application No.: US20100272333A1  Published: 28/Oct/2010

Title: METHOD AND APPARATUS FOR CHARACTERIZING PIGMENT SPOTS

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/763656   Filing Date: 20/Apr/2010

Abstract:A method involving filters of an extracted plane from a digital image of an area of skin to obtain a first ripple image and a second roughness image, from which appropriate computation devices are used to calculate different types of gray levels to characterize a pigment spot, notably with regard to the uniformity or disparity of the spot. A method measures the effectiveness of a cutaneous pigment spot treatment by an active pigmenting or depigmenting agent.

Priority: FR20090052662 Applic. Date: 2009-04-23

Inventor: STEPHAN SANDRINE [FR]; PELLE DE QUERAL DELPHINE [FR]


Application No.: US20100272602A1  Published: 28/Oct/2010

Title: Antiseptic wipes

Applicant/Assignee:

Application No.: 12/803495   Filing Date: 30/Jun/2010

Abstract:A personal skin cleansing wipe comprising a flexible substantially dry matrix formed from synthetic, woven, non-woven or knitted fibers impregnated with a substantially anhydrous antimicrobial, antiseptic, antifungal solution in an amount wherein the matrix retains its substantially dry characteristics and the treatment solution includes an amount of PVP-iodine as active in solution in glycol and or glycerin. The treatment solution, in addition to an effective amount of PVP-iodine as active, contains surfactants, preferably Tego TM Betaine CK D, and optionally a compatible fragrance and/or moisturizer. The wipe is activated with water just prior to use.

Priority: US2009-589820 Applic. Date: 2009-10-30; US2005-118197 Applic. Date: 2005-05-02

Inventor: KELLY ALBERT R [US]; SAFERSTEIN LOWELL [US]


Application No.: US20100272655A1  Published: 28/Oct/2010

Title: Menthylcarboxamides and Their Use as Cooling Agents

Applicant/Assignee:

Application No.: 12/430585   Filing Date: 27/Apr/2009

Abstract:Described is a new cooling agent represented by Structure I and compositions with known coolers having cooling properties and the application of Structure I in foodstuffs and chewing gum:

Priority:

Inventor: BARDSLEY KATHRYN ANNE [US]; DEWIS MARK L [US]; GRAINGER BRIAN TREVOR [US]; JANCZUK ADAM JAN [US]; KAZIMIERSKI ARKADIUSZ [US]; KRAUT KENNETH J [US]; SONDRUP JOHN L [US]; YANG YING [US]


Application No.: US20100272660A1  Published: 28/Oct/2010

Title: COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT

Applicant/Assignee:

Application No.: 12/681473   Filing Date: 02/Oct/2008

Abstract:The present application relates to a cosmetic or pharmaceutical composition comprising a polycondensate capable of being obtained by the reaction of the following monomers alone: of 10 to 30% by weight, relative to the total weight of the polycondensate, of one or more polyols comprising 3 to 6 hydroxyl groups

of 30 to 80% by weight, relative to the total weight of the polycondensate, of one or more linear, branched and/or cyclic, saturated or unsaturated, non-aromatic monocarboxylic acids comprising 6 to 32 carbon atoms

of 1 to 40% by weight, relative to the total weight of the polycondensate, of one or more polycarboxylic acids and/or cyclic anhydrides of such a polycarboxylic acid and/or lactones comprising at least one COOH group

and optionally of 0.1 to 15% by weight, relative to the total weight of the polycondensate, of one or more silicones having a hydroxyl and/or carboxyl functional group. The application also relates to a method of cosmetic treatment using the said composition, and the polycondensate thus defined.

Priority: FR20070058057 Applic. Date: 2007-10-04; US20070984739P Applic. Date: 2007-11-02; WO2008FR51782 Applic. Date: 2008-10-02

Inventor: MALLE GERARD [FR]


Application No.: US20100272662A1  Published: 28/Oct/2010

Title: COSMETIC COMPOSITION CONTAINING AN ADENIUM OBESUM EXTRACT, USE THEREOF AND METHOD FOR COSMETIC CARE INCLUDING THE USE THEREOF

Applicant/Assignee: LVMH RECHERCHE

Application No.: 12/599591   Filing Date: 07/May/2008

Abstract:The invention relates to a cosmetic composition. This cosmetic composition comprises an extract of Adenium obesum, and at least one cosmetically acceptable excipient. This composition can be used to strengthen the cutaneous barrier, to reinforce the cohesion of the dermal-epidermal junction, to prevent or delay the effects of skin aging, or else to provide a protective, corrective, restructuring, hydrating or moisturizing effect.

Priority: FR20070055042 Applic. Date: 2007-05-11; WO2008FR50811 Applic. Date: 2008-05-07

Inventor: BONTE FREDERIC [FR]; DUMAS MARCH [FR]; ARCHAMBAULT JEAN-CHRISTOPHE [FR]


Application No.: US20100272690A1  Published: 28/Oct/2010

Title: Antimicrobial Compositions and R